id,adj.P.Val.xBirA.Cre.over.NoBirA,AveExpr.xBirA.Cre.over.NoBirA,Log.P.Value.xBirA.Cre.over.NoBirA,logFC.xBirA.Cre.over.NoBirA,P.Value.xBirA.Cre.over.NoBirA,t.xBirA.Cre.over.NoBirA,Amanda_newDatabase..126.126.127.128.129.130.131..NoBirA_6.multimedian,Amanda_newDatabase..128.126.127.128.129.130.131..NoBirA_4.multimedian,Amanda_newDatabase..129.126.127.128.129.130.131..NoBirA_5.multimedian,Amanda_newDatabase..127.126.127.128.129.130.131..BirA.Cre_3.multimedian,Amanda_newDatabase..130.126.127.128.129.130.131..BirA.Cre_2.multimedian,Amanda_newDatabase..131.126.127.128.129.130.131..BirA.Cre_1.multimedian,id.query,id.mapped,id.concat,accession_number,geneSymbol,numColumnsProteinObserved,numSpectraProteinObserved,numPepsUnique,numPepsUniqueSubgroupSpecificCI,accession_numbers,species,protein_mw,percentCoverage,groupNum,subgroupNum,scoreUnique,scoreUniqueSubgroupSpecificCI,orfCategory,sequenceLength,entry_name,cellular_component,biological_process,molecular_function,Amanda_newDatabase.unique_peptides,Amanda_newDatabase.numSpectra,Amanda_newDatabase.totalIntensity,Amanda_newDatabase.pct_cov
E9Q414,0.000145021,-0.986333333,48.81476681,4.245333333,1.31378E-05,10.74186101,-3.684,-2.732,-2.911,1.391,0.903,1.115,E9Q414,Apob,E9Q414_Apob,E9Q414,Apob,1,1087,250,250,E9Q414,MOUSE,510791.9,51.4,1,1.1,3841.73,3841.73,,4505,Apolipoprotein B-100,extracellular region|cytoplasm|endoplasmic reticulum|Golgi apparatus|plasma membrane|vesicle membrane|actin cytoskeleton|vesicle lumen|mature chylomicron|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|chylomicron|neuronal cell body|extracellular exosome|,in utero embryonic development|lipid metabolic process|triglyceride mobilization|spermatogenesis|nervous system development|cholesterol metabolic process|fertilization|response to virus|response to carbohydrate|post-embryonic development|response to selenium ion|positive regulation of gene expression|positive regulation of macrophage derived foam cell differentiation|positive regulation of lipid storage|positive regulation of cholesterol storage|lipid catabolic process|triglyceride catabolic process|cholesterol transport|sperm motility|response to lipopolysaccharide|cholesterol efflux|low-density lipoprotein particle remodeling|low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|cholesterol homeostasis|lipoprotein transport|regulation of cholesterol biosynthetic process|artery morphogenesis|cellular response to tumor necrosis factor|cellular response to prostaglandin stimulus|,phospholipid binding|heparin binding|cholesterol transporter activity|lipase binding|low-density lipoprotein particle receptor binding|,250,1087,1.13E+12,51.4%
P01027,0.000145021,-1.053333333,48.31288103,4.568,1.47473E-05,10.55680271,-3.977,-2.713,-3.322,1.371,0.906,1.415,P01027,C3,P01027_C3,P01027,C3,1,1123,179,156,P01027|P01027-2|Q2UVX4|G3X7A5,MOUSE,188021,88.2,2,2.1,2935.15,2624.27,,1663,Complement C3,extracellular space|extracellular exosome|blood microparticle|,"positive regulation of type IIa hypersensitivity|positive regulation of protein phosphorylation|positive regulation of activation of membrane attack complex|tolerance induction|fatty acid metabolic process|inflammatory response|complement activation|complement activation, alternative pathway|complement activation, classical pathway|blood coagulation|positive regulation of vascular endothelial growth factor production|positive regulation of glucose transport|regulation of triglyceride biosynthetic process|positive regulation of lipid storage|negative regulation of endopeptidase activity|response to magnesium ion|response to estradiol|response to progesterone|positive regulation of G-protein coupled receptor protein signaling pathway|positive regulation of angiogenesis|positive regulation of developmental growth|positive regulation of phagocytosis|response to glucocorticoid|positive regulation of ERK1 and ERK2 cascade|positive regulation of apoptotic cell clearance|",endopeptidase inhibitor activity|protein binding|lipid binding|C5L2 anaphylatoxin chemotactic receptor binding|cofactor binding|,180,1123,3.95E+12,88.2%
A0A0F6QNP7,0.000418133,-0.111,36.12228203,4.905333333,0.000244215,9.252762306,,-3.79,,1.162,0.947,1.237,A0A0F6QNP7,NotFound,A0A0F6QNP7_NotFound,A0A0F6QNP7,C3,1,1,25,1,A0A0F6QNP7,BOVIN,188719.1,9.4,2,2.2,329.19,6.23,,1661,Complement component 3,,,,1,1,11900000,0.6%
Q61838,0.000148189,-1.072333333,46.63743045,4.306666667,2.16899E-05,9.95944441,-3.995,-2.674,-3.008,1.155,1.088,1,Q61838,NotFound,Q61838_NotFound,Q61838,Pzp,1,2114,146,141,Q61838,MOUSE,167218.8,73.9,3,3.1,2637.49,2559.86,,1495,Pregnancy zone protein,extracellular region|extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|protein complex binding|,146,2114,9.17E+13,73.9%
F1MI18,0.036361166,-0.158666667,14.86745253,2.680666667,0.032602789,2.674394746,-2.05,0.047,-2.494,3.117,0.107,0.321,F1MI18,NotFound,F1MI18_NotFound,F1MI18,,1,5,9,4,F1MI18|F1MJK3,BOVIN,167182.2,6.9,3,3.2,102.8,25.17,,1478,Uncharacterized protein,,,,4,5,120000000,3.9%
A0A087WSN6,0.003340119,-0.201,25.78179901,3.56,0.002641314,4.60705891,-0.645,-2.1,-3.198,1.913,2.337,0.487,A0A087WSN6,Fn1,A0A087WSN6_Fn1,A0A087WSN6,Fn1,1,488,113,113,A0A087WSN6|B9EHT6|A0A087WR50|Q3UHL6|P11276|B7ZNJ1|A0A087WS56|Q4KL80,MOUSE,256658.4,59.1,4,4.1,1819.32,1819.32,,2296,Fibronectin,fibrinogen complex|proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|apical plasma membrane|extracellular matrix|extracellular exosome|blood microparticle|extracellular matrix|,"regulation of protein phosphorylation|cell-substrate junction assembly|cell adhesion|cell-matrix adhesion|calcium-independent cell-matrix adhesion|positive regulation of cell proliferation|positive regulation of gene expression|positive regulation of peptidase activity|peptide cross-linking|integrin activation|substrate adhesion-dependent cell spreading|endodermal cell differentiation|wound healing|positive regulation of axon extension|positive regulation of fibroblast proliferation|regulation of ERK1 and ERK2 cascade|positive regulation of substrate-dependent cell migration, cell attachment to substrate|negative regulation of transforming growth factor-beta secretion|",protease binding|integrin binding|protein binding|peptidase activator activity|,113,488,3.79E+11,59.1%
P06684,0.000145021,-1.119,47.74229807,4.479333333,1.68178E-05,10.34988412,-3.839,-2.648,-3.589,1.457,0.969,0.936,P06684,Hc,P06684_Hc,P06684,C5,1,530,117,117,P06684|A0A0J9YUU3,MOUSE,190586.2,56.2,5,5.1,1757.91,1757.91,,1680,Complement C5,membrane attack complex|extracellular space|extracellular exosome|,"in utero embryonic development|inflammatory response|complement activation, alternative pathway|complement activation, classical pathway|positive regulation of vascular endothelial growth factor production|negative regulation of macrophage chemotaxis|negative regulation of endopeptidase activity|cytolysis|positive regulation of angiogenesis|positive regulation of chemokine secretion|activation of mitophagy in response to mitochondrial depolarization|",endopeptidase inhibitor activity|,117,530,7.19E+11,56.2%
P28665,0.000171011,-0.952,42.98779798,4.191333333,5.02597E-05,8.759879687,-3.929,-2.485,-2.729,1.508,0.923,1,P28665,Mug1,P28665_Mug1,P28665,Mug1,1,702,103,50,P28665,MOUSE,166721,61.1,6,6.1,1699.07,904.45,,1476,Murinoglobulin-1,extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,103,702,1.54E+12,61.1%
P28666,0.000157801,-0.5742,44.83668335,4.223833333,3.28346E-05,11.01204367,-3.133,-3.084,,1.026,1.024,1.296,P28666,Mug2,P28666_Mug2,P28666,Mug2,1,16,54,9,P28666,MOUSE,163805.4,34.1,6,6.2,783.79,109.44,,1451,Murinoglobulin-2,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,9,16,364000000,7.0%
A0A0N4SVU1,0.00014804,-0.9685,47.07838459,4.275666667,1.95957E-05,10.11367422,-3.649,-2.53,-3.14,1.565,1.027,0.916,A0A0N4SVU1,NotFound,A0A0N4SVU1_NotFound,A0A0N4SVU1,Gm7298,1,3,36,1,A0A0N4SVU1,MOUSE,166767.7,23.6,6,6.3,505.96,8.37,,1476,Predicted gene 7298,,,,1,3,79800000,1.2%
Q921I1,0.000165808,-1.0075,43.3292732,4.449666667,4.64593E-05,8.866548218,-4.199,-2.522,-2.976,1.43,1.292,0.93,Q921I1,Trf,Q921I1_Trf,Q921I1,Tf,1,890,84,81,Q921I1|E9Q035|E9Q939|Q29443,MOUSE,78890.5,80.3,7,7.1,1538.39,1487.32,,697,Serotransferrin,extracellular space|endosome|early endosome|late endosome|coated pit|basal plasma membrane|cell surface|membrane|cytoplasmic membrane-bounded vesicle|apical plasma membrane|vesicle coat|endocytic vesicle|vesicle|basal part of cell|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|blood microparticle|dense body|,"iron ion transport|cellular iron ion homeostasis|actin filament organization|activation of JUN kinase activity|ferric iron transport|osteoclast differentiation|positive regulation of phosphorylation|positive regulation of bone resorption|positive regulation of transcription, DNA-templated|SMAD protein signal transduction|ERK1 and ERK2 cascade|positive regulation of cell motility|",protein binding|ferric iron binding|ferric iron transmembrane transporter activity|,84,890,1.4E+13,80.3%
Q2HJF0,0.000399994,-0.112,36.38020416,3.8475,0.000230133,7.808228279,-2.177,-2.664,,1.976,1.444,0.861,Q2HJF0,NotFound,Q2HJF0_NotFound,Q2HJF0,LOC525947,1,10,8,5,Q2HJF0,BOVIN,70893.5,4.8,7,7.2,83.43,32.36,,622,Serotransferrin-like,,,,5,10,5510000000,1.4%
P01029,0.000145021,-0.898333333,48.40984452,4.158,1.44217E-05,10.59233128,-3.546,-2.656,-2.73,1.375,0.903,1.264,P01029,C4b,P01029_C4b,P01029,C4b,1,519,105,105,P01029|E1BH06|P01030|F1MVK1,MOUSE,194566.4,57.5,8,8.1,1513.92,1513.92,,1738,Complement C4-B,extracellular space|,"inflammatory response|complement activation, classical pathway|negative regulation of endopeptidase activity|innate immune response|",endopeptidase inhibitor activity|,105,519,6.89E+11,57.5%
E9Q8I0,0.000145021,-1.0025,47.47383089,4.323666667,1.78903E-05,10.25378358,-3.828,-2.894,-2.771,1.029,0.937,1.512,E9Q8I0,Cfh,E9Q8I0_Cfh,E9Q8I0,Cfh,1,456,89,72,E9Q8I0|P06909|D6RGQ0|E9Q8H9|A0A0A6YVP8,MOUSE,145947.1,72.1,9,9.1,1469.82,1205.88,,1252,Complement factor H,extracellular exosome|blood microparticle|,regulation of complement activation|,complement component C3b binding|heparin binding|heparan sulfate proteoglycan binding|,89,456,1.34E+12,72.1%
E9Q8B5,0.000202271,-1.023,41.50076658,4.594,7.07821E-05,8.307963178,-3.135,-2.44,-4.385,1.423,0.861,1.538,E9Q8B5,Gm4788,E9Q8B5_Gm4788,E9Q8B5,Gm4788,1,11,49,4,E9Q8B5|E9Q8B6,MOUSE,102688.5,63.2,9,9.2,786.52,70.24,,879,Predicted gene 4788,,,,4,11,7540000000,6.8%
E9PUM5,0.000960721,0.19525,31.72382172,4.236333333,0.000672385,7.466040502,,-2.982,,1.336,0.906,1.521,E9PUM5,NotFound,E9PUM5_NotFound,E9PUM5,Gm4788,1,1,46,1,E9PUM5,MOUSE,94467.4,63.9,9,9.3,733.15,16.87,,808,Predicted gene 4788,,,,1,1,6480000,2.5%
Q4LDF6,0.000261034,-0.6262,39.31949188,4.2355,0.000116964,8.813389443,-3.676,-2.659,,1.371,0.905,0.928,Q4LDF6,Cfhr2,Q4LDF6_Cfhr2,Q4LDF6,Cfhr2,1,8,16,4,Q4LDF6|Q61405,MOUSE,39129.7,57.8,9,9.4,290.43,68.45,,332,Complement factor H-related 2,,,,4,8,561000000,14.1%
P20918,0.000296673,-0.908333333,38.29783143,4.605333333,0.000147985,7.400047494,-3.941,-2.043,-3.649,2.189,1.113,0.881,P20918,Plg,P20918_Plg,P20918,Plg,1,623,85,85,P20918,MOUSE,93544.9,83,10,10.1,1418.1,1418.1,,812,Plasminogen,extracellular region|extracellular space|cell surface|extrinsic component of plasma membrane|extrinsic component of external side of plasma membrane|plasma lipoprotein particle|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,blood coagulation|negative regulation of cell-substrate adhesion|negative regulation of angiogenesis|extracellular matrix disassembly|tissue regeneration|fibrinolysis|myoblast differentiation|muscle cell cellular homeostasis|tissue remodeling|proteolysis involved in cellular protein catabolic process|negative regulation of fibrinolysis|positive regulation of fibrinolysis|trophoblast giant cell differentiation|labyrinthine layer blood vessel development|mononuclear cell migration|,fibronectin binding|serine-type endopeptidase activity|receptor binding|protein domain specific binding|apolipoprotein binding|,85,623,4.03E+12,83.0%
E9PZD8,0.000229743,-0.8665,40.4195965,4.106333333,9.07905E-05,7.991806641,-3.962,-2.477,-2.32,1.39,1.261,0.909,E9PZD8,Cp,E9PZD8_Cp,E9PZD8,Cp,1,543,75,1,E9PZD8|Q61147,MOUSE,125007.5,59,11,11.1,1370.51,17.49,,1086,Ceruloplasmin,extracellular space|lysosomal membrane|extracellular exosome|blood microparticle|,copper ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|chaperone binding|,75,543,1.76E+12,59.0%
G3X8Q5,0.001465852,0.2905,29.65570809,3.791333333,0.001082503,6.735154219,,-2.553,,1.405,1.418,0.892,G3X8Q5,Cp,G3X8Q5_Cp,G3X8Q5,Cp,1,3,75,1,G3X8Q5|G3X9T8,MOUSE,124936.5,58.9,11,11.2,1364.63,11.61,,1085,Ceruloplasmin,extracellular space|lysosomal membrane|extracellular exosome|blood microparticle|,copper ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|chaperone binding|,1,3,58600000,1.0%
B8JJN0,0.000148189,-0.943,46.07089194,4.209333333,2.47122E-05,9.764339351,-3.691,-2.62,-2.832,1.609,0.929,0.947,B8JJN0,NotFound,B8JJN0_NotFound,B8JJN0,Gm20547,1,372,86,61,B8JJN0|B8JJM5|P04186|B8JJM6|F6XQ00,MOUSE,144605,52.4,12,12.1,1337.16,955.56,,1276,Predicted gene 20547,,proteolysis|,serine-type endopeptidase activity|,86,372,6.11E+11,52.4%
P21180,0.000145021,-0.801333333,48.72950336,3.929333333,1.33983E-05,10.7102184,-2.944,-2.503,-2.851,1.601,0.877,1.012,P21180,C2,P21180_C2,P21180,C2,1,29,35,10,P21180|P21180-2|B8JJN2|B8JJM9,MOUSE,85995.1,45.9,12,12.2,512.78,131.18,,760,Complement C2,extracellular exosome|,"proteolysis|complement activation|complement activation, classical pathway|response to nutrient|innate immune response|positive regulation of apoptotic cell clearance|",serine-type endopeptidase activity|metal ion binding|,10,29,18200000000,15.2%
P07724,0.000145021,-1.076333333,48.05653825,4.315333333,1.56439E-05,10.46338872,-3.924,-2.753,-3.025,1.201,1.073,0.97,P07724,Alb,P07724_Alb,P07724,Alb,1,608,70,67,P07724,MOUSE,70745.2,91.4,13,13.1,1190.54,1140.76,,608,Serum albumin,extracellular region|extracellular space|nucleus|cytoplasm|myelin sheath|protein complex|extracellular exosome|blood microparticle|,retina homeostasis|transport|cellular response to starvation|hemolysis by symbiont of host erythrocytes|negative regulation of apoptotic process|maintenance of mitochondrion location|,DNA binding|fatty acid binding|drug binding|toxic substance binding|pyridoxal phosphate binding|metal ion binding|chaperone binding|oxygen binding|,70,608,5.85E+12,91.4%
P02769,0.402906497,-0.458666667,4.046416181,1.236666667,0.393874969,0.909991163,-2.578,2.367,-3.02,0.326,0.044,0.109,P02769,NotFound,P02769_NotFound,P02769,ALB,1,21,10,7,P02769,BOVIN,71289,15.6,13,13.2,130.24,80.46,,607,Serum albumin,,,,7,21,4600000000,10.2%
O88783,0.000145021,-0.927,48.40979435,4.262,1.44218E-05,10.59231287,-3.475,-2.519,-3.18,1.539,1.185,0.888,O88783,F5,O88783_F5,O88783,F5,1,215,74,74,O88783,MOUSE,248366.9,34.5,14,14.1,1085.6,1085.6,,2183,Coagulation factor V,extracellular space|membrane|platelet alpha granule|extracellular vesicle|,blood coagulation|blood circulation|platelet activation|,copper ion binding|,74,215,52800000000,34.5%
E9PVD2,0.000145021,-0.915833333,49.06956273,4.143666667,1.23892E-05,10.83692123,-3.233,-2.564,-3.166,1.567,0.921,0.98,E9PVD2,Itih4,E9PVD2_Itih4,E9PVD2,Itih4,1,284,60,1,E9PVD2|A0A0R4J1N1|E9Q5L2,MOUSE,104757.7,63.4,15,15.1,914.88,24.1,,941,"Inter alpha-trypsin inhibitor, heavy chain 4",cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|calcium ion binding|hyaluronic acid binding|,60,284,5.08E+11,63.4%
A6X935,0.000272426,-0.2754,38.92835848,3.721833333,0.000127986,8.673502847,-2.631,-2.386,,1.61,1.175,0.855,A6X935,Itih4,A6X935_Itih4,A6X935,Itih4,1,7,60,1,A6X935|A6X935-2,MOUSE,104828.7,63.4,15,15.2,914.19,23.41,,942,"Inter alpha-trypsin inhibitor, heavy chain 4",cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,acute-phase response|negative regulation of endopeptidase activity|hyaluronan metabolic process|response to cytokine|,serine-type endopeptidase inhibitor activity|protein binding|calcium ion binding|hyaluronic acid binding|,1,7,2690000000,2.3%
Q9DBD0,0.000145021,-0.916,47.85912861,4.247333333,1.63714E-05,10.39195475,-3.602,-2.574,-2.943,1.54,1.179,0.904,Q9DBD0,1300017J02Rik,Q9DBD0_1300017J02Rik,Q9DBD0,Ica,1,302,57,57,Q9DBD0|D3YY36,MOUSE,78761.2,66.8,16,16.1,914.29,914.29,,700,Inhibitor of carbonic anhydrase,extracellular space|,negative regulation of catalytic activity|,enzyme inhibitor activity|iron ion binding|,57,302,7.23E+11,66.8%
P06728,0.000145021,-1.212,48.95253766,4.676666667,1.27276E-05,10.79316753,-3.912,-2.772,-3.967,1.179,1.257,0.943,P06728,Apoa4,P06728_Apoa4,P06728,Apoa4,1,535,51,51,P06728,MOUSE,45028.2,85.8,17,17.1,858.62,858.62,,395,Apolipoprotein A-IV,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|cell surface|,innate immune response in mucosa|cholesterol biosynthetic process|lipid transport|response to lipid hydroperoxide|leukocyte cell-cell adhesion|cholesterol metabolic process|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|removal of superoxide radicals|triglyceride catabolic process|regulation of intestinal cholesterol absorption|neuron projection regeneration|regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|negative regulation of plasma lipoprotein particle oxidation|response to stilbenoid|lipoprotein metabolic process|cholesterol homeostasis|hydrogen peroxide catabolic process|reverse cholesterol transport|multicellular organismal lipid catabolic process|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipoprotein lipase activity|lipid homeostasis|protein-lipid complex assembly|triglyceride homeostasis|,copper ion binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|phosphatidylcholine binding|protein homodimerization activity|phosphatidylcholine-sterol O-acyltransferase activator activity|,51,535,9.38E+12,85.8%
P21614,0.0001846,-0.973,42.37083161,4.318,5.79318E-05,8.569922518,-4.091,-2.463,-2.842,1.529,1.14,0.889,P21614,Gc,P21614_Gc,P21614,Gc,1,228,47,47,P21614,MOUSE,55196.9,89.2,18,18.1,841.06,841.06,,476,Vitamin D-binding protein,extracellular space|cytosol|axon|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|,female pregnancy|lactation|response to nutrient levels|response to estradiol|vitamin D metabolic process|vitamin transport|,actin binding|vitamin transporter activity|calcidiol binding|,47,228,3.81E+11,89.2%
Q5SWU9,0.014436601,0.123,19.04517348,2.205333333,0.012458985,3.33560583,-1.686,-0.518,-0.735,2.566,0.31,0.801,Q5SWU9,Acaca,Q5SWU9_Acaca,Q5SWU9,Acaca,1,110,65,55,Q5SWU9|Q5SWU9-2,MOUSE,266849.4,30.1,19,19.1,823.39,688.64,,2345,Acetyl-CoA carboxylase 1,nucleolus|cytoplasm|mitochondrion|cytosol|actin cytoskeleton|extracellular exosome|,tissue homeostasis|acetyl-CoA metabolic process|lipid metabolic process|fatty acid biosynthetic process|multicellular organismal protein metabolic process|protein homotetramerization|lipid homeostasis|cellular response to prostaglandin E stimulus|malonyl-CoA biosynthetic process|,acetyl-CoA carboxylase activity|biotin carboxylase activity|protein binding|ATP binding|metal ion binding|,65,110,6810000000,30.1%
E9Q4Z2,0.007304678,0.380166667,22.16337996,2.326333333,0.006076619,3.874052937,-1.051,-0.225,-1.073,2.716,0.602,1.312,E9Q4Z2,Acacb,E9Q4Z2_Acacb,E9Q4Z2,Acacb,1,7,17,7,E9Q4Z2,MOUSE,278141.4,7.9,19,19.2,196.21,61.46,,2448,Acetyl-CoA carboxylase 2,nucleus|mitochondrion|endomembrane system|membrane|,acetyl-CoA metabolic process|fatty acid biosynthetic process|positive regulation of lipid storage|negative regulation of fatty acid oxidation|protein homotetramerization|positive regulation of heart growth|malonyl-CoA biosynthetic process|,acetyl-CoA carboxylase activity|biotin carboxylase activity|ATP binding|metal ion binding|,7,7,114000000,3.3%
Q8K0E8,0.078395761,-0.116333333,11.42366606,2.645333333,0.072049902,2.12701557,0.909,-2.82,-2.406,0.733,3.2,-0.314,Q8K0E8,Fgb,Q8K0E8_Fgb,Q8K0E8,Fgb,1,200,51,51,Q8K0E8|F1MAV0|P02676,MOUSE,55436.4,79.2,20,20.1,823.22,823.22,,481,Fibrinogen beta chain,fibrinogen complex|extracellular space|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|extracellular vesicle|,"cell-matrix adhesion|signal transduction|plasminogen activation|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|induction of bacterial agglutination|cellular protein complex assembly|cellular response to leptin stimulus|innate immune response|positive regulation of vasoconstriction|positive regulation of exocytosis|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to interleukin-1|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of endothelial cell apoptotic process|","structural molecule activity|protein binding, bridging|chaperone binding|receptor binding|cell adhesion molecule binding|",51,200,1.73E+11,79.2%
Q80YQ1,0.00895176,-0.976333333,21.22218425,3.345333333,0.007547126,3.748151611,-0.572,-3.129,-4.246,0.792,0.86,0.437,Q80YQ1,Thbs1,Q80YQ1_Thbs1,Q80YQ1,Thbs1,1,193,56,56,Q80YQ1|P35441,MOUSE,133681.8,49.3,21,21.1,822.52,822.52,,1171,Thrombospondin-1,fibrinogen complex|extracellular space|external side of plasma membrane|cell surface|secretory granule|extracellular matrix|platelet alpha granule|extracellular exosome|extracellular matrix|,activation of MAPK activity|negative regulation of endothelial cell proliferation|negative regulation of cell-matrix adhesion|sprouting angiogenesis|chronic inflammatory response|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|negative regulation of dendritic cell antigen processing and presentation|outflow tract morphogenesis|endocardial cushion development|growth plate cartilage development|inflammatory response|immune response|cell cycle arrest|cell adhesion|response to glucose|positive regulation of endothelial cell migration|negative regulation of endothelial cell migration|negative regulation of plasma membrane long-chain fatty acid transport|negative regulation of nitric oxide mediated signal transduction|negative regulation of cGMP-mediated signaling|negative regulation of plasminogen activation|positive regulation of fibroblast migration|positive regulation of cell-substrate adhesion|cell migration|negative regulation of angiogenesis|peptide cross-linking|positive regulation of blood coagulation|positive regulation of cell migration|positive regulation of transforming growth factor beta receptor signaling pathway|regulation of cGMP metabolic process|response to magnesium ion|negative regulation of interleukin-12 production|negative regulation of fibroblast growth factor receptor signaling pathway|positive regulation of phosphorylation|response to drug|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of macrophage activation|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of blood vessel endothelial cell migration|negative regulation of blood vessel endothelial cell migration|engulfment of apoptotic cell|positive regulation of translation|positive regulation of angiogenesis|blood vessel morphogenesis|positive regulation of chemotaxis|response to calcium ion|positive regulation of protein kinase B signaling|negative regulation of fibrinolysis|cellular response to nitric oxide|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|positive regulation of endothelial cell apoptotic process|positive regulation of reactive oxygen species metabolic process|negative regulation of endothelial cell chemotaxis|,phosphatidylserine binding|fibronectin binding|integrin binding|calcium ion binding|heparin binding|fibroblast growth factor binding|low-density lipoprotein particle binding|laminin binding|extracellular matrix binding|fibrinogen binding|collagen V binding|,56,193,91700000000,49.3%
P32261,0.000165808,-0.771166667,43.43065704,4.240333333,4.53873E-05,8.898430935,-3.707,-2.36,-2.607,1.7,1.46,0.887,P32261,Serpinc1,P32261_Serpinc1,P32261,Serpinc1,1,327,54,54,P32261|A0A0A6YX49|A0A0A6YXS8,MOUSE,52516.1,67,22,22.1,814.04,814.04,,465,Antithrombin-III,extracellular space|extracellular exosome|blood microparticle|,"response to nutrient|blood coagulation|negative regulation of endopeptidase activity|negative regulation of inflammatory response|regulation of blood coagulation, intrinsic pathway|",protease binding|serine-type endopeptidase inhibitor activity|heparin binding|,54,327,1.12E+12,67.0%
P19221,0.000187858,-1.064333333,42.14244781,4.544666667,6.10598E-05,8.500496536,-3.882,-2.309,-3.819,1.728,0.904,0.992,P19221,F2,P19221_F2,P19221,F2,1,283,48,48,P19221|H7BX99,MOUSE,71693.8,57.6,23,23.1,768.82,768.82,,618,Prothrombin,extracellular space|cytosol|extracellular matrix|extracellular exosome|blood microparticle|,positive regulation of protein phosphorylation|proteolysis|acute-phase response|cell surface receptor signaling pathway|positive regulation of cell proliferation|regulation of cell shape|response to wounding|regulation of gene expression|positive regulation of phosphatidylinositol 3-kinase signaling|response to inactivity|platelet activation|positive regulation of blood coagulation|positive regulation of cell growth|positive regulation of collagen biosynthetic process|fibrinolysis|negative regulation of proteolysis|negative regulation of astrocyte differentiation|positive regulation of release of sequestered calcium ion into cytosol|cytosolic calcium ion homeostasis|thrombin receptor signaling pathway|cellular response to mechanical stimulus|positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway|positive regulation of reactive oxygen species metabolic process|,serine-type endopeptidase activity|receptor binding|calcium ion binding|protein binding|peptidase activity|thrombospondin receptor activity|,48,283,7.11E+11,57.6%
Q61702,0.000165321,-0.978,43.50208158,4.383333333,4.4647E-05,8.920951074,-4.045,-2.463,-3.001,1.583,1.151,0.907,Q61702,Itih1,Q61702_Itih1,Q61702,Itih1,1,218,47,2,Q61702,MOUSE,101521.5,50.8,24,24.1,763.37,29.72,,907,Inter-alpha-trypsin inhibitor heavy chain H1,extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,47,218,2.78E+11,50.8%
F8WJ05,0.000644681,-0.505,33.85253581,4.879166667,0.000411857,7.023012111,-4.435,-2.43,,1.897,1.502,0.941,F8WJ05,Itih1,F8WJ05_Itih1,F8WJ05,Itih1,1,4,46,2,F8WJ05,MOUSE,102089.1,50.9,24,24.2,747.87,18.52,,911,Inter-alpha-trypsin inhibitor heavy chain H1,extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,2,4,497000000,4.0%
P26262,0.000498005,-0.838166667,35.17285784,4.243,0.000303888,6.59244929,-4.353,-2.58,-1.946,1.574,1.369,0.907,P26262,Klkb1,P26262_Klkb1,P26262,Klkb1,1,242,45,45,P26262|P04187,MOUSE,73492.3,65.8,25,25.1,751.27,751.27,,638,Plasma kallikrein,extracellular space|extracellular exosome|,inflammatory response|blood coagulation|plasminogen activation|fibrinolysis|positive regulation of fibrinolysis|liver regeneration|,serine-type endopeptidase activity|,45,242,3.83E+11,65.8%
Q00623,0.00017017,-1.026,43.09286048,4.468666667,4.90585E-05,8.792581365,-4.256,-2.585,-2.94,1.498,1.186,0.941,Q00623,Apoa1,Q00623_Apoa1,Q00623,Apoa1,1,746,44,44,Q00623,MOUSE,30615,81.4,26,26.1,706.1,706.1,,264,Apolipoprotein A-I,extracellular region|extracellular space|nucleus|cytosol|cell surface|endocytic vesicle|cytoplasmic vesicle|very-low-density lipoprotein particle|high-density lipoprotein particle|discoidal high-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,regulation of protein phosphorylation|endothelial cell proliferation|negative regulation of cytokine secretion involved in immune response|phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol biosynthetic process|G-protein coupled receptor signaling pathway|integrin-mediated signaling pathway|response to nutrient|cholesterol metabolic process|glucocorticoid metabolic process|negative regulation of tumor necrosis factor-mediated signaling pathway|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|negative regulation of very-low-density lipoprotein particle remodeling|protein oxidation|peptidyl-methionine modification|triglyceride catabolic process|lipid storage|regulation of intestinal cholesterol absorption|cholesterol transport|adrenal gland development|organ regeneration|regulation of Cdc42 protein signal transduction|cholesterol efflux|phospholipid efflux|negative regulation of heterotypic cell-cell adhesion|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|positive regulation of Rho protein signal transduction|lipoprotein biosynthetic process|response to drug|cholesterol homeostasis|blood vessel endothelial cell migration|response to estrogen|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|negative regulation of interleukin-1 beta secretion|negative regulation of inflammatory response|protein stabilization|negative chemotaxis|positive regulation of lipoprotein lipase activity|vitamin transport|positive regulation of hydrolase activity|negative regulation of hydrolase activity|positive regulation of stress fiber assembly|phospholipid homeostasis|negative regulation of lipase activity|negative regulation of cell adhesion molecule production|negative regulation of response to cytokine stimulus|triglyceride homeostasis|cholesterol import|positive regulation of substrate adhesion-dependent cell spreading|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|phospholipid transporter activity|high-density lipoprotein particle binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|apolipoprotein receptor binding|apolipoprotein A-I receptor binding|identical protein binding|chemorepellent activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding|lipoprotein particle binding|cholesterol transporter activity|,44,746,1.3E+14,81.4%
E9PV24,0.092823099,-0.266666667,10.63157886,2.572,0.086465352,2.002109799,1.142,-2.806,-2.994,0.544,2.786,-0.272,E9PV24,Fga,E9PV24_Fga,E9PV24,Fga,1,214,53,53,E9PV24|E9PV24-2|P02672|A5PJE3,MOUSE,88169.4,55.5,27,27.1,705.71,705.71,,789,Fibrinogen alpha chain,fibrinogen complex|extracellular space|rough endoplasmic reticulum|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|extracellular vesicle|,"protein complex assembly|acute-phase response|cell-matrix adhesion|signal transduction|blood coagulation|plasminogen activation|response to estradiol|response to genistein|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|induction of bacterial agglutination|response to morphine|cellular protein complex assembly|innate immune response|positive regulation of vasoconstriction|positive regulation of exocytosis|response to cycloheximide|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to interleukin-6|cellular response to organic cyclic compound|blood coagulation, common pathway|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|liver regeneration|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|cellular response to granulocyte colony-stimulating factor|negative regulation of endothelial cell apoptotic process|","structural molecule activity|protein binding, bridging|receptor binding|cell adhesion molecule binding|",53,214,3.65E+11,55.5%
Q61129,0.000145021,-1.026,48.83044196,4.285333333,1.30905E-05,10.74768744,-3.778,-2.701,-3.027,1.242,1.171,0.937,Q61129,Cfi,Q61129_Cfi,Q61129,Cfi,1,209,41,41,Q61129,MOUSE,69541.5,59.8,28,28.1,695.91,695.91,,603,Complement factor I,extracellular space|membrane|extracellular exosome|,"proteolysis|receptor-mediated endocytosis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|scavenger receptor activity|metal ion binding|,41,209,3.41E+11,59.8%
P20029,0.000148189,-1.0485,46.13216611,4.351666667,2.4366E-05,9.785277429,-3.739,-2.458,-3.476,1.428,1.072,0.882,P20029,Hspa5,P20029_Hspa5,P20029,Hspa5,1,179,44,41,P20029,MOUSE,72534.8,54.5,29,29.1,674.84,638.53,,655,78 kDa glucose-regulated protein,extracellular region|nucleus|mitochondrion|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|smooth endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|plasma membrane|focal adhesion|cell surface|membrane|integral component of endoplasmic reticulum membrane|midbody|endoplasmic reticulum chaperone complex|melanosome|myelin sheath|extracellular exosome|COP9 signalosome|,ER overload response|activation of signaling protein activity involved in unfolded protein response|cerebellum structural organization|cerebellar Purkinje cell layer development|substantia nigra development|positive regulation of cell migration|negative regulation of transforming growth factor beta receptor signaling pathway|positive regulation of protein ubiquitination|response to endoplasmic reticulum stress|maintenance of protein localization in endoplasmic reticulum|positive regulation of embryonic development|cellular response to glucose starvation|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|cellular response to antibiotic|cellular response to interleukin-4|toxin transport|,glycoprotein binding|protein binding|ATP binding|ATPase activity|enzyme binding|protein domain specific binding|ubiquitin protein ligase binding|ribosome binding|unfolded protein binding|misfolded protein binding|,44,179,1.25E+11,54.5%
P63017,0.000357489,-0.6535,37.03307364,3.193,0.000198013,7.064406981,-3.065,-1.668,-2.017,1.167,0.78,0.882,P63017,Hspa8,P63017_Hspa8,P63017,Hspa8,1,26,19,16,P63017|Q504P4|P17156|P16627|P17879|Q61696,MOUSE,71098,27.8,29,29.2,215.7,179.39,,646,Heat shock cognate 71 kDa protein,Prp19 complex|extracellular space|intracellular|nucleus|spliceosomal complex|nucleolus|cytosol|plasma membrane|focal adhesion|membrane|ribonucleoprotein complex|melanosome|myelin sheath|extracellular exosome|blood microparticle|ubiquitin ligase complex|,"transcription, DNA-templated|mRNA processing|protein folding|RNA splicing|protein refolding|negative regulation of transcription, DNA-templated|ATP metabolic process|positive regulation of mRNA splicing, via spliceosome|chaperone mediated protein folding requiring cofactor|regulation of cell cycle|clathrin coat disassembly|negative regulation of fibril organization|","G-protein coupled receptor binding|protein binding|ATP binding|ATPase activity|enzyme binding|MHC class II protein complex binding|heat shock protein binding|ubiquitin protein ligase binding|ATPase activity, coupled|poly(A) RNA binding|unfolded protein binding|C3HC4-type RING finger domain binding|",16,26,635000000,25.0%
A0A0R4J038,0.000145021,-1.091,48.72816442,4.584,1.34024E-05,10.70972217,-3.849,-2.681,-3.619,1.478,1.195,0.93,A0A0R4J038,Kng1,A0A0R4J038_Kng1,A0A0R4J038,Kng1,1,255,37,32,A0A0R4J038|O08677|D3YTY9|O08677-3|B99909|P01044|P01045,MOUSE,74183.9,51.5,30,30.1,651.49,583.81,,661,Kininogen-1,,,,37,255,1.69E+12,51.5%
Q6S9I0,0.000153199,-1.077833333,45.47026648,4.519666667,2.83774E-05,9.561170594,-3.705,-2.518,-3.79,1.646,1,0.9,Q6S9I0,Kng2,Q6S9I0_Kng2,Q6S9I0,Kng2,1,86,28,24,Q6S9I0|Q6S9I3|Q6S9I2|E0CYI5,MOUSE,48970.3,56.5,30,30.2,458.75,399.07,,433,Kininogen 2,extracellular space|cytosol|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|,cysteine-type endopeptidase inhibitor activity|receptor binding|,24,86,50700000000,51.9%
P06683,0.000145021,-1.177333333,50.67179116,4.605333333,8.56684E-06,11.45229959,-4.001,-2.884,-3.555,1.181,1.26,0.935,P06683,C9,P06683_C9,P06683,C9,1,169,41,41,A0A0R4J032|P06683,MOUSE,63256.4,65.5,31,31.1,648.47,648.47,,548,Complement component C9,membrane attack complex|cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",,41,169,2.51E+11,65.5%
A0A0R4J0I1,0.000145021,-1.052833333,49.30654731,4.239,1.17313E-05,10.92601531,-3.753,-2.719,-3.045,1.082,1.139,0.979,A0A0R4J0I1,Serpina3k,A0A0R4J0I1_Serpina3k,A0A0R4J0I1,Serpina3k,1,791,32,22,A0A0R4J0I1|P07759,MOUSE,46900.1,66.5,32,32.1,637.37,432.25,,418,MCG1051009,,,,32,791,9.45E+12,66.5%
G3X8T9,0.000254442,-1.043833333,39.67848803,4.249,0.000107684,7.780889651,-3.078,-2.224,-4.203,1.398,0.968,0.876,G3X8T9,Serpina3n,G3X8T9_Serpina3n,G3X8T9,Serpina3n,1,14,30,2,G3X8T9|Q6P4P1|D3Z451,MOUSE,46936.4,53.8,32,32.2,473.66,43.82,,418,"Serine (Or cysteine) peptidase inhibitor, clade A, member 3N, isoform CRA_a",extracellular region|extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,2,14,13400000000,6.6%
Q91WP6,0.00046422,-0.2916,35.53250333,3.213166667,0.000279737,7.537164493,-2.555,-1.884,,1.016,1.175,0.79,Q91WP6,NotFound,Q91WP6_NotFound,Q91WP6,Serpina3n,1,1,30,1,Q91WP6|Q5I2A0|F2Z405,MOUSE,46888.3,54.3,32,32.3,451.23,7.37,,418,Serine protease inhibitor A3N,extracellular region|extracellular space|extracellular exosome|blood microparticle|,acute-phase response|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,1,1,9690000,4.3%
Q03734,0.000213663,-0.474333333,40.93265907,3.572,8.06741E-05,8.140565891,-2.785,-2.352,-1.644,1.724,1.324,0.887,Q03734,Serpina3m,Q03734_Serpina3m,Q03734,Serpina3m,1,47,23,12,Q03734,MOUSE,47234.5,54,32,32.4,419.26,195.01,,418,Serine protease inhibitor A3M,extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,12,47,28400000000,31.8%
P29621,0.000233281,-0.6604,40.28980975,4.242666667,9.35447E-05,9.168991867,-3.706,-2.706,,1.164,0.905,1.041,P29621,Serpina3c,P29621_Serpina3c,P29621,Serpina3c,1,15,15,10,P29621|Q80X76,MOUSE,46936.4,40.7,32,32.5,213.56,124.36,,417,Serine protease inhibitor A3C,extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,10,15,1460000000,29.7%
Q8K182,0.000145021,-1.000333333,52.28239889,4.36,5.91235E-06,12.10278611,-3.577,-3.012,-2.952,1.229,0.918,1.392,Q8K182,C8a,Q8K182_C8a,Q8K182,C8a,1,180,43,43,Q8K182|A2A997|A2A998,MOUSE,67733.7,65.4,33,33.1,636.16,636.16,,587,Complement component C8 alpha chain,membrane attack complex|extracellular exosome|blood microparticle|,"complement activation|complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",complement binding|protein complex binding|,43,180,1.91E+11,65.4%
E9Q6D8,0.00014804,-0.887833333,46.97890242,4.299666667,2.00498E-05,10.07869551,-3.634,-2.882,-2.597,1.163,1.708,0.915,E9Q6D8,NotFound,E9Q6D8_NotFound,E9Q6D8,C6,1,118,40,40,E9Q6D8|Q91X70,MOUSE,108049.4,46.8,34,34.1,631.6,631.6,,931,Complement component 6,membrane attack complex|extracellular exosome|,in utero embryonic development|immune response|,,40,118,30600000000,46.8%
P42703,0.000165321,-1.095,43.90008226,5.392666667,4.07373E-05,9.047338037,-3.607,-2.894,-4.873,0.929,1.798,2.077,P42703,Lifr,P42703_Lifr,P42703,Lifr,1,207,42,3,P42703,MOUSE,123883.7,36.5,35,35.1,627.03,35.48,,1092,Leukemia inhibitory factor receptor,plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,positive regulation of cell proliferation|negative regulation of muscle cell apoptotic process|response to organic cyclic compound|cytokine-mediated signaling pathway|organ regeneration|response to cytokine|oncostatin-M-mediated signaling pathway|neuron projection morphogenesis|leukemia inhibitory factor signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor binding|protein binding|growth factor binding|cytokine binding|protein heterodimerization activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|,42,207,3.54E+11,36.5%
P42703-2,0.000673015,-0.2905,33.60687335,3.690333333,0.000435826,6.213984009,-2.223,-1.077,-3.107,0.915,1.793,1.956,P42703,Lifr,P42703-2_Lifr,P42703-2,Lifr,1,11,40,2,P42703-2,MOUSE,82255.7,52.9,35,35.2,604.54,35.46,,1092,Isoform 2 of Leukemia inhibitory factor receptor,plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,positive regulation of cell proliferation|negative regulation of muscle cell apoptotic process|response to organic cyclic compound|cytokine-mediated signaling pathway|organ regeneration|response to cytokine|oncostatin-M-mediated signaling pathway|neuron projection morphogenesis|leukemia inhibitory factor signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor binding|protein binding|growth factor binding|cytokine binding|protein heterodimerization activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|,2,11,10200000000,3.7%
E9PUU8,0.000265003,-1.2815,39.15627513,4.743666667,0.000121443,7.635021006,-3.239,-2.689,-5.032,1.161,1.196,0.914,E9PUU8,NotFound,E9PUU8_NotFound,E9PUU8,Pkhd1l1,1,80,49,49,E9PUU8|Q80ZA4|F8WH29|Q80ZA4-2,MOUSE,469488.1,13.3,36,36.1,620.9,620.9,,4249,Fibrocystin-L,cilium|,,protein binding|,49,80,6570000000,13.3%
Q07968,0.000148189,-0.923333333,46.65337012,4.065333333,2.16104E-05,9.964983085,-3.6,-2.801,-2.467,1.157,1.256,0.915,Q07968,F13b,Q07968_F13b,Q07968,F13b,1,179,39,39,Q07968,MOUSE,78476.1,54.4,37,37.1,599.4,599.4,,669,Coagulation factor XIII B chain,extracellular region|,blood coagulation|,,39,179,1.51E+11,54.4%
P01872,0.000145021,-0.837666667,48.69852881,4.333333333,1.34942E-05,10.698744,-3.234,-2.882,-2.897,1.081,1.974,0.932,P01872,NotFound,P01872_NotFound,P01872,Ighm,1,221,36,35,P01872|P01872-2|P04221,MOUSE,50655.7,61.8,38,38.1,592.48,572.81,,454,Ig mu chain C region,"extracellular space|plasma membrane|external side of plasma membrane|integral component of membrane|B cell receptor complex|immunoglobulin complex, circulating|perinuclear region of cytoplasm|",activation of MAPK activity|humoral immune response mediated by circulating immunoglobulin|immunoglobulin mediated immune response|antigen processing and presentation|positive regulation of B cell proliferation|positive regulation of MAPK cascade|early endosome to late endosome transport|positive regulation of endocytosis|positive regulation of peptidyl-tyrosine phosphorylation|defense response to Gram-negative bacterium|B cell receptor signaling pathway|positive regulation of B cell activation|,antigen binding|transmembrane signaling receptor activity|protein binding|immunoglobulin receptor binding|identical protein binding|,36,221,7.84E+11,61.8%
P03988,0.001397953,0.1815,29.90584935,3.672666667,0.001021916,6.820216169,,-2.573,,0.873,1.243,1.183,P03988,NotFound,P03988_NotFound,P03988,,1,1,2,1,P03988,RABIT,50581.1,6.9,38,38.2,30.89,11.22,,458,Ig mu chain C region secreted form,,,,1,1,6630000,4.8%
Q60841,0.000145021,-1.073166667,52.75628266,4.399666667,5.30117E-06,12.30052739,-3.442,-2.857,-3.52,0.93,1.308,1.142,Q60841,Reln,Q60841_Reln,Q60841,Reln,1,101,47,47,Q60841|Q60841-2|Q60841-3,MOUSE,394505.8,13.6,39,39.1,589.9,589.9,,3461,Reelin,proteinaceous extracellular matrix|extracellular space|cytoplasm|dendrite|,"cell morphogenesis involved in differentiation|neuron migration|proteolysis|cell adhesion|axon guidance|central nervous system development|brain development|learning|long-term memory|associative learning|glial cell differentiation|regulation of gene expression|positive regulation of neuron projection development|positive regulation of phosphatidylinositol 3-kinase signaling|dendrite development|cell migration|peptidyl-tyrosine phosphorylation|spinal cord patterning|ventral spinal cord development|hippocampus development|cerebral cortex tangential migration|layer formation in cerebral cortex|cerebral cortex development|forebrain development|positive regulation of TOR signaling|positive regulation of CREB transcription factor activity|protein localization to synapse|reelin-mediated signaling pathway|positive regulation of protein kinase activity|response to pain|positive regulation of peptidyl-tyrosine phosphorylation|regulation of behavior|regulation of synaptic transmission|positive regulation of small GTPase mediated signal transduction|positive regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|positive regulation of dendritic spine morphogenesis|positive regulation of protein tyrosine kinase activity|positive regulation of synapse maturation|postsynaptic density assembly|N-methyl-D-aspartate receptor clustering|postsynaptic density protein 95 clustering|receptor localization to synapse|lateral motor column neuron migration|positive regulation of long-term synaptic potentiation|positive regulation of lateral motor column neuron migration|regulation of N-methyl-D-aspartate selective glutamate receptor activity|positive regulation of excitatory postsynaptic membrane potential|positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity|",protein binding|serine-type peptidase activity|metal ion binding|lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,47,101,7780000000,13.6%
G3X977,0.000165321,-0.9305,43.51615608,4.344333333,4.45025E-05,8.925394514,-3.739,-2.262,-3.307,1.683,1.154,0.888,G3X977,Itih2,G3X977_Itih2,G3X977,Itih2,1,211,37,37,G3X977|Q61703,MOUSE,106758.8,40.3,40,40.1,586.51,586.51,,950,"Inter-alpha trypsin inhibitor, heavy chain 2",extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,37,211,5.23E+11,40.3%
D3YXF5,0.000145021,-1.325666667,49.06095413,4.786666667,1.24138E-05,10.83369719,-4.114,-2.901,-4.142,1.061,1.209,0.933,D3YXF5,C7,D3YXF5_C7,D3YXF5,C7,1,105,37,37,D3YXF5,MOUSE,96587.9,42.1,41,41.1,567.22,567.22,,845,Complement component 7,membrane attack complex|extracellular exosome|,immune response|,,37,105,22200000000,42.1%
P08113,0.000204259,-1.551,41.41215719,5.157333333,7.22411E-05,8.281666212,-4.059,-2.933,-5.397,1.017,1.145,0.921,P08113,Hsp90b1,P08113_Hsp90b1,P08113,Hsp90b1,1,100,44,42,P08113|E9PX27,MOUSE,92759.4,44.2,42,42.1,564.41,529.41,,802,Endoplasmin,extracellular region|nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|cytosol|plasma membrane|focal adhesion|membrane|midbody|extracellular matrix|endoplasmic reticulum chaperone complex|melanosome|perinuclear region of cytoplasm|extracellular exosome|,"response to hypoxia|protein folding|ER-associated ubiquitin-dependent protein catabolic process|retrograde protein transport, ER to cytosol|actin rod assembly|negative regulation of apoptotic process|regulation of phosphoprotein phosphatase activity|cellular response to ATP|",RNA binding|protein binding|ATP binding|protein phosphatase binding|virion binding|low-density lipoprotein particle receptor binding|unfolded protein binding|,44,100,23200000000,44.2%
P11499,0.01819059,-0.0982,17.97913437,2.879666667,0.015925261,3.362462274,-3.19,-0.462,,0.524,1.443,1.194,P11499,Hsp90ab1,P11499_Hsp90ab1,P11499,Hsp90ab1,1,2,7,2,P11499,MOUSE,83622,9.2,42,42.2,77.09,18.8,,724,Heat shock protein HSP 90-beta,intracellular|cytoplasm|mitochondrion|cytosol|cell surface|membrane|inclusion body|basolateral plasma membrane|apical plasma membrane|brush border membrane|melanosome|extracellular exosome|COP9 signalosome|,"placenta development|protein folding|response to salt stress|virion attachment to host cell|positive regulation of protein binding|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of protein import into nucleus, translocation|negative regulation of neuron apoptotic process|positive regulation of nitric oxide biosynthetic process|positive regulation of cell size|regulation of interferon-gamma-mediated signaling pathway|regulation of type I interferon-mediated signaling pathway|cellular response to interleukin-4|cellular response to organic cyclic compound|positive regulation of protein serine/threonine kinase activity|fibril organization|",UTP binding|CTP binding|double-stranded RNA binding|protein binding|ATP binding|GTP binding|sulfonylurea receptor binding|kinase binding|protein kinase binding|MHC class II protein complex binding|nitric-oxide synthase regulator activity|TPR domain binding|dATP binding|ion channel binding|poly(A) RNA binding|unfolded protein binding|,2,2,23700000,3.0%
P07901,0.044511457,0.87125,13.96505172,-2.419666667,0.040132372,-2.759608665,,2.686,,1.087,-0.799,0.511,P07901,Hsp90aa1,P07901_Hsp90aa1,P07901,Hsp90aa1,1,1,4,1,P07901,MOUSE,85185.7,5.4,42,42.3,27.7,4.41,,733,Heat shock protein HSP 90-alpha,intracellular|nucleus|nucleoplasm|cytoplasm|mitochondrion|cytosol|membrane|ruffle membrane|melanosome|myelin sheath|extracellular exosome|,nitric oxide biosynthetic process|response to unfolded protein|response to cold|protein refolding|protein import into mitochondrial outer membrane|positive regulation of nitric oxide biosynthetic process|positive regulation of cytotoxic T cell differentiation|regulation of catalytic activity|chaperone-mediated protein complex assembly|,protein binding|ATP binding|ATPase activity|MHC class II protein complex binding|nitric-oxide synthase regulator activity|TPR domain binding|identical protein binding|protein homodimerization activity|poly(A) RNA binding|GTPase binding|unfolded protein binding|,1,1,725000,1.2%
Q91ZX7,0.000156464,-0.7715,45.09178051,3.542333333,3.09615E-05,9.435050761,-2.887,-2.74,-2.001,1.111,0.975,0.913,Q91ZX7,Lrp1,Q91ZX7_Lrp1,Q91ZX7,Lrp1,1,72,47,47,A0A0R4J0I9|Q91ZX7|Q3U5J2|Q9JI18|A2API5|E9Q202|Q3TES0|A0A0N4SWH8|D6RHQ8,MOUSE,523675.1,11.9,43,43.1,563.24,563.24,,4545,Prolow-density lipoprotein receptor-related protein 1,nucleolus|cytoplasm|lysosomal membrane|integral component of plasma membrane|coated pit|focal adhesion|membrane|receptor complex|perinuclear region of cytoplasm|,receptor-mediated endocytosis|cholesterol metabolic process|positive regulation of cholesterol efflux|negative regulation of smooth muscle cell migration|negative regulation of Wnt signaling pathway|positive regulation of lipid transport|regulation of cholesterol transport|regulation of phospholipase A2 activity|regulation of actin cytoskeleton organization|aorta morphogenesis|apoptotic cell clearance|beta-amyloid clearance|negative regulation of platelet-derived growth factor receptor-beta signaling pathway|,calcium ion binding|protein binding|protein complex binding|apolipoprotein binding|poly(A) RNA binding|,47,72,7540000000,11.9%
P09103,0.000145021,-1.174333333,47.39232408,4.758,1.82292E-05,10.22476493,-3.785,-2.719,-4.156,1.448,1.263,0.903,P09103,P4hb,P09103_P4hb,P09103,P4hb,1,98,42,42,P09103|P05307|A6H7J6|E9Q8G8,MOUSE,57456.8,66.6,44,44.1,558.57,558.57,,509,Protein disulfide-isomerase,endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|focal adhesion|external side of plasma membrane|procollagen-proline 4-dioxygenase complex|endoplasmic reticulum chaperone complex|melanosome|extracellular exosome|,protein folding|peptidyl-proline hydroxylation to 4-hydroxy-L-proline|response to endoplasmic reticulum stress|cell redox homeostasis|cellular response to hypoxia|regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|integrin binding|protein binding|enzyme binding|poly(A) RNA binding|protein heterodimerization activity|procollagen-proline 4-dioxygenase activity|peptidyl-proline 4-dioxygenase activity|,42,98,27500000000,66.6%
Q91WP0,0.000145021,-1.144,52.10114648,4.468666667,6.16432E-06,12.02792945,-3.816,-2.935,-3.384,1.265,1.061,0.945,Q91WP0,Masp2,Q91WP0_Masp2,Q91WP0,Masp2,1,180,39,39,Q91WP0|Q91WP0-2,MOUSE,76998.6,53.2,45,45.1,556.57,556.57,,685,Mannan-binding lectin serine protease 2,extracellular exosome|,"complement activation, lectin pathway|proteolysis|complement activation, classical pathway|",complement component C4b binding|serine-type endopeptidase activity|calcium ion binding|protein binding|peptidase activity|calcium-dependent protein binding|,39,180,1.9E+11,53.2%
Q00897,0.000185939,-0.91,42.24365252,4.195333333,5.96533E-05,8.531202717,-3.962,-2.61,-2.451,1.477,1.162,0.924,Q00897,Serpina1d,Q00897_Serpina1d,Q00897,Serpina1d,1,234,32,10,Q00897,MOUSE,46168.7,65.8,46,46.1,552.17,174.82,,413,Alpha-1-antitrypsin 1-4,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|identical protein binding|,32,234,1.65E+12,65.8%
P22599,0.003676378,-0.7605,25.32437317,3.900333333,0.002934693,4.516656817,-4.616,-2.475,-1.041,1.531,1.14,0.898,P22599,Serpina1b,P22599_Serpina1b,P22599,Serpina1b,1,40,30,9,P22599,MOUSE,46145,64.8,46,46.2,541.85,155.97,,413,Alpha-1-antitrypsin 1-2,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,in utero embryonic development|protein N-linked glycosylation|acute-phase response|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|protein binding|identical protein binding|,9,40,1.01E+11,21.7%
A0A0A0MQA3,0.000279725,-0.4534,38.75242933,3.597666667,0.000133278,8.61121665,-2.907,-2.317,,1.204,0.841,0.912,A0A0A0MQA3,Serpina1a,A0A0A0MQA3_Serpina1a,A0A0A0MQA3,Serpina1a,1,2,30,2,A0A0A0MQA3|P07758,MOUSE,49023.3,61.6,46,46.3,499.34,22.52,,436,Alpha-1-antitrypsin 1-1,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,protein N-linked glycosylation|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|protein binding|identical protein binding|,2,2,23400000,11.9%
A0A0R4J0X5,0.000282311,-0.3595,38.68527219,3.076333333,0.000135355,7.505365952,-2.517,-1.646,-1.53,1.519,1,1.017,A0A0R4J0X5,Serpina1c,A0A0R4J0X5_Serpina1c,A0A0R4J0X5,Serpina1c,1,31,28,1,A0A0R4J0X5,MOUSE,46024.7,63.6,46,46.4,505.41,25.66,,413,Alpha-1-antitrypsin 1-3,,,,1,31,2440000000,7.2%
Q00898,0.006347184,-0.873666667,22.78008632,4.734666667,0.005272194,4.031588138,-3.325,-0.754,-5.644,0.61,2.022,1.849,Q00898,Serpina1e,Q00898_Serpina1e,Q00898,Serpina1e,1,9,22,3,Q00898,MOUSE,46118.8,33.6,46,46.5,333.31,44.6,,413,Alpha-1-antitrypsin 1-5,extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|identical protein binding|,3,9,829000000,8.7%
P98064,0.000145021,-1.173666667,54.10962627,4.396666667,3.88184E-06,12.88178511,-3.737,-3.113,-3.266,1,1.009,1.065,P98064,Masp1,P98064_Masp1,P98064,Masp1,1,127,35,15,P98064,MOUSE,81621.4,54.6,47,47.1,548.78,237.77,,704,Mannan-binding lectin serine protease 1,extracellular space|,"complement activation, lectin pathway|proteolysis|",serine-type endopeptidase activity|calcium ion binding|protein homodimerization activity|calcium-dependent protein binding|,35,127,33700000000,54.6%
P98064-2,0.000171655,-1.084166667,42.9530981,4.221666667,5.06629E-05,8.749101825,-4.146,-2.889,-2.55,1.011,1.143,0.926,P98064,Masp1,P98064-2_Masp1,P98064-2,Masp1,1,18,27,7,P98064-2,MOUSE,83984.9,40.1,47,47.2,414.38,103.37,,704,Isoform 2 of Mannan-binding lectin serine protease 1,extracellular space|,"complement activation, lectin pathway|proteolysis|",serine-type endopeptidase activity|calcium ion binding|protein homodimerization activity|calcium-dependent protein binding|,7,18,2670000000,9.2%
Q8BH35,0.000145021,-1.14,50.66392032,4.528666667,8.58238E-06,11.4492007,-3.684,-2.79,-3.739,1.245,0.914,1.214,Q8BH35,C8b,Q8BH35_C8b,Q8BH35,C8b,1,127,34,34,Q8BH35|Q8BH35-2,MOUSE,68053.9,54.6,48,48.1,529.75,529.75,,589,Complement component C8 beta chain,membrane attack complex|extracellular space|extracellular exosome|extracellular vesicle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",protein complex binding|,34,127,56600000000,54.6%
O08601-2,0.000152509,-0.8925,45.7588105,4.221,2.65533E-05,9.658306863,-3.477,-2.328,-3.204,1.617,1.157,0.88,O08601,Mttp,O08601-2_Mttp,O08601-2,Mttp,1,76,36,36,O08601-2|O08601,MOUSE,101433.7,36.3,49,49.1,529.36,529.36,,894,Isoform 2 of Microsomal triglyceride transfer protein large subunit,endoplasmic reticulum|rough endoplasmic reticulum|Golgi apparatus|basolateral plasma membrane|brush border membrane|microvillus membrane|membrane-bounded vesicle|receptor complex|,protein lipidation|lipid metabolic process|triglyceride metabolic process|lipid transport|circadian rhythm|cholesterol metabolic process|lipoprotein metabolic process|cholesterol homeostasis|lipoprotein transport|response to calcium ion|,lipid transporter activity|protein binding|lipid binding|apolipoprotein binding|protein heterodimerization activity|,36,76,9120000000,36.3%
Q91X72,0.000148189,-0.714666667,46.53790913,4.037333333,2.21926E-05,9.924924418,-2.382,-2.832,-2.986,1.2,1.864,0.848,Q91X72,Hpx,Q91X72_Hpx,Q91X72,Hpx,1,162,34,34,Q91X72,MOUSE,52058.5,53,50,50.1,526.84,526.84,,460,Hemopexin,extracellular space|extracellular exosome|blood microparticle|,positive regulation of immunoglobulin production|positive regulation of humoral immune response mediated by circulating immunoglobulin|transport|hemoglobin metabolic process|heme metabolic process|positive regulation of tyrosine phosphorylation of Stat1 protein|regulation of protein metabolic process|positive regulation of response to interferon-gamma|positive regulation of interferon-gamma-mediated signaling pathway|,heme binding|metal ion binding|,34,162,1.55E+11,53.0%
Q06890,0.00014804,-0.682166667,46.79912173,3.926333333,2.08972E-05,10.01575485,-2.898,-2.443,-2.595,1.835,1.141,0.867,Q06890,Clu,Q06890_Clu,Q06890,Clu,1,172,33,33,Q06890,MOUSE,52282.3,45.7,51,51.1,521.16,521.16,,448,Clusterin,extracellular space|intracellular|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|cytosol|extracellular matrix|mitochondrial membrane|spherical high-density lipoprotein particle|chromaffin granule|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|neurofibrillary tangle|apical dendrite|extracellular matrix|,cell morphogenesis|microglial cell activation|response to virus|protein import|central nervous system myelin maintenance|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|negative regulation of protein homooligomerization|positive regulation of tumor necrosis factor production|positive regulation of apoptotic process|positive regulation of nitric oxide biosynthetic process|protein stabilization|positive regulation of NF-kappaB transcription factor activity|chaperone-mediated protein complex assembly|response to misfolded protein|chaperone-mediated protein folding|microglial cell proliferation|intrinsic apoptotic signaling pathway|regulation of beta-amyloid clearance|regulation of neuron death|positive regulation of neuron death|positive regulation of beta-amyloid formation|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|negative regulation of beta-amyloid formation|regulation of neuronal signal transduction|positive regulation of tau-protein kinase activity|positive regulation of neurofibrillary tangle assembly|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of intrinsic apoptotic signaling pathway|,protein binding|ubiquitin protein ligase binding|misfolded protein binding|ATPase activity|,33,172,4.44E+11,45.7%
Q01339,0.000272426,-0.781,38.93926072,3.962666667,0.000127666,7.575059619,-3.793,-2.431,-2.063,1.541,1.157,0.903,Q01339,Apoh,Q01339_Apoh,Q01339,Apoh,1,196,33,33,Q01339,MOUSE,39930.4,70.7,52,52.1,497.06,497.06,,345,Beta-2-glycoprotein 1,extracellular space|cell surface|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|extracellular matrix|,"negative regulation of endothelial cell proliferation|triglyceride metabolic process|blood coagulation, intrinsic pathway|negative regulation of endothelial cell migration|negative regulation of angiogenesis|regulation of blood coagulation|negative regulation of blood coagulation|organ regeneration|plasminogen activation|negative regulation of myeloid cell apoptotic process|negative regulation of smooth muscle cell apoptotic process|positive regulation of lipoprotein lipase activity|regulation of fibrinolysis|negative regulation of fibrinolysis|",glycoprotein binding|phospholipid binding|heparin binding|lipid binding|identical protein binding|lipoprotein lipase activator activity|,33,196,7.35E+11,70.7%
E9QPD7,0.010419734,0.242166667,20.52438226,2.164333333,0.008862613,3.587073506,-1.002,-0.533,-0.985,2.617,0.386,0.97,E9QPD7,Pcx,E9QPD7_Pcx,E9QPD7,Pcx,1,76,38,38,E9QPD7|G5E8R3|Q05920,MOUSE,130571.1,34.8,53,53.1,484.29,484.29,,1179,Pyruvate carboxylase,mitochondrion|,pyruvate metabolic process|gluconeogenesis|negative regulation of gene expression|viral RNA genome packaging|positive regulation by host of viral release from host cell|,DNA binding|biotin carboxylase activity|pyruvate carboxylase activity|ATP binding|biotin binding|metal ion binding|,38,76,10700000000,34.8%
Q8VCU2,0.001992479,-0.765333333,28.21418215,3.789333333,0.001508627,5.10580686,-4.004,-2.946,-1.03,1.43,1.028,0.93,Q8VCU2,Gpld1,Q8VCU2_Gpld1,Q8VCU2,Gpld1,1,120,32,32,Q8VCU2|O70362,MOUSE,94192.4,44.2,54,54.1,480.09,480.09,,842,Glycosylphosphatidylinositol specific phospholipase D1,proteinaceous extracellular matrix|extracellular space|intracellular|cytoplasm|lysosomal membrane|intracellular membrane-bounded organelle|extracellular exosome|,cell migration involved in sprouting angiogenesis|complement receptor mediated signaling pathway|GPI anchor release|negative regulation of cell proliferation|insulin receptor signaling pathway|response to glucose|positive regulation of endothelial cell migration|cellular response to insulin stimulus|cellular response to drug|positive regulation of apoptotic process|positive regulation of cytolysis|positive regulation of membrane protein ectodomain proteolysis|cellular response to calcium ion|cellular response to cholesterol|cellular response to triglyceride|cellular response to pH|regulation of cellular response to insulin stimulus|,glycosylphosphatidylinositol phospholipase D activity|phospholipase D activity|protein binding|,32,120,63100000000,44.2%
O89020,0.000175786,-1.283333333,42.75915822,4.842,5.29766E-05,8.689071249,-3.587,-2.731,-4.795,1.373,1.124,0.916,O89020,Afm,O89020_Afm,O89020,Afm,1,127,35,35,O89020|O89020-3|O89020-2,MOUSE,71317.7,53.6,55,55.1,472.88,472.88,,608,Afamin,extracellular space|extracellular exosome|blood microparticle|,vitamin transport|,vitamin E binding|,35,127,64400000000,53.6%
Q19LI2,0.001544408,-0.2365,29.4216713,4.232333333,0.001142439,5.365468848,-2.921,-2.448,-1.689,1,3.639,1,Q19LI2,A1bg,Q19LI2_A1bg,Q19LI2,A1bg,1,176,30,30,Q19LI2,MOUSE,57237.7,66,56,56.1,470.14,470.14,,512,Alpha-1B-glycoprotein,extracellular region|extracellular space|extracellular exosome|blood microparticle|,,,30,176,6.96E+11,66.0%
E9PWQ3,0.000145021,-0.974833333,50.71465058,3.912333333,8.48272E-06,11.46918755,-3.271,-2.632,-2.89,0.944,0.956,1.044,E9PWQ3,NotFound,E9PWQ3_NotFound,E9PWQ3,Col6a3,1,62,39,39,E9PWQ3|J3QQ16|A0A087WS16,MOUSE,355522.7,12.7,57,57.1,463.78,463.78,,3284,"Collagen, type VI, alpha 3",proteinaceous extracellular matrix|collagen trimer|extracellular space|extracellular matrix|sarcolemma|extracellular exosome|extracellular vesicle|extracellular matrix|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,39,62,4800000000,12.7%
Q8CG16,0.000156464,-0.943166667,45.1273479,4.090333333,3.0709E-05,9.446840512,-3.712,-2.725,-2.528,1.424,0.954,0.928,Q8CG16,C1ra,Q8CG16_C1ra,Q8CG16,C1ra,1,88,31,29,Q8CG16|Q8CFG9,MOUSE,81555.2,53.3,58,58.1,461.63,433.28,,707,Complement C1r-A subcomponent,extracellular exosome|blood microparticle|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|calcium ion binding|,31,88,22900000000,53.3%
Q3UZ09,0.000153199,-0.5515,45.52885641,3.207,2.79972E-05,9.580825017,-2.119,-1.97,-2.376,1.287,0.939,0.93,Q3UZ09,C1rl,Q3UZ09_C1rl,Q3UZ09,C1rl,1,24,14,12,Q3UZ09,MOUSE,54233.1,26.5,58,58.2,144.43,116.08,,482,Complement C1r subcomponent-like protein,extracellular space|extracellular exosome|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|,12,24,1550000000,22.1%
Q8CG14,0.000431875,-1.4485,35.91750206,5.149666667,0.000256006,6.923054615,-3.941,-2.556,-5.573,1.438,1.015,0.926,Q8CG14,C1s1,Q8CG14_C1s1,Q8CG14,C1sa,1,96,26,26,Q8CG14|E9Q6C2|A0A1W2P7F1|Q8CFG8,MOUSE,78396.6,48.4,59,59.1,457.61,457.61,,688,Complement C1s-A subcomponent,extracellular exosome|blood microparticle|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|calcium ion binding|identical protein binding|,26,96,25900000000,48.4%
P13020,0.000145021,-0.855,48.17845625,3.884666667,1.52109E-05,10.50772433,-3.296,-2.586,-2.51,1.202,1.154,0.906,P13020,Gsn,P13020_Gsn,P13020,Gsn,1,84,31,31,P13020|P13020-2,MOUSE,86339.4,38.5,60,60.1,447.98,447.98,,780,Gelsolin,ruffle|podosome|extracellular region|extracellular space|cytoplasm|cytosol|plasma membrane|focal adhesion|sarcoplasm|lamellipodium|actin cap|cortical actin cytoskeleton|myelin sheath|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|nucleus|focal adhesion|cortical actin cytoskeleton|,"phagocytosis, engulfment|aging|positive regulation of gene expression|oligodendrocyte development|striated muscle atrophy|vesicle-mediated transport|actin filament polymerization|protein destabilization|tissue regeneration|sequestering of actin monomers|actin nucleation|response to ethanol|negative regulation of viral entry into host cell|phosphatidylinositol-mediated signaling|actin filament severing|barbed-end actin filament capping|positive regulation of actin nucleation|response to folic acid|actin filament capping|cilium morphogenesis|cellular response to cadmium ion|regulation of podosome assembly|actin filament reorganization|renal protein absorption|hepatocyte apoptotic process|positive regulation of keratinocyte apoptotic process|regulation of wound healing, spreading of epidermal cells|regulation of establishment of T cell polarity|regulation of plasma membrane raft polarization|regulation of receptor clustering|positive regulation of protein processing in phagocytic vesicle|amyloid fibril formation|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|",actin binding|calcium ion binding|protein binding|protein domain specific binding|myosin II binding|,31,84,62500000000,38.5%
B2RPV6,0.00027274,-0.534833333,38.90327145,3.515,0.000128728,7.565152653,-1.762,-3.059,-2.056,1.354,1.55,0.764,B2RPV6,Mmrn1,B2RPV6_Mmrn1,B2RPV6,Mmrn1,1,74,36,36,B2RPV6|G3UVV6|A0A0N4SVL8,MOUSE,137358.3,30.8,61,61.1,443.73,443.73,,1210,Multimerin-1,extracellular region|,,,36,74,7090000000,30.8%
Q8BPB5,0.000145021,-0.783166667,48.4035864,3.859,1.44425E-05,10.590035,-3.068,-2.788,-2.282,1.2,1.298,0.941,Q8BPB5,Efemp1,Q8BPB5_Efemp1,Q8BPB5,Efemp1,1,94,27,27,Q8BPB5,MOUSE,57234.1,59.2,62,62.1,442.07,442.07,,493,EGF-containing fibulin-like extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|extracellular matrix|,"regulation of transcription, DNA-templated|epidermal growth factor receptor signaling pathway|peptidyl-tyrosine phosphorylation|negative regulation of chondrocyte differentiation|",epidermal growth factor-activated receptor activity|epidermal growth factor receptor binding|calcium ion binding|growth factor activity|,27,94,63200000000,59.2%
Q61508,0.002140856,-0.1685,27.87376619,3.917666667,0.001631636,5.034099313,-1.16,-2.144,-3.078,1.521,3.209,0.641,Q61508,Ecm1,Q61508_Ecm1,Q61508,Ecm1,1,91,31,31,Q61508|F8WI14|Q61508-2,MOUSE,64485.6,59.9,63,63.1,429.32,429.32,,559,Extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|,ossification|angiogenesis|positive regulation of endothelial cell proliferation|negative regulation of cytokine-mediated signaling pathway|regulation of type 2 immune response|regulation of transcription from RNA polymerase II promoter|inflammatory response|signal transduction|negative regulation of peptidase activity|negative regulation of bone mineralization|biomineral tissue development|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of angiogenesis|regulation of T cell migration|,protease binding|signal transducer activity|interleukin-2 receptor binding|protein C-terminus binding|enzyme binding|laminin binding|,31,91,43200000000,59.9%
Q5XQN5,0.096595598,-0.6455,10.43540368,1.964333333,0.090460635,1.971153118,0.139,-1.037,-3.985,0.009,0.596,0.405,Q5XQN5,NotFound,Q5XQN5_NotFound,Q5XQN5,KRT5,1,106,36,23,Q5XQN5|Q922U2|P07744|P11679|Q99M73|Q9DCV7|P19246,BOVIN,63107,41,64,64.1,411.21,256.89,,601,"Keratin, type II cytoskeletal 5",,,,37,106,77600000000,41.0%
P50446,0.27883318,-0.268833333,5.689500744,1.188333333,0.269804958,1.201061076,0.551,-0.02,-3.12,-0.226,-0.032,1.234,P50446,Krt6a,P50446_Krt6a,P50446,Krt6a,1,11,22,7,P50446|Q9Z331|Q3UV11|Q6IFZ8,MOUSE,59676.4,30.9,64,64.2,246.89,72.15,,553,"Keratin, type II cytoskeletal 6A",keratin filament|extracellular exosome|,morphogenesis of an epithelium|Wnt signaling pathway|keratinization|wound healing|intermediate filament organization|,structural molecule activity|,7,11,3660000000,11.0%
Q3TTY5,0.002360772,-0.597333333,27.40673047,2.804666667,0.001816883,4.863915862,-0.879,-2.092,-3.028,0.547,1.114,0.754,Q3TTY5,Krt2,Q3TTY5_Krt2,Q3TTY5,Krt2,1,42,15,9,Q3TTY5,MOUSE,71377.9,12.3,64,64.3,169.71,101.92,,707,"Keratin, type II cytoskeletal 2 epidermal",extracellular space|nucleus|Golgi apparatus|membrane|keratin filament|extracellular exosome|,keratinization|keratinocyte activation|keratinocyte proliferation|keratinocyte migration|,structural molecule activity|,9,42,40900000000,9.0%
Q3UV17,0.169269819,-0.496833333,7.919072446,1.371666667,0.161470338,1.570417382,0.613,-1.118,-3.043,-0.114,0.455,0.226,Q3UV17,Krt76,Q3UV17_Krt76,Q3UV17,Krt76,1,7,12,1,Q3UV17,MOUSE,63357,13.8,64,64.4,150.76,17.6,,594,"Keratin, type II cytoskeletal 2 oral",nucleus|keratin filament|extracellular exosome|,epidermis development|sebaceous gland development|,structural molecule activity|,1,7,40500000000,1.5%
Q6IFZ6,0.085031665,-0.804666667,11.03561928,1.944,0.078784008,2.065831166,0.322,-2.069,-3.583,0.344,0.471,-0.313,Q6IFZ6,Krt77,Q6IFZ6_Krt77,Q6IFZ6,Krt77,1,4,10,3,Q6IFZ6|Q6IFZ9,MOUSE,61414.7,12,64,64.5,107.56,30.97,,572,"Keratin, type II cytoskeletal 1b",cytoskeleton|keratin filament|extracellular exosome|,,structural molecule activity|,3,4,150000000,5.7%
Q8VED5,0.092910269,-0.706,10.62170012,1.851333333,0.086662256,2.000551283,0.12,-1.252,-3.763,0.073,0.397,0.189,Q8VED5,Krt79,Q8VED5_Krt79,Q8VED5,Krt79,1,7,10,1,Q8VED5,MOUSE,57836.6,10.3,64,64.6,102.21,19.85,,531,"Keratin, type II cytoskeletal 79",keratin filament|extracellular exosome|,,structural molecule activity|enzyme binding|,1,7,3110000000,2.2%
Q6NXH9,0.132866604,-0.446833333,9.016305053,1.852333333,0.125420779,1.746330711,0.299,-0.436,-3.982,0.433,0.692,0.313,Q6NXH9,Krt73,Q6NXH9_Krt73,Q6NXH9,Krt73,1,6,9,3,Q6NXH9,MOUSE,59538,11.1,64,64.7,101.29,24.01,,539,"Keratin, type II cytoskeletal 73",nucleus|keratin filament|extracellular exosome|,activation of mitophagy in response to mitochondrial depolarization|,structural molecule activity|,3,6,15200000000,4.0%
P04104,0.133236365,-0.971,8.998509953,2.266,0.125935742,1.74349626,0.289,-1.346,-5.255,-0.024,0.396,0.114,P04104,Krt1,P04104_Krt1,P04104,Krt1,1,18,8,4,P04104,MOUSE,66118.3,6.4,64,64.8,108.62,59.05,,637,"Keratin, type II cytoskeletal 1",extracellular space|nucleus|plasma membrane|membrane|extracellular matrix|keratin filament|extracellular exosome|blood microparticle|,"complement activation, lectin pathway|retina homeostasis|negative regulation of inflammatory response|establishment of skin barrier|",structural molecule activity|carbohydrate binding|,4,18,61000000000,2.0%
Q9R0H5,0.018465415,0.98775,17.90783808,3.935666667,0.016188857,3.623687489,,-1.964,,3.351,0.802,1.762,Q9R0H5,Krt71,Q9R0H5_Krt71,Q9R0H5,Krt71,1,1,7,1,Q9R0H5,MOUSE,57895,10.1,64,64.9,88.05,8.21,,524,"Keratin, type II cytoskeletal 71",cytoplasm|keratin filament|extracellular exosome|,hair follicle morphogenesis|intermediate filament organization|,structural molecule activity|,1,1,1520000,2.2%
Q6IME9,0.106564186,-1.223666667,9.997329267,3.014,0.100061515,1.901950225,0.101,-1.641,-6.652,0.157,0.589,0.104,Q6IME9,Krt72,Q6IME9_Krt72,Q6IME9,Krt72,1,2,5,1,Q6IME9,MOUSE,57262.8,7.3,64,64.1,62.07,15.75,,520,"Keratin, type II cytoskeletal 72",keratin filament|extracellular exosome|,,structural molecule activity|,1,2,8300000,2.3%
Q9ESB3,0.000247541,-0.769333333,39.86023279,4.264,0.000103271,7.832185903,-3.65,-2.236,-2.818,2.217,0.965,0.906,Q9ESB3,Hrg,Q9ESB3_Hrg,Q9ESB3,Hrg,1,149,25,25,A0A0R4J039|Q9ESB3,MOUSE,60131.6,42.8,65,65.1,402.8,402.8,,525,Histidine-rich glycoprotein,extracellular region|vesicle|endolysosome|phagolysosome membrane|,angiogenesis|positive regulation of immune response to tumor cell|chemotaxis|negative regulation of cell adhesion|negative regulation of cell proliferation|regulation of gene expression|regulation of platelet activation|negative regulation of lamellipodium assembly|negative regulation of endopeptidase activity|response to organic cyclic compound|heme transport|negative regulation of angiogenesis|platelet activation|regulation of blood coagulation|negative regulation of cell growth|regulation of actin cytoskeleton organization|negative regulation of cell adhesion mediated by integrin|regulation of transcription from RNA polymerase II promoter in response to iron|fibrinolysis|positive regulation of apoptotic process|regulation of protein complex assembly|negative regulation of blood vessel endothelial cell migration|regulation of peptidyl-tyrosine phosphorylation|defense response to fungus|positive regulation of focal adhesion assembly|negative regulation of fibrinolysis|heme export|negative regulation of vascular endothelial growth factor signaling pathway|positive regulation of blood vessel remodeling|negative regulation of endothelial cell chemotaxis|,serine-type endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity|receptor binding|protein binding|heparin binding|zinc ion binding|immunoglobulin binding|heme binding|heparan sulfate proteoglycan binding|metal ion binding|,25,149,4.86E+11,42.8%
P97290,0.00014804,-0.986666667,46.78883557,4.272666667,2.09467E-05,10.01216424,-3.754,-2.56,-3.055,1.486,1.068,0.895,P97290,Serping1,P97290_Serping1,P97290,Serping1,1,110,26,26,P97290|A2ATR8,MOUSE,55868.8,38.8,66,66.1,381.91,381.91,,504,Plasma protease C1 inhibitor,extracellular space|extracellular exosome|blood microparticle|,"negative regulation of complement activation, lectin pathway|complement activation, classical pathway|aging|blood coagulation|negative regulation of endopeptidase activity|fibrinolysis|innate immune response|",serine-type endopeptidase inhibitor activity|,26,110,91700000000,38.8%
Q61247,0.00014804,-1.0725,46.86878918,4.680333333,2.05646E-05,10.0401038,-3.77,-2.58,-3.888,1.545,1.366,0.892,Q61247,Serpinf2,Q61247_Serpinf2,Q61247,Serpinf2,1,134,24,24,Q61247,MOUSE,55199.1,39.9,67,67.1,380.87,380.87,,491,Alpha-2-antiplasmin,fibrinogen complex|extracellular space|cell surface|extracellular exosome|blood microparticle|,regulation of blood vessel size by renin-angiotensin|acute-phase response|response to organic substance|negative regulation of plasminogen activation|negative regulation of endopeptidase activity|collagen fibril organization|positive regulation of collagen biosynthetic process|positive regulation of cell differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of JNK cascade|blood vessel morphogenesis|positive regulation of smooth muscle cell proliferation|positive regulation of stress fiber assembly|negative regulation of fibrinolysis|positive regulation of ERK1 and ERK2 cascade|positive regulation of transforming growth factor beta production|,protease binding|serine-type endopeptidase inhibitor activity|protein homodimerization activity|,24,134,3.75E+11,39.9%
A2A7A7,0.000152335,-0.910333333,45.88378029,3.94,2.58001E-05,9.700644566,-3.494,-2.817,-2.33,1.187,0.906,1.086,A2A7A7,H6pd,A2A7A7_H6pd,A2A7A7,H6pd,1,71,27,27,A2A7A7|Q8CFX1,MOUSE,90478.8,36,68,68.1,372.92,372.92,,797,GDH/6PGL endoplasmic bifunctional protein,mitochondrion|,glucose metabolic process|pentose-phosphate shunt|oxidation-reduction process|response to alcohol|,glucose-6-phosphate dehydrogenase activity|6-phosphogluconolactonase activity|carbohydrate binding|NADP binding|,27,71,15400000000,36.0%
Q9JKR6,0.000438634,-0.844833333,35.84094439,3.701666667,0.000260559,6.75907036,-3.698,-2.754,-1.635,1.016,1.074,0.928,Q9JKR6,Hyou1,Q9JKR6_Hyou1,Q9JKR6,Hyou1,1,65,28,28,Q9JKR6|E0CYZ2,MOUSE,111407.3,30.6,69,69.1,368.82,368.82,,999,Hypoxia up-regulated protein 1,extracellular region|endoplasmic reticulum lumen|focal adhesion|membrane|endoplasmic reticulum chaperone complex|extracellular exosome|,response to ischemia|response to endoplasmic reticulum stress|negative regulation of apoptotic process|cellular response to hypoxia|negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway|negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway|,ATP binding|,28,65,6510000000,30.6%
Q3UER8,0.049002787,-0.034,13.51767237,2.924,0.044486963,2.458341168,0.424,-2.708,-2.204,0.743,3.662,-0.121,Q3UER8,Fgg,Q3UER8_Fgg,Q3UER8,Fgg,1,106,26,26,Q3UER8|Q8VCM7|P12799|F1MGU7|Q3SZZ9,MOUSE,51033.2,55.7,70,70.1,365.71,365.71,,443,Fibrinogen gamma chain,fibrinogen complex|extracellular space|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|,"cell-matrix adhesion|signal transduction|protein secretion|plasminogen activation|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|cellular protein complex assembly|positive regulation of vasoconstriction|positive regulation of exocytosis|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of endothelial cell apoptotic process|","receptor binding|structural molecule activity|protein binding, bridging|cell adhesion molecule binding|",26,106,1.14E+11,55.7%
F8VQ07,0.00014804,-0.9515,46.86678704,4.199,2.05741E-05,10.03940332,-3.665,-2.553,-2.935,1.491,1.06,0.893,F8VQ07,5830473C10Rik,F8VQ07_5830473C10Rik,F8VQ07,5830473C10Rik,1,63,29,29,F8VQ07|A0A0J9YV75,MOUSE,72340.4,41.7,71,71.1,360.29,360.29,,620,RIKEN cDNA 5830473C10 gene,extracellular space|,transport|,,29,63,6460000000,41.7%
Q9QWK4,0.000148189,-0.838,46.71525296,4.214666667,2.13047E-05,9.986511773,-2.745,-2.733,-3.358,1,1.903,0.905,Q9QWK4,Cd5l,Q9QWK4_Cd5l,Q9QWK4,Cd5l,1,101,24,24,Q9QWK4,MOUSE,40345.4,57.1,72,72.1,353.12,353.12,,352,CD5 antigen-like,membrane|extracellular exosome|blood microparticle|,receptor-mediated endocytosis|apoptotic process|,scavenger receptor activity|,24,101,1.82E+11,57.1%
Q8BH61,0.005088686,0.202666667,23.84528936,3.762666667,0.004125447,4.231138765,-0.879,-1.709,-2.448,1.669,3.972,0.611,Q8BH61,F13a1,Q8BH61_F13a1,Q8BH61,F13a1,1,74,24,24,Q8BH61,MOUSE,83719.2,28.4,73,73.1,353.01,353.01,,732,Coagulation factor XIII A chain,cytoplasm|blood microparticle|,blood coagulation|peptide cross-linking|,protein-glutamine gamma-glutamyltransferase activity|metal ion binding|,24,74,14400000000,28.4%
A2AS37,0.000145021,-1.011,48.57612943,4.518666667,1.38799E-05,10.65350951,-3.662,-2.686,-3.463,1.712,1.132,0.901,A2AS37,AI182371,A2AS37_AI182371,A2AS37,AI182371,1,82,22,22,A2AS37,MOUSE,40887.3,52.2,74,74.1,350.48,350.48,,356,Expressed sequence AI182371,extracellular region|,inflammatory response|complement activation|negative regulation of endopeptidase activity|,endopeptidase inhibitor activity|,22,82,76900000000,52.2%
P26928,0.000261034,-1.307833333,39.31120138,4.744333333,0.000117187,7.678062181,-3.568,-2.531,-4.941,1.298,0.964,0.931,P26928,Mst1,P26928_Mst1,P26928,Mst1,1,67,27,27,P26928|E0CXN0,MOUSE,83185.1,39.1,75,75.1,349.98,349.98,,716,Hepatocyte growth factor-like protein,extracellular exosome|,proteolysis|spermatogenesis|embryo implantation|sperm motility|,serine-type endopeptidase activity|,27,67,13400000000,39.1%
P49182,0.000145021,-1.012333333,48.76630279,4.542,1.32852E-05,10.72386497,-3.754,-2.755,-3.341,1.746,1.103,0.927,P49182,Serpind1,P49182_Serpind1,P49182,Serpind1,1,108,24,24,P49182,MOUSE,54781,47.6,76,76.1,349.56,349.56,,478,Heparin cofactor 2,extracellular space|extracellular exosome|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|heparin binding|,24,108,96900000000,47.6%
Q01279,0.000145021,-0.894166667,50.16692079,4.249,9.62294E-06,11.25505945,-3.436,-2.984,-2.636,0.937,1.513,1.241,Q01279,Egfr,Q01279_Egfr,Q01279,Egfr,1,77,25,25,Q01279|Q9WVF5,MOUSE,138274.2,18,77,77.1,343.23,343.23,,1210,Epidermal growth factor receptor,"Golgi membrane|intracellular|nucleus|cytoplasm|endosome|endoplasmic reticulum membrane|plasma membrane|focal adhesion|cell surface|endosome membrane|membrane|integral component of membrane|basolateral plasma membrane|endocytic vesicle|early endosome membrane|nuclear membrane|receptor complex|membrane raft|perinuclear region of cytoplasm|multivesicular body, internal vesicle lumen|",cell morphogenesis|embryonic placenta development|positive regulation of protein phosphorylation|hair follicle development|signal transduction|cell surface receptor signaling pathway|epidermal growth factor receptor signaling pathway|salivary gland morphogenesis|learning or memory|cell proliferation|positive regulation of cell proliferation|epidermis development|single organismal cell-cell adhesion|peptidyl-tyrosine phosphorylation|cerebral cortex cell migration|signal transduction by protein phosphorylation|positive regulation of cell migration|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle|positive regulation of catenin import into nucleus|regulation of cell proliferation|negative regulation of protein catabolic process|positive regulation of phosphorylation|negative regulation of apoptotic process|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of DNA repair|positive regulation of DNA replication|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|positive regulation of fibroblast proliferation|digestive tract morphogenesis|positive regulation of epithelial cell proliferation|regulation of peptidyl-tyrosine phosphorylation|regulation of nitric-oxide synthase activity|positive regulation of protein kinase B signaling|morphogenesis of an epithelial fold|response to UV-A|positive regulation of ERK1 and ERK2 cascade|cellular response to amino acid stimulus|cellular response to epidermal growth factor stimulus|cellular response to estradiol stimulus|,chromatin binding|protein tyrosine kinase activity|receptor signaling protein tyrosine kinase activity|signal transducer activity|transmembrane signaling receptor activity|epidermal growth factor-activated receptor activity|protein binding|ATP binding|kinase activity|enzyme binding|protein phosphatase binding|ubiquitin protein ligase binding|identical protein binding|protein heterodimerization activity|actin filament binding|nitric-oxide synthase regulator activity|,25,77,30600000000,18.0%
Q8BHN3-2,0.000145021,-0.955,50.30018222,4.079333333,9.33215E-06,11.30681932,-3.441,-2.741,-2.802,1.232,1.122,0.9,Q8BHN3,Ganab,Q8BHN3-2_Ganab,Q8BHN3-2,Ganab,1,54,28,28,Q8BHN3-2|Q8BHN3|Q8BHN3-3,MOUSE,109858.4,28.7,78,78.1,336.6,336.6,,944,Isoform 2 of Neutral alpha-glucosidase AB,endoplasmic reticulum|Golgi apparatus|membrane|glucosidase II complex|melanosome|extracellular exosome|,N-glycan processing|,"protein binding|glucosidase activity|carbohydrate binding|glucan 1,3-alpha-glucosidase activity|poly(A) RNA binding|",28,54,6080000000,28.7%
Q8R121,0.000145021,-0.953833333,50.93901059,4.349666667,8.05562E-06,11.5579631,-3.531,-2.725,-3.13,1.386,1.376,0.901,Q8R121,Serpina10,Q8R121_Serpina10,Q8R121,Serpina10,1,79,23,23,Q8R121|Q8R121-2,MOUSE,51910.6,46.8,79,79.1,330.79,330.79,,448,Protein Z-dependent protease inhibitor,extracellular space|extracellular exosome|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|heparin binding|,23,79,25100000000,46.8%
P14211,0.000152509,-1.2065,45.78229849,4.453,2.64101E-05,9.66625182,-4.325,-3.011,-2.963,1.15,0.979,0.931,P14211,Calr,P14211_Calr,P14211,Calr,1,69,24,24,P14211,MOUSE,48164.8,46.3,80,80.1,330.5,330.5,,416,Calreticulin,acrosomal vesicle|extracellular region|extracellular space|nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|Golgi apparatus|cytosol|polysome|focal adhesion|external side of plasma membrane|membrane|extracellular matrix|sarcoplasmic reticulum lumen|MHC class I peptide loading complex|phagocytic vesicle|perinuclear region of cytoplasm|extracellular exosome|,"negative regulation of transcription from RNA polymerase II promoter|peptide antigen assembly with MHC class I protein complex|protein export from nucleus|cell cycle arrest|spermatogenesis|positive regulation of cell proliferation|positive regulation of gene expression|negative regulation of translation|cortical actin cytoskeleton organization|response to estradiol|negative regulation of intracellular steroid hormone receptor signaling pathway|response to testosterone|protein localization to nucleus|regulation of meiotic nuclear division|response to drug|negative regulation of neuron differentiation|positive regulation of DNA replication|positive regulation of cell cycle|negative regulation of transcription, DNA-templated|negative regulation of retinoic acid receptor signaling pathway|positive regulation of phagocytosis|protein stabilization|cardiac muscle cell differentiation|chaperone-mediated protein folding|cellular response to lithium ion|cellular response to organic substance|cellular senescence|positive regulation of substrate adhesion-dependent cell spreading|positive regulation of dendritic cell chemotaxis|",glycoprotein binding|mRNA binding|integrin binding|iron ion binding|calcium ion binding|protein binding|carbohydrate binding|ubiquitin protein ligase binding|peptide binding|hormone binding|poly(A) RNA binding|androgen receptor binding|unfolded protein binding|,24,69,32100000000,46.3%
P39039,0.000165321,-1.120333333,44.02704817,4.482,3.95635E-05,9.087979117,-4.223,-2.517,-3.344,1.365,1.031,0.966,P39039,Mbl1,P39039_Mbl1,P39039,Mbl1,1,115,20,20,P39039|P39039-2|A0A2C9F2B6,MOUSE,25852,66.9,81,81.1,307.81,307.81,,239,Mannose-binding protein A,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|positive regulation of phagocytosis|defense response to Gram-positive bacterium|protein homotetramerization|killing by host of symbiont cells|protein homotrimerization|",protease binding|calcium ion binding|mannose binding|polysaccharide binding|protein homodimerization activity|calcium-dependent protein binding|phosphatidylinositol-4-phosphate binding|,20,115,5.27E+11,66.9%
P08226,0.000145021,-0.986,50.71734062,4.204666667,8.47746E-06,11.47024826,-3.506,-2.667,-3.092,0.934,1.22,1.195,P08226,Apoe,P08226_Apoe,P08226,Apoe,1,75,24,24,P08226,MOUSE,35923,58.8,82,82.1,306.67,306.67,,311,Apolipoprotein E,extracellular region|extracellular space|nucleus|endoplasmic reticulum|Golgi apparatus|cytosol|membrane|extracellular matrix|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,negative regulation of endothelial cell proliferation|response to dietary excess|lipid metabolic process|triglyceride metabolic process|cholesterol biosynthetic process|cholesterol catabolic process|cellular calcium ion homeostasis|receptor-mediated endocytosis|response to oxidative stress|G-protein coupled receptor signaling pathway|nitric oxide mediated signal transduction|cholesterol metabolic process|regulation of gene expression|negative regulation of platelet activation|positive regulation of cholesterol esterification|positive regulation of cholesterol efflux|long-chain fatty acid transport|protein import|virion assembly|triglyceride catabolic process|cGMP-mediated signaling|negative regulation of blood coagulation|regulation of axon extension|positive regulation of cGMP biosynthetic process|regulation of cholesterol transport|regulation of Cdc42 protein signal transduction|positive regulation of low-density lipoprotein particle receptor catabolic process|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|chylomicron remnant clearance|high-density lipoprotein particle clearance|very-low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|vasodilation|cholesterol homeostasis|negative regulation of MAP kinase activity|negative regulation of neuron apoptotic process|negative regulation of blood vessel endothelial cell migration|reverse cholesterol transport|positive regulation by host of viral process|negative regulation of cholesterol biosynthetic process|positive regulation of lipid biosynthetic process|artery morphogenesis|negative regulation of inflammatory response|positive regulation of nitric-oxide synthase activity|positive regulation of membrane protein ectodomain proteolysis|negative regulation of lipid biosynthetic process|maintenance of location in cell|lipid homeostasis|fatty acid homeostasis|positive regulation of dendritic spine development|negative regulation of dendritic spine development|cardiovascular system development|negative regulation of cholesterol efflux|alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering|N-methyl-D-aspartate receptor clustering|regulation of beta-amyloid clearance|regulation of neuron death|negative regulation of neuron death|positive regulation of neuron death|negative regulation of postsynaptic membrane organization|positive regulation of postsynaptic membrane organization|negative regulation of presynaptic membrane organization|positive regulation of presynaptic membrane organization|positive regulation of beta-amyloid formation|negative regulation of beta-amyloid formation|regulation of tau-protein kinase activity|negative regulation of dendritic spine maintenance|positive regulation of dendritic spine maintenance|positive regulation of phospholipid efflux|positive regulation of neurofibrillary tangle assembly|negative regulation of phospholipid efflux|negative regulation of lipid transport across blood brain barrier|positive regulation of lipid transport across blood brain barrier|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|heparin binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|identical protein binding|protein homodimerization activity|metal chelating activity|tau protein binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|very-low-density lipoprotein particle receptor binding|lipoprotein particle binding|,24,75,33300000000,58.8%
P00920,0.000288867,-0.642666667,38.51840732,3.846,0.000140656,7.459860438,-3.5,-2.386,-1.811,1.651,0.867,1.323,P00920,Car2,P00920_Car2,P00920,Ca2,1,51,18,18,P00920|A0A0A6YX78|P00921,MOUSE,29146.1,66.5,83,83.1,306.31,306.31,,260,Carbonic anhydrase 2,extracellular space|cytoplasm|cytosol|plasma membrane|microvillus|basolateral plasma membrane|axon|myelin sheath|apical part of cell|extracellular exosome|,"kidney development|morphogenesis of an epithelium|one-carbon metabolic process|regulation of pH|response to pH|response to zinc ion|carbon dioxide transport|positive regulation of synaptic transmission, GABAergic|positive regulation of cellular pH reduction|angiotensin-activated signaling pathway|odontogenesis of dentin-containing tooth|response to estrogen|regulation of anion transport|positive regulation of osteoclast differentiation|positive regulation of bone resorption|secretion|regulation of intracellular pH|cellular response to fluid shear stress|positive regulation of dipeptide transmembrane transport|regulation of chloride transport|",arylesterase activity|carbonate dehydratase activity|zinc ion binding|,18,51,8390000000,66.5%
Q3U3V1,0.000165321,-1.276833333,44.01259449,4.895,3.96954E-05,9.083344659,-3.913,-2.685,-4.575,1.529,1.068,0.915,Q3U3V1,F10,Q3U3V1_F10,Q3U3V1,F10,1,75,20,20,Q3U3V1|O88947|D3Z215|D3Z521,MOUSE,56680.8,40.9,84,84.1,305.63,305.63,,493,Coagulation factor X,extracellular region|membrane|intracellular membrane-bounded organelle|,proteolysis|blood coagulation|positive regulation of protein kinase B signaling|,serine-type endopeptidase activity|calcium ion binding|phospholipid binding|,20,75,69400000000,40.9%
Q64726,0.000148189,-0.9375,46.13564746,4.421666667,2.43464E-05,9.786468232,-3.478,-2.418,-3.549,1.691,1.254,0.875,Q64726,Azgp1,Q64726_Azgp1,Q64726,Azgp1,1,63,21,21,Q64726,MOUSE,35559.5,53.7,85,85.1,300.68,300.68,,307,Zinc-alpha-2-glycoprotein,extracellular space|nucleus|plasma membrane|MHC class I protein complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|antigen processing and presentation of peptide antigen via MHC class I|immune response|cell adhesion|regulation of multicellular organism growth|,glycoprotein binding|peptide antigen binding|,21,63,31600000000,53.7%
P23953,0.000199576,-1.237,41.62938228,4.726,6.87166E-05,8.346257337,-3.684,-2.522,-4.594,1.494,0.968,0.916,P23953,Ces1c,P23953_Ces1c,P23953,Ces1c,1,58,20,12,P23953|Q8VCT4|E9PYP1,MOUSE,61339.9,34.1,86,86.1,296.6,187.34,,554,Carboxylesterase 1C,extracellular space|endoplasmic reticulum lumen|,metabolic process|,"hydrolase activity, acting on ester bonds|carboxylic ester hydrolase activity|",20,58,17000000000,34.1%
D3Z5G7,0.000259707,-0.732166667,39.52413611,3.702333333,0.00011158,7.737540681,-3.442,-2.384,-1.924,1.465,1,0.892,D3Z5G7,Ces1b,D3Z5G7_Ces1b,D3Z5G7,Ces1b,1,11,16,7,D3Z5G7,MOUSE,62538.2,31.3,86,86.2,224.92,99.04,,567,Carboxylic ester hydrolase,,metabolic process|,hydrolase activity|,7,11,774000000,17.6%
Q8VCC2,0.000627085,0.10725,33.99818743,4.720333333,0.000398273,8.347580105,,-3.433,,1.438,1.492,0.932,Q8VCC2,Ces1g,Q8VCC2_Ces1g,Q8VCC2,Ces1,1,1,4,1,Q8VCC2,MOUSE,63078.1,7.4,86,86.3,55.01,10.07,,565,Liver carboxylesterase 1,endoplasmic reticulum lumen|,metabolic process|,carboxylic ester hydrolase activity|,1,1,10700000,2.1%
Q8BK48,0.000145021,-0.996166667,48.33365162,4.252333333,1.46769E-05,10.56440431,-3.625,-2.542,-3.2,1.316,1.188,0.886,Q8BK48,Ces2e,Q8BK48_Ces2e,Q8BK48,Ces2e,1,70,20,15,Q8BK48|F6Z9B9|Q08ED5|Q149K3,MOUSE,62716,39.1,87,87.1,295.77,229.97,,559,Pyrethroid hydrolase Ces2e,endoplasmic reticulum|,metabolic process|,carboxylic ester hydrolase activity|,20,70,14100000000,39.1%
Q91WG0,0.000510464,-0.845166667,35.03903643,3.787666667,0.000313398,6.559452165,-3.984,-1.986,-2.247,1.35,0.921,0.875,Q91WG0,Ces2c,Q91WG0_Ces2c,Q91WG0,Ces2c,1,15,14,7,Q91WG0,MOUSE,62753.8,26.7,87,87.2,193.78,97.8,,561,Acylcarnitine hydrolase,endoplasmic reticulum|intracellular membrane-bounded organelle|,metabolic process|,acylcarnitine hydrolase activity|,7,15,506000000,13.5%
Q8QZR3,0.000165808,-0.7596,43.33827032,4.573166667,4.63632E-05,10.37070364,-3.91,-3.097,,1.268,1.004,0.937,Q8QZR3,Ces2a,Q8QZR3_Ces2a,Q8QZR3,Ces2a,1,12,10,5,Q8QZR3|Q8QZR3-2,MOUSE,62395.6,17.7,87,87.3,133.23,69.99,,558,Pyrethroid hydrolase Ces2a,,,carboxylic ester hydrolase activity|,5,12,575000000,10.2%
Q6PDB7,0.009589239,-0.940833333,20.90422498,3.265,0.008120401,3.691453075,-3.252,-0.505,-3.963,1.19,0.374,0.511,Q6PDB7,Ces2b,Q6PDB7_Ces2b,Q6PDB7,Ces2b,1,1,9,1,Q6PDB7,MOUSE,62211.2,16,87,87.4,113.1,7.68,,556,Carboxylic ester hydrolase,,metabolic process|,hydrolase activity|,1,1,16900000,2.5%
Q61704,0.000318063,-0.638333333,37.82066506,3.498,0.000165171,7.271965972,-3.031,-2.632,-1.499,1.433,0.992,0.907,Q61704,Itih3,Q61704_Itih3,Q61704,Itih3,1,63,22,22,Q61704,MOUSE,99698.3,25.3,88,88.1,294.79,294.79,,889,Inter-alpha-trypsin inhibitor heavy chain H3,extracellular exosome|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,22,63,25700000000,25.3%
A11111,0.000153199,-1.179666667,45.34841416,4.497333333,2.91849E-05,9.520407129,-4.127,-2.583,-3.575,1.34,0.963,0.904,A11111,NotFound,A11111_NotFound,A11111,,1,47,19,19,A11111|P06709,MOUSE,39099.5,69.3,89,89.1,287.99,287.99,,,BirAG3ER,,,,19,47,1.93E+11,69.3%
P63260,0.005453006,-0.9585,23.51175699,3.399,0.00445476,4.168128885,-2.788,-0.896,-4.29,0.899,0.539,0.785,P63260,Actg1,P63260_Actg1,P63260,Actg1,1,58,20,1,P63260|G3UYG0|B1ATY1|Q8BFZ3|V9GXQ2,MOUSE,42134.4,49.6,90,90.1,287.72,23.1,,375,"Actin, cytoplasmic 2",extracellular space|nucleus|cytosol|plasma membrane|focal adhesion|actin cytoskeleton|membrane|myofibril|filamentous actin|costamere|myelin sheath|extracellular exosome|blood microparticle|dense body|,retina homeostasis|sarcomere organization|response to calcium ion|platelet aggregation|,structural constituent of cytoskeleton|protein binding|ATP binding|ubiquitin protein ligase binding|identical protein binding|,20,58,19900000000,49.6%
P60710,0.011238884,-0.3654,20.16403928,3.085166667,0.00962933,3.789443113,-3.55,-0.883,,1.143,0.658,0.805,P60710,Actb,P60710_Actb,P60710,Actb,1,3,20,1,P60710|E9Q1F2,MOUSE,42078.3,49.6,90,90.2,285.05,20.43,,375,"Actin, cytoplasmic 1",nuclear chromatin|extracellular space|cytosol|plasma membrane|focal adhesion|membrane|ribonucleoprotein complex|cortical cytoskeleton|NuA4 histone acetyltransferase complex|cytoplasmic ribonucleoprotein granule|myelin sheath|protein complex|extracellular exosome|MLL5-L complex|blood microparticle|dense body|,retina homeostasis|substantia nigra development|ATP-dependent chromatin remodeling|platelet aggregation|,protein binding|ATP binding|kinesin binding|Tat protein binding|identical protein binding|nitric-oxide synthase binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,1,3,224000000,4.5%
P68134,0.000676049,-0.1784,33.57066897,3.239333333,0.000439474,6.939628157,-1.776,-2.468,,1.58,0.873,0.899,P68134,Acta1,P68134_Acta1,P68134,Acta1,1,4,16,3,P68134|P68033|P62737|P63268,MOUSE,42392.6,39.5,90,90.3,215.77,28.71,,377,"Actin, alpha skeletal muscle",stress fiber|extracellular space|cytoplasm|striated muscle thin filament|actin filament|actin cytoskeleton|sarcomere|lamellipodium|filopodium|protein complex|cell body|extracellular exosome|blood microparticle|,response to mechanical stimulus|response to extracellular stimulus|response to lithium ion|positive regulation of gene expression|cell growth|skeletal muscle thin filament assembly|skeletal muscle fiber adaptation|response to steroid hormone|skeletal muscle fiber development|mesenchyme migration|,protein binding|ATP binding|,3,4,872000000,12.9%
E9Q557,0.095216977,-0.6845,10.50361219,2.043666667,0.089050996,1.981918332,-0.105,-0.781,-4.233,0.098,0.586,0.328,E9Q557,Dsp,E9Q557_Dsp,E9Q557,Dsp,1,45,31,31,E9Q557|E9PZW0,MOUSE,335359.7,9.6,91,91.1,284.66,284.66,,2883,Desmoplakin,cornified envelope|nucleus|cytoplasm|plasma membrane|cell-cell junction|fascia adherens|intercalated disc|membrane|basolateral plasma membrane|desmosome|extracellular exosome|intermediate filament|,desmosome organization|ventricular compact myocardium morphogenesis|single organismal cell-cell adhesion|peptide cross-linking|keratinocyte differentiation|adherens junction organization|wound healing|skin development|intermediate filament cytoskeleton organization|intermediate filament organization|protein localization to adherens junction|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,"protein kinase C binding|structural molecule activity|protein binding|protein binding, bridging|poly(A) RNA binding|cell adhesion molecule binding|scaffold protein binding|",31,45,1180000000,9.6%
Q07456,0.000145021,-1.0775,51.07903408,4.446333333,7.80004E-06,11.61368504,-3.732,-2.913,-3.257,1.5,1.013,0.924,Q07456,Ambp,Q07456_Ambp,Q07456,Ambp,1,62,18,18,Q07456,MOUSE,39941.4,48.7,92,92.1,280.99,280.99,,349,Protein AMBP,extracellular space|plasma membrane|cell surface|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|protein-chromophore linkage|protein catabolic process|protein maturation|,serine-type endopeptidase inhibitor activity|IgA binding|heme binding|small molecule binding|protein homodimerization activity|,18,62,59600000000,48.7%
P97298,0.000230198,-1.347333333,40.38823553,4.974666667,9.14485E-05,7.982787155,-3.93,-2.576,-4.998,1.41,1.1,0.91,P97298,Serpinf1,P97298_Serpinf1,P97298,Serpinf1,1,61,17,17,P97298|E9PWS2,MOUSE,46290.3,51,93,93.1,276.77,276.77,,417,Pigment epithelium-derived factor,extracellular region|basement membrane|extracellular space|melanosome|axon hillock|perinuclear region of cytoplasm|extracellular exosome|extracellular matrix|,kidney development|aging|short-term memory|response to acidic pH|negative regulation of endothelial cell migration|negative regulation of gene expression|negative regulation of endopeptidase activity|positive regulation of neuron projection development|negative regulation of angiogenesis|ovulation cycle|response to arsenic-containing substance|negative regulation of inflammatory response|positive regulation of neurogenesis|retina development in camera-type eye|negative regulation of epithelial cell proliferation involved in prostate gland development|cellular response to cobalt ion|cellular response to retinoic acid|cellular response to glucose stimulus|cellular response to dexamethasone stimulus|negative regulation of neuron death|,serine-type endopeptidase inhibitor activity|,17,61,13000000000,51.0%
O70165,0.000165321,-1.0735,43.94312505,4.412333333,4.03355E-05,9.061098227,-4.237,-2.735,-2.867,1.165,1.338,0.895,O70165,Fcna,O70165_Fcna,O70165,Fcn1,1,66,18,18,O70165,MOUSE,36868.4,38.9,94,94.1,272.41,272.41,,334,Ficolin-1,collagen trimer|extrinsic component of external side of plasma membrane|blood microparticle|,cell surface pattern recognition receptor signaling pathway|G-protein coupled receptor signaling pathway|recognition of apoptotic cell|negative regulation of viral entry into host cell|defense response to virus|negative regulation of RNA biosynthetic process|positive regulation of interleukin-8 secretion|,antigen binding|protein binding|signaling pattern recognition receptor activity|carbohydrate binding|metal ion binding|carbohydrate derivative binding|,18,66,65200000000,38.9%
P70389,0.00017017,-0.8255,43.09633486,3.620333333,4.90192E-05,8.793664572,-3.26,-2.629,-2.018,0.982,0.998,0.974,P70389,Igfals,P70389_Igfals,P70389,Igfals,1,47,21,21,A0A0R4J0S2|P70389,MOUSE,67757.5,39.6,95,95.1,268.23,268.23,,603,Insulin-like growth factor-binding protein complex acid labile subunit,nucleoplasm|insulin-like growth factor ternary complex|extracellular exosome|,cell adhesion|,,21,47,5130000000,39.6%
P41317,0.000165321,-1.5425,43.50192302,5.375,4.46486E-05,8.920901027,-4.476,-2.96,-5.254,1.343,1.162,0.93,P41317,Mbl2,P41317_Mbl2,P41317,Mbl2,1,77,16,16,P41317,MOUSE,26356,59,96,96.1,264.96,264.96,,244,Mannose-binding protein C,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|innate immune response|negative regulation of viral process|positive regulation of phagocytosis|defense response to Gram-positive bacterium|killing by host of symbiont cells|",receptor binding|calcium ion binding|mannose binding|calcium-dependent protein binding|,16,77,1.52E+11,59.0%
P16294,0.000165321,-0.8072,43.75460151,4.909666667,4.2125E-05,10.5453907,-4.22,-3.286,,1.409,1.133,0.928,P16294,F9,P16294_F9,P16294,F9,1,55,16,16,P16294,MOUSE,54289.1,42,97,97.1,264.2,264.2,,471,Coagulation factor IX,extracellular space|extracellular exosome|,proteolysis|blood coagulation|zymogen activation|,endopeptidase activity|serine-type endopeptidase activity|calcium ion binding|peptidase activity|,16,55,37800000000,42.0%
Q03311,0.000894816,-1.682166667,32.10256722,5.699666667,0.000616231,5.973584827,-3.977,-2.836,-6.783,1.357,1.24,0.906,Q03311,Bche,Q03311_Bche,Q03311,Bche,1,50,18,18,Q03311,MOUSE,68974.5,27.3,98,98.1,263.72,263.72,,603,Cholinesterase,nuclear envelope lumen|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|blood microparticle|,learning|negative regulation of cell proliferation|neuroblast differentiation|choline metabolic process|response to drug|response to alkaloid|negative regulation of synaptic transmission|response to glucocorticoid|response to folic acid|,acetylcholinesterase activity|cholinesterase activity|choline binding|identical protein binding|,18,50,15100000000,27.3%
Q9JHH6,0.000156464,-0.7025,45.03473931,4.089666667,3.13708E-05,9.416169698,-3.34,-2.718,-2.184,1.586,1.548,0.893,Q9JHH6,Cpb2,Q9JHH6_Cpb2,Q9JHH6,Cpb2,1,58,18,18,Q9JHH6,MOUSE,49269,36.7,99,99.1,263.13,263.13,,422,Carboxypeptidase B2,extracellular space|cell|extracellular exosome|,positive regulation of extracellular matrix constituent secretion|proteolysis|blood coagulation|response to heat|negative regulation of plasminogen activation|response to drug|fibrinolysis|negative regulation of fibrinolysis|cellular response to glucose stimulus|liver regeneration|negative regulation of hepatocyte proliferation|,carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding|,18,58,26600000000,36.7%
Q02819,0.000145021,-1.145833333,48.06718459,4.358333333,1.56056E-05,10.46725361,-3.47,-2.639,-3.866,0.935,1.165,1,Q02819,Nucb1,Q02819_Nucb1,Q02819,Nucb1,1,40,21,21,Q02819|A0A1C7CYU3,MOUSE,53407.7,44.4,100,100.1,262.31,262.31,,459,Nucleobindin-1,extracellular space|nucleus|early endosome|rough endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi-associated vesicle|cis-Golgi network|trans-Golgi network|microtubule cytoskeleton|membrane|Golgi cisterna membrane|extracellular exosome|extrinsic component of Golgi membrane|lumenal side of Golgi membrane|,response to cisplatin|regulation of protein targeting|,G-protein alpha-subunit binding|DNA binding|calcium ion binding|,21,40,3260000000,44.4%
P35917,0.000145021,-1.1295,53.52714455,4.326333333,4.439E-06,12.62856498,-3.379,-2.942,-3.557,1.033,1.141,0.927,P35917,Flt4,P35917_Flt4,P35917,Flt4,1,35,19,19,P35917,MOUSE,155124.7,15.7,101,101.1,261.04,261.04,,1363,Vascular endothelial growth factor receptor 3,nucleus|cytoplasm|plasma membrane|integral component of plasma membrane|receptor complex|,positive regulation of protein phosphorylation|positive regulation of endothelial cell proliferation|vasculature development|lymph vessel development|lymphangiogenesis|sprouting angiogenesis|positive regulation of cell proliferation|positive regulation of vascular endothelial growth factor production|positive regulation of endothelial cell migration|peptidyl-tyrosine phosphorylation|cellular response to vascular endothelial growth factor stimulus|vascular endothelial growth factor signaling pathway|negative regulation of apoptotic process|positive regulation of MAPK cascade|positive regulation of JNK cascade|protein autophosphorylation|vascular endothelial growth factor receptor signaling pathway|blood vessel morphogenesis|regulation of blood vessel remodeling|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein kinase C signaling|,transmembrane receptor protein tyrosine kinase activity|vascular endothelial growth factor-activated receptor activity|protein binding|ATP binding|growth factor binding|protein phosphatase binding|,19,35,2650000000,15.7%
P29699,0.000201384,-0.9455,41.54854349,4.078333333,7.00077E-05,8.322171101,-3.958,-2.594,-2.402,1.303,1.059,0.919,P29699,Ahsg,P29699_Ahsg,P29699,Ahsg,1,86,17,17,P29699,MOUSE,38123.7,63.1,102,102.1,255.32,255.32,,345,Alpha-2-HS-glycoprotein,extracellular space|extracellular exosome|blood microparticle|,ossification|acute-phase response|negative regulation of endopeptidase activity|negative regulation of bone mineralization|regulation of inflammatory response|positive regulation of phagocytosis|,cysteine-type endopeptidase inhibitor activity|,17,86,2.16E+11,63.1%
O70570,0.000145021,-0.975666667,51.58467703,4.047333333,6.94276E-06,11.81695265,-2.984,-2.718,-3.296,1.222,0.891,1.031,O70570,Pigr,O70570_Pigr,O70570,Pigr,1,35,18,18,O70570,MOUSE,86309.5,27.2,103,103.1,253.96,253.96,,771,Polymeric immunoglobulin receptor,extracellular space|plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|epidermal growth factor receptor signaling pathway|Fc receptor signaling pathway|receptor clustering|,polymeric immunoglobulin receptor activity|,18,35,2440000000,27.2%
P00761,0.00369417,-0.165333333,25.29315066,1.464666667,0.002955867,4.450436897,-0.647,-0.916,-1.13,0.649,0.507,0.545,P00761,NotFound,P00761_NotFound,P00761,,1,275,14,13,P00761|B99908,PIG,25093.7,64,104,104.1,251.12,234.92,,231,Trypsin,,,,14,275,4.01E+13,64.0%
B99907,0.001096862,-0.2605,31.05651643,2.123666667,0.000784058,5.631632092,-0.994,-1.161,-1.812,1.054,0.762,0.588,B99907,NotFound,B99907_NotFound,B99907,,1,46,5,4,B99907,PromTArt7,5560.1,98,104,104.2,101.82,85.62,,50,"Promega trypsin artifact 2 K to R mods +28 (2239.1, 2914)(1987, 2003) [Sus scrofa]",,,,4,46,46900000000,98.0%
P29788,0.000157801,-0.720666667,44.9160176,3.744,3.22402E-05,9.376977329,-2.901,-2.815,-2.062,1.55,0.976,0.928,P29788,Vtn,P29788_Vtn,P29788,Vtn,1,86,16,16,P29788,MOUSE,55646.8,34.5,105,105.1,246.52,246.52,,478,Vitronectin,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|blood microparticle|extracellular matrix|,receptor-mediated endocytosis|immune response|cell-matrix adhesion|positive regulation of cell-substrate adhesion|negative regulation of endopeptidase activity|positive regulation of smooth muscle cell migration|extracellular matrix organization|positive regulation of protein binding|cell adhesion mediated by integrin|endodermal cell differentiation|positive regulation of receptor-mediated endocytosis|oligodendrocyte differentiation|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell-matrix adhesion|,scavenger receptor activity|integrin binding|heparin binding|polysaccharide binding|extracellular matrix binding|,16,86,1.7E+11,34.5%
Q61730-2,0.000165808,-0.857833333,43.40895072,3.957666667,4.56147E-05,8.891596592,-3.571,-2.644,-2.295,1.487,0.906,0.97,Q61730,Il1rap,Q61730-2_Il1rap,Q61730-2,Il1rap,1,42,19,19,Q61730-2|Q61730-3|E9Q6I2|Q61730|G3UY13,MOUSE,42194.2,44.1,106,106.1,245.79,245.79,,570,Isoform 2 of Interleukin-1 receptor accessory protein,extracellular region|plasma membrane|membrane|integral component of membrane|,inflammatory response|cytokine-mediated signaling pathway|interleukin-2 biosynthetic process|innate immune response|,signal transducer activity|interleukin-1 receptor activity|protein binding|,19,42,5900000000,44.1%
A0A0A6YXW6,0.000148189,-0.969,46.56688906,4.736,2.20451E-05,9.934965486,-3.637,-2.869,-3.505,1.006,0.959,2.232,A0A0A6YXW6,NotFound,A0A0A6YXW6_NotFound,A0A0A6YXW6,Igha,1,65,12,3,A0A0A6YXW6,MOUSE,42869.8,39,107,107.1,243.25,52.76,,389,Immunoglobulin heavy constant alpha (Fragment),,,,12,65,77600000000,39.0%
P01878,0.002279552,0.51725,27.57285235,3.907,0.001748698,6.060104949,,-2.413,,1.586,0.929,1.967,P01878,NotFound,P01878_NotFound,P01878,,1,2,10,1,P01878,MOUSE,37616.9,40.4,107,107.2,197.17,6.68,,344,Ig alpha chain C region,,,antigen binding|immunoglobulin receptor binding|,1,2,30200000,6.3%
P70375,0.001234626,-0.7115,30.50501447,3.652333333,0.000890222,5.510892662,-3.731,-2.783,-1.099,1.258,1.154,0.932,P70375,F7,P70375_F7,P70375,F7,1,74,19,19,P70375,MOUSE,51701.8,36.9,108,108.1,242.95,242.95,,446,Coagulation factor VII,extracellular region|extracellular space|vesicle|,positive regulation of leukocyte chemotaxis|proteolysis|blood coagulation|circadian rhythm|positive regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of blood coagulation|organ regeneration|response to vitamin K|response to estrogen|positive regulation of positive chemotaxis|positive regulation of protein kinase B signaling|response to growth hormone|,glycoprotein binding|serine-type endopeptidase activity|receptor binding|calcium ion binding|,19,74,22400000000,36.9%
Q06194,0.000240734,-1.311666667,40.02039875,4.727333333,9.95314E-05,7.877620931,-3.27,-2.761,-4.995,1.12,1.137,0.899,Q06194,F8,Q06194_F8,Q06194,F8,1,32,21,21,Q06194|B2RRC9,MOUSE,267560.2,8.5,109,109.1,242.2,242.2,,2319,Coagulation factor VIII,extracellular space|,acute-phase response|platelet activation|oxidation-reduction process|,copper ion binding|oxidoreductase activity|,21,32,1980000000,8.5%
Q9QWL7,0.128067996,-0.571666667,9.187531365,1.650666667,0.120572111,1.773579271,0.222,-0.832,-3.581,-0.108,0.472,0.397,Q9QWL7,Krt17,Q9QWL7_Krt17,Q9QWL7,Krt17,1,74,20,6,Q9QWL7|Q9D312|Q8CCX5|Q8CCX5-2|Q99PS0,MOUSE,48446.3,33.9,110,110.1,239.59,73.93,,433,"Keratin, type I cytoskeletal 17",cytoplasm|intermediate filament|extracellular exosome|cell periphery|,morphogenesis of an epithelium|signal transduction|positive regulation of cell growth|hair follicle morphogenesis|keratinization|intermediate filament organization|positive regulation of translation|positive regulation of hair follicle development|,structural molecule activity|protein binding|MHC class II receptor activity|MHC class II protein binding|,21,74,2.29E+11,33.9%
Q61781,0.000579056,-0.479333333,34.4042735,2.474,0.000362721,6.404620947,-1.685,-1.222,-2.242,0.801,0.606,0.866,Q61781,Krt14,Q61781_Krt14,Q61781,Krt14,1,3,20,3,Q61781|Q9Z320|Q8VCW2,MOUSE,53208.4,35.7,110,110.2,236.5,29.07,,484,"Keratin, type I cytoskeletal 14",intracellular|nucleus|cytoplasm|intermediate filament|keratin filament|extracellular exosome|cell periphery|,aging|response to zinc ion|response to ionizing radiation|epithelial cell differentiation|hair cycle|intermediate filament bundle assembly|,structural molecule activity|protein binding|keratin filament binding|,3,3,13800000,7.2%
Q6IFX2,0.144612657,-1.210333333,8.625542669,3.033333333,0.137228948,1.683964911,0.127,-1.016,-7.292,-0.143,0.587,0.475,Q6IFX2,Krt42,Q6IFX2_Krt42,Q6IFX2,Krt42,1,8,20,5,Q6IFX2,MOUSE,50474.5,30.5,110,110.3,214.31,46.8,,452,"Keratin, type I cytoskeletal 42",cytoplasm|intermediate filament|,,structural molecule activity|,5,8,1270000000,7.3%
Q9Z2K1,0.144847905,-0.5715,8.612787902,1.609666667,0.137632567,1.681924556,0.168,-0.632,-3.665,-0.136,0.284,0.552,Q9Z2K1,Krt16,Q9Z2K1_Krt16,Q9Z2K1,Krt16,1,11,15,6,Q9Z2K1,MOUSE,52004.9,23.6,110,110.4,181.07,82.81,,469,"Keratin, type I cytoskeletal 16",nucleus|cytoskeleton|intermediate filament|extracellular exosome|,morphogenesis of an epithelium|inflammatory response|aging|keratinocyte differentiation|negative regulation of cell migration|keratinization|hair cycle|innate immune response|intermediate filament cytoskeleton organization|keratinocyte migration|establishment of skin barrier|,structural constituent of cytoskeleton|protein binding|,6,11,2660000000,11.5%
P08730,0.006065485,-0.355333333,23.0049469,4.144666667,0.005006167,4.073308483,-1.957,-1.286,-4.04,0.733,0.784,3.634,P08730,Krt13,P08730_Krt13,P08730,Krt13,1,4,14,3,P08730|P08730-2,MOUSE,48095.6,19.6,110,110.5,151.6,25.83,,437,"Keratin, type I cytoskeletal 13",nucleus|keratin filament|intermediate filament cytoskeleton|extracellular exosome|,cytoskeleton organization|response to radiation|tongue morphogenesis|cellular response to retinoic acid|,structural molecule activity|protein binding|,3,4,462000000,5.9%
O77727,0.011375604,-0.6725,20.10521875,2.874333333,0.009760636,3.550584786,-0.567,-1.858,-3.904,0.613,1.009,0.672,O77727,NotFound,O77727_NotFound,O77727,KRT15,1,16,12,4,O77727,SHEEP,48769.2,18.3,110,110.6,153.11,49.61,,453,"Keratin, type I cytoskeletal 15",,,,4,16,9220000000,5.7%
P02535,0.045346244,-0.631833333,13.87836219,2.103,0.040941503,2.515819496,-0.071,-1.476,-3.503,0.178,0.82,0.261,P02535,Krt10,P02535_Krt10,P02535,Krt10,1,33,11,7,P02535|P02535-2|A2A513|P02535-3,MOUSE,57940,16.6,110,110.7,167.52,109.55,,570,"Keratin, type I cytoskeletal 10",keratin filament|,epithelial cell differentiation|cellular response to calcium ion|,structural molecule activity|protein binding|,7,33,1.06E+11,11.7%
B1AQ77,0.082836655,0.272,11.16674782,1.734166667,0.076440799,2.151166369,-1.494,-0.043,,2.22,0.041,0.636,B1AQ77,Krt15,B1AQ77_Krt15,B1AQ77,Krt15,1,1,9,1,B1AQ77|Q61414,MOUSE,49664.3,11.4,110,110.8,110.68,7.38,,456,"Keratin 15, isoform CRA_a",nucleus|intermediate filament|extracellular exosome|,activation of mitophagy in response to mitochondrial depolarization|,structural molecule activity|scaffold protein binding|,1,1,32700000,3.9%
P19001,0.054072379,-0.729166667,13.07822691,2.018333333,0.049224046,2.388520141,-0.189,-1.345,-3.681,0.153,0.363,0.324,P19001,Krt19,P19001_Krt19,P19001,Krt19,1,2,6,1,P19001,MOUSE,44541,11.4,110,110.9,76.3,9.39,,403,"Keratin, type I cytoskeletal 19",intermediate filament|plasma membrane|dystrophin-associated glycoprotein complex|Z disc|sarcolemma|costamere|extracellular exosome|cell periphery|terminal web|,Notch signaling pathway|response to estrogen|sarcomere organization|cell differentiation involved in embryonic placenta development|,protein binding|structural constituent of muscle|protein complex binding|,1,2,45800000,2.9%
Q9BGM5,0.083574327,-0.692666667,11.11653845,1.845333333,0.07732967,2.078589863,0.166,-1.454,-3.558,0.132,0.528,0.03,Q9BGM5,NotFound,Q9BGM5_NotFound,Q9BGM5,KRT25,1,7,2,1,Q9BGM5,SHEEP,49883,4,110,110.1,31.83,17.44,,450,"Keratin, type I cytoskeletal 25",,,,1,7,18600000000,2.0%
Q9CQF9,0.000145021,-1.0405,51.06999702,4.179666667,7.81628E-06,11.61008138,-3.154,-2.73,-3.507,1.217,1.025,0.906,Q9CQF9,Pcyox1,Q9CQF9_Pcyox1,Q9CQF9,Pcyox1,1,37,17,17,Q9CQF9|A0A0N4SWD3,MOUSE,56721.9,40.3,111,111.1,238.91,238.91,,505,Prenylcysteine oxidase,lysosome|vacuolar membrane|plasma membrane|very-low-density lipoprotein particle|extracellular exosome|,prenylated protein catabolic process|prenylcysteine catabolic process|oxidation-reduction process|chloride transmembrane transport|,prenylcysteine oxidase activity|chloride-transporting ATPase activity|,17,37,2950000000,40.3%
P08607,0.000304926,-0.800833333,38.09861129,3.755,0.000154931,7.346355835,-3.502,-2.844,-1.689,1.161,0.89,1.179,P08607,C4bp,P08607_C4bp,P08607,C4bpa,1,51,15,15,P08607|E9PUZ8,MOUSE,53006.2,32.4,112,112.1,238.41,238.41,,469,C4b-binding protein,extracellular region|,"complement activation, classical pathway|innate immune response|",protein binding|,15,51,23900000000,32.4%
Q9DBB9,0.000145021,-1.255,51.08002446,4.833333333,7.79826E-06,11.61408003,-3.649,-3.089,-4.277,1.394,1.153,0.938,Q9DBB9,Cpn2,Q9DBB9_Cpn2,Q9DBB9,Cpn2,1,71,16,16,Q9DBB9,MOUSE,61333.9,34.1,113,113.1,236.74,236.74,,547,Carboxypeptidase N subunit 2,extracellular exosome|blood microparticle|,,,16,71,37200000000,34.1%
Q9R1E6-2,0.000165808,-0.9005,43.3475956,4.305,4.62637E-05,8.872302915,-3.165,-2.377,-3.617,1.922,0.964,0.87,Q9R1E6,Enpp2,Q9R1E6-2_Enpp2,Q9R1E6-2,Enpp2,1,33,18,18,Q9R1E6-2|G3UXY9|Q9R1E6-3|Q9R1E6,MOUSE,106969.5,23.8,114,114.1,236.63,236.63,,862,Isoform 2 of Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,extracellular space|integral component of plasma membrane|,receptor-mediated endocytosis|chemotaxis|immune response|phospholipid catabolic process|positive regulation of epithelial cell migration|regulation of cell migration|phosphatidylcholine catabolic process|regulation of angiogenesis|positive regulation of peptidyl-tyrosine phosphorylation|nucleic acid phosphodiester bond hydrolysis|positive regulation of lamellipodium morphogenesis|,nucleic acid binding|phosphodiesterase I activity|nucleotide diphosphatase activity|lysophospholipase activity|scavenger receptor activity|calcium ion binding|zinc ion binding|polysaccharide binding|alkylglycerophosphoethanolamine phosphodiesterase activity|,18,33,3470000000,23.8%
P46412,0.000145021,-1.5005,47.95136976,5.161,1.60274E-05,10.42527845,-4.399,-3.092,-4.752,1.229,0.961,1.05,P46412,Gpx3,P46412_Gpx3,P46412,Gpx3,1,119,17,17,P46412|P21765,MOUSE,25581.2,48.2,115,115.1,233.57,233.57,,226,Glutathione peroxidase 3,extracellular space|extracellular exosome|,response to oxidative stress|hydrogen peroxide catabolic process|protein homotetramerization|oxidation-reduction process|,glutathione peroxidase activity|selenium binding|,17,119,3E+11,48.2%
Q9Z0Z4,0.000237548,-1.387333333,40.14507393,4.795333333,9.67147E-05,7.913137651,-3.337,-2.884,-5.134,1.119,0.987,0.925,Q9Z0Z4,Heph,Q9Z0Z4_Heph,Q9Z0Z4,Heph,1,30,18,18,Q9Z0Z4|Q9Z0Z4-2|A2AI62,MOUSE,130576.7,19.3,116,116.1,232.18,232.18,,1157,Hephaestin,intracellular|integral component of membrane|basolateral plasma membrane|perinuclear region of cytoplasm|,copper ion transport|iron ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|ferrous iron binding|,18,30,1900000000,19.3%
Q6GQT1,0.000145021,-1.105,53.30863912,4.456666667,4.66806E-06,12.53476957,-3.79,-3.156,-3.054,1.116,1.115,1.139,Q6GQT1,A2m,Q6GQT1_A2m,Q6GQT1,A2m,1,76,19,15,Q6GQT1|K4JBR5|K4JF13|K4JB97,MOUSE,165776,13.7,117,117.1,229.1,184.95,,1474,Alpha-2-macroglobulin-P,extracellular exosome|blood microparticle|,"negative regulation of complement activation, lectin pathway|female pregnancy|negative regulation of endopeptidase activity|stem cell differentiation|",protease binding|serine-type endopeptidase inhibitor activity|receptor binding|protein binding|growth factor binding|enzyme binding|interleukin-8 binding|interleukin-1 binding|peptidase inhibitor activity|tumor necrosis factor binding|calcium-dependent protein binding|,21,76,6.88E+12,13.7%
Q7SIH1,0.000257057,-0.3906,39.59391483,4.067333333,0.000109802,8.912709245,-3.238,-2.424,,1.559,1.031,1.119,Q7SIH1,NotFound,Q7SIH1_NotFound,Q7SIH1,A2M,1,2,8,2,Q7SIH1|K4JR81|K4JDS3|K4JDR8|K4JBA2|R9QSM8,BOVIN,169056.4,5.8,117,117.2,74.56,9.58,,1510,Alpha-2-macroglobulin,,,,2,2,107000000,2.6%
Q9JJN5,0.006326758,-0.3985,22.8006009,3.217,0.005247349,4.035385617,-3.38,-2.448,-0.193,1.511,1.21,0.909,Q9JJN5,Cpn1,Q9JJN5_Cpn1,Q9JJN5,Cpn1,1,43,15,15,Q9JJN5|Q2KJ83,MOUSE,52129.7,37.4,118,118.1,225.56,225.56,,457,Carboxypeptidase N catalytic chain,extracellular space|,proteolysis|bradykinin catabolic process|response to glucocorticoid|,carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding|,15,43,9900000000,37.4%
P33587,0.000338812,-1.317333333,37.43313327,5.019333333,0.000180587,7.241438802,-3.542,-2.635,-5.304,1.652,1.023,0.902,P33587,Proc,P33587_Proc,P33587,Proc,1,31,15,15,P33587,MOUSE,53186.4,38,119,119.1,224.62,224.62,,460,Vitamin K-dependent protein C,extracellular space|,proteolysis|blood coagulation|negative regulation of blood coagulation|negative regulation of apoptotic process|,calcium ion binding|peptidase activity|,15,31,3210000000,38.0%
P01898,0.000199576,-0.877166667,41.60672265,4.100333333,6.90761E-05,8.339499927,-3.866,-2.575,-2.341,1.49,1.141,0.888,P01898,H2-Q10,P01898_H2-Q10,P01898,H2-Q10,1,58,14,8,P01898|G3UXE9|E9Q0G4|A7VMS6|V9GXR0|V9GXI4|Q05A75|G3UZL7|A0A0B4J1G3,MOUSE,37478.5,40.6,120,120.1,224.24,130.21,,325,"H-2 class I histocompatibility antigen, Q10 alpha chain",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|integral component of lumenal side of endoplasmic reticulum membrane|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,14,58,18700000000,40.6%
Q8HWB2,0.0001846,-1.2515,42.37431771,4.694333333,5.78853E-05,8.570985954,-3.867,-2.479,-4.45,1.318,1.084,0.885,Q8HWB2,H2-Q4,Q8HWB2_H2-Q4,Q8HWB2,H2-Q4,1,7,13,4,Q8HWB2|P01899|O19441|E9PX63|P01900|P01902|P14427|P01895-2,MOUSE,39902.4,34.7,120,120.2,169.16,50.5,,354,"Histocompatibility 2, Q region locus 4",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,4,7,259000000,12.1%
P79568,0.000370527,-0.6114,36.78839493,4.486,0.000209489,7.941652711,-4.035,-2.571,,1.532,1.144,0.873,P79568,H2-Q6,P79568_H2-Q6,P79568,H2-Q6,1,2,5,2,P79568|P14429|E9QJR9|E9PWT4|P14431|P14426|P04223|P04223-2|L7N260|P01901|Q3TH01|P03991|P06339,MOUSE,37691.1,16.2,120,120.3,65.3,13.07,,326,Class Ib MHC antigen Qa-2,endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,2,2,17900000,3.6%
E0CZ58,0.000330002,-0.888833333,37.60886509,3.895,0.000173426,7.215682108,-1.954,-2.676,-3.879,1.38,0.96,0.836,E0CZ58,Prg4,E0CZ58_Prg4,E0CZ58,Prg4,1,30,16,16,E0CZ58|Q9JM99|Q9JM99-2|E9QQ17|Q9JM99-3|E9QQ18|Q9JM99-4|A0A0R4J207|Q9JM99-5,MOUSE,135831.6,14.5,121,121.1,221.07,221.07,,1221,Proteoglycan 4,extracellular space|cytoplasm|,receptor-mediated endocytosis|immune response|peptide cross-linking|regulation of cell proliferation|negative regulation of interleukin-6 biosynthetic process|hematopoietic stem cell proliferation|,scavenger receptor activity|polysaccharide binding|,16,30,6570000000,14.5%
A0A0A6YVP0,0.000261034,-1.199166667,39.32479653,4.673666667,0.000116821,7.68184853,-3.093,-2.636,-4.879,1.233,1.262,0.918,A0A0A6YVP0,NotFound,A0A0A6YVP0_NotFound,A0A0A6YVP0,Ighg2b,1,41,16,14,A0A0A6YVP0|P01867|P01867-2|P01865|P01863,MOUSE,45094.4,46.6,122,122.1,217.94,185.23,,405,Immunoglobulin heavy constant gamma 2B (Fragment),"extracellular space|immunoglobulin complex, circulating|","positive regulation of type IIa hypersensitivity|positive regulation of type I hypersensitivity|humoral immune response mediated by circulating immunoglobulin|phagocytosis, recognition|phagocytosis, engulfment|complement activation, classical pathway|immunoglobulin mediated immune response|positive regulation of phagocytosis|positive regulation of immune response|",antigen binding|,16,41,7100000000,46.6%
F6TQW2,0.000218045,-0.6164,40.73409276,4.221833333,8.44483E-05,9.335994476,-3.617,-2.682,,1.138,1.141,0.938,F6TQW2,NotFound,F6TQW2_NotFound,F6TQW2,Ighg2c,1,26,12,10,F6TQW2|P01864,MOUSE,44892.5,32.9,122,122.2,191.84,159.13,,404,Immunoglobulin heavy constant gamma 2C (Fragment),"extracellular space|immunoglobulin complex, circulating|",humoral immune response mediated by circulating immunoglobulin|immunoglobulin mediated immune response|antibacterial humoral response|defense response to bacterium|,antigen binding|,10,26,4690000000,28.2%
A8DUK4,0.000374289,-0.811,36.72543787,4.140666667,0.000212548,6.984609125,-4.069,-2.076,-2.499,1.774,0.798,1.206,A8DUK4,Hbb-bs,A8DUK4_Hbb-bs,A8DUK4,Hbb-bs,1,92,12,4,A8DUK4|P02081|P02104|D4QBB3|P02070|P06642|P06643,MOUSE,15804.8,89.7,123,123.1,215.7,67.24,,147,Beta-globin,hemoglobin complex|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,13,92,1.89E+11,89.7%
P02088,0.016939911,0.674666667,18.31949,4.017333333,0.014724854,3.243451817,-0.78,-0.307,-2.915,1.929,5.299,0.822,P02088,Hbb-b1,P02088_Hbb-b1,P02088,Hbb-b1,1,9,11,3,P02088,MOUSE,15954,88.4,123,123.2,199.89,47.41,,147,Hemoglobin subunit beta-1,hemoglobin complex|myelin sheath|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,3,9,10400000000,25.8%
P02089,0.018726926,0.435,17.83444349,4.139166667,0.016464769,3.335005496,-3.292,-0.805,,1.658,4.1,0.514,P02089,Hbb-b2,P02089_Hbb-b2,P02089,Hbb-b2,1,18,11,5,P02089,MOUSE,15992.1,77.5,123,123.3,181.25,88.18,,147,Hemoglobin subunit beta-2,hemoglobin complex|,oxygen transport|positive regulation of myeloid cell differentiation|regulation of erythrocyte differentiation|erythrocyte development|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,5,18,2740000000,35.3%
P68368,0.00039292,-0.586166667,36.48598929,3.623,0.000224596,6.922985787,-2.507,-1.486,-3.2,1.504,0.721,1.451,P68368,Tuba4a,P68368_Tuba4a,P68368,Tuba4a,1,29,18,4,P68368|Q9JJZ2|Q3UX10,MOUSE,50665.2,42.1,124,124.1,214.83,45.52,,448,Tubulin alpha-4A chain,cytoplasm|microtubule|extracellular exosome|,microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,18,29,2810000000,42.1%
P05213,0.034898777,-0.2158,15.05780898,2.303666667,0.031204635,2.825018628,-2.887,-0.309,,1.093,0.241,0.783,P05213,Tuba1b,P05213_Tuba1b,P05213,Tuba1b,1,4,17,3,P05213|P68369|P68373|P05214,MOUSE,50835.4,39.6,124,124.2,211.09,41.78,,451,Tubulin alpha-1B chain,cytosol|microtubule|cytoplasmic microtubule|myelin sheath|extracellular exosome|,microtubule cytoskeleton organization|protein folding|protein polymerization|cellular response to interleukin-4|,double-stranded RNA binding|GTPase activity|structural constituent of cytoskeleton|protein binding|GTP binding|ubiquitin protein ligase binding|,3,4,98100000,9.7%
P55065,0.000145021,-0.783833333,47.43221821,3.941,1.80625E-05,10.2389592,-3.253,-2.687,-2.323,1.307,1.334,0.919,P55065,Pltp,P55065_Pltp,P55065,Pltp,1,37,14,14,P55065|A2A5K2,MOUSE,54680.3,40.1,125,125.1,213.67,213.67,,493,Phospholipid transfer protein,extracellular space|,lipid metabolic process|lipid transport|vitamin E biosynthetic process|positive regulation of cholesterol efflux|sperm motility|high-density lipoprotein particle remodeling|,lipid binding|,14,37,7690000000,40.1%
Q08761,0.000296673,-0.925,38.28212106,4.082,0.000148521,7.395802052,-4.101,-2.677,-2.12,1.35,1.108,0.89,Q08761,Pros1,Q08761_Pros1,Q08761,Pros1,1,46,17,17,Q08761,MOUSE,76987.1,28.1,126,126.1,213.16,213.16,,675,Vitamin K-dependent protein S,extracellular space|protein complex|extracellular exosome|blood microparticle|,blood coagulation|response to lipopolysaccharide|fibrinolysis|positive regulation of phagocytosis|,calcium ion binding|protein complex binding|,17,46,12000000000,28.1%
Q9EQH2,0.0001846,-1.401666667,42.39367969,4.946666667,5.76278E-05,8.576894362,-3.607,-2.942,-5.076,1.334,0.94,0.941,Q9EQH2,Erap1,Q9EQH2_Erap1,Q9EQH2,Erap1,1,27,19,19,Q9EQH2,MOUSE,107167.8,22.2,127,127.1,209.86,209.86,,930,Endoplasmic reticulum aminopeptidase 1,extracellular region|extracellular space|cytoplasm|endoplasmic reticulum lumen|endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,immune system process|proteolysis|membrane protein ectodomain proteolysis|positive regulation of angiogenesis|,aminopeptidase activity|interleukin-6 receptor binding|tumor necrosis factor receptor binding|peptidase activity|metalloexopeptidase activity|zinc ion binding|,19,27,1550000000,22.2%
Q9R098,0.000175749,-1.070333333,42.79257173,4.340666667,5.25706E-05,8.699388745,-3.011,-2.501,-4.21,1.216,1.197,0.887,Q9R098,Hgfac,Q9R098_Hgfac,Q9R098,Hgfac,1,30,15,15,Q9R098,MOUSE,72905.8,25.7,128,128.1,208.45,208.45,,653,Hepatocyte growth factor activator,extracellular space|cytoplasm|rough endoplasmic reticulum|,proteolysis|,serine-type endopeptidase activity|,15,30,2650000000,25.7%
P28653,0.001760228,-0.251166667,28.80995412,1.851666667,0.001315239,5.150569051,-0.711,-1.344,-1.476,0.665,0.762,0.597,P28653,Bgn,P28653_Bgn,P28653,Bgn,1,27,15,15,P28653,MOUSE,42094.9,46.3,129,129.1,207.66,207.66,,369,Biglycan,proteinaceous extracellular matrix|intracellular|cell surface|transport vesicle|sarcolemma|extracellular exosome|extracellular matrix|,blood vessel remodeling|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|,glycosaminoglycan binding|extracellular matrix binding|,15,27,6470000000,46.3%
Q06770,0.000259876,-1.356166667,39.49816317,5.061666667,0.000112249,7.730265706,-3.848,-2.627,-5.186,1.55,1.062,0.912,Q06770,Serpina6,Q06770_Serpina6,Q06770,Serpina6,1,47,13,13,Q06770,MOUSE,44939.5,31.9,130,130.1,207.6,207.6,,397,Corticosteroid-binding globulin,extracellular space|extracellular exosome|,transport|glucocorticoid metabolic process|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|steroid binding|,13,47,48100000000,31.9%
P70663,0.00014804,-1.022,46.77431782,4.102666667,2.10169E-05,10.00709843,-2.94,-2.547,-3.733,1.104,1.088,0.896,P70663,Sparcl1,P70663_Sparcl1,P70663,Sparcl1,1,37,16,16,P70663,MOUSE,73141.8,26.4,131,131.1,205.81,205.81,,650,SPARC-like protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|,signal transduction|,calcium ion binding|,16,37,2270000000,26.4%
Q8VDD5,0.178042743,-0.393833333,7.688300486,1.360333333,0.170282474,1.533055074,0.913,-2.761,-1.374,0.31,-0.056,0.605,Q8VDD5,Myh9,Q8VDD5_Myh9,Q8VDD5,Myh9,1,22,20,20,Q8VDD5|Q6URW6-3|Q6URW6|K3W4R2|Q6URW6-2|O08638|E9QPE7|O08638-2|Q3UH59|Q5SV64|Q61879|F2Z494,MOUSE,227566.2,12.1,132,132.1,205.65,205.65,,1960,Myosin-9,stress fiber|ruffle|uropod|nucleus|cytoplasm|actomyosin contractile ring|cytosol|plasma membrane|brush border|cell-cell adherens junction|cell cortex|actin cytoskeleton|membrane|myosin complex|myosin II complex|cortical cytoskeleton|cell leading edge|cleavage furrow|actomyosin|protein complex|extracellular exosome|myosin II filament|immunological synapse|spindle|plasma membrane|focal adhesion|COP9 signalosome|integrin complex|neuromuscular junction|,"meiotic spindle organization|cell morphogenesis involved in differentiation|cytokinesis|angiogenesis|in utero embryonic development|establishment of T cell polarity|membrane protein ectodomain proteolysis|phagocytosis, engulfment|cell adhesion|myoblast fusion|regulation of cell shape|protein transport|single organismal cell-cell adhesion|actin filament-based movement|platelet formation|monocyte differentiation|actomyosin structure organization|actin cytoskeleton reorganization|uropod organization|blood vessel endothelial cell migration|establishment of meiotic spindle localization|platelet aggregation|negative regulation of actin filament severing|positive regulation of protein processing in phagocytic vesicle|actin filament polymerization|actin filament capping|",microfilament motor activity|actin binding|protein binding|calmodulin binding|ATP binding|ATPase activity|protein domain specific binding|actin-dependent ATPase activity|protein homodimerization activity|protein anchor|ADP binding|poly(A) RNA binding|actin filament binding|,20,22,413000000,12.1%
P82198,0.000145021,-0.990833333,51.09992372,4.142333333,7.76261E-06,11.62201898,-3.129,-2.679,-3.378,1.069,0.894,1.278,P82198,Tgfbi,P82198_Tgfbi,P82198,Tgfbi,1,33,16,16,P82198|Q3UXJ2,MOUSE,75223.3,23.4,133,133.1,205.56,205.56,,683,Transforming growth factor-beta-induced protein ig-h3,proteinaceous extracellular matrix|basement membrane|extracellular space|trans-Golgi network|extracellular exosome|extracellular matrix|,angiogenesis|chondrocyte differentiation|cell adhesion|extracellular matrix organization|,collagen binding|cell adhesion molecule binding|extracellular matrix binding|,16,33,1330000000,23.4%
Q9R0E2,0.000145021,-1.004666667,47.47670026,4.097333333,1.78785E-05,10.25480648,-3.44,-2.4,-3.32,1.12,1.083,0.929,Q9R0E2,Plod1,Q9R0E2_Plod1,Q9R0E2,Plod1,1,37,21,20,Q9R0E2|A8Y5E6,MOUSE,84164,31,134,134.1,203.43,195.1,,728,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",rough endoplasmic reticulum membrane|extracellular exosome|,response to hypoxia|epidermis development|peptidyl-lysine hydroxylation|cellular response to hormone stimulus|oxidation-reduction process|,ferrous iron binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|peptide binding|,21,37,1330000000,31.0%
Q9R0E1,0.000742034,-0.762166667,33.09197354,3.723666667,0.000490685,6.093112428,-3.396,-3.241,-1.235,1.076,1.185,1.038,Q9R0E1,Plod3,Q9R0E1_Plod3,Q9R0E1,Plod3,1,11,7,6,Q9R0E1,MOUSE,85491.3,11.8,134,134.2,55.26,46.93,,741,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",rough endoplasmic reticulum membrane|extracellular exosome|,in utero embryonic development|endothelial cell morphogenesis|protein localization|neural tube development|collagen fibril organization|cellular response to hormone stimulus|vasodilation|epidermis morphogenesis|oxidation-reduction process|lung morphogenesis|basement membrane assembly|,iron ion binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|procollagen glucosyltransferase activity|,6,11,378000000,10.5%
O35930,0.000213663,-0.4652,40.91770336,4.012166667,8.09524E-05,9.405796327,-3.193,-2.552,,1.332,1.186,0.901,O35930,Gp1ba,O35930_Gp1ba,O35930,Gp1ba,1,30,14,14,O35930,MOUSE,80567.4,20.2,135,135.1,202.69,202.69,,734,Platelet glycoprotein Ib alpha chain,plasma membrane|integral component of plasma membrane|cell surface|membrane|extracellular exosome|anchored component of external side of plasma membrane|,cell morphogenesis|cell adhesion|blood coagulation|hemostasis|fibrinolysis|,,14,30,3850000000,20.2%
Q8CG19,0.000192766,-0.497333333,41.94803796,3.340666667,6.38552E-05,8.441772758,-2.473,-2.391,-1.639,1.135,1.517,0.867,Q8CG19,Ltbp1,Q8CG19_Ltbp1,Q8CG19,Ltbp1,1,19,13,13,Q8CG19|Q8CG19-2|Q8CG19-3|Q61810|F8VQ06|Q61810-2,MOUSE,195158.2,10.1,136,136.1,202.07,202.07,,1712,Latent-transforming growth factor beta-binding protein 1,microfibril|proteinaceous extracellular matrix|extracellular matrix|protein complex|extracellular matrix|,transforming growth factor beta receptor signaling pathway|,calcium ion binding|transforming growth factor beta binding|microfibril binding|,13,19,421000000,10.1%
O54782,0.000158712,-0.744833333,44.59283755,3.752333333,3.47309E-05,9.271006366,-3.272,-2.269,-2.322,1.118,1.331,0.945,O54782,Man2b2,O54782_Man2b2,O54782,Man2b2,1,40,16,16,O54782,MOUSE,115835.7,18.3,137,137.1,201.18,201.18,,1018,Epididymis-specific alpha-mannosidase,extracellular exosome|,mannose metabolic process|,alpha-mannosidase activity|zinc ion binding|carbohydrate binding|,16,40,6510000000,18.3%
P16858,0.00102261,-0.579333333,31.41422361,3.846666667,0.000722067,5.718527703,-2.38,-1.344,-3.784,1.887,0.684,1.461,P16858,Gapdh,P16858_Gapdh,P16858,Gapdh,1,33,14,14,A0A0A0MQF6|P16858|A0A1D5RLD8|S4R1W1|P10096|Q64467|S4R2G5|A0A0R4J0X7|V9GX06|V9GXA7,MOUSE,36094.6,44.7,138,138.1,200.69,200.69,,333,Glyceraldehyde-3-phosphate dehydrogenase,nucleus|cytoplasm|cytosol|microtubule cytoskeleton|myelin sheath|GAIT complex|,microtubule cytoskeleton organization|glucose metabolic process|glycolytic process|negative regulation of translation|peptidyl-cysteine S-trans-nitrosylation|protein stabilization|neuron apoptotic process|oxidation-reduction process|,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity|protein binding|microtubule binding|enzyme binding|peptidyl-cysteine S-nitrosylase activity|NADP binding|NAD binding|,14,33,2620000000,44.7%
P00687,0.000145021,-0.992333333,47.38963381,4.119333333,1.82405E-05,10.22380837,-3.469,-2.429,-3.258,1.309,0.993,0.9,P00687,Amy1,P00687_Amy1,P00687,Amy1,1,32,15,15,P00687|P00688|E9PV85|Q3MHH8,MOUSE,58327.3,32,139,139.1,199.32,199.32,,511,Alpha-amylase 1,extracellular space|extracellular exosome|,carbohydrate catabolic process|,alpha-amylase activity|calcium ion binding|amylase activity|chloride ion binding|,15,32,5010000000,32.0%
P27773,0.000440039,-1.424333333,35.81796926,4.908666667,0.000261941,6.87802801,-3.672,-2.538,-5.426,1.104,1.115,0.871,P27773,Pdia3,P27773_Pdia3,P27773,Pdia3,1,26,16,16,P27773|A5D7E8|P38657,MOUSE,57133.7,31.8,140,140.1,197.96,197.96,,505,Protein disulfide-isomerase A3,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|focal adhesion|cell surface|melanosome|myelin sheath|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|positive regulation of extrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|protein binding|poly(A) RNA binding|,16,26,1910000000,31.8%
Q5I012,0.001465541,-1.286333333,29.66395762,4.518,0.001080449,5.418596715,-3.044,-2.101,-5.491,1.13,0.868,0.92,Q5I012,Slc38a10,Q5I012_Slc38a10,Q5I012,Slc38a10,1,23,13,13,Q5I012|J3QNE8|Q5I012-2|Q5I012-3|Q5I012-4,MOUSE,117762.2,19,141,141.1,195.97,195.97,,1090,Putative sodium-coupled neutral amino acid transporter 10,Golgi apparatus|integral component of membrane|,amino acid transmembrane transport|sodium ion transport|bone development|,amino acid transmembrane transporter activity|,13,23,6060000000,19.0%
Q9QXC1,0.000310385,-0.6616,37.98972832,4.507333333,0.000158865,8.345654409,-4.029,-2.703,,1.518,0.926,0.98,Q9QXC1,Fetub,Q9QXC1_Fetub,Q9QXC1,Fetub,1,44,14,14,Q9QXC1|Q6YJU1,MOUSE,43567.8,28.6,142,142.1,195.89,195.89,,388,Fetuin-B,extracellular region|extracellular space|extracellular exosome|,single fertilization|binding of sperm to zona pellucida|negative regulation of endopeptidase activity|,cysteine-type endopeptidase inhibitor activity|metalloendopeptidase inhibitor activity|,14,44,31400000000,28.6%
Q61207,0.000148189,-1.402833333,46.43047059,5.060333333,2.27485E-05,9.887776803,-4.03,-2.981,-4.788,1.028,1.38,0.974,Q61207,Psap,Q61207_Psap,Q61207,Psap,1,43,13,13,Q61207|J3QPG5|K3W4L3|Q8BFQ1|E9PZ00,MOUSE,63303.9,30.5,143,143.1,192.92,192.92,,557,Prosaposin,extracellular space|nucleoplasm|nucleolus|mitochondrion|lysosome|Golgi apparatus|intracellular membrane-bounded organelle|extracellular exosome|,sphingolipid metabolic process|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway|regulation of lipid metabolic process|regulation of MAPK cascade|positive regulation of MAPK cascade|developmental growth|prostate gland growth|epithelial cell differentiation involved in prostate gland development|cellular response to organic substance|negative regulation of hydrogen peroxide-induced cell death|,G-protein coupled receptor binding|,13,43,7550000000,30.5%
Q9R097,0.000209742,-0.5784,41.13207867,4.429333333,7.70535E-05,9.487880693,-3.669,-2.803,,1.504,1.182,0.894,Q9R097,Spint1,Q9R097_Spint1,Q9R097,Spint1,1,24,15,15,Q9R097,MOUSE,58358.6,30.9,144,144.1,186.73,186.73,,507,Kunitz-type protease inhibitor 1,extracellular space|plasma membrane|extracellular exosome|,neural tube closure|embryonic placenta development|negative regulation of endopeptidase activity|extracellular matrix organization|branching involved in labyrinthine layer morphogenesis|placenta blood vessel development|,serine-type endopeptidase inhibitor activity|,15,24,1220000000,30.9%
Q3U9N4,0.00045897,-1.141,35.60786078,4.444,0.000274925,6.700579382,-2.768,-2.429,-4.892,1.172,1.176,0.895,Q3U9N4,Grn,Q3U9N4_Grn,Q3U9N4,Grn,1,34,13,13,Q3U9N4|P28798,MOUSE,70037.8,27.4,145,145.1,186.13,186.13,,602,Granulins,extracellular space|mitochondrion|cell surface|intracellular membrane-bounded organelle|extracellular exosome|,blastocyst hatching|embryo implantation|response to estradiol|chondrocyte proliferation|synaptic vesicle endocytosis|positive regulation of epithelial cell proliferation|male mating behavior|positive regulation of dendritic spine development|neural precursor cell proliferation|,poly(A) RNA binding|,13,34,2370000000,27.4%
Q3UTR7,0.00017017,-0.706666667,43.06476559,3.744,4.93769E-05,8.78382639,-3.15,-2.133,-2.453,1.654,0.941,0.901,Q3UTR7,Agt,Q3UTR7_Agt,Q3UTR7,Agt,1,46,12,12,Q3UTR7|P11859,MOUSE,52954.5,31.3,146,146.1,185.76,185.76,,482,Angiotensinogen,extracellular space|cytoplasm|extracellular exosome|blood microparticle|,"ovarian follicle rupture|blood vessel development|branching involved in ureteric bud morphogenesis|kidney development|regulation of systemic arterial blood pressure by circulatory renin-angiotensin|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure|renin-angiotensin regulation of aldosterone production|regulation of renal output by angiotensin|regulation of heart rate|brain renin-angiotensin system|renal system process|angiotensin-mediated drinking behavior|positive regulation of extracellular matrix constituent secretion|cellular sodium ion homeostasis|cell-matrix adhesion|G-protein coupled receptor signaling pathway|activation of phospholipase C activity|activation of NF-kappaB-inducing kinase activity|female pregnancy|aging|excretion|establishment of blood-nerve barrier|regulation of blood pressure|negative regulation of cell proliferation|response to cold|response to salt stress|regulation of gene expression|positive regulation of activation of JAK2 kinase activity|positive regulation of endothelial cell migration|positive regulation of cardiac muscle hypertrophy|positive regulation of gene expression|positive regulation of cholesterol esterification|negative regulation of endopeptidase activity|regulation of norepinephrine secretion|positive regulation of phosphatidylinositol 3-kinase signaling|artery smooth muscle contraction|response to muscle activity involved in regulation of muscle adaptation|negative regulation of angiogenesis|extracellular matrix organization|negative regulation of cell growth|peristalsis|positive regulation of cellular protein metabolic process|positive regulation of superoxide anion generation|positive regulation of peptidyl-serine phosphorylation|negative regulation of tissue remodeling|catenin import into nucleus|positive regulation of renal sodium excretion|positive regulation of multicellular organism growth|vasodilation|hormone metabolic process|drinking behavior|regulation of apoptotic process|positive regulation of MAPK cascade|negative regulation of neuron apoptotic process|positive regulation of nitric oxide biosynthetic process|positive regulation of fatty acid biosynthetic process|positive regulation of epidermal growth factor receptor signaling pathway|positive regulation of transcription, DNA-templated|positive regulation of vasodilation|positive regulation of organ growth|astrocyte activation|fibroblast proliferation|positive regulation of fibroblast proliferation|regulation of long-term neuronal synaptic plasticity|smooth muscle cell proliferation|cytokine secretion|regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell differentiation|negative regulation of neurotrophin TRK receptor signaling pathway|stress-activated MAPK cascade|regulation of calcium ion transport|regulation of transmission of nerve impulse|cell growth involved in cardiac muscle cell development|positive regulation of protein tyrosine kinase activity|ERK1 and ERK2 cascade|uterine smooth muscle contraction|cellular response to mechanical stimulus|positive regulation of branching involved in ureteric bud morphogenesis|positive regulation of protein kinase C activity|regulation of extracellular matrix assembly|positive regulation of membrane hyperpolarization|positive regulation of gap junction assembly|regulation of cardiac conduction|positive regulation of extrinsic apoptotic signaling pathway|",serine-type endopeptidase inhibitor activity|hormone activity|sodium channel regulator activity|type 1 angiotensin receptor binding|type 2 angiotensin receptor binding|,12,46,17500000000,31.3%
P07309,0.006326758,-2.132333333,22.80618746,6.763333333,0.005240603,4.036420055,-4.114,-2.709,-9.719,1.598,1.249,0.901,P07309,Ttr,P07309_Ttr,P07309,Ttr,1,54,13,13,P07309,MOUSE,15889.7,61.2,147,147.1,184.6,184.6,,147,Transthyretin,extracellular space|protein complex|extracellular exosome|,retinol metabolic process|thyroid hormone transport|,hormone activity|protein binding|identical protein binding|protein heterodimerization activity|thyroid hormone binding|,13,54,58400000000,61.2%
Q8CIF4,0.000196828,-0.799,41.74502371,3.927333333,6.6911E-05,8.380814767,-3.508,-2.809,-1.971,1.4,1.172,0.922,Q8CIF4,Btd,Q8CIF4_Btd,Q8CIF4,Btd,1,47,11,11,A0A0R4J131|Q8CIF4,MOUSE,58952,24.4,148,148.1,184.08,184.08,,520,Biotinidase,extracellular space|nucleolus|perikaryon|apical part of cell|extracellular exosome|,biotin metabolic process|,biotinidase activity|,11,47,12000000000,24.4%
G3X8T3,0.000148189,-1.058,46.20660027,4.385333333,2.39519E-05,9.810765527,-3.464,-2.463,-3.825,1.284,1.235,0.885,G3X8T3,Ctsa,G3X8T3_Ctsa,G3X8T3,Ctsa,1,43,12,12,G3X8T3|P16675,MOUSE,56352.8,27.2,149,149.1,183.12,183.12,,492,Carboxypeptidase,nucleoplasm|mitochondrion|membrane|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis|,serine-type carboxypeptidase activity|protein binding|,12,43,6470000000,27.2%
P45700,0.000145021,-0.897666667,49.08735038,3.976666667,1.23386E-05,10.84358569,-3.367,-2.624,-2.667,1.174,1.199,0.899,P45700,Man1a,P45700_Man1a,P45700,Man1a1,1,31,19,19,P45700|A0A1W2P6N0,MOUSE,73502.6,30.6,150,150.1,182.78,182.78,,655,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA",Golgi membrane|cytoplasm|endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|extracellular exosome|,N-glycan processing|,"mannosyl-oligosaccharide 1,2-alpha-mannosidase activity|calcium ion binding|",19,31,1670000000,30.6%
Q60590,0.000145021,-0.920666667,52.30874923,4.055333333,5.87659E-06,12.11370428,-3.244,-2.774,-2.827,1.097,1.244,0.98,Q60590,Orm1,Q60590_Orm1,Q60590,Orm1,1,36,12,7,Q60590|J3JRU4|Q63805,MOUSE,24008.9,33.8,151,151.1,181.9,109.51,,207,Alpha-1-acid glycoprotein 1,extracellular space|,regulation of immune system process|transport|acute-phase response|,,12,36,23900000000,33.8%
P07361,0.008581083,-1.305333333,21.41869646,4.068666667,0.00721324,3.783382259,-0.672,-4.629,-4.718,0.456,0.658,1.073,P07361,Orm2,P07361_Orm2,P07361,Orm2,1,7,9,4,P07361,MOUSE,23957.1,28.5,151,151.2,118.16,45.77,,207,Alpha-1-acid glycoprotein 2,extracellular space|,regulation of immune system process|transport|acute-phase response|,,4,7,478000000,12.5%
Q3UEL9,0.000213663,-0.724666667,40.9348179,4.238,8.0634E-05,8.141196647,-2.398,-2.449,-3.684,2.059,0.821,1.303,Q3UEL9,Serpina7,Q3UEL9_Serpina7,Q3UEL9,Serpina7,1,35,14,14,Q3UEL9|P61939|Q8BII9,MOUSE,48364.8,29.3,152,152.1,181.59,181.59,,426,Thyroxine-binding globulin,extracellular space|extracellular exosome|,aging|post-embryonic development|negative regulation of endopeptidase activity|response to vitamin A|response to prostaglandin E|response to drug|response to peptide hormone|response to corticosterone|thyroid hormone transport|,serine-type endopeptidase inhibitor activity|hormone binding|,14,35,4130000000,29.3%
P11680,0.000145021,-1.012833333,47.99109727,4.531,1.58815E-05,10.43966005,-3.938,-2.689,-3.208,1.341,1.501,0.916,P11680,Cfp,P11680_Cfp,P11680,Cfp,1,58,12,12,P11680,MOUSE,52836.7,32.5,153,153.1,181.53,181.53,,464,Properdin,extracellular region|extracellular matrix|,"complement activation, alternative pathway|",,12,58,90100000000,32.5%
P16301,0.000272426,-1.299666667,38.91975174,5.102666667,0.00012824,7.583063471,-4.014,-2.459,-5.08,1.63,1.232,0.893,P16301,Lcat,P16301_Lcat,P16301,Lcat,1,55,11,11,P16301,MOUSE,50088.2,29.6,154,154.1,180.71,180.71,,438,Phosphatidylcholine-sterol acyltransferase,extracellular space|high-density lipoprotein particle|extracellular exosome|,phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol metabolic process|cholesterol transport|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|cholesterol esterification|lipoprotein biosynthetic process|cholesterol homeostasis|reverse cholesterol transport|response to copper ion|response to glucocorticoid|regulation of high-density lipoprotein particle assembly|,phosphatidylcholine-sterol O-acyltransferase activity|phospholipase A2 activity|apolipoprotein A-I binding|,11,55,90000000000,29.6%
P47879,0.000145021,-0.798833333,47.49698269,4.098333333,1.77952E-05,10.26203959,-3.224,-2.376,-2.944,1.65,1.214,0.887,P47879,Igfbp4,P47879_Igfbp4,P47879,Igfbp4,1,43,13,13,P47879|H3BLB7,MOUSE,28947.5,48.8,155,155.1,179.07,179.07,,254,Insulin-like growth factor-binding protein 4,extracellular space|,regulation of cell growth|inflammatory response|regulation of glucose metabolic process|regulation of growth|positive regulation of MAPK cascade|positive regulation of insulin-like growth factor receptor signaling pathway|type B pancreatic cell proliferation|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,13,43,16300000000,48.8%
Q61805,0.000145021,-0.812666667,47.82029228,3.942,1.65185E-05,10.37795291,-3.133,-2.529,-2.689,1.613,0.916,0.946,Q61805,Lbp,Q61805_Lbp,Q61805,Lbp,1,32,14,14,Q61805|A2AC65,MOUSE,53282.7,28.4,156,156.1,179.01,179.01,,481,Lipopolysaccharide-binding protein,extracellular space|cell surface|extracellular exosome|,"liver development|leukocyte chemotaxis involved in inflammatory response|macrophage activation involved in immune response|acute-phase response|opsonization|lipopolysaccharide transport|lipopolysaccharide-mediated signaling pathway|detection of molecule of bacterial origin|response to lipopolysaccharide|negative regulation of tumor necrosis factor production|positive regulation of chemokine production|positive regulation of interleukin-6 production|positive regulation of interleukin-8 production|positive regulation of tumor necrosis factor production|positive regulation of toll-like receptor 4 signaling pathway|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of macrophage activation|negative regulation of growth of symbiont in host|innate immune response|defense response to Gram-negative bacterium|defense response to Gram-positive bacterium|positive regulation of phagocytosis, engulfment|positive regulation of respiratory burst involved in inflammatory response|cellular response to lipopolysaccharide|cellular response to lipoteichoic acid|positive regulation of neutrophil chemotaxis|regulation of membrane permeability|",lipopolysaccharide binding|receptor binding|lipoteichoic acid binding|,14,32,2410000000,28.4%
Q8VCG4,0.000185939,-0.5504,42.20455387,4.359333333,6.01928E-05,9.908218722,-3.535,-2.797,,1.37,0.923,1.287,Q8VCG4,C8g,Q8VCG4_C8g,Q8VCG4,C8g,1,55,11,11,Q8VCG4|Q9DAC2,MOUSE,22678.7,62.3,157,157.1,176.6,176.6,,202,Complement component C8 gamma chain,membrane attack complex|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",complement binding|retinol binding|protein complex binding|,11,55,23400000000,62.3%
O09164,0.000145021,-0.692,47.7252995,3.584666667,1.68838E-05,10.34377561,-2.787,-2.273,-2.393,1.363,1.013,0.925,O09164,Sod3,O09164_Sod3,O09164,Sod3,1,31,10,10,O09164,MOUSE,27733.7,44.2,158,158.1,176.57,176.57,,251,Extracellular superoxide dismutase [Cu-Zn],extracellular space|nucleus|cytoplasm|Golgi lumen|trans-Golgi network|extracellular exosome|extracellular matrix|,response to hypoxia|removal of superoxide radicals|response to copper ion|oxidation-reduction process|,superoxide dismutase activity|copper ion binding|protein binding|zinc ion binding|,10,31,11400000000,44.2%
P29533,0.000722104,-0.772833333,33.24305054,3.649666667,0.000473909,6.128399112,-3.525,-2.97,-1.298,1.064,1.172,0.92,P29533,NotFound,P29533_NotFound,P29533,Vcam1,1,25,15,15,P29533|Q3UPN1|P29533-2,MOUSE,82457.1,22.1,159,159.1,176.49,176.49,,739,Vascular cell adhesion protein 1,podosome|extracellular space|early endosome|endoplasmic reticulum|Golgi apparatus|microvillus|external side of plasma membrane|cell surface|integral component of membrane|filopodium|anchored component of membrane|apical part of cell|extracellular exosome|alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex|cell periphery|,cell adhesion|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|cell-matrix adhesion|heart development|amine metabolic process|viral process|positive regulation of T cell proliferation|leukocyte tethering or rolling|oxidation-reduction process|embryonic placenta morphogenesis|chorio-allantoic fusion|visceral serous pericardium development|cellular response to glucose stimulus|,integrin binding|primary amine oxidase activity|cell adhesion molecule binding|,15,25,1060000000,22.1%
Q02566,0.203671987,-1.1665,7.08891295,2.594333333,0.195482869,1.435240633,-2.8,1.717,-6.308,0.335,-0.073,0.13,Q02566,Myh6,Q02566_Myh6,Q02566,Myh6,1,21,17,4,Q02566|Q5SX39|Q5SX40|G3UW82|P13542|B1AR69,MOUSE,224360.2,9.4,160,160.1,174.76,43.64,,1938,Myosin-6,stress fiber|nucleoplasm|cytoplasm|mitochondrion|muscle myosin complex|focal adhesion|myosin complex|myofibril|Z disc|myosin filament|,in utero embryonic development|regulation of the force of heart contraction|regulation of heart rate|muscle contraction|striated muscle contraction|adult heart development|visceral muscle development|regulation of heart contraction|regulation of blood pressure|response to heat|actin filament-based movement|muscle filament sliding|myofibril assembly|BMP signaling pathway|regulation of ATPase activity|sarcomere organization|ATP metabolic process|cardiac muscle fiber development|atrial cardiac muscle tissue morphogenesis|ventricular cardiac muscle tissue morphogenesis|cardiac muscle contraction|canonical Wnt signaling pathway|regulation of heart growth|,microfilament motor activity|actin binding|protein binding|calmodulin binding|ATP binding|ATPase activity|protein kinase binding|actin-dependent ATPase activity|calcium-dependent ATPase activity|protein homodimerization activity|protein heterodimerization activity|,18,21,9310000000,9.4%
Q91Z83,0.729638663,0.3456,1.40149385,-0.5465,0.724186818,-0.370421295,-1.947,3.294,,0.488,-0.449,0.342,Q91Z83,Myh7,Q91Z83_Myh7,Q91Z83,Myh7,1,1,15,1,Q91Z83,MOUSE,223673.7,8.2,160,160.2,148.98,12.52,,1935,Myosin-7,stress fiber|nucleoplasm|cytoplasm|muscle myosin complex|focal adhesion|myosin complex|myofibril|Z disc|myosin filament|,response to reactive oxygen species|regulation of the force of heart contraction|regulation of heart rate|skeletal muscle contraction|muscle contraction|striated muscle contraction|adult heart development|regulation of the force of skeletal muscle contraction|transition between fast and slow fiber|muscle filament sliding|regulation of slow-twitch skeletal muscle fiber contraction|ATP metabolic process|ventricular cardiac muscle tissue morphogenesis|cardiac muscle contraction|,microfilament motor activity|actin binding|calmodulin binding|ATP binding|ATPase activity|actin-dependent ATPase activity|protein homodimerization activity|protein heterodimerization activity|,1,1,7730000,0.8%
P13541,0.279323921,0.41125,5.676278187,-0.741,0.270627659,-1.237719326,,0.967,,0.685,-0.104,0.097,P13541,Myh3,P13541_Myh3,P13541,Myh3,1,1,5,1,P13541,MOUSE,224870.7,2.9,160,160.3,42.07,5.96,,1940,Myosin-3,myosin complex|myofibril|myosin filament|contractile fiber|extracellular exosome|,skeletal muscle contraction|ATP metabolic process|,"microfilament motor activity|calmodulin binding|ATP binding|ATPase activity, coupled|actin filament binding|",1,1,33700000,1.0%
P16882-2,0.000209742,-0.6686,41.13614642,4.633166667,7.69813E-05,9.48944438,-3.991,-2.906,,1.263,1.381,0.91,P16882,Ghr,P16882-2_Ghr,P16882-2,Ghr,1,39,10,10,P16882-2|P16882|Q3UP14,MOUSE,34617.4,36.7,161,161.1,174.72,174.72,,650,Isoform 2 of Growth hormone receptor,extracellular region|extracellular space|nucleus|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|extrinsic component of membrane|receptor complex|growth hormone receptor complex|,allantoin metabolic process|citrate metabolic process|2-oxoglutarate metabolic process|succinate metabolic process|oxaloacetate metabolic process|isoleucine metabolic process|valine metabolic process|creatine metabolic process|fatty acid metabolic process|endocytosis|cytokine-mediated signaling pathway|taurine metabolic process|response to estradiol|cellular response to hormone stimulus|regulation of multicellular organism growth|positive regulation of multicellular organism growth|multicellular organismal metabolic process|creatinine metabolic process|insulin-like growth factor receptor signaling pathway|positive regulation of peptidyl-tyrosine phosphorylation|growth hormone receptor signaling pathway|,growth hormone receptor activity|protein binding|peptide hormone binding|growth factor binding|protein homodimerization activity|,11,39,39100000000,36.7%
Q02257,0.086452743,-0.717166667,10.95780496,2.082333333,0.080208336,2.053561462,-0.222,-0.8,-4.253,0.211,0.529,0.232,Q02257,Jup,Q02257_Jup,Q02257,Jup,1,27,16,16,Q02257|Q02248|E9Q6A9,MOUSE,82541,26.3,162,162.1,173.95,173.95,,745,Junction plakoglobin,nucleus|cytoplasm|cytosol|intermediate filament|plasma membrane|cell-cell junction|cell-cell adherens junction|focal adhesion|intercalated disc|membrane|catenin complex|Z disc|desmosome|protein-DNA complex|extracellular exosome|gamma-catenin-TCF7L2 complex|,desmosome assembly|cell adhesion|signal transduction|single organismal cell-cell adhesion|cell migration|adherens junction assembly|regulation of cell proliferation|positive regulation of protein import into nucleus|regulation of cell fate specification|skin development|detection of mechanical stimulus|positive regulation of sequence-specific DNA binding transcription factor activity|cellular response to indole-3-methanol|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|establishment of protein localization to plasma membrane|regulation of ventricular cardiac muscle cell action potential|positive regulation of transcription from RNA polymerase II promoter|,transcription coactivator activity|signal transducer activity|structural molecule activity|protein binding|protein phosphatase binding|alpha-catenin binding|cadherin binding|cell adhesion molecule binding|nuclear hormone receptor binding|,16,27,1060000000,26.3%
Q63880,0.00014804,-1.054166667,47.10826204,4.107,1.94614E-05,10.12420036,-3.73,-2.539,-3.054,1.059,0.949,0.99,Q63880,Ces3a,Q63880_Ces3a,Q63880,Ces3a,1,37,13,6,Q63880|Q63880-2,MOUSE,63715.9,23.4,163,163.1,172.68,88.57,,571,Carboxylesterase 3A,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,13,37,5190000000,23.4%
Q8VCU1,0.000170428,-0.523,43.03958471,3.936666667,4.9664E-05,10.24700229,-3.036,-2.734,,1.065,1.107,0.983,Q8VCU1,Ces3b,Q8VCU1_Ces3b,Q8VCU1,Ces3b,1,4,10,3,Q8VCU1|Q8VCU1-2,MOUSE,63751.2,16.2,163,163.2,120.33,36.22,,571,Carboxylesterase 3B,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,3,4,315000000,5.7%
Q91WU0,0.000314254,-1.389333333,37.89385947,4.727333333,0.00016241,7.291497444,-3.676,-2.493,-5.09,1.098,0.97,0.855,Q91WU0,Ces1f,Q91WU0_Ces1f,Q91WU0,Ces1f,1,24,14,14,Q91WU0,MOUSE,62010.5,33.1,164,164.1,172.65,172.65,,561,Carboxylesterase 1F,lipid particle|cytosol|,short-chain fatty acid catabolic process|,hydrolase activity|,14,24,79500000000,33.1%
P28654,0.018473993,-0.295833333,17.89965664,1.291,0.016219383,3.145197231,-0.25,-1.217,-1.357,0.362,0.474,0.213,P28654,Dcn,P28654_Dcn,P28654,Dcn,1,38,14,14,P28654,MOUSE,40150.6,34.1,165,165.1,171.85,171.85,,354,Decorin,collagen type VI trimer|extracellular space|extracellular matrix|,kidney development|placenta development|skeletal muscle tissue development|aging|response to mechanical stimulus|positive regulation of autophagy|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|response to lipopolysaccharide|wound healing|,collagen binding|glycosaminoglycan binding|poly(A) RNA binding|protein N-terminus binding|extracellular matrix binding|,14,38,9880000000,34.1%
P12399,0.00016939,-0.6914,43.15992417,4.2885,4.83067E-05,10.29667934,-3.603,-2.926,,1.097,1.027,0.948,P12399,Ctla2a,P12399_Ctla2a,P12399,Ctla2a,1,45,11,11,P12399|A0A286YDF0|A0A286YD17|P12400|A0A0R4J245,MOUSE,16053.8,59.8,166,166.1,168.96,168.96,,137,Protein CTLA-2-alpha,extracellular space|lysosome|dendrite|,negative regulation of protein processing|regulation of regulatory T cell differentiation|negative regulation of inflammatory response|proteolysis involved in cellular protein catabolic process|,cysteine-type endopeptidase activity|,11,45,72500000000,59.8%
A0A075B5T3,0.000145021,-0.998333333,51.59469428,4.321333333,6.92677E-06,11.82101223,-3.39,-2.761,-3.326,1.107,1.464,0.916,A0A075B5T3,NotFound,A0A075B5T3_NotFound,A0A075B5T3,Ighv6-6,1,42,12,7,A0A075B5T3,MOUSE,13464,81.5,167,167.1,168.07,104.48,,119,Immunoglobulin heavy variable 6-6 (Fragment),,,,12,42,48100000000,81.5%
A0A075B5T2,0.000165321,-0.6754,43.59158552,4.694333333,4.37362E-05,10.47667516,-3.888,-3.096,,0.972,1.466,1.169,A0A075B5T2,NotFound,A0A075B5T2_NotFound,A0A075B5T2,Ighv6-3,1,20,10,5,A0A075B5T2,MOUSE,13430,56.7,167,167.2,136.41,75.25,,118,Immunoglobulin heavy variable 6-3 (Fragment),,,,5,20,9960000000,26.2%
P01801,,2.225666667,,,,,,,,1,3.012,2.665,P01801,NotFound,P01801_NotFound,P01801,,1,1,9,1,P01801|P01796|P01799|P01797|P01802|P01800|P01803,MOUSE,12924.2,58.2,167,167.3,109.35,4.2,,115,Ig heavy chain V-III region J606,,,antigen binding|,1,1,24000000,13.0%
P01798,0.001054758,-0.1,31.25687845,3.805,0.000748707,6.284542362,-3.013,-1.753,,1.434,2.064,0.768,P01798,NotFound,P01798_NotFound,P01798,,1,1,5,1,P01798,MOUSE,12761.1,36.2,167,167.4,64.53,6.51,,113,Ig heavy chain V-III region E109,,,antigen binding|,1,1,4500000,7.9%
A0A0A6YWU3,0.000678381,-0.3304,33.54740305,4.970166667,0.000441835,6.93278139,-3.983,-2.642,,1.379,0.88,2.714,A0A0A6YWU3,NotFound,A0A0A6YWU3_NotFound,A0A0A6YWU3,Ighv6-7,1,2,4,1,A0A0A6YWU3,MOUSE,13943.6,24.3,167,167.5,47.87,15.11,,119,Immunoglobulin heavy variable V6-7 (Fragment),,,,1,2,30900000,7.5%
P00760,0.015894401,-0.152166667,18.60238605,1.200333333,0.013796261,3.261585198,-0.39,-0.609,-1.258,0.473,0.485,0.386,P00760,NotFound,P00760_NotFound,P00760,,1,31,10,10,P00760,BOVIN,26469.4,50.8,168,168.1,166.69,166.69,,246,Cationic trypsin,,,,10,31,14900000000,50.8%
O08795-2,0.000145021,-1.024333333,50.02341728,4.356,9.94622E-06,11.19956189,-3.598,-2.663,-3.346,1.304,1.276,0.881,O08795,Prkcsh,O08795-2_Prkcsh,O08795-2,Prkcsh,1,28,14,14,O08795-2|O08795,MOUSE,60528.5,18.3,169,169.1,165.9,165.9,,521,Isoform 2 of Glucosidase 2 subunit beta,endoplasmic reticulum|,in utero embryonic development|liver development|N-glycan processing|nitrogen compound metabolic process|negative regulation of neuron projection development|protein heterooligomerization|renal system development|,RNA binding|protein kinase C binding|calcium ion binding|protein binding|ion channel binding|phosphoprotein binding|,14,28,3400000000,18.3%
Q9CQW3,0.000652748,-0.7765,33.78163066,3.997666667,0.000418636,6.255401766,-3.927,-2.966,-1.433,1.387,1.34,0.94,Q9CQW3,Proz,Q9CQW3_Proz,Q9CQW3,Proz,1,41,9,9,Q9CQW3|Q8CI01,MOUSE,45615.9,33.8,170,170.1,162.39,162.39,,399,Vitamin K-dependent protein Z,extracellular region|extracellular exosome|,proteolysis|blood coagulation|,serine-type endopeptidase activity|calcium ion binding|,9,41,18800000000,33.8%
Q9D154,0.000165321,-1.5405,43.84685785,5.229666667,4.12396E-05,9.030347788,-3.99,-3.14,-5.336,0.996,1.28,0.947,Q9D154,Serpinb1a,Q9D154_Serpinb1a,Q9D154,Serpinb1a,1,21,16,16,Q9D154|Q8VHP7|Q5SV42|Q9JK88|I7HJI5|Q9DAV6|Q9D6A7,MOUSE,42745.3,39.5,171,171.1,161.88,161.88,,379,Leukocyte elastase inhibitor A,extracellular space|cytoplasm|membrane|extracellular exosome|,negative regulation of endopeptidase activity|regulation of protein catabolic process|,serine-type endopeptidase inhibitor activity|,16,21,616000000,39.5%
P01837,0.000145021,-1.090333333,55.3888717,4.577333333,2.89143E-06,13.45455458,-3.318,-3.213,-3.606,0.93,1.42,1.245,P01837,NotFound,P01837_NotFound,P01837,,1,49,11,11,P01837|A0A075B5P2,MOUSE,11948.8,94.3,172,172.1,161.04,161.04,,106,Ig kappa chain C region,plasma membrane|,,antigen binding|,11,49,1.43E+11,94.3%
P03987,0.000261034,-1.2125,39.41855617,4.771666667,0.000114326,7.708002629,-2.821,-3.022,-4.952,1.084,1.564,0.872,P03987,NotFound,P03987_NotFound,P03987,,1,49,11,11,A0A1Y7VJN6|P03987|P03987-2,MOUSE,44498.8,28.3,173,173.1,160.75,160.75,,398,Ig gamma-3 chain C region,extracellular region|plasma membrane|integral component of membrane|,,antigen binding|immunoglobulin receptor binding|,11,49,14600000000,28.3%
P18242,0.000145021,-1.078833333,48.41429763,4.297666667,1.44069E-05,10.59396552,-3.385,-2.576,-3.722,1.107,1.161,0.942,P18242,Ctsd,P18242_Ctsd,P18242,Ctsd,1,24,11,11,P18242|F8WIR1,MOUSE,45409.4,27.8,174,174.1,159.83,159.83,,410,Cathepsin D,extracellular space|mitochondrion|lysosome|melanosome|membrane raft|extracellular exosome|extracellular matrix|,autophagosome assembly|proteolysis|autophagy|protein catabolic process|epithelial tube branching involved in lung morphogenesis|,aspartic-type endopeptidase activity|peptidase activity|peptide binding|,11,24,8950000000,27.8%
P52480,0.000250561,-0.483333333,39.78172529,2.971333333,0.000105154,7.809993855,-2.335,-1.506,-2.066,1.316,0.791,0.9,P52480,Pkm,P52480_Pkm,P52480,Pkm,1,25,15,15,P52480|P52480-2|P53657|G3X925|E9Q509,MOUSE,58414.4,35.4,175,175.1,158.72,158.72,,531,Pyruvate kinase PKM,nucleus|cytoplasm|mitochondrion|plasma membrane|cilium|extracellular matrix|vesicle|myelin sheath|extracellular exosome|extracellular vesicle|,glycolytic process|programmed cell death|phosphorylation|,magnesium ion binding|pyruvate kinase activity|protein binding|ATP binding|MHC class II protein complex binding|potassium ion binding|poly(A) RNA binding|,16,25,253000000,35.4%
G5E8J0,0.000145021,-1.087833333,55.04874952,4.170333333,3.12698E-06,13.29999654,-3.166,-3.266,-3.087,1.039,1.022,0.931,G5E8J0,Notch2,G5E8J0_Notch2,G5E8J0,Notch2,1,23,14,14,G5E8J0|O35516|O35516-2,MOUSE,279492.6,6.3,176,176.1,156.79,156.79,,2473,Neurogenic locus notch homolog protein 2,nucleus|integral component of plasma membrane|cell surface|receptor complex|,pulmonary valve morphogenesis|cell cycle arrest|Notch signaling pathway|negative regulation of cell proliferation|cell growth|cell differentiation|positive regulation of Ras protein signal transduction|bone remodeling|regulation of developmental process|atrial septum morphogenesis|,calcium ion binding|,14,23,725000000,6.3%
Q8K0D2,0.000558561,-0.6738,34.60415878,4.520333333,0.000346405,7.249355518,-4.27,-2.502,,1.526,0.964,0.913,Q8K0D2,Habp2,Q8K0D2_Habp2,Q8K0D2,Habp2,1,26,13,13,Q8K0D2|E9QM92|E9Q092|Q8K0D2-2|Q3V1J8|E9Q0C5,MOUSE,64409.4,22.5,177,177.1,156.68,156.68,,558,Hyaluronan-binding protein 2,extracellular region|,proteolysis|,serine-type endopeptidase activity|peptidase activity|,13,26,2000000000,22.5%
P98086,0.000850745,-0.132166667,32.40116454,4.097666667,0.000575286,5.974833733,-2.632,-2.246,-1.665,1.555,3.37,0.825,P98086,C1qa,P98086_C1qa,P98086,C1qa,1,48,10,10,P98086,MOUSE,26202.1,35.1,178,178.1,155.68,155.68,,245,Complement C1q subcomponent subunit A,collagen trimer|extracellular exosome|,"complement activation, classical pathway|innate immune response|",protein binding|,10,48,60700000000,35.1%
P47877,0.000165321,-1.312333333,43.93638247,5.037333333,4.03982E-05,9.058941526,-3.933,-2.793,-4.767,1.621,1.098,0.9,P47877,Igfbp2,P47877_Igfbp2,P47877,Igfbp2,1,22,11,11,P47877|D3YU40,MOUSE,33930.2,38.6,179,179.1,154.53,154.53,,305,Insulin-like growth factor-binding protein 2,extracellular region|extracellular space|apical plasma membrane|cytoplasmic vesicle|extracellular exosome|,regulation of cell growth|signal transduction|female pregnancy|aging|response to nutrient|response to mechanical stimulus|response to lithium ion|response to estradiol|response to retinoic acid|cellular response to hormone stimulus|positive regulation of activated T cell proliferation|response to drug|regulation of insulin-like growth factor receptor signaling pathway|response to glucocorticoid|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,11,22,4150000000,38.6%
Q80YC5,0.000152509,-0.984333333,45.68041423,4.360666667,2.7037E-05,9.631830242,-3.936,-2.859,-2.699,1.583,1.089,0.916,Q80YC5,F12,Q80YC5_F12,Q80YC5,F12,1,33,11,11,Q80YC5|E9Q698,MOUSE,67982.3,21.7,180,180.1,154,154,,597,Coagulation factor XII,extracellular space|extracellular exosome|,plasma kallikrein-kinin cascade|Factor XII activation|blood coagulation|positive regulation of plasminogen activation|protein processing|protein autoprocessing|regulation of blood coagulation|positive regulation of blood coagulation|zymogen activation|fibrinolysis|response to misfolded protein|positive regulation of fibrinolysis|,serine-type endopeptidase activity|peptidase activity|serine-type aminopeptidase activity|,11,33,8540000000,21.7%
P98063,0.000145021,-1.238,54.35985358,4.462,3.6645E-06,12.99200494,-3.851,-3.294,-3.262,1.073,0.939,0.967,P98063,Bmp1,P98063_Bmp1,P98063,Bmp1,1,19,14,14,P98063|Q9WVM6|E9Q5B9|G3X9F5|Q62381|Q62381-2,MOUSE,113889.4,16.8,181,181.1,153.57,153.57,,991,Bone morphogenetic protein 1,proteinaceous extracellular matrix|extracellular space|Golgi apparatus|membrane-bounded vesicle|,ossification|proteolysis|cell differentiation|cartilage development|positive regulation of cartilage development|,metalloendopeptidase activity|cytokine activity|calcium ion binding|protein binding|growth factor activity|peptidase activity|zinc ion binding|,14,19,1290000000,16.8%
P52430,0.00026945,-0.854,39.05164706,4.186666667,0.000124404,7.606064358,-4.07,-2.258,-2.514,1.579,1.269,0.87,P52430,Pon1,P52430_Pon1,P52430,Pon1,1,34,10,10,P52430|H3BLB8,MOUSE,39735.6,30.1,182,182.1,151.36,151.36,,355,Serum paraoxonase/arylesterase 1,extracellular space|high-density lipoprotein particle|spherical high-density lipoprotein particle|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,blood circulation|cholesterol metabolic process|response to toxic substance|positive regulation of cholesterol efflux|dephosphorylation|aromatic compound catabolic process|response to nutrient levels|positive regulation of transporter activity|carboxylic acid catabolic process|organophosphate catabolic process|phosphatidylcholine metabolic process|positive regulation of binding|response to fatty acid|response to fluoride|,aryldialkylphosphatase activity|arylesterase activity|calcium ion binding|phospholipid binding|high-density lipoprotein particle binding|protein homodimerization activity|,10,34,8480000000,30.1%
Q91Y47,0.000192766,-1.158833333,41.95070396,5.002333333,6.3816E-05,8.442575737,-3.356,-2.779,-4.845,0.911,1.813,1.303,Q91Y47,F11,Q91Y47_F11,Q91Y47,F11,1,23,12,12,Q91Y47,MOUSE,71784.4,17.1,183,183.1,151.34,151.34,,624,Coagulation factor XI,extracellular space|extracellular exosome|,blood coagulation|regulation of blood coagulation|plasminogen activation|positive regulation of fibrinolysis|,serine-type endopeptidase activity|heparin binding|,12,23,829000000,17.1%
O55111,0.002074901,-1.8855,28.02388306,5.900333333,0.001576201,5.065641615,-3.751,-3.021,-7.735,1.242,0.984,0.968,O55111,Dsg2,O55111_Dsg2,O55111,Dsg2,1,14,11,11,O55111|Q811I1|Q8VCE3,MOUSE,123181.5,13.1,184,184.1,148.04,148.04,,1122,Desmoglein-2,plasma membrane|cell surface|intercalated disc|integral component of membrane|apical plasma membrane|lateral plasma membrane|desmosome|extracellular exosome|,desmosome organization|Purkinje myocyte development|cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|response to progesterone|maternal process involved in female pregnancy|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,calcium ion binding|cell adhesion molecule binding|,11,14,229000000,13.1%
Q8C196,0.2196084,-0.893666667,6.754492976,2.022,0.211130367,1.380102258,-2.655,1.64,-4.699,0.311,-0.025,0.066,Q8C196,Cps1,Q8C196_Cps1,Q8C196,Cps1,1,16,13,13,Q8C196,MOUSE,165813.2,9.5,185,185.1,147.89,147.89,,1500,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",nucleolus|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial nucleoid|protein complex|,urea cycle|glycogen catabolic process|'de novo' pyrimidine nucleobase biosynthetic process|proteolysis|arginine biosynthetic process|glutamine metabolic process|midgut development|response to toxic substance|response to zinc ion|response to amine|triglyceride catabolic process|response to food|response to lipopolysaccharide|response to drug|response to starvation|response to amino acid|cellular response to fibroblast growth factor stimulus|positive regulation of vasodilation|nitric oxide metabolic process|homocysteine metabolic process|anion homeostasis|response to growth hormone|hepatocyte differentiation|carbamoyl phosphate biosynthetic process|cellular response to cAMP|cellular response to glucagon stimulus|cellular response to oleic acid|response to dexamethasone|,carbamoyl-phosphate synthase (ammonia) activity|carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity|endopeptidase activity|calcium ion binding|protein binding|ATP binding|phospholipid binding|glutamate binding|protein complex binding|modified amino acid binding|,13,16,799000000,9.5%
P03953,0.000564021,-1.390833333,34.54450009,4.890333333,0.000351196,6.569125412,-3.756,-2.344,-5.408,1,1.004,1.159,P03953,Cfd,P03953_Cfd,P03953,Cfd,1,40,8,8,P03953|P03953-2,MOUSE,28569.8,35.9,186,186.1,144.85,144.85,,259,Complement factor D,extracellular space|extracellular exosome|,"proteolysis|complement activation, alternative pathway|",serine-type endopeptidase activity|,8,40,27600000000,35.9%
Q8CIT9,0.000960721,-1.375666667,31.72535182,4.904666667,0.000672148,5.885244306,-3.178,-2.494,-5.812,0.988,1.168,1.074,Q8CIT9,Sbsn,Q8CIT9_Sbsn,Q8CIT9,Sbsn,1,20,10,10,Q8CIT9|E9QPB2|S4R2I1|Q8CIT9-3|A0A0R4J2A5,MOUSE,72446.7,19.7,187,187.1,143.41,143.41,,700,Suprabasin,cytoplasm|extracellular exosome|,,,10,20,1550000000,19.7%
P12246,0.000444089,-0.3318,35.76910155,4.203666667,0.000264905,7.612013851,-3.173,-2.535,,1.035,2.154,0.86,P12246,Apcs,P12246_Apcs,P12246,Apcs,1,29,10,10,P12246,MOUSE,26417.6,30.3,188,188.1,141.46,141.46,,224,Serum amyloid P-component,extracellular space|nucleus|protein complex|extracellular exosome|blood microparticle|extracellular matrix|,protein complex assembly|negative regulation by host of viral exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|innate immune response|negative regulation of monocyte differentiation|negative regulation of viral entry into host cell|negative regulation of viral process|negative regulation of exo-alpha-sialidase activity|negative regulation of glycoprotein metabolic process|,complement component C1q binding|calcium ion binding|carbohydrate binding|virion binding|,10,29,7840000000,30.3%
Q9CWF2,0.000477465,-0.572833333,35.37771588,3.619,0.000289887,6.64320522,-2.387,-1.464,-3.296,1.598,0.712,1.4,Q9CWF2,Tubb2b,Q9CWF2_Tubb2b,Q9CWF2,Tubb2b,1,18,11,1,Q9CWF2|Q7TMM9|A0A1D5RM76,MOUSE,50408.6,28,189,189.1,141.21,16.49,,445,Tubulin beta-2B chain,nucleus|cytoplasm|microtubule|,neuron migration|microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,11,18,835000000,28.0%
P99024,0.017086926,0.0466,18.26914037,2.360166667,0.014896559,3.37507357,,-0.42,-2.319,1.481,0.325,1.166,P99024,Tubb5,P99024_Tubb5,P99024,Tubb5,1,1,11,1,P99024,MOUSE,50126.4,28.1,189,189.2,135.22,10.5,,444,Tubulin beta-5 chain,nucleus|nuclear envelope lumen|cytosol|microtubule|cytoplasmic ribonucleoprotein granule|cell body|tubulin complex|extracellular exosome|,protein folding|microtubule-based process|cellular process|spindle assembly|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|protein domain specific binding|ubiquitin protein ligase binding|protein complex binding|GTPase activating protein binding|MHC class I protein binding|,1,1,12900000,3.3%
P68372,0.003086083,0.46525,26.15967357,3.431,0.002421211,5.63375561,,-2.108,,1.516,0.822,1.631,P68372,Tubb4b,P68372_Tubb4b,P68372,Tubb4b,1,1,10,1,P68372|Q9D6F9|Q922F4,MOUSE,50286.6,24.7,189,189.3,119.71,5.11,,445,Tubulin beta-4B chain,nucleus|cytoplasm|microtubule|myelin sheath|tubulin complex|extracellular exosome|extracellular vesicle|,microtubule-based process|metabolic process|protein polymerization|,double-stranded RNA binding|GTPase activity|structural constituent of cytoskeleton|GTP binding|,1,1,57000000,3.3%
A2AQ07,0.000854278,-0.5655,32.35858102,4.077,0.000580954,5.962430859,-1.987,-1.79,-4.035,1.865,0.748,1.806,A2AQ07,Tubb1,A2AQ07_Tubb1,A2AQ07,Tubb1,1,4,6,3,A2AQ07,MOUSE,51124.7,12.6,189,189.4,66.83,37.1,,451,Tubulin beta-1 chain,cytoplasm|microtubule|extracellular exosome|,microtubule-based process|metabolic process|spindle assembly|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,3,4,161000000,8.4%
Q922D8,0.000179501,-1.102833333,42.63257648,4.059666667,5.45434E-05,8.650079303,-3.184,-2.305,-3.909,1.026,0.859,0.896,Q922D8,Mthfd1,Q922D8_Mthfd1,Q922D8,Mthfd1,1,16,14,14,Q922D8|A0A1W2P733,MOUSE,101882.4,15.4,190,190.1,140.73,140.73,,935,"C-1-tetrahydrofolate synthase, cytoplasmic",mitochondrion|cytosol|membrane|extracellular exosome|,histidine biosynthetic process|neutrophil homeostasis|neural tube closure|purine nucleotide biosynthetic process|methionine metabolic process|one-carbon metabolic process|heart development|serine family amino acid metabolic process|serine family amino acid biosynthetic process|methionine biosynthetic process|10-formyltetrahydrofolate biosynthetic process|transsulfuration|tetrahydrofolate interconversion|oxidation-reduction process|somite development|,formate-tetrahydrofolate ligase activity|methenyltetrahydrofolate cyclohydrolase activity|methylenetetrahydrofolate dehydrogenase (NAD+) activity|methylenetetrahydrofolate dehydrogenase (NADP+) activity|ATP binding|,14,16,516000000,15.4%
Q62009,0.000145021,-0.947333333,51.72335026,3.897333333,6.72458E-06,11.87326478,-2.988,-2.637,-3.063,0.91,1.102,0.992,Q62009,Postn,Q62009_Postn,Q62009,Postn,1,16,13,13,Q62009|Q62009-2|Q62009-3|Q62009-5|Q62009-4,MOUSE,93826.5,18.3,191,191.1,139.01,139.01,,838,Periostin,proteinaceous extracellular matrix|extracellular space|trans-Golgi network|extracellular matrix|,cell adhesion|regulation of Notch signaling pathway|tissue development|extracellular matrix organization|,heparin binding|cell adhesion molecule binding|,13,16,203000000,18.3%
P31532,0.000157801,-0.795,44.80135607,4.28,3.31028E-05,9.339260011,-3.619,-2.348,-2.838,1.711,1.458,0.866,P31532,Saa4,P31532_Saa4,P31532,Saa4,1,28,10,10,P31532,MOUSE,15144.6,68.4,192,192.1,138.66,138.66,,130,Serum amyloid A-4 protein,extracellular space|high-density lipoprotein particle|,acute-phase response|positive chemotaxis|cell chemotaxis|,chemoattractant activity|,10,28,7160000000,68.4%
Q60994,0.000145649,-1.483666667,47.32808815,5.185333333,1.85008E-05,10.20194664,-4.117,-3.149,-4.963,0.941,1.283,1.103,Q60994,Adipoq,Q60994_Adipoq,Q60994,Adipoq,1,55,8,8,Q60994,MOUSE,26922.6,27.1,193,193.1,137.85,137.85,,247,Adiponectin,collagen trimer|extracellular space|endoplasmic reticulum|cell surface|perinuclear region of cytoplasm|extracellular exosome|cell periphery|,"response to hypoxia|positive regulation of protein phosphorylation|glucose metabolic process|fatty acid beta-oxidation|response to nutrient|circadian rhythm|response to sucrose|response to glucose|positive regulation of signal transduction|negative regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of protein kinase A signaling|negative regulation of macrophage derived foam cell differentiation|negative regulation of tumor necrosis factor-mediated signaling pathway|positive regulation of cholesterol efflux|regulation of glucose metabolic process|response to activity|negative regulation of smooth muscle cell migration|fatty acid oxidation|negative regulation of cell migration|negative regulation of granulocyte differentiation|negative regulation of protein autophosphorylation|positive regulation of cellular protein metabolic process|negative regulation of tumor necrosis factor production|positive regulation of interleukin-8 production|cellular response to insulin stimulus|positive regulation of myeloid cell apoptotic process|adiponectin-activated signaling pathway|negative regulation of heterotypic cell-cell adhesion|low-density lipoprotein particle clearance|response to tumor necrosis factor|cellular response to drug|glucose homeostasis|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of MAP kinase activity|response to ethanol|negative regulation of fat cell differentiation|negative regulation of macrophage differentiation|negative regulation of low-density lipoprotein particle receptor biosynthetic process|negative regulation of gluconeogenesis|negative regulation of blood pressure|positive regulation of blood pressure|negative regulation of transcription, DNA-templated|positive regulation of fatty acid metabolic process|positive regulation of glucose import|negative regulation of hormone secretion|negative regulation of smooth muscle cell proliferation|negative regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|negative regulation of phagocytosis|negative regulation of synaptic transmission|brown fat cell differentiation|protein homooligomerization|response to glucocorticoid|membrane depolarization|membrane hyperpolarization|protein heterotrimerization|negative regulation of ERK1 and ERK2 cascade|response to linoleic acid|detection of oxidative stress|cellular response to cAMP|positive regulation of monocyte chemotactic protein-1 production|cellular response to epinephrine stimulus|protein localization to plasma membrane|negative regulation of intracellular protein transport|negative regulation of receptor binding|negative regulation of DNA biosynthetic process|positive regulation of glycogen (starch) synthase activity|positive regulation of metanephric glomerular visceral epithelial cell development|positive regulation of cAMP-dependent protein kinase activity|positive regulation of renal albumin absorption|negative regulation of platelet-derived growth factor receptor-alpha signaling pathway|negative regulation of metanephric mesenchymal cell migration|",receptor binding|hormone activity|protein binding|sialic acid binding|identical protein binding|protein homodimerization activity|,8,55,1.18E+11,27.1%
Q3TQC7,0.000145021,-0.896333333,47.39032862,4.081333333,1.82376E-05,10.22405541,-3.433,-2.523,-2.855,1.544,0.92,0.969,Q3TQC7,Entpd5,Q3TQC7_Entpd5,Q3TQC7,Entpd5,1,20,10,10,Q3TQC7|Q9WUZ9,MOUSE,50293.2,25.8,194,194.1,136.5,136.5,,452,Ectonucleoside triphosphate diphosphohydrolase 5,extracellular exosome|,metabolic process|,hydrolase activity|,10,20,2380000000,25.8%
Q3SXB8-2,0.000255214,-1.334833333,39.64000094,5.137,0.000108643,7.770062241,-3.435,-2.906,-5.369,1.221,1.575,0.905,Q3SXB8,Colec11,Q3SXB8-2_Colec11,Q3SXB8-2,Colec11,1,20,11,11,Q3SXB8-2|A0A1Y7VKG6|Q3SXB8|A0A0R4J0M6,MOUSE,29981.5,33,195,195.1,135.11,135.11,,272,Isoform 2 of Collectin-11,extracellular region|collagen trimer|,multicellular organismal development|developmental process|,mannose binding|,11,20,1150000000,33.0%
Q8BND5,0.011158944,-2.194833333,20.20768316,6.743666667,0.009533046,3.568524269,-3.356,-2.922,-10.422,1.261,1.35,0.92,Q8BND5,Qsox1,Q8BND5_Qsox1,Q8BND5,Qsox1,1,20,13,2,Q8BND5|Q8BND5-2,MOUSE,83582.5,18.1,196,196.1,134.94,29.07,,748,Sulfhydryl oxidase 1,extracellular space|endoplasmic reticulum|Golgi apparatus|integral component of Golgi membrane|intracellular membrane-bounded organelle|intercellular bridge|extracellular exosome|,protein folding|negative regulation of macroautophagy|cell redox homeostasis|oxidation-reduction process|,protein disulfide isomerase activity|flavin-linked sulfhydryl oxidase activity|,13,20,930000000,18.1%
Q8BND5-3,0.000261034,-0.464,39.44726113,3.259333333,0.000113573,7.716024297,-1.827,-1.786,-2.668,1.654,0.843,1,Q8BND5,Qsox1,Q8BND5-3_Qsox1,Q8BND5-3,Qsox1,1,3,13,3,Q8BND5-3,MOUSE,64076.9,21.1,196,196.2,120.8,20.64,,748,Isoform 3 of Sulfhydryl oxidase 1,extracellular space|endoplasmic reticulum|Golgi apparatus|integral component of Golgi membrane|intracellular membrane-bounded organelle|intercellular bridge|extracellular exosome|,protein folding|negative regulation of macroautophagy|cell redox homeostasis|oxidation-reduction process|,protein disulfide isomerase activity|flavin-linked sulfhydryl oxidase activity|,3,3,39500000,3.8%
P04202,0.000261034,-0.3476,39.31267413,3.878166667,0.000117147,8.81093434,-3.004,-2.345,,1.312,1.425,0.874,P04202,Tgfb1,P04202_Tgfb1,P04202,Tgfb1,1,18,13,13,P04202,MOUSE,44993.8,31.5,197,197.1,134.39,134.39,,390,Transforming growth factor beta-1,proteinaceous extracellular matrix|extracellular space|nucleus|cytoplasm|cell surface|secretory granule|axon|neuronal cell body|blood microparticle|microvillus|,"protein import into nucleus, translocation|negative regulation of transcription from RNA polymerase II promoter|MAPK cascade|skeletal system development|ureteric bud development|response to hypoxia|cell activation|epithelial to mesenchymal transition|negative regulation of protein phosphorylation|positive regulation of protein phosphorylation|regulation of sodium ion transport|chondrocyte differentiation|hematopoietic progenitor cell differentiation|CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment|adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|tolerance induction to self antigen|protein phosphorylation|protein export from nucleus|ATP biosynthetic process|phosphate-containing compound metabolic process|cellular calcium ion homeostasis|defense response|inflammatory response|cell cycle arrest|mitotic cell cycle checkpoint|epidermal growth factor receptor signaling pathway|transforming growth factor beta receptor signaling pathway|common-partner SMAD protein phosphorylation|SMAD protein complex assembly|SMAD protein import into nucleus|Notch signaling pathway|negative regulation of neuroblast proliferation|salivary gland morphogenesis|endoderm development|skeletal muscle tissue development|female pregnancy|aging|negative regulation of DNA replication|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|germ cell migration|response to radiation|response to wounding|response to glucose|defense response to fungus, incompatible interaction|organ morphogenesis|regulation of gene expression|positive regulation of gene expression|negative regulation of gene expression|positive regulation of epithelial to mesenchymal transition|positive regulation of fibroblast migration|positive regulation of peptidyl-threonine phosphorylation|positive regulation of pathway-restricted SMAD protein phosphorylation|negative regulation of macrophage cytokine production|oligodendrocyte development|cell growth|regulation of striated muscle tissue development|regulation of transforming growth factor beta receptor signaling pathway|evasion or tolerance of host defenses by virus|negative regulation of cell-cell adhesion|hyaluronan catabolic process|T cell differentiation|negative regulation of ossification|negative regulation of cell growth|positive regulation of cell migration|positive regulation of bone mineralization|mammary gland development|positive regulation of histone deacetylation|organ regeneration|positive regulation of protein complex assembly|positive regulation of exit from mitosis|lipopolysaccharide-mediated signaling pathway|positive regulation of cellular protein metabolic process|response to estradiol|response to progesterone|regulation of interleukin-23 production|negative regulation of interleukin-17 production|positive regulation of interleukin-17 production|receptor catabolic process|regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation|positive regulation of superoxide anion generation|mononuclear cell proliferation|positive regulation of collagen biosynthetic process|positive regulation of peptidyl-serine phosphorylation|response to vitamin D|response to laminar fluid shear stress|positive regulation of histone acetylation|positive regulation of protein dephosphorylation|wound healing|T cell activation|regulation of cell proliferation|negative regulation of T cell proliferation|regulation of protein import into nucleus|positive regulation of protein import into nucleus|positive regulation of odontogenesis|response to drug|myelination|regulation of apoptotic process|myeloid dendritic cell differentiation|T cell homeostasis|positive regulation of apoptotic process|positive regulation of MAP kinase activity|regulation of MAPK cascade|protein kinase B signaling|positive regulation of blood vessel endothelial cell migration|negative regulation of blood vessel endothelial cell migration|positive regulation of phosphatidylinositol 3-kinase activity|ossification involved in bone remodeling|regulatory T cell differentiation|cell-cell junction organization|negative regulation of fat cell differentiation|negative regulation of myoblast differentiation|negative regulation of cell cycle|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|negative regulation of mitotic cell cycle|positive regulation of transcription from RNA polymerase II promoter|positive regulation of fibroblast proliferation|positive regulation of isotype switching to IgA isotypes|cell development|lymph node development|digestive tract development|negative regulation of skeletal muscle tissue development|inner ear development|positive regulation of epithelial cell proliferation|negative regulation of epithelial cell proliferation|positive regulation of protein secretion|negative regulation of phagocytosis|negative regulation of T cell activation|positive regulation of chemotaxis|positive regulation of NF-kappaB transcription factor activity|regulation of binding|regulation of DNA binding|positive regulation of smooth muscle cell differentiation|negative regulation of release of sequestered calcium ion into cytosol|positive regulation of protein kinase B signaling|face morphogenesis|frontal suture morphogenesis|pathway-restricted SMAD protein phosphorylation|positive regulation of SMAD protein import into nucleus|SMAD protein signal transduction|mammary gland branching involved in thelarche|branch elongation involved in mammary gland duct branching|regulation of branching involved in mammary gland duct morphogenesis|negative regulation of gene silencing by miRNA|regulation of cartilage development|lens fiber cell differentiation|response to cholesterol|positive regulation of cell cycle arrest|cellular response to growth factor stimulus|cellular response to organic cyclic compound|cellular response to dexamethasone stimulus|cellular response to transforming growth factor beta stimulus|T-helper 17 cell lineage commitment|extracellular matrix assembly|positive regulation of branching involved in ureteric bud morphogenesis|extrinsic apoptotic signaling pathway|negative regulation of hyaluronan biosynthetic process|positive regulation of protein localization to nucleus|positive regulation of NAD+ ADP-ribosyltransferase activity|regulation of actin cytoskeleton reorganization|positive regulation of transcription regulatory region DNA binding|",glycoprotein binding|antigen binding|type II transforming growth factor beta receptor binding|cytokine activity|transforming growth factor beta receptor binding|protein binding|growth factor activity|enzyme binding|type I transforming growth factor beta receptor binding|type III transforming growth factor beta receptor binding|protein homodimerization activity|protein heterodimerization activity|protein N-terminus binding|,13,18,751000000,31.5%
Q8CJH3,0.000213663,-0.784166667,40.90686731,3.721666667,8.11546E-05,8.133033336,-3.4,-2.655,-1.88,1.144,1.164,0.922,Q8CJH3,Plxnb1,Q8CJH3_Plxnb1,Q8CJH3,Plxnb1,1,21,11,11,Q8CJH3,MOUSE,234738.4,5.9,198,198.1,133.08,133.08,,2119,Plexin-B1,semaphorin receptor complex|integral component of plasma membrane|,negative regulation of cell adhesion|regulation of cell shape|positive regulation of phosphatidylinositol 3-kinase signaling|negative regulation of osteoblast proliferation|positive regulation of GTPase activity|ossification involved in bone maturation|neuron projection morphogenesis|positive regulation of axonogenesis|regulation of cytoskeleton organization|semaphorin-plexin signaling pathway|semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis|,protein binding|semaphorin receptor activity|GTPase activating protein binding|,11,21,890000000,5.9%
G5E8Q8,0.000156464,-0.6606,45.04620365,4.367333333,3.12881E-05,11.10455641,-3.462,-3.1,,1.184,1.149,0.926,G5E8Q8,Adgrf5,G5E8Q8_Adgrf5,G5E8Q8,Adgrf5,1,18,10,10,G5E8Q8,MOUSE,151723.4,9.1,199,199.1,132.77,132.77,,1348,Adhesion G protein-coupled receptor F5,,,,10,18,3130000000,9.1%
P22629,0.002357532,-0.159166667,27.41972732,1.763666667,0.001811454,4.866524849,-0.725,-0.891,-1.507,0.856,0.611,0.701,P22629,NotFound,P22629_NotFound,P22629,,1,185,7,1,P22629,STRAV,18833.4,43.1,200,200.1,127.86,23.95,,183,Streptavidin,,,,7,185,5.28E+12,43.1%
Q53532,0.008087503,-0.171833333,21.70178568,1.500333333,0.00675805,3.792279438,-0.428,-0.845,-1.493,0.707,0.645,0.383,Q53532,NotFound,Q53532_NotFound,Q53532,,1,26,7,2,Q53532|Q53533,STRVL,18863.4,43.1,200,200.2,113.35,30.52,,183,Streptavidin-V1,,,,2,26,2.9E+11,20.2%
P01592,0.000739303,-1.425333333,33.11617123,4.876666667,0.000487958,6.215710059,-3.101,-2.751,-5.739,0.958,1.096,0.985,P01592,Jchain,P01592_Jchain,P01592,Jchain,1,36,10,10,P01592,MOUSE,18469.7,71.6,201,201.1,125.78,125.78,,159,Immunoglobulin J chain,extracellular space|extracellular exosome|monomeric IgA immunoglobulin complex|dimeric IgA immunoglobulin complex|secretory IgA immunoglobulin complex|secretory dimeric IgA immunoglobulin complex|pentameric IgM immunoglobulin complex|blood microparticle|,adaptive immune response|glomerular filtration|humoral immune response|antibacterial humoral response|positive regulation of protein oligomerization|innate immune response|positive regulation of respiratory burst|,antigen binding|IgA binding|protein homodimerization activity|single-stranded DNA binding|phosphatidylcholine binding|immunoglobulin receptor binding|peptidoglycan binding|,10,36,44700000000,71.6%
Q7TSK7,0.000157801,-0.5802,44.82967143,4.487166667,3.28877E-05,11.00895986,-3.414,-3.131,,1.264,1.458,0.922,Q7TSK7,Adamtsl2,Q7TSK7_Adamtsl2,Q7TSK7,Adamtsl2,1,16,10,10,Q7TSK7,MOUSE,109068.3,11.8,202,202.1,125.15,125.15,,957,ADAMTS-like protein 2,extracellular region|proteinaceous extracellular matrix|,proteolysis|negative regulation of transforming growth factor beta receptor signaling pathway|,metalloendopeptidase activity|zinc ion binding|,10,16,647000000,11.8%
P51885,0.000145021,-0.979833333,51.12550873,3.901666667,7.71701E-06,11.63223358,-3.16,-2.623,-3.009,1.071,0.964,0.878,P51885,Lum,P51885_Lum,P51885,Lum,1,15,10,10,P51885,MOUSE,38663.6,34.9,203,203.1,125.04,125.04,,338,Lumican,proteinaceous extracellular matrix|fibrillar collagen trimer|extracellular space|extracellular exosome|extracellular matrix|,visual perception|response to organic cyclic compound|collagen fibril organization|positive regulation of transforming growth factor beta1 production|positive regulation of transcription from RNA polymerase II promoter|cartilage development|response to growth factor|,collagen binding|,10,15,2010000000,34.9%
P11152,0.000145021,-1.1092,47.71431389,5.353833333,1.69266E-05,12.34716269,-4.736,-3.907,,1.042,1.055,1,P11152,Lpl,P11152_Lpl,P11152,Lpl,1,18,9,9,P11152,MOUSE,53679,23.8,204,204.1,124.19,124.19,,474,Lipoprotein lipase,extracellular space|plasma membrane|cell surface|extracellular matrix|anchored component of membrane|very-low-density lipoprotein particle|chylomicron|extracellular exosome|,fatty acid biosynthetic process|response to cold|positive regulation of macrophage derived foam cell differentiation|positive regulation of cholesterol storage|positive regulation of sequestering of triglyceride|triglyceride biosynthetic process|triglyceride catabolic process|very-low-density lipoprotein particle remodeling|response to drug|triglyceride homeostasis|,lipoprotein lipase activity|triglyceride lipase activity|receptor binding|protein binding|heparin binding|triglyceride binding|apolipoprotein binding|,9,18,1770000000,23.8%
P70274,0.000145021,-1.026833333,53.94258495,4.411666667,4.03405E-06,12.80869073,-3.388,-2.983,-3.327,1.45,1.168,0.919,P70274,Selenop,P70274_Selenop,P70274,Selenop,1,28,9,9,P70274,MOUSE,43595.1,20.7,205,205.1,123.69,123.69,,380,Selenoprotein P,extracellular region|extracellular space|extracellular exosome|,selenium compound metabolic process|brain development|locomotory behavior|post-embryonic development|sexual reproduction|growth|,selenium binding|,9,28,6450000000,20.7%
Q5MJS3,0.000165321,-0.807333333,43.49926492,3.670666667,4.46759E-05,8.920062059,-2.778,-1.996,-3.154,1.245,0.946,0.893,Q5MJS3,Fam20c,Q5MJS3_Fam20c,Q5MJS3,Fam20c,1,16,10,10,Q5MJS3|Q8CID3,MOUSE,66392.3,17.2,206,206.1,121.58,121.58,,579,Extracellular serine/threonine protein kinase FAM20C,extracellular space|Golgi apparatus|extracellular exosome|,skeletal system development|protein phosphorylation|positive regulation of bone mineralization|biomineral tissue development|osteoclast maturation|regulation of fibroblast growth factor receptor signaling pathway|positive regulation of osteoblast differentiation|regulation of phosphorus metabolic process|enamel mineralization|odontoblast differentiation|dentinogenesis|,protein serine/threonine kinase activity|calcium ion binding|manganese ion binding|,10,16,858000000,17.2%
Q04857,0.000145021,-0.994833333,50.78911808,4.068333333,8.3385E-06,11.498584,-3.333,-2.593,-3.161,1,1.099,1.019,Q04857,Col6a1,Q04857_Col6a1,Q04857,Col6a1,1,11,10,10,Q04857,MOUSE,109628.6,11.6,207,207.1,121.29,121.29,,1025,Collagen alpha-1(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|lysosomal membrane|membrane|extracellular matrix|sarcolemma|protein complex|extracellular exosome|extracellular matrix|,osteoblast differentiation|cell adhesion|endodermal cell differentiation|protein heterotrimerization|cellular response to amino acid stimulus|,platelet-derived growth factor binding|,10,11,519000000,11.6%
Q71KU9,0.000145021,-0.964666667,49.63170132,4.004,1.0885E-05,11.04933163,-2.826,-2.673,-3.401,0.914,1.261,0.937,Q71KU9,Fgl1,Q71KU9_Fgl1,Q71KU9,Fgl1,1,18,10,10,Q71KU9|A0A0R4J0E1|Q3SZZ7,MOUSE,36724.1,26.7,208,208.1,120.73,120.73,,314,Fibrinogen-like protein 1,extracellular exosome|,cholesterol metabolic process|regulation of glucose metabolic process|response to stilbenoid|adipose tissue development|,,10,18,667000000,26.7%
Q07113,0.000145021,-0.855166667,48.62932838,3.708333333,1.37109E-05,10.67314883,-3.072,-2.375,-2.681,1.059,1.036,0.902,Q07113,Igf2r,Q07113_Igf2r,Q07113,Igf2r,1,18,12,12,Q07113,MOUSE,280828.2,4.9,209,209.1,120.3,120.3,,2483,Cation-independent mannose-6-phosphate receptor,nucleus|nuclear envelope lumen|lysosomal membrane|endosome|early endosome|late endosome|trans-Golgi network|focal adhesion|cell surface|membrane|integral component of membrane|endocytic vesicle|trans-Golgi network transport vesicle|extracellular exosome|,transport|,glycoprotein binding|transporter activity|insulin-like growth factor binding|mannose binding|identical protein binding|phosphoprotein binding|,12,18,988000000,4.9%
A0A075B5R5,0.000366887,-0.6086,36.85044993,4.435666667,0.000206517,7.962104667,-4.008,-2.532,,1.401,1.215,0.881,A0A075B5R5,NotFound,A0A075B5R5_NotFound,A0A075B5R5,Ighv4-1,1,20,7,7,A0A075B5R5|P01807|P01808|P01812|P01806|P01809|P01810|A0A075B5Q2|A0A075B5P7|A0A0A6YWG4,MOUSE,13044.9,68.1,210,210.1,119.2,114.55,,116,Immunoglobulin heavy variable 4-1 (Fragment),,,,9,20,1800000000,68.1%
P18524,0.001108339,0.3125,30.99620383,4.61,0.000795023,7.201598305,-3.145,,,0.916,1.936,1.543,P18524,NotFound,P18524_NotFound,P18524,,1,1,3,1,P18524,MOUSE,13036.9,23.9,210,210.2,21.29,4.98,,117,Ig heavy chain V region RF,,,antigen binding|,1,1,1340000,9.4%
P27656,0.000145021,-1.104,47.87945152,4.414666667,1.6295E-05,10.39928858,-3.39,-2.636,-3.908,1.266,1.137,0.907,P27656,Lipc,P27656_Lipc,P27656,Lipc,1,17,8,8,P27656|Q3TYU0,MOUSE,58072.5,17.8,211,211.1,118.07,118.07,,510,Hepatic triacylglycerol lipase,extracellular space|high-density lipoprotein particle|,fatty acid biosynthetic process|cholesterol metabolic process|triglyceride catabolic process|cholesterol transport|very-low-density lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|cholesterol homeostasis|triglyceride homeostasis|,triglyceride lipase activity|protein binding|heparin binding|lipase activity|,8,17,740000000,17.8%
E9QN70,0.000272426,-0.6086,38.94080808,4.522333333,0.00012762,8.677925343,-3.957,-2.687,,0.927,1.215,1.459,E9QN70,Lamb1,E9QN70_Lamb1,E9QN70,Lamb1,1,14,11,11,E9QN70|P02469,MOUSE,209741,5.7,212,212.1,117.7,117.7,,1834,Laminin subunit beta-1,proteinaceous extracellular matrix|basement membrane|basal lamina|laminin-1 complex|laminin-2 complex|extracellular space|extracellular matrix|laminin complex|laminin-8 complex|laminin-10 complex|extracellular exosome|basement membrane|,embryo implantation|cell migration|neuronal-glial interaction involved in cerebral cortex radial glia guided migration|positive regulation of cell migration|neuron projection development|substrate adhesion-dependent cell spreading|endodermal cell differentiation|odontogenesis|,integrin binding|extracellular matrix structural constituent|protein binding|enzyme binding|glycosphingolipid binding|,11,14,322000000,5.7%
P14106,0.001835412,0.2502,28.59226614,4.626166667,0.001382845,5.716402227,-2.382,-2.669,,1.869,3.54,0.893,P14106,C1qb,P14106_C1qb,P14106,C1qb,1,40,8,8,P14106,MOUSE,26945.1,38.7,213,213.1,117.2,117.2,,253,Complement C1q subcomponent subunit B,collagen trimer|extracellular exosome|blood microparticle|,"complement activation, classical pathway|innate immune response|inner ear development|",protein homodimerization activity|,8,40,85800000000,38.7%
P11589,0.000364151,-1.605333333,36.91187345,5.700666667,0.000203616,7.188528599,-4.183,-3,-6.184,1.15,1.673,0.912,P11589,NotFound,P11589_NotFound,P11589,Mup2,1,21,9,9,P11589|Q4FZE8|A2BIN1|P04938|A2CEK7|P02762|P11588|A2CEL1|A2AKN8|Q58EV3|B5X0G2|A9C496|E9PVW0|A2CEL0|E9QA79|A9C497|A2AKN9|A9R9W0|A2CEK6|L7N222|A2BIN0|P11591|A2AV72|P04939|Q3KQQ2|Q80YX8|A2ANT6,MOUSE,20948.4,50.5,214,214.1,116.99,116.99,,180,Major urinary protein 2,extracellular space|nucleus|cytosol|,"energy reserve metabolic process|transport|insulin receptor signaling pathway|aerobic respiration|positive regulation of gene expression|negative regulation of lipid storage|positive regulation of glucose metabolic process|heat generation|glucose homeostasis|locomotor rhythm|negative regulation of gluconeogenesis|positive regulation of lipid metabolic process|negative regulation of transcription, DNA-templated|negative regulation of lipid biosynthetic process|positive regulation of protein kinase B signaling|negative regulation of insulin secretion involved in cellular response to glucose stimulus|mitochondrion morphogenesis|cellular response to lipid|",insulin-activated receptor activity|transporter activity|pheromone binding|small molecule binding|,9,21,1850000000,50.5%
P00698,0.003529714,-0.256,25.51475118,1.556666667,0.002808826,4.492813798,-0.63,-1.183,-1.29,0.535,0.527,0.505,P00698,NotFound,P00698_NotFound,P00698,LYZ,1,17,9,9,P00698,CHICK,16751.9,65.3,215,215.1,116.5,116.5,,147,Lysozyme C,,,,9,17,3020000000,65.3%
Q91VB8,0.000245307,-0.944166667,39.91258491,4.306333333,0.000102033,7.847013178,-4.129,-2.248,-2.915,1.674,0.894,1.059,Q91VB8,Hba-a1,Q91VB8_Hba-a1,Q91VB8,Hba-a1,1,47,7,7,Q91VB8|P01942|P01966,MOUSE,15169,63.3,216,216.1,115.82,115.82,,142,Alpha globin 1,hemoglobin complex|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,7,47,1.94E+11,63.3%
A0A075B5Y4,0.00050652,-0.516333333,35.0815402,3.878666667,0.000310346,6.569919033,-3.302,-2.584,-1.481,1.117,2.221,0.931,A0A075B5Y4,NotFound,A0A075B5Y4_NotFound,A0A075B5Y4,Ighv1-81,1,20,8,4,A0A075B5Y4|A0A0A6YVW3|P06327|A0A075B5X2|A0A075B5W5|A0A0A6YXA5,MOUSE,13102.5,60.6,217,217.1,114.65,74.75,,117,Immunoglobulin heavy variable 1-81 (Fragment),,,,8,20,1170000000,60.6%
P06330,0.000156464,-1.303833333,45.03568439,5.171666667,3.1364E-05,9.416482258,-3.759,-2.982,-4.928,0.92,1.615,1.311,P06330,NotFound,P06330_NotFound,P06330,,1,12,7,4,P06330|A0A075B5V0|A0A075B5V1|P01757|P01756|A0A075B5V6|A0A075B5V2|A0A075B5U6|A0A075B5V7|A0A075B5U5,MOUSE,13048.2,71.1,217,217.2,107.09,65.97,,118,Ig heavy chain V region AC38 205.12,,,antigen binding|,4,12,6280000000,44.9%
A0A075B5U4,0.000355931,-0.405,37.08910692,4.266666667,0.000195474,8.041178482,-3.539,-2.391,,1.701,1.349,0.855,A0A075B5U4,NotFound,A0A075B5U4_NotFound,A0A075B5U4,Ighv1-18,1,6,5,2,A0A075B5U4,MOUSE,11351.7,50.9,217,217.3,72.77,39.51,,102,Immunoglobulin heavy variable V1-18,,,,2,6,283000000,34.3%
A0A075B5U7,0.000359116,-0.471,36.99173413,4.619166667,0.000199906,8.008835813,-3.686,-2.799,,0.991,2.191,0.948,A0A075B5U7,NotFound,A0A075B5U7_NotFound,A0A075B5U7,Ighv1-22,1,4,4,2,A0A075B5U7|P01758,MOUSE,13135.6,50.4,217,217.4,66.59,44.12,,117,Immunoglobulin heavy variable 1-22 (Fragment),,,,2,4,62700000,29.9%
A0A0B4J1J7,0.000204082,-0.6172,41.43123415,4.144666667,7.19245E-05,9.603494343,-3.467,-2.741,,0.892,1.249,0.981,A0A0B4J1J7,NotFound,A0A0B4J1J7_NotFound,A0A0B4J1J7,Ighv1-82,1,5,4,2,A0A0B4J1J7,MOUSE,10763.9,34.6,217,217.5,42.08,22.88,,98,Immunoglobulin heavy variable 1-82,,,,2,5,71300000,25.5%
A0A075B5Y3,0.001430794,-1.414166667,29.79023049,4.838333333,0.001049487,5.446424725,-2.329,-3.244,-5.927,0.849,1.297,0.869,A0A075B5Y3,NotFound,A0A075B5Y3_NotFound,A0A075B5Y3,Ighv1-80,1,1,3,1,A0A075B5Y3,MOUSE,12877.4,24.7,217,217.6,41.33,22.13,,117,Immunoglobulin heavy variable 1-80 (Fragment),,,,1,1,21000000,17.0%
A0A0B4J1M0,,1.679,,,,,,,,1.39,2.647,1,A0A0B4J1M0,NotFound,A0A0B4J1M0_NotFound,A0A0B4J1M0,Ighv1-77,1,2,3,1,A0A0B4J1M0,MOUSE,10775.9,24.4,217,217.7,37.38,18.18,,98,Immunoglobulin heavy variable 1-77,,,,1,2,6370000,15.3%
A0A075B674,0.000691065,-0.3962,33.45037149,3.752166667,0.000451817,6.904285373,-3.261,-2.034,,0.803,1.595,0.916,A0A075B674,NotFound,A0A075B674_NotFound,A0A075B674,Ighv1-78,1,2,3,1,A0A075B674,MOUSE,11161.3,25.5,217,217.8,31.86,12.66,,98,Immunoglobulin heavy variable 1-78,,,,1,2,89800000,16.3%
P01746,0.001463346,-0.841166667,29.67781096,3.489,0.001077008,5.333062591,-2.374,-1.391,-3.992,0.986,0.737,0.987,P01746,NotFound,P01746_NotFound,P01746,,1,4,2,1,P01746|P01747,MOUSE,15628.2,17.1,217,217.9,21.68,8.39,,140,Ig heavy chain V region 93G7,,,antigen binding|,1,4,189000000,7.1%
Q02105,0.00028468,-0.5205,38.62647685,4.953,0.000137199,7.48930656,-2.749,-2.614,-3.628,1.67,3.295,0.903,Q02105,C1qc,Q02105_C1qc,Q02105,C1qc,1,36,8,8,Q02105,MOUSE,26390.5,35.3,218,218.1,114.02,114.02,,246,Complement C1q subcomponent subunit C,collagen trimer|extracellular space|membrane|extracellular exosome|blood microparticle|,"complement activation, classical pathway|negative regulation of granulocyte differentiation|innate immune response|negative regulation of macrophage differentiation|",tumor necrosis factor receptor binding|,8,36,83000000000,35.3%
O88968,0.000145021,-1.2145,48.32062314,4.273,1.4721E-05,10.55963559,-3.547,-2.682,-3.824,0.953,0.905,0.908,O88968,Tcn2,O88968_Tcn2,O88968,Tcn2,1,23,9,9,O88968,MOUSE,48041.3,21.1,219,219.1,112.93,112.93,,430,Transcobalamin-2,extracellular space|extracellular exosome|,cobalt ion transport|cobalamin transport|,cobalamin binding|metal ion binding|,9,23,3920000000,21.1%
P02662,0.000165321,-0.643833333,43.66435631,3.335,4.30095E-05,8.972297904,-2.642,-1.956,-2.336,1.394,0.833,0.844,P02662,NotFound,P02662_NotFound,P02662,CSN1S1,1,17,7,7,P02662,BOVIN,24585.5,36.9,220,220.1,111.28,111.28,,214,"Alpha-S1-casein, Michrom mix 6",,,,7,17,1390000000,36.9%
Q8VCS0,0.000164241,-0.812,44.24416291,3.921333333,3.76343E-05,9.157840988,-3.327,-2.146,-2.845,1.481,1.135,0.83,Q8VCS0,Pglyrp2,Q8VCS0_Pglyrp2,Q8VCS0,Pglyrp2,1,15,7,7,Q8VCS0|Q8VCS0-2|Q8VCS0-3,MOUSE,58219.2,18.3,221,221.1,106.95,106.95,,530,N-acetylmuramoyl-L-alanine amidase,membrane|extracellular exosome|,pattern recognition receptor signaling pathway|peptidoglycan catabolic process|detection of bacterium|negative regulation of interferon-gamma production|negative regulation of natural killer cell differentiation involved in immune response|growth of symbiont in host|regulation of inflammatory response|defense response to Gram-positive bacterium|,zinc ion binding|N-acetylmuramoyl-L-alanine amidase activity|peptidoglycan receptor activity|peptidoglycan binding|,7,15,677000000,18.3%
O08689,0.000145021,-0.947,48.40611626,4.119333333,1.44341E-05,10.59096323,-2.728,-2.704,-3.588,1.192,1.251,0.895,O08689,Mstn,O08689_Mstn,O08689,Mstn,1,17,10,10,O08689|A0A087WQL8|Q9Z1W4,MOUSE,43662.3,28.9,222,222.1,106.45,106.45,,376,Growth/differentiation factor 8,extracellular space|cytoplasm|,"positive regulation of defense response to virus by host|transforming growth factor beta receptor signaling pathway|response to heat|response to gravity|positive regulation of pathway-restricted SMAD protein phosphorylation|skeletal muscle atrophy|negative regulation of muscle hypertrophy|response to muscle activity|ovulation cycle process|response to testosterone|negative regulation of kinase activity|regulation of apoptotic process|skeletal muscle tissue regeneration|regulation of MAPK cascade|response to estrogen|response to ethanol|negative regulation of myoblast differentiation|positive regulation of transcription, DNA-templated|negative regulation of insulin receptor signaling pathway|muscle cell cellular homeostasis|cell development|negative regulation of skeletal muscle tissue growth|response to electrical stimulus|negative regulation of protein kinase B signaling|SMAD protein signal transduction|cellular response to dexamethasone stimulus|activation of mitophagy in response to mitochondrial depolarization|negative regulation of skeletal muscle satellite cell proliferation|negative regulation of satellite cell differentiation|negative regulation of myoblast proliferation|",receptor binding|cytokine activity|transforming growth factor beta receptor binding|protein binding|growth factor activity|heparin binding|identical protein binding|,10,17,838000000,28.9%
P55284,0.000157801,-0.6468,44.76889541,4.533666667,3.33511E-05,10.98226403,-3.619,-3.115,,1.289,1.291,0.92,P55284,Cdh5,P55284_Cdh5,P55284,Cdh5,1,12,9,9,P55284,MOUSE,88186.6,12.5,223,223.1,106.11,106.11,,784,Cadherin-5,plasma membrane|cell-cell junction|adherens junction|bicellular tight junction|integral component of membrane|cell junction|cell periphery|,blood vessel maturation|homophilic cell adhesion via plasma membrane adhesion molecules|negative regulation of cell proliferation|single organismal cell-cell adhesion|regulation of establishment of cell polarity|,receptor binding|calcium ion binding|protein binding|beta-catenin binding|protein phosphatase binding|ion channel binding|,9,12,500000000,12.5%
B2RXS4,0.000196828,-1.0635,41.74466277,4.342333333,6.69166E-05,8.380706722,-2.831,-2.57,-4.303,1.192,1.233,0.898,B2RXS4,Plxnb2,B2RXS4_Plxnb2,B2RXS4,Plxnb2,1,17,10,10,B2RXS4,MOUSE,209079.3,6.3,224,224.1,106.08,106.08,,1842,Plexin-B2,integral component of plasma membrane|cell surface|extracellular exosome|,neural tube closure|regulation of protein phosphorylation|neuroblast proliferation|brain development|regulation of cell shape|regulation of GTPase activity|positive regulation of axonogenesis|semaphorin-plexin signaling pathway|regulation of neuron migration|,protein binding|semaphorin receptor activity|,10,17,935000000,6.3%
E9QPK1,0.000148189,-1.0035,46.26525547,4.171666667,2.36306E-05,9.830891647,-2.652,-2.787,-3.829,0.977,1.27,1,E9QPK1,Cgref1,E9QPK1_Cgref1,E9QPK1,Cgref1,1,21,8,8,E9QPK1|Q8R1U2,MOUSE,35428.9,33.5,225,225.1,105.96,105.96,,325,Cell growth regulator with EF hand domain protein 1,,negative regulation of cell growth|,calcium ion binding|,8,21,24900000000,33.5%
Q9WUB3,0.001221616,-1.081666667,30.55853032,4.107333333,0.00087932,5.617834788,-2.288,-2.262,-4.856,1.199,0.842,0.875,Q9WUB3,Pygm,Q9WUB3_Pygm,Q9WUB3,Pygm,1,13,12,12,Q9WUB3|E9PUM3|Q8CI94|Q9ET01|Q3UEJ6,MOUSE,97741,16.5,226,226.1,105.52,105.52,,842,"Glycogen phosphorylase, muscle form",cytoplasm|sarcoplasmic reticulum|Z disc|extracellular exosome|,response to hypoxia|glycogen catabolic process|cellular calcium ion homeostasis|response to cAMP|,drug binding|glycogen phosphorylase activity|AMP binding|pyridoxal phosphate binding|carbohydrate binding|,12,13,376000000,16.5%
O09159,0.000357616,-0.3566,37.01963332,4.075666667,0.000198626,8.018091271,-3.352,-2.252,,1.433,1.518,0.87,O09159,Man2b1,O09159_Man2b1,O09159,Man2b1,1,14,12,12,O09159,MOUSE,115216.7,13.6,227,227.1,104.55,104.55,,1013,Lysosomal alpha-mannosidase,lysosome|extracellular exosome|,mannose metabolic process|cellular protein modification process|learning or memory|,alpha-mannosidase activity|mannose binding|zinc ion binding|,12,14,466000000,13.6%
Q91XL1,0.000145021,-1.047,52.62075108,4.13,5.46921E-06,12.24367157,-3.262,-2.775,-3.299,1.037,0.925,1.092,Q91XL1,Lrg1,Q91XL1_Lrg1,Q91XL1,Lrg1,1,26,7,7,Q91XL1,MOUSE,37829.6,21.6,228,228.1,100.29,100.29,,342,Leucine-rich HEV glycoprotein,extracellular space|extracellular exosome|,positive regulation of endothelial cell proliferation|positive regulation of transforming growth factor beta receptor signaling pathway|positive regulation of angiogenesis|brown fat cell differentiation|,transforming growth factor beta receptor binding|,7,26,5480000000,21.6%
Q99P87,0.000172925,-1.26,42.88460894,4.586666667,5.14682E-05,8.727862071,-3.431,-2.659,-4.57,1.19,0.889,1.021,Q99P87,Retn,Q99P87_Retn,Q99P87,Retn,1,14,6,6,Q99P87,MOUSE,13119,55.2,229,229.1,99.37,99.37,,114,Resistin,extracellular region|extracellular space|extracellular exosome|,,hormone activity|,6,14,4150000000,55.2%
P39876,0.000148189,-0.722833333,46.1423349,3.593,2.4309E-05,9.788756038,-2.864,-2.245,-2.449,1.445,0.893,0.883,P39876,Timp3,P39876_Timp3,P39876,Timp3,1,15,9,9,P39876,MOUSE,24923.3,37.9,230,230.1,99.27,99.27,,211,Metalloproteinase inhibitor 3,proteinaceous extracellular matrix|basement membrane|extracellular space|nucleus|cytoplasm|extracellular exosome|extracellular matrix|,central nervous system development|aging|response to mechanical stimulus|response to hormone|negative regulation of endopeptidase activity|response to cytokine|tissue regeneration|response to estrogen|negative regulation of metalloenzyme activity|negative regulation of membrane protein ectodomain proteolysis|response to folic acid|cellular response to organic substance|,protease binding|metalloendopeptidase inhibitor activity|metal ion binding|,9,15,796000000,37.9%
P02663,0.001030071,-0.703833333,31.37500062,3.443,0.000728618,5.702171378,-3.072,-3.129,-1.075,1.258,0.916,0.879,P02663,NotFound,P02663_NotFound,P02663,CSN1S2,1,21,8,8,P02663,BOVIN,26189.4,30.6,231,231.1,97.03,97.03,,222,Alpha-S2-casein,,,,8,21,2000000000,30.6%
Q07235,0.000296298,-0.4392,38.33332499,4.139666667,0.00014678,8.464399327,-3.24,-2.606,,1.799,0.876,0.975,Q07235,Serpine2,Q07235_Serpine2,Q07235,Serpine2,1,13,8,8,Q07235,MOUSE,44263.6,22.1,232,232.1,96.89,96.89,,397,Glia-derived nexin,extracellular region|extracellular space|cytosol|extracellular matrix|platelet alpha granule|extrinsic component of external side of plasma membrane|neuromuscular junction|neuronal cell body|extracellular vesicle|,"embryo implantation|blood coagulation|negative regulation of cell proliferation|response to radiation|response to wounding|negative regulation of peptidase activity|negative regulation of platelet activation|negative regulation of plasminogen activation|negative regulation of sodium ion transport|negative regulation of endopeptidase activity|negative regulation of protein processing|positive regulation of neuron projection development|negative regulation of phosphatidylinositol 3-kinase signaling|cerebellar granular layer morphogenesis|negative regulation of blood coagulation|negative regulation of cell growth|secretion by cell|secretory granule organization|negative regulation of protein catabolic process|mating plug formation|negative regulation of proteolysis|negative regulation of smoothened signaling pathway|regulation of timing of cell differentiation|positive regulation of astrocyte differentiation|detection of mechanical stimulus involved in sensory perception|regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|innervation|seminal vesicle epithelium development|dense core granule biogenesis|negative regulation of platelet aggregation|",serine-type endopeptidase inhibitor activity|receptor binding|glycosaminoglycan binding|heparin binding|,8,13,216000000,22.1%
Q61406,0.000145021,-1.020166667,47.68931776,4.437,1.70243E-05,10.33085601,-3.209,-2.639,-3.868,1.457,0.879,1.259,Q61406,Cfhr1,Q61406_Cfhr1,Q61406,Cfhr1,1,19,7,7,Q61406,MOUSE,39640.4,26.5,233,233.1,95.78,95.78,,343,Complement factor H-related 1,extracellular exosome|blood microparticle|,,,7,19,2080000000,26.5%
Q01705,0.000145021,-0.728666667,48.02831024,3.458,1.5746E-05,10.45314745,-2.384,-2.269,-2.72,0.959,1.138,0.904,Q01705,Notch1,Q01705_Notch1,Q01705,Notch1,1,12,9,9,Q01705|Q01705-3|Q01705-4|Q01705-2,MOUSE,284808.6,4.3,234,234.1,95.61,95.61,,2531,Neurogenic locus notch homolog protein 1,Golgi membrane|acrosomal vesicle|ruffle|MAML1-RBP-Jkappa- ICN1 complex|extracellular region|nucleus|nucleoplasm|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|cytosol|cytoskeleton|plasma membrane|integral component of plasma membrane|cell surface|lamellipodium|cytoplasmic vesicle|receptor complex|cell periphery|,"negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|cell fate specification|epithelial to mesenchymal transition|liver development|heart looping|sprouting angiogenesis|osteoblast fate commitment|positive regulation of neuroblast proliferation|inflammatory response to antigenic stimulus|endocardium development|endocardium morphogenesis|atrioventricular node development|coronary vein morphogenesis|aortic valve morphogenesis|atrioventricular valve morphogenesis|pulmonary valve morphogenesis|mitral valve formation|epithelial to mesenchymal transition involved in endocardial cushion formation|endocardial cushion morphogenesis|cardiac chamber formation|cardiac ventricle morphogenesis|cardiac atrium morphogenesis|cardiac right atrium morphogenesis|cardiac left ventricle morphogenesis|cardiac right ventricle formation|ventricular trabecula myocardium morphogenesis|growth involved in heart morphogenesis|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation|cell migration involved in endocardial cushion formation|pericardium morphogenesis|regulation of transcription from RNA polymerase II promoter|transcription from RNA polymerase II promoter|humoral immune response|Notch signaling pathway|positive regulation of transcription of Notch receptor target|spermatogenesis|determination of left/right symmetry|compartment pattern specification|axonogenesis|foregut morphogenesis|endoderm development|heart development|positive regulation of cell proliferation|negative regulation of cell proliferation|epidermis development|regulation of Notch signaling pathway|auditory receptor cell fate commitment|glial cell differentiation|regulation of gene expression|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-substrate adhesion|negative regulation of myotube differentiation|mesenchymal cell development|regulation of somitogenesis|cell differentiation in spinal cord|neural tube development|cell differentiation|neuron differentiation|keratinocyte differentiation|negative regulation of ossification|lung development|embryonic limb morphogenesis|regulation of cell migration|positive regulation of cell migration|positive regulation of BMP signaling pathway|negative regulation of BMP signaling pathway|forebrain development|hair follicle morphogenesis|organ regeneration|response to corticosteroid|response to muramyl dipeptide|response to lipopolysaccharide|embryonic hindlimb morphogenesis|tube formation|skeletal muscle cell differentiation|cellular response to vascular endothelial growth factor stimulus|regulation of cell proliferation|tissue regeneration|positive regulation of apoptotic process|negative regulation of catalytic activity|cell fate commitment|negative regulation of cell differentiation|positive regulation of endothelial cell differentiation|regulation of auditory receptor cell differentiation|negative regulation of auditory receptor cell differentiation|positive regulation of keratinocyte differentiation|negative regulation of myoblast differentiation|negative regulation of neuron differentiation|negative regulation of osteoblast differentiation|positive regulation of Notch signaling pathway|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|negative regulation of calcium ion-dependent exocytosis|positive regulation of JAK-STAT cascade|negative regulation of photoreceptor cell differentiation|somatic stem cell division|neuron fate commitment|astrocyte differentiation|oligodendrocyte differentiation|positive regulation of astrocyte differentiation|negative regulation of oligodendrocyte differentiation|branching morphogenesis of an epithelial tube|regulation of epithelial cell proliferation|positive regulation of epithelial cell proliferation|regulation of neurogenesis|negative regulation of neurogenesis|cardiac muscle tissue morphogenesis|cardiac muscle cell proliferation|positive regulation of cardiac muscle cell proliferation|negative regulation of glial cell proliferation|cilium morphogenesis|cardiac epithelial to mesenchymal transition|cardiac septum morphogenesis|ventricular septum morphogenesis|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development|negative regulation of cell death|prostate gland epithelium morphogenesis|regulation of epithelial cell proliferation involved in prostate gland development|arterial endothelial cell differentiation|venous endothelial cell differentiation|cardiac vascular smooth muscle cell development|endocardial cell differentiation|vasculogenesis involved in coronary vascular morphogenesis|coronary artery morphogenesis|Notch signaling involved in heart development|regulation of cell adhesion involved in heart morphogenesis|heart trabecula morphogenesis|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia|left/right axis specification|cellular response to follicle-stimulating hormone stimulus|distal tubule development|collecting duct development|glomerular mesangial cell development|interleukin-4 secretion|negative regulation of cell migration involved in sprouting angiogenesis|negative regulation of canonical Wnt signaling pathway|neuronal stem cell maintenance|positive regulation of ephrin receptor signaling pathway|regulation of extracellular matrix assembly|apoptotic process involved in embryonic digit morphogenesis|negative regulation of stem cell differentiation|negative regulation of anoikis|negative regulation of pro-B cell differentiation|negative regulation of endothelial cell chemotaxis|",core promoter binding|RNA polymerase II transcription factor binding transcription activator activity|chromatin binding|sequence-specific DNA binding transcription factor activity|enzyme inhibitor activity|receptor activity|Notch binding|calcium ion binding|protein binding|enzyme binding|chromatin DNA binding|sequence-specific DNA binding|protein heterodimerization activity|,9,12,407000000,4.3%
Q8C7G5,0.000197264,-0.833166667,41.70528781,3.635,6.7526E-05,8.368926871,-3.376,-2.072,-2.504,1.23,0.851,0.872,Q8C7G5,Apoa5,Q8C7G5_Apoa5,Q8C7G5,Apoa5,1,11,8,8,Q8C7G5|A0A1L1SQP3|A0A1L1SV61,MOUSE,41318.5,25,235,235.1,95.58,95.58,,368,Apolipoprotein A-V,extracellular region|extracellular space|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|blood microparticle|,triglyceride metabolic process|cholesterol biosynthetic process|lipid transport|response to hormone|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|positive regulation of very-low-density lipoprotein particle remodeling|triglyceride catabolic process|regulation of intestinal cholesterol absorption|organ regeneration|neuron projection regeneration|cholesterol efflux|phospholipid efflux|triglyceride-rich lipoprotein particle remodeling|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|lipoprotein metabolic process|tissue regeneration|cholesterol homeostasis|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipid catabolic process|positive regulation of lipoprotein lipase activity|acylglycerol homeostasis|triglyceride homeostasis|,phospholipid binding|enzyme activator activity|heparin binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|lipase binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|lipase activator activity|lipoprotein lipase activator activity|lipoprotein particle receptor binding|,8,11,309000000,25.0%
Q62356,0.000145021,-1.017166667,48.03427331,4.035666667,1.57243E-05,10.45531013,-3.469,-2.451,-3.185,0.995,1.048,0.959,Q62356,Fstl1,Q62356_Fstl1,Q62356,Fstl1,1,9,7,7,Q62356,MOUSE,35694.4,27.4,236,236.1,93.34,93.34,,306,Follistatin-related protein 1,extracellular space|extracellular exosome|,response to starvation|,calcium ion binding|protein binding|heparin binding|,7,9,179000000,27.4%
P62827,0.000998567,-0.571166667,31.53289755,3.262333333,0.000702603,5.737367401,-3.382,-1.812,-1.413,1.442,0.824,0.914,P62827,Ran,P62827_Ran,P62827,Ran,1,9,8,8,P62827|Q14AA6|Q61820,MOUSE,24593.8,33.3,237,237.1,91.77,91.77,,216,GTP-binding nuclear protein Ran,nucleus|nuclear envelope|nucleoplasm|nucleolus|cytoplasm|centriole|membrane|midbody|melanosome|RNA nuclear export complex|recycling endosome|extracellular exosome|chromatin|,"ribosomal subunit export from nucleus|ribosomal large subunit export from nucleus|ribosomal small subunit export from nucleus|protein import into nucleus, translocation|protein import into nucleus|protein export from nucleus|mitotic nuclear division|small GTPase mediated signal transduction|metabolic process|actin cytoskeleton organization|positive regulation of protein binding|cellular protein localization|cellular protein complex localization|cell division|protein localization to nucleolus|",GTPase activity|protein binding|GTP binding|GDP binding|poly(A) RNA binding|pre-miRNA binding|,8,9,4630000000,33.3%
Q8VC49,0.000145021,-0.933333333,51.66877895,3.909333333,6.80961E-06,11.85107532,-2.925,-2.661,-3.078,1.175,1.011,0.878,Q8VC49,Ifi27l2b,Q8VC49_Ifi27l2b,Q8VC49,Ifi27l2b,1,11,6,6,Q8VC49,MOUSE,27886.1,26.1,238,238.1,91.53,91.53,,283,Interferon alpha-inducible protein 27-like protein 2B,integral component of membrane|,,,6,11,8510000000,26.1%
P43025,0.000254442,-0.665,39.67648236,4.1825,0.000107734,8.942783711,-3.704,-2.645,,1.033,1.047,0.944,P43025,NotFound,P43025_NotFound,P43025,Clec3b,1,13,6,6,P43025|Q8CFZ6,MOUSE,22656.5,28.7,239,239.1,91.52,91.52,,202,Tetranectin,granular component|proteinaceous extracellular matrix|extracellular space|cytoplasm|extracellular exosome|,skeletal system development|ossification|positive regulation of plasminogen activation|bone mineralization|,calcium ion binding|protein binding|heparin binding|carbohydrate binding|kringle domain binding|,6,13,320000000,28.7%
Q9ET66,0.000190179,-1.2455,42.07251345,4.516333333,6.2051E-05,8.47933252,-3.804,-2.412,-4.295,1.218,0.939,0.881,Q9ET66,Pi16,Q9ET66_Pi16,Q9ET66,Pi16,1,17,6,6,E9QNE5|Q9ET66|D3Z6T6|Q9ET66-2,MOUSE,53234.3,15.1,240,240.1,90.52,90.52,,489,Peptidase inhibitor 16,extracellular space|integral component of membrane|extracellular exosome|,negative regulation of peptidase activity|negative regulation of cell growth involved in cardiac muscle cell development|,peptidase inhibitor activity|,6,17,908000000,15.1%
Q8QZR4,0.000476306,-0.5332,35.40192961,4.229666667,0.000288275,7.496120258,-3.776,-2.366,,1.587,1.036,0.853,Q8QZR4,Oaf,Q8QZR4_Oaf,Q8QZR4,Oaf,1,8,8,8,Q8QZR4,MOUSE,32151.3,26.2,241,241.1,90.03,90.03,,282,Out at first protein homolog,extracellular exosome|,,,8,8,613000000,26.2%
O88200,0.00080842,-0.6225,32.67025025,3.236333333,0.000540723,5.995385101,-3.121,-2.462,-1.139,0.994,1.087,0.906,O88200,Clec11a,O88200_Clec11a,O88200,Clec11a,1,10,8,8,O88200,MOUSE,36793.1,24.3,242,242.1,86.94,86.94,,328,C-type lectin domain family 11 member A,extracellular region|extracellular space|cytoplasm|,positive regulation of cell proliferation|,growth factor activity|carbohydrate binding|,8,10,691000000,24.3%
A0A075B5S2,0.000164241,-1.065833333,44.25035229,4.445666667,3.75807E-05,9.159839345,-3.716,-2.38,-3.77,1.004,1.543,0.924,A0A075B5S2,NotFound,A0A075B5S2_NotFound,A0A075B5S2,Ighv7-1,1,17,7,7,A0A075B5S2|P01791|P01794|P01788|P01787|P01790|P01793|P01792|P01789,MOUSE,13815.5,56.1,243,243.1,86.57,86.57,,121,Immunoglobulin heavy variable 7-1 (Fragment),,,,8,17,1260000000,56.1%
P11627,0.000145021,-1.193833333,50.16082348,4.473,9.63646E-06,11.25269636,-3.501,-2.842,-3.948,1.152,1.071,0.905,P11627,NotFound,P11627_NotFound,P11627,L1cam,1,12,9,9,P11627|Q6PGJ3|A2AFG8|A2AFG7,MOUSE,141935.8,6.9,244,244.1,85.86,85.86,,1260,Neural cell adhesion molecule L1,plasma membrane|focal adhesion|external side of plasma membrane|cell surface|membrane|integral component of membrane|presynaptic membrane|terminal bouton|,homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|cell surface receptor signaling pathway|axon guidance|positive regulation of cell-cell adhesion|neuron projection development|cell-cell adhesion mediated by integrin|homotypic cell-cell adhesion|positive regulation of calcium-mediated signaling|,integrin binding|protein binding|sialic acid binding|identical protein binding|protein self-association|,9,12,228000000,6.9%
O35664-3,0.000396826,-0.673,36.43357693,4.508333333,0.000227322,7.825565625,-4.153,-2.603,,1.464,1.051,0.876,O35664,Ifnar2,O35664-3_Ifnar2,O35664-3,Ifnar2,1,23,7,7,O35664-3|O35664|O35664-2|F6XX07,MOUSE,28268.1,19.3,245,245.1,85.84,85.84,,513,Isoform 3 of Interferon alpha/beta receptor 2,extracellular space|plasma membrane|integral component of plasma membrane|integral component of membrane|,regulation of transcription from RNA polymerase II promoter|cell proliferation|cytokine-mediated signaling pathway|response to interferon-alpha|type I interferon signaling pathway|,type I interferon receptor activity|protein kinase binding|type I interferon binding|,7,23,7720000000,19.3%
A0A140T8M2,0.000622542,-0.3998,34.0382907,4.663666667,0.000394613,7.078406304,-3.996,-2.4,,2.154,1.383,0.86,A0A140T8M2,NotFound,A0A140T8M2_NotFound,A0A140T8M2,Igkv12-44,1,21,5,3,A0A140T8M2,MOUSE,12728.1,43.4,246,246.1,83.99,43.97,,115,Immunoglobulin kappa variable 12-44 (Fragment),,,,5,21,6560000000,43.4%
P01636,0.002819244,-0.4678,26.58008556,4.473666667,0.002197817,5.208693393,-4.463,-1.841,,1.997,1.185,0.783,P01636,NotFound,P01636_NotFound,P01636,,1,1,3,1,P01636,MOUSE,12144.3,35.1,246,246.2,47.48,7.46,,108,Ig kappa chain V-V region MOPC 149,,,antigen binding|,1,1,7820000,9.2%
Q9Z0M6,0.000145021,-1.029666667,49.36437341,4.412666667,1.15761E-05,10.94785492,-3.679,-2.67,-3.359,1.178,1.464,0.888,Q9Z0M6,Adgre5,Q9Z0M6_Adgre5,Q9Z0M6,Cd97,1,12,6,6,E9QJS7|Q9Z0M6|Q9Z0M6-3|E9QMJ5|Q9Z0M6-2|A0A0D9SEG8|Q9DC42,MOUSE,92922.2,7.9,247,247.1,83.7,83.7,,818,CD97 antigen,plasma membrane|focal adhesion|membrane|integral component of membrane|extracellular exosome|,cell adhesion|G-protein coupled receptor signaling pathway|positive regulation of synapse assembly|,transmembrane signaling receptor activity|G-protein coupled receptor activity|calcium ion binding|,6,12,170000000,7.9%
Q99K41,0.002869052,-0.220666667,26.49017538,3.147333333,0.002243791,4.687033465,-0.843,-1.487,-3.053,1.796,1.783,0.48,Q99K41,Emilin1,Q99K41_Emilin1,Q99K41,Emilin1,1,8,7,7,Q99K41,MOUSE,108895,9.1,248,248.1,82.51,82.51,,1017,EMILIN-1,extracellular region|proteinaceous extracellular matrix|collagen trimer|extracellular matrix|extracellular exosome|extracellular matrix|,cell adhesion|positive regulation of cell-substrate adhesion|extracellular matrix organization|,protein binding|extracellular matrix constituent conferring elasticity|identical protein binding|,7,8,57600000,9.1%
A0A0B4J1H7,0.000145021,-1.037166667,47.71072704,5.062333333,1.69405E-05,10.33854149,-3.988,-2.745,-3.972,0.923,1.73,1.829,A0A0B4J1H7,NotFound,A0A0B4J1H7_NotFound,A0A0B4J1H7,Igkv1-135,1,19,6,1,A0A0B4J1H7,MOUSE,13419.1,32.5,249,249.1,82.23,16.3,,120,Immunoglobulin kappa variable 1-135 (Fragment),,,,6,19,6150000000,32.5%
A0A0B4J1H8,0.000734441,-0.678666667,33.15935648,4.038,0.00048313,6.108832714,-1.794,-2.327,-3.972,1.062,0.812,2.147,A0A0B4J1H8,NotFound,A0A0B4J1H8_NotFound,A0A0B4J1H8,Igkv1-133,1,4,6,3,A0A0B4J1H8|A0A0B4J1H9,MOUSE,13351.1,32.5,249,249.2,72.78,29.92,,120,Immunoglobulin kappa variable 1-133 (Fragment),,,,3,4,30400000,21.6%
P01869,0.000145021,-0.739833333,47.52898226,4.044333333,1.76645E-05,10.27346049,-2.896,-2.999,-2.391,1.134,0.924,1.789,P01869,NotFound,P01869_NotFound,P01869,Ighg1,1,13,5,5,P01869|P01868,MOUSE,44070.3,20.8,250,250.1,81.62,81.62,,393,"Ig gamma-1 chain C region, membrane-bound form",plasma membrane|integral component of membrane|,,antigen binding|immunoglobulin receptor binding|,5,13,355000000,20.8%
P14847,0.000201384,-0.5134,41.53533087,4.129333333,7.0221E-05,9.64401826,-3.222,-2.76,,1.502,1.013,0.9,P14847,Crp,P14847_Crp,P14847,Crp,1,8,7,7,P14847,MOUSE,25530.6,35.1,251,251.1,81.42,81.42,,225,C-reactive protein,extracellular space|extracellular exosome|,acute-phase response|positive regulation of gene expression|negative regulation of macrophage derived foam cell differentiation|negative regulation of lipid storage|positive regulation of superoxide anion generation|negative regulation of vasodilation|regulation of interleukin-8 secretion|,complement component C1q binding|calcium ion binding|low-density lipoprotein particle binding|low-density lipoprotein particle receptor binding|,7,8,155000000,35.1%
A0A075B5R6,0.000228633,-0.611666667,40.45888808,4.282,8.99728E-05,8.003118857,-3.634,-2.082,-2.542,1.688,2.038,0.862,A0A075B5R6,NotFound,A0A075B5R6_NotFound,A0A075B5R6,Ighv11-1,1,11,7,7,A0A075B5R6|A0A075B5R8,MOUSE,13378.9,51.2,252,252.1,81.35,81.35,,117,Immunoglobulin heavy variable 11-1 (Fragment),,,,7,11,623000000,51.2%
P01845,0.000153199,-0.878333333,45.60067422,4.031333333,2.7538E-05,9.604965021,-3.551,-2.698,-2.433,0.981,0.968,1.463,P01845,NotFound,P01845_NotFound,P01845,Iglc3,1,12,5,2,P01845,MOUSE,11541.6,65.3,253,253.1,81.17,41.91,,104,Ig lambda-3 chain C region,plasma membrane|,,antigen binding|,5,12,4960000000,65.3%
P01844,0.000213663,-0.6616,40.93624739,4.572333333,8.06075E-05,9.412871792,-3.945,-2.865,,0.899,1.305,1.298,P01844,NotFound,P01844_NotFound,P01844,Iglc2,1,8,5,2,P01844,MOUSE,11425.5,65.3,253,253.2,80.68,41.42,,104,Ig lambda-2 chain C region,plasma membrane|,,,2,8,1060000000,38.4%
P10493,0.000238062,-0.699666667,40.12150779,3.242,9.7241E-05,7.906414207,-2.687,-1.616,-2.659,1.008,0.899,0.857,P10493,Nid1,P10493_Nid1,P10493,Nid1,1,11,9,9,P10493,MOUSE,139387.9,8.3,254,254.1,81.02,81.02,,1245,Nidogen-1,extracellular region|proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular matrix|extracellular exosome|cell periphery|extracellular matrix|,cell-matrix adhesion|positive regulation of cell-substrate adhesion|extracellular matrix organization|glomerular basement membrane development|,calcium ion binding|protein binding|collagen binding|laminin binding|laminin-1 binding|proteoglycan binding|extracellular matrix binding|,9,11,261000000,8.3%
P47878,0.000180141,-1.228666667,42.54775072,4.430666667,5.56192E-05,8.624032961,-3.052,-2.765,-4.515,0.939,1.02,1.001,P47878,Igfbp3,P47878_Igfbp3,P47878,Igfbp3,1,12,7,7,P47878,MOUSE,32713.3,22.6,255,255.1,80.78,80.78,,292,Insulin-like growth factor-binding protein 3,extracellular space|nucleus|insulin-like growth factor ternary complex|extracellular exosome|,regulation of cell growth|osteoblast differentiation|negative regulation of protein phosphorylation|protein phosphorylation|negative regulation of cell proliferation|regulation of glucose metabolic process|negative regulation of smooth muscle cell migration|regulation of growth|positive regulation of apoptotic process|positive regulation of catalytic activity|positive regulation of MAPK cascade|positive regulation of insulin-like growth factor receptor signaling pathway|type B pancreatic cell proliferation|positive regulation of myoblast differentiation|negative regulation of smooth muscle cell proliferation|,fibronectin binding|insulin-like growth factor binding|protein tyrosine phosphatase activator activity|insulin-like growth factor I binding|insulin-like growth factor II binding|,7,12,1490000000,22.6%
Q8R357,0.048998581,-3.758166667,13.52400663,9.631666667,0.044422126,2.459349177,-3.923,-3.047,-18.752,1.254,0.992,0.927,Q8R357,Olfm1,Q8R357_Olfm1,Q8R357,Olfm1,1,8,6,6,Q8R357|O88998|G3X9Q7|O88998-3|A3KGE4|O88998-2|O88998-4,MOUSE,55769.1,13.6,256,256.1,79.67,79.67,,485,Noelin,extracellular space|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|synaptic membrane|,atrioventricular valve formation|positive regulation of gene expression|negative regulation of gene expression|positive regulation of epithelial to mesenchymal transition|protein oligomerization|cardiac epithelial to mesenchymal transition|regulation of beta-amyloid formation|negative regulation of beta-amyloid formation|negative regulation of neuron migration|,beta-amyloid binding|protein binding|,6,8,347000000,13.6%
P05366,0.09000057,-0.564333333,10.7773146,1.402666667,0.083611986,2.019779903,0.146,-2.688,-1.255,0.077,0.22,0.114,P05366,Saa1,P05366_Saa1,P05366,Saa1,1,17,6,5,P05366|P04918,MOUSE,13884.1,50,257,257.1,79.08,68.17,,122,Serum amyloid A-1 protein,extracellular space|cytosol|cytoplasmic microtubule|high-density lipoprotein particle|extracellular exosome|,acute-phase response|cholesterol metabolic process|positive chemotaxis|cell chemotaxis|,G-protein coupled receptor binding|protein binding|heparin binding|chemoattractant activity|,6,17,1320000000,50.0%
P05367,0.494597261,-0.1415,3.122873549,0.643,0.487206019,0.734389949,1.409,-0.545,-2.253,0.386,-0.16,0.314,P05367,Saa2,P05367_Saa2,P05367,Saa2,1,7,5,4,P05367|A0A1B0GQV5,MOUSE,13736,36,257,257.2,54.06,43.15,,122,Serum amyloid A-2 protein,extracellular space|cytosol|cytoplasmic microtubule|high-density lipoprotein particle|extracellular exosome|,acute-phase response|response to stilbenoid|positive chemotaxis|cell chemotaxis|,G-protein coupled receptor binding|protein binding|chemoattractant activity|,4,7,347000000,27.8%
Q9CZT5,0.000281571,-0.3955,38.70795735,2.787666667,0.000134649,7.511569592,-1.961,-2.074,-1.333,1.275,0.816,0.904,Q9CZT5,Vasn,Q9CZT5_Vasn,Q9CZT5,Vasn,1,8,7,7,Q9CZT5,MOUSE,73401,12.3,258,258.1,78.48,78.48,,673,Vasorin,extracellular space|mitochondrion|lysosomal membrane|plasma membrane|cell surface|integral component of membrane|extracellular exosome|,negative regulation of epithelial to mesenchymal transition|negative regulation of transforming growth factor beta receptor signaling pathway|cellular response to hypoxia|cellular response to redox state|,protein binding|transforming growth factor beta binding|,7,8,163000000,12.3%
Q80VA0-2,0.000758224,-1.600833333,32.98190587,5.444333333,0.00050328,6.183232587,-3.881,-2.728,-6.36,1.335,1.121,0.908,Q80VA0,Galnt7,Q80VA0-2_Galnt7,Q80VA0-2,Galnt7,1,13,8,8,Q80VA0-2|Q80VA0|Q80VA0-3,MOUSE,76183.4,10.9,259,259.1,77.97,77.97,,657,Isoform 2 of N-acetylgalactosaminyltransferase 7,Golgi membrane|membrane|integral component of membrane|extracellular exosome|,protein O-linked glycosylation|,polypeptide N-acetylgalactosaminyltransferase activity|carbohydrate binding|metal ion binding|,8,13,399000000,10.9%
Q91ZA3,0.004248739,-0.323333333,24.6689578,1.912666667,0.003412748,4.332239975,-0.867,-1.097,-1.875,1.16,0.19,0.549,Q91ZA3,Pcca,Q91ZA3_Pcca,Q91ZA3,Pcca,1,9,7,7,Q91ZA3,MOUSE,80547.9,11.4,260,260.1,77.09,77.09,,724,"Propionyl-CoA carboxylase alpha chain, mitochondrial",mitochondrion|mitochondrial matrix|,metabolic process|,biotin carboxylase activity|propionyl-CoA carboxylase activity|ATP binding|enzyme binding|metal ion binding|,7,9,61700000,11.4%
Q61171,0.000314218,-0.664333333,37.90484607,4.103333333,0.000162,7.294432742,-3.22,-1.638,-3.29,1.74,0.772,1.65,Q61171,Prdx2,Q61171_Prdx2,Q61171,Prdx2,1,9,7,7,Q61171,MOUSE,21949.4,39.3,261,261.1,76.73,76.73,,198,Peroxiredoxin-2,mitochondrion|myelin sheath|extracellular exosome|,activation of MAPK activity|respiratory burst involved in inflammatory response|response to oxidative stress|regulation of hydrogen peroxide metabolic process|removal of superoxide radicals|positive regulation of blood coagulation|negative regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of NF-kappaB transcription factor activity|response to lipopolysaccharide|cellular response to oxidative stress|T cell proliferation|hydrogen peroxide metabolic process|hydrogen peroxide catabolic process|regulation of apoptotic process|negative regulation of T cell differentiation|thymus development|homeostasis of number of cells|oxidation-reduction process|negative regulation of reactive oxygen species metabolic process|negative regulation of extrinsic apoptotic signaling pathway|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|,peroxidase activity|protein binding|thioredoxin peroxidase activity|selenium binding|antioxidant activity|,7,9,725000000,39.3%
P01843,0.000145021,-0.8866,47.82730823,5.0015,1.64918E-05,12.40253473,-4.121,-3.654,,0.961,1.285,1.096,P01843,NotFound,P01843_NotFound,P01843,,1,16,4,4,A0A0G2JE99|P01843,MOUSE,11745.8,64.7,262,262.1,76.27,76.27,,105,Ig lambda-1 chain C region,plasma membrane|,,antigen binding|,4,16,6880000000,64.7%
Q02788,0.000165321,-0.893,43.76828471,3.79,4.19925E-05,9.005315898,-2.985,-2.063,-3.316,1.011,0.932,1.063,Q02788,Col6a2,Q02788_Col6a2,Q02788,Col6a2,1,13,7,7,Q02788|D3Z7D5,MOUSE,111473.4,5.6,263,263.1,75.9,75.9,,1034,Collagen alpha-2(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|extracellular space|extracellular matrix|sarcolemma|protein complex|extracellular exosome|extracellular vesicle|extracellular matrix|,cell adhesion|response to glucose|protein heterotrimerization|,,7,13,502000000,5.6%
P01631,0.000145021,-1.294833333,54.11786422,5.027666667,3.87448E-06,12.88539989,-4.234,-3.484,-3.708,0.98,1.661,1.016,P01631,NotFound,P01631_NotFound,P01631,,1,23,5,5,P01631|A0A140T8M0|A0A0B4J1I0|A0A075B5K8|A0A140T8N1|A0A140T8M9|A0A075B5N0,MOUSE,12386.7,40.7,264,264.1,75.81,75.81,,113,Ig kappa chain V-II region 26-10,,,antigen binding|,5,23,32800000000,40.7%
E9QPU1,0.000327472,-0.567666667,37.65259843,3.503333333,0.000171688,7.227275473,-1.892,-1.824,-3.242,0.848,1.429,1.275,E9QPU1,Vwf,E9QPU1_Vwf,E9QPU1,Vwf,1,11,7,7,E9QPU1|Q8CIZ8,MOUSE,322558.9,2.4,265,265.1,74.77,74.77,,2813,von Willebrand factor,extracellular region|proteinaceous extracellular matrix|endoplasmic reticulum|external side of plasma membrane|extracellular matrix|Weibel-Palade body|extracellular exosome|,liver development|placenta development|cell adhesion|blood coagulation|hemostasis|platelet activation|cell-substrate adhesion|protein homooligomerization|platelet activation|,glycoprotein binding|protease binding|integrin binding|protein binding|collagen binding|immunoglobulin binding|identical protein binding|protein homodimerization activity|protein N-terminus binding|chaperone binding|,7,11,537000000,2.4%
Q91YW3,0.000163538,-0.6722,44.36942577,4.313833333,3.65643E-05,10.80826846,-3.488,-3.033,,0.909,1.085,1.166,Q91YW3,Dnajc3,Q91YW3_Dnajc3,Q91YW3,Dnajc3,1,7,7,7,Q91YW3,MOUSE,57919.4,12.6,266,266.1,72.9,72.9,,504,DnaJ homolog subfamily C member 3,cytoplasm|endoplasmic reticulum lumen|smooth endoplasmic reticulum|cytosol|membrane|extracellular exosome|extracellular vesicle|endoplasmic reticulum Sec complex|,negative regulation of protein kinase activity|endoplasmic reticulum unfolded protein response|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation|negative regulation of cyclin-dependent protein kinase activity|,protein binding|chaperone binding|misfolded protein binding|,7,7,176000000,12.6%
E9QP56,0.000342426,-0.715833333,37.34665034,4.135666667,0.000184219,7.14647872,-2.884,-1.747,-3.72,1.841,1.417,0.798,E9QP56,Apoc3,E9QP56_Apoc3,E9QP56,Apoc3,1,25,4,4,E9QP56|P33622|A0A0R4J1N3,MOUSE,15162.8,36.4,267,267.1,71.64,71.64,,137,Apolipoprotein C-III,extracellular region|,triglyceride metabolic process|triglyceride mobilization|lipid transport|cholesterol metabolic process|triglyceride catabolic process|lipoprotein metabolic process|,lipid binding|,4,25,15000000000,36.4%
P01645,0.000296673,-0.6158,38.29060003,4.696166667,0.000148231,8.44955483,-4.155,-2.712,,0.923,1.474,1.391,P01645,NotFound,P01645_NotFound,P01645,,1,15,6,5,P01645|P01644|P01646|P01647|A0A140T8M1|P01648|P01643|P01649|A0A075B5L0,MOUSE,12068.2,58.3,268,268.1,71.3,60.46,,108,Ig kappa chain V-V region HP 93G7,,,antigen binding|,7,15,2590000000,58.3%
P01670,0.00017017,-0.621666667,43.07646909,3.336666667,4.9244E-05,8.787472551,-1.983,-2.105,-2.782,1.338,0.84,0.962,P01670,NotFound,P01670_NotFound,P01670,,1,3,3,1,P01670,MOUSE,12153.4,25.2,268,268.2,33.31,18.59,,111,Ig kappa chain V-III region PC 6684,,,antigen binding|,1,3,170000000,15.3%
Q8BYB9,0.003081533,-0.764166667,26.1729807,3.511,0.002413804,4.685190675,-4.028,-2.581,-0.95,0.895,0.9,1.179,Q8BYB9,Poglut1,Q8BYB9_Poglut1,Q8BYB9,Poglut1,1,7,6,6,Q8BYB9,MOUSE,46892.1,15.5,269,269.1,70.49,70.49,,392,Protein O-glucosyltransferase 1,endoplasmic reticulum lumen|extracellular exosome|,protein O-linked glycosylation|regulation of Notch signaling pathway|cardiovascular system development|,protein xylosyltransferase activity|UDP-glucosyltransferase activity|UDP-xylosyltransferase activity|glucosyltransferase activity|,6,7,512000000,15.5%
G3UX19,0.000294998,-1.200166667,38.37201488,4.481666667,0.000145478,7.420120572,-2.979,-2.559,-4.785,1.152,0.914,1.056,G3UX19,NotFound,G3UX19_NotFound,G3UX19,Atf6b,1,8,5,5,G3UX19|A0A0A0MQ69|O35451,MOUSE,77389.6,9.1,270,270.1,69.61,69.61,,709,Cyclic AMP-dependent transcription factor ATF-6 beta,intracellular|nucleus|endoplasmic reticulum membrane|protein-DNA complex|,endoplasmic reticulum unfolded protein response|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|,sequence-specific DNA binding transcription factor activity|cAMP response element binding|sequence-specific DNA binding|transcription regulatory region DNA binding|,5,8,236000000,9.1%
Q9QUM0,0.000240734,-1.007,40.02040994,4.539333333,9.95311E-05,7.877624113,-2.982,-2.416,-4.432,1.657,0.858,1.273,Q9QUM0,Itga2b,Q9QUM0_Itga2b,Q9QUM0,Itga2b,1,8,7,7,Q9QUM0,MOUSE,113760,8.2,271,271.1,69.19,69.19,,1033,Integrin alpha-IIb,focal adhesion|integrin complex|external side of plasma membrane|cell surface|extracellular exosome|blood microparticle|,positive regulation of leukocyte migration|cell-matrix adhesion|integrin-mediated signaling pathway|platelet aggregation|,identical protein binding|metal ion binding|extracellular matrix binding|fibrinogen binding|,7,8,141000000,8.2%
Q8CBR6,0.002157099,-0.619333333,27.83384937,3.042666667,0.001646702,4.950099195,-1.851,-1.104,-3.467,1.059,0.889,0.758,Q8CBR6,Tsku,Q8CBR6_Tsku,Q8CBR6,Tsku,1,7,4,4,Q8CBR6,MOUSE,38760.8,16.6,272,272.1,69.1,69.1,,354,Tsukushin,extracellular space|,regulation of gene expression|corpus callosum morphogenesis|lateral ventricle development|anterior commissure morphogenesis|negative regulation of Wnt signaling pathway|camera-type eye development|ciliary body morphogenesis|,protein binding|,4,7,90600000,16.6%
Q9R182,0.000196828,-1.017666667,41.76288771,4.109333333,6.66364E-05,8.386163806,-3.79,-3.306,-2.121,0.989,1.196,0.926,Q9R182,Angptl3,Q9R182_Angptl3,Q9R182,Angptl3,1,8,6,6,Q9R182,MOUSE,52770.3,15.3,273,273.1,68.38,68.38,,455,Angiopoietin-related protein 3,extracellular region|extracellular space|early endosome|Golgi apparatus|cell surface|,glycerol metabolic process|fatty acid metabolic process|triglyceride metabolic process|phospholipid metabolic process|cell-matrix adhesion|signal transduction|cholesterol metabolic process|phospholipid catabolic process|response to hormone|negative regulation of phospholipase activity|lipid storage|positive regulation of cell migration|cholesterol homeostasis|positive regulation of angiogenesis|positive regulation of lipid metabolic process|artery morphogenesis|positive regulation of lipid catabolic process|negative regulation of lipoprotein lipase activity|lipid homeostasis|acylglycerol homeostasis|phospholipid homeostasis|triglyceride homeostasis|,enzyme inhibitor activity|phospholipase inhibitor activity|integrin binding|growth factor activity|,6,8,643000000,15.3%
A0A075B5R2,0.000261273,-0.384,39.27714892,4.045,0.00011811,8.798151214,-2.424,-3.198,,1.478,0.862,1.362,A0A075B5R2,NotFound,A0A075B5R2_NotFound,A0A075B5R2,Ighv7-3,1,14,4,4,A0A075B5R2|A0A075B5R3|P01786,MOUSE,13628.3,29.1,274,274.1,67.85,67.85,,120,Immunoglobulin heavy variable 7-3 (Fragment),,,,4,14,689000000,29.1%
Q8BI84,0.000145021,-0.926333333,49.77194304,4.068666667,1.05392E-05,11.10290604,-3.428,-2.756,-2.698,1,0.997,1.327,Q8BI84,Mia3,Q8BI84_Mia3,Q8BI84,Mia3,1,13,8,8,Q8BI84|Q8BI84-2|J3KMH5|Q8BI84-3,MOUSE,214298.7,5,275,275.1,67.49,67.49,,1930,Transport and Golgi organization protein 1 homolog,endoplasmic reticulum membrane|membrane|integral component of membrane|intracellular membrane-bounded organelle|,chondrocyte development|positive regulation of leukocyte migration|exocytosis|negative regulation of cell adhesion|protein transport|collagen fibril organization|negative regulation of cell migration|positive regulation of bone mineralization|wound healing|,,8,13,3080000000,5.0%
E9QPX1,0.000171011,-0.770166667,42.99218662,3.651666667,5.0209E-05,8.761243612,-2.479,-2.082,-3.227,1.353,0.968,0.846,E9QPX1,Col18a1,E9QPX1_Col18a1,E9QPX1,Col18a1,1,9,5,5,E9QPX1|P39061|P39061-1|P39061-2,MOUSE,183320.5,3.4,276,276.1,67.34,67.34,,1774,Collagen alpha-1(XVIII) chain,collagen trimer|basement membrane|extracellular space|extracellular matrix|extracellular exosome|extracellular matrix|,angiogenesis|endothelial cell morphogenesis|cell adhesion|positive regulation of cell proliferation|extracellular matrix organization|positive regulation of cell migration|positive regulation of endothelial cell apoptotic process|,structural molecule activity|identical protein binding|,5,9,1050000000,3.4%
Q9WUU7,0.000145021,-1.0755,49.12643611,4.607666667,1.2228E-05,10.85824282,-3.601,-2.697,-3.84,1.451,1.319,0.915,Q9WUU7,Ctsz,Q9WUU7_Ctsz,Q9WUU7,Ctsz,1,14,6,6,Q9WUU7,MOUSE,34680.3,18.9,277,277.1,66.77,66.77,,306,Cathepsin Z,extracellular space|lysosome|endoplasmic reticulum|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis involved in cellular protein catabolic process|epithelial tube branching involved in lung morphogenesis|,cysteine-type endopeptidase activity|,6,14,1180000000,18.9%
A0A075B5N4,0.000272426,-0.3748,38.96547355,4.290333333,0.000126897,8.686693107,-3.189,-2.709,,1.162,1.972,0.89,A0A075B5N4,NotFound,A0A075B5N4_NotFound,A0A075B5N4,Igkv8-27,1,16,5,2,A0A075B5N4|A0A140T8P7,MOUSE,11090.2,60,278,278.1,66.55,26.15,,100,Immunoglobulin kappa chain variable 8-27,,,,5,16,2760000000,60.0%
A0A140T8M4,0.000366887,-0.638,36.86258285,4.624166667,0.00020594,7.966108631,-4.157,-2.668,,0.882,1.649,1.104,A0A140T8M4,NotFound,A0A140T8M4_NotFound,A0A140T8M4,Igkv8-19,1,1,4,1,A0A140T8M4,MOUSE,11230.2,42.5,278,278.2,64.78,21.85,,101,Immunoglobulin kappa variable 8-19,,,,1,1,4820000,14.8%
A0A140T8P5,0.000320661,-0.3658,37.76953786,4.250333333,0.000167127,8.270315435,-2.888,-2.944,,0.996,2.104,0.903,A0A140T8P5,NotFound,A0A140T8P5_NotFound,A0A140T8P5,Igkv8-24,1,5,4,2,A0A140T8P5,MOUSE,13434.9,35.5,278,278.3,56.26,32.68,,121,Immunoglobulin kappa chain variable 8-24 (Fragment),,,,2,5,302000000,17.3%
A0A140T8M3,0.000252855,-0.4406,39.7292705,4.2015,0.000106432,8.962057974,-3.178,-2.745,,1.032,1.8,0.888,A0A140T8M3,NotFound,A0A140T8M3_NotFound,A0A140T8M3,Igkv8-30,1,2,4,1,A0A140T8M3,MOUSE,13506,35.5,278,278.4,52.23,11.83,,121,Immunoglobulin kappa chain variable 8-30 (Fragment),,,,1,2,69000000,9.9%
A0A075B5N3,0.000165321,-0.6208,43.85054869,5.747833333,4.12045E-05,10.58602654,-4.416,-3.723,,0.921,1.969,2.145,A0A075B5N3,NotFound,A0A075B5N3_NotFound,A0A075B5N3,Igkv8-28,1,2,4,2,A0A075B5N3,MOUSE,11017,50.4,278,278.5,48.96,22.85,,101,Immunoglobulin kappa variable 8-28,,,,2,2,145000000,31.6%
A0A140T8N5,0.000152509,-0.729,45.660833,4.600833333,2.71592E-05,11.38008322,-3.715,-3.264,,0.938,1.301,1.095,A0A140T8N5,NotFound,A0A140T8N5_NotFound,A0A140T8N5,Igkv6-23,1,9,2,2,A0A140T8N5,MOUSE,12901.2,15.6,278,278.6,30.67,30.67,,115,Immunoglobulin kappa variable 6-23 (Fragment),,,,2,9,851000000,15.6%
Q8R0Z6,0.003527173,-0.2375,25.5246815,2.986333333,0.002802411,4.494717951,-2.278,-2.635,-0.279,1.037,1.775,0.955,Q8R0Z6,Angptl6,Q8R0Z6_Angptl6,Q8R0Z6,Angptl6,1,8,6,6,Q8R0Z6,MOUSE,51493.9,15.7,279,279.1,66.53,66.53,,457,Angiopoietin-related protein 6,secretory granule|extracellular exosome|,angiogenesis|cell differentiation|,,6,8,298000000,15.7%
Q9JHI0,0.000148189,-0.667833333,46.23941393,3.617,2.37716E-05,9.82202027,-2.89,-2.303,-2.236,1.421,1.139,0.862,Q9JHI0,Mmp19,Q9JHI0_Mmp19,Q9JHI0,Mmp19,1,5,5,5,Q9JHI0|Q3UW97,MOUSE,59349.2,14.2,280,280.1,66.27,66.27,,527,Matrix metalloproteinase-19,extracellular region|proteinaceous extracellular matrix|plasma membrane|anchored component of membrane|,angiogenesis|ovarian follicle development|ovulation from ovarian follicle|luteolysis|proteolysis|response to hormone|cell differentiation|collagen catabolic process|response to cAMP|,metalloendopeptidase activity|calcium ion binding|zinc ion binding|,5,5,25700000,14.2%
P70428,0.000152509,-0.836,45.70538698,3.816666667,2.6882E-05,9.640257332,-2.815,-2.177,-3.241,1.276,0.941,1,P70428,Ext2,P70428_Ext2,P70428,Ext2,1,11,6,6,P70428|V9GX32|E9Q1M5,MOUSE,82804.6,9,281,281.1,66.25,66.25,,718,Exostosin-2,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|membrane|integral component of membrane|UDP-N-acetylglucosamine transferase complex|extracellular exosome|,"ossification|mesoderm formation|glycosaminoglycan biosynthetic process|protein glycosylation|heparan sulfate proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|cell differentiation|cellular polysaccharide biosynthetic process|","acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity, transferring glycosyl groups|heparan sulfate N-acetylglucosaminyltransferase activity|protein homodimerization activity|metal ion binding|protein heterodimerization activity|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|acetylglucosaminyltransferase activity|",6,11,111000000,9.0%
Q08879-2,0.001343426,-0.903333333,30.10088976,3.777333333,0.000977037,5.464587058,-2.013,-1.951,-4.412,1.142,0.856,0.958,Q08879,Fbln1,Q08879-2_Fbln1,Q08879-2,Fbln1,1,11,7,7,Q08879-2|Q08879,MOUSE,79390.4,10.8,282,282.1,65.28,65.28,,705,Isoform C of Fibulin-1,proteinaceous extracellular matrix|basement membrane|extracellular space|extracellular exosome|elastic fiber|fibrinogen complex|extracellular matrix|,"negative regulation of protein phosphorylation|negative regulation of cell adhesion|embryo implantation|positive regulation of gene expression|positive regulation of peptidase activity|extracellular matrix organization|positive regulation of fibroblast proliferation|negative regulation of ERK1 and ERK2 cascade|blood coagulation, fibrin clot formation|negative regulation of substrate adhesion-dependent cell spreading|negative regulation of transformation of host cell by virus|positive regulation of substrate-dependent cell migration, cell attachment to substrate|negative regulation of cell motility|negative regulation of stem cell proliferation|negative regulation of transforming growth factor-beta secretion|",fibronectin binding|integrin binding|extracellular matrix structural constituent|calcium ion binding|protein binding|protein C-terminus binding|peptidase activator activity|protein complex binding|identical protein binding|fibrinogen binding|,7,11,230000000,10.8%
A0A075B5N7,0.000148189,-0.7158,46.0356696,4.598666667,2.49134E-05,11.5511957,-3.721,-3.229,,1.116,1.053,1.202,A0A075B5N7,NotFound,A0A075B5N7_NotFound,A0A075B5N7,Igkv6-13,1,15,5,3,A0A075B5N7|A0A140T8P1,MOUSE,10554.5,56.8,283,283.1,64.38,39.33,,95,Immunoglobulin kappa variable 6-13,,,,5,15,2140000000,56.8%
A0A140T8Q3,0.000831224,-0.3144,32.52603866,3.839333333,0.00055898,6.637507332,-3.27,-1.966,,1.009,0.835,1.82,A0A140T8Q3,NotFound,A0A140T8Q3_NotFound,A0A140T8Q3,Igkv6-17,1,3,4,1,A0A140T8Q3|P01633,MOUSE,12874.2,40,283,283.2,61.85,13.82,,115,Immunoglobulin kappa variable 6-17 (Fragment),,,,1,3,421000000,7.8%
A0A140T8M5,0.000192766,-0.6574,41.96512907,5.041,6.36044E-05,9.812960309,-4.114,-3.25,,0.947,1.929,1.201,A0A140T8M5,NotFound,A0A140T8M5_NotFound,A0A140T8M5,Igkv6-15,1,10,4,3,A0A140T8M5,MOUSE,12871.1,40,283,283.3,52.1,38.25,,115,Immunoglobulin kappa variable 6-15 (Fragment),,,,3,10,2370000000,32.1%
A0A140T8N7,0.000180141,-0.4284,42.52904474,4.4435,5.58593E-05,10.03864951,-3.306,-2.883,,1.512,1.637,0.898,A0A140T8N7,NotFound,A0A140T8N7_NotFound,A0A140T8N7,Igkv6-25,1,3,3,1,A0A140T8N7,MOUSE,12853.2,33.9,283,283.4,53.65,16.82,,115,Immunoglobulin kappa chain variable 6-25 (Fragment),,,,1,3,140000000,7.8%
Q769J6,0.000532782,-0.404166667,34.82684045,2.781,0.000329091,6.507384933,-2.435,-1.838,-1.111,1.021,1.089,0.849,Q769J6,Adamts13,Q769J6_Adamts13,Q769J6,Adamts13,1,8,6,6,Q769J6|A2ALB3,MOUSE,160032.5,6.3,284,284.1,63.23,63.23,,1426,A disintegrin and metalloproteinase with thrombospondin motifs 13,proteinaceous extracellular matrix|extracellular space|,proteolysis|blood coagulation|response to toxic substance|response to interferon-gamma|response to tumor necrosis factor|peptide catabolic process|response to interleukin-4|,endopeptidase activity|metalloendopeptidase activity|zinc ion binding|,6,8,66100000,6.3%
Q02596,0.000145021,-1.109,49.4301764,4.427333333,1.1402E-05,10.97275513,-3.373,-2.744,-3.851,1.296,0.887,1.131,Q02596,Glycam1,Q02596_Glycam1,Q02596,Glycam1,1,4,4,4,Q02596,MOUSE,16208.6,29.1,285,285.1,62.95,62.95,,151,Glycosylation-dependent cell adhesion molecule 1,extracellular region|plasma membrane|,cell adhesion|,sulfate binding|cell adhesion molecule binding|,4,4,308000000,29.1%
P09813,0.000279426,-0.935,38.77524314,4.616,0.000132579,7.529994318,-2.732,-2.484,-4.513,1.808,1.478,0.833,P09813,Apoa2,P09813_Apoa2,P09813,Apoa2,1,18,4,4,P09813,MOUSE,11366,43.1,286,286.1,62.35,62.35,,102,Apolipoprotein A-II,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|high-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|,acute inflammatory response|negative regulation of cytokine secretion involved in immune response|protein folding|fatty acid metabolic process|phosphatidylcholine biosynthetic process|lipid transport|cholesterol metabolic process|phospholipid catabolic process|response to glucose|positive regulation of cholesterol esterification|negative regulation of very-low-density lipoprotein particle remodeling|beta-glucoside transport|protein oxidation|peptidyl-methionine modification|regulation of intestinal cholesterol absorption|organ regeneration|regulation of protein stability|negative regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|triglyceride-rich lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|high-density lipoprotein particle clearance|lipoprotein metabolic process|response to drug|cholesterol homeostasis|positive regulation of catalytic activity|response to estrogen|reverse cholesterol transport|positive regulation of interleukin-8 biosynthetic process|diacylglycerol catabolic process|negative regulation of lipid catabolic process|positive regulation of lipid catabolic process|response to glucocorticoid|negative regulation of lipase activity|negative regulation of cholesterol import|negative regulation of cholesterol transporter activity|,lipid transporter activity|phospholipid binding|high-density lipoprotein particle binding|lipid binding|cholesterol binding|phosphatidylcholine binding|apolipoprotein receptor binding|protein homodimerization activity|protein heterodimerization activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding|cholesterol transporter activity|,4,18,42300000000,43.1%
Q9R100,0.000341559,-1.123666667,37.36772424,4.62,0.000183327,7.152021097,-2.952,-2.455,-4.894,1.287,0.993,1.279,Q9R100,Cdh17,Q9R100_Cdh17,Q9R100,Cdh17,1,7,5,5,Q9R100|A2AKS7,MOUSE,92100.1,8.3,287,287.1,62.33,62.33,,827,Cadherin-17,plasma membrane|integral component of plasma membrane|basolateral plasma membrane|,oligopeptide transport|homophilic cell adhesion via plasma membrane adhesion molecules|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|oligopeptide transmembrane transport|,proton-dependent oligopeptide secondary active transmembrane transporter activity|calcium ion binding|protein binding|,5,7,261000000,8.3%
Q8BLY1,0.001113442,-0.518333333,30.96872245,3.048,0.00080007,5.612292598,-3.002,-2.136,-0.989,1.192,0.903,0.922,Q8BLY1,Smoc1,Q8BLY1_Smoc1,Q8BLY1,Smoc1,1,11,5,5,A0A0R4J1E4|Q8BLY1|E9QKW2|Q8BLY1-2|D3Z3A3,MOUSE,52330.4,12.5,288,288.1,60.53,60.53,,463,SPARC-related modular calcium-binding protein 1,basement membrane|,eye development|signal transduction|positive regulation of cell-substrate adhesion|cell differentiation|extracellular matrix organization|regulation of osteoblast differentiation|limb development|,calcium ion binding|extracellular matrix binding|,5,11,2550000000,12.5%
P01887,0.000199576,-0.7272,41.60562543,4.773,6.90935E-05,9.671469716,-4.16,-3.022,,1.299,1.321,0.926,P01887,B2m,P01887_B2m,P01887,B2m,1,23,4,4,P01887,MOUSE,13892.8,22.6,289,289.1,59.98,59.98,,119,Beta-2-microglobulin,extracellular space|cytoplasm|Golgi apparatus|plasma membrane|focal adhesion|external side of plasma membrane|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|,"positive regulation of T cell mediated cytotoxicity|response to molecule of bacterial origin|antigen processing and presentation of peptide antigen via MHC class I|antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent|cellular defense response|T cell differentiation in thymus|protein refolding|response to drug|response to cadmium ion|iron ion homeostasis|negative regulation of receptor binding|",glycoprotein binding|protein binding|identical protein binding|,4,23,29900000000,22.6%
O35887,0.000341559,-0.7114,37.37081771,4.356,0.000183197,8.135377573,-4.035,-2.615,,1,1.201,0.892,O35887,Calu,O35887_Calu,O35887,Calu,1,5,5,5,O35887|Q6XLQ8|G3V004|G3UWR0|G3UWV3,MOUSE,37177.2,17.4,290,290.1,59.97,59.97,,315,Calumenin,extracellular region|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|sarcoplasmic reticulum lumen|melanosome|,peripheral nervous system axon regeneration|response to organic cyclic compound|negative regulation of catalytic activity|,enzyme inhibitor activity|calcium ion binding|enzyme binding|,5,5,425000000,17.4%
Q3U367,0.000832834,-0.4404,32.50959891,3.335166667,0.0005611,6.632838017,-3.066,-1.817,,1.032,0.778,0.871,Q3U367,Aldh9a1,Q3U367_Aldh9a1,Q3U367,Aldh9a1,1,6,5,5,Q3U367|Q9JLJ2,MOUSE,56856.5,9.8,291,291.1,59.43,59.43,,518,4-trimethylaminobutyraldehyde dehydrogenase,mitochondrion|cytosol|extracellular exosome|,cellular aldehyde metabolic process|carnitine metabolic process|neurotransmitter biosynthetic process|oxidation-reduction process|,"aldehyde dehydrogenase (NAD) activity|oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor|aminobutyraldehyde dehydrogenase activity|4-trimethylammoniobutyraldehyde dehydrogenase activity|",5,6,571000000,9.8%
A0A075B5M7,0.002407041,0.0794,27.2937388,4.399,0.001864774,5.384894943,-2.911,-2.209,,1.277,3.343,0.897,A0A075B5M7,NotFound,A0A075B5M7_NotFound,A0A075B5M7,Igkv5-39,1,18,4,4,A0A075B5M7|A0A0B4J1J1|A0A0B4J1J2,MOUSE,10459.3,52.6,292,292.1,59.41,59.41,,95,Immunoglobulin kappa variable 5-39,,,,4,18,5220000000,52.6%
A0A075B5K0,0.000148189,-0.628666667,46.06917094,3.685333333,2.4722E-05,9.763751836,-2.93,-2.192,-2.292,1.271,1.47,0.901,A0A075B5K0,NotFound,A0A075B5K0_NotFound,A0A075B5K0,Igkv14-126,1,18,4,2,A0A075B5K0|P01637,MOUSE,13228.7,41.8,293,293.1,59.14,35.94,,117,Immunoglobulin kappa variable 14-126 (Fragment),,,,5,18,9940000000,41.8%
A0A140T8P9,0.000406026,-0.3706,36.30580352,4.892333333,0.00023411,7.784114439,-3.636,-2.976,,1,2.623,1.136,A0A140T8P9,NotFound,A0A140T8P9_NotFound,A0A140T8P9,Igkv14-111,1,3,4,1,A0A140T8P9,MOUSE,13403.1,40.1,293,293.2,54.26,21.51,,117,Immunoglobulin kappa variable 14-111 (Fragment),,,,1,3,111000000,15.3%
Q9Z1T2,0.00369417,-1.6315,25.28987731,5.963,0.002958096,4.509880667,-2.937,-2.955,-7.947,0.99,1.699,1.361,Q9Z1T2,Thbs4,Q9Z1T2_Thbs4,Q9Z1T2,Thbs4,1,4,4,3,Q9Z1T2,MOUSE,109046.1,6,294,294.1,57.77,42.08,,963,Thrombospondin-4,basement membrane|extracellular space|endoplasmic reticulum|sarcoplasmic reticulum|extracellular matrix|extracellular exosome|,positive regulation of endothelial cell proliferation|response to unfolded protein|negative regulation of angiogenesis|regulation of tissue remodeling|response to endoplasmic reticulum stress|behavioral response to pain|tissue remodeling|positive regulation of peptidyl-tyrosine phosphorylation|myoblast migration|positive regulation of cell division|endothelial cell-cell adhesion|positive regulation of neutrophil chemotaxis|,integrin binding|calcium ion binding|protein binding|growth factor activity|heparin binding|,4,4,855000000,6.0%
Q9R0G6,0.000204082,-0.5958,41.43387547,4.156166667,7.18807E-05,9.6045207,-3.472,-2.707,,1.188,1.118,0.894,Q9R0G6,Comp,Q9R0G6_Comp,Q9R0G6,Comp,1,3,4,3,Q9R0G6,MOUSE,84965.2,6.3,294,294.2,52.71,37.02,,755,Cartilage oligomeric matrix protein,proteinaceous extracellular matrix|extracellular space|extracellular exosome|extracellular matrix|,growth plate cartilage development|apoptotic process|cell adhesion|extracellular matrix organization|negative regulation of apoptotic process|limb development|,protease binding|extracellular matrix structural constituent|calcium ion binding|protein binding|collagen binding|heparin binding|heparan sulfate proteoglycan binding|,3,3,20700000,5.0%
Q61982,0.000663532,-0.752666667,33.67686415,3.482666667,0.000428858,6.230547783,-2.042,-1.729,-3.711,1.04,0.985,0.941,Q61982,Notch3,Q61982_Notch3,Q61982,Notch3,1,8,5,5,Q61982,MOUSE,257423.3,2.4,295,295.1,57.74,57.74,,2318,Neurogenic locus notch homolog protein 3,nucleoplasm|cytoplasm|plasma membrane|integral component of plasma membrane|actin cytoskeleton|receptor complex|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|Notch signaling pathway|forebrain development|negative regulation of cell differentiation|negative regulation of neuron differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of smooth muscle cell proliferation|neuron fate commitment|artery morphogenesis|glomerular capillary formation|",calcium ion binding|protein binding|enzyme binding|,5,8,89200000,2.4%
O88325,0.001881447,-1.316833333,28.47034793,4.553666667,0.001422215,5.160194871,-2.846,-2.211,-5.724,0.995,0.989,0.896,O88325,Naglu,O88325_Naglu,O88325,Naglu,1,5,5,5,O88325,MOUSE,83165.4,9.7,296,296.1,57.18,57.18,,739,Alpha-N-acetylglucosaminidase,extracellular exosome|,lysosome organization|cerebellar Purkinje cell layer development|middle ear morphogenesis|locomotor rhythm|retinal rod cell development|inner ear receptor cell development|,,5,5,23000000,9.7%
O08538,0.003312931,-0.85,25.82413856,3.78,0.002615689,4.615478619,-1.45,-2.127,-4.643,1.321,1.156,0.643,O08538,Angpt1,O08538_Angpt1,O08538,Angpt1,1,6,6,6,O08538,MOUSE,58088.5,12.6,297,297.1,57.14,57.14,,498,Angiopoietin-1,extracellular space|plasma membrane|microvillus|membrane raft|extracellular exosome|,angiogenesis|patterning of blood vessels|vasculogenesis|in utero embryonic development|negative regulation of protein phosphorylation|sprouting angiogenesis|positive regulation of receptor internalization|negative regulation of cytokine secretion involved in immune response|endocardium morphogenesis|negative regulation of cell adhesion|transmembrane receptor protein tyrosine kinase signaling pathway|activation of transmembrane receptor protein tyrosine kinase activity|endoderm development|positive regulation of endothelial cell migration|positive regulation of phosphatidylinositol 3-kinase signaling|regulation of satellite cell proliferation|hemopoiesis|heparin biosynthetic process|positive regulation of vascular endothelial growth factor receptor signaling pathway|positive regulation of protein ubiquitination|cell-substrate adhesion|regulation of tumor necrosis factor production|positive regulation of peptidyl-serine phosphorylation|protein localization to cell surface|negative regulation of protein import into nucleus|negative regulation of apoptotic process|negative regulation of vascular permeability|regulation of I-kappaB kinase/NF-kappaB signaling|regulation of protein binding|negative regulation of neuron apoptotic process|positive regulation of blood vessel endothelial cell migration|positive regulation of cell adhesion|Tie signaling pathway|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|positive regulation of protein kinase B signaling|cardiac muscle tissue morphogenesis|vasculogenesis involved in coronary vascular morphogenesis|positive regulation of ERK1 and ERK2 cascade|glomerulus vasculature development|negative regulation of endothelial cell apoptotic process|regulation of macrophage migration inhibitory factor signaling pathway|,receptor binding|vascular endothelial growth factor receptor binding|receptor tyrosine kinase binding|,6,6,146000000,12.6%
D3Z4E2,0.000241952,-0.6016,39.98541819,4.530666667,0.000100336,9.05610351,-3.873,-2.767,,1.491,1.251,0.89,D3Z4E2,NotFound,D3Z4E2_NotFound,D3Z4E2,Nrn1,1,11,4,4,D3Z4E2|A0A286YD56|Q8CFV4,MOUSE,17406.3,20.8,298,298.1,56.69,56.69,,158,Neuritin,alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|,axonogenesis|,,4,11,1590000000,20.8%
P34928,0.000320661,-0.3834,37.76455999,4.641,0.000167319,8.268619025,-3.708,-2.628,,2.052,1.48,0.887,P34928,Apoc1,P34928_Apoc1,P34928,Apoc1,1,17,5,5,P34928,MOUSE,9696.2,32.9,299,299.1,56.17,56.17,,88,Apolipoprotein C-I,endoplasmic reticulum|very-low-density lipoprotein particle|high-density lipoprotein particle|extracellular exosome|,triglyceride metabolic process|cholesterol metabolic process|negative regulation of phosphatidylcholine catabolic process|negative regulation of very-low-density lipoprotein particle clearance|negative regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|plasma lipoprotein particle remodeling|chylomicron remnant clearance|very-low-density lipoprotein particle clearance|lipoprotein metabolic process|negative regulation of fatty acid biosynthetic process|negative regulation of receptor-mediated endocytosis|negative regulation of lipoprotein lipase activity|,phospholipase inhibitor activity|fatty acid binding|,5,17,11400000000,32.9%
O09043,0.000157801,-0.7945,44.93124829,3.858333333,3.21274E-05,9.381997334,-3.165,-2.939,-2.067,1.172,1.332,0.9,O09043,Napsa,O09043_Napsa,O09043,Napsa,1,8,3,3,O09043,MOUSE,45942.9,10,300,300.1,55.47,55.47,,419,Napsin-A,extracellular space|lysosome|extracellular exosome|alveolar lamellar body|,protein catabolic process|membrane protein proteolysis|surfactant homeostasis|,endopeptidase activity|aspartic-type endopeptidase activity|protein binding|peptidase activity|,3,8,229000000,10.0%
P62983,0.041613684,-0.617166667,14.27544117,1.732333333,0.037364217,2.564434209,-1.568,-0.081,-2.801,0.412,0.044,0.291,P62983,Rps27a,P62983_Rps27a,P62983,Rps27a,1,10,6,6,P62983|P0CG50|P0CG49|P62984|A0A0A6YW67|E9QNP0|D3YYZ2,MOUSE,18292.9,32.6,301,301.1,54.91,54.91,,156,Ubiquitin-40S ribosomal protein S27a,nucleoplasm|nucleolus|cytoplasm|cytosol|small ribosomal subunit|membrane|cytosolic small ribosomal subunit|myelin sheath|extracellular exosome|,translation|circadian rhythm|,structural constituent of ribosome|poly(A) RNA binding|metal ion binding|,6,10,87800000,32.6%
Q9EQ21,0.000259876,-0.955833333,39.4961916,4.281666667,0.0001123,7.7297137,-3.048,-2.131,-4.111,1.572,1.11,0.873,Q9EQ21,Hamp,Q9EQ21_Hamp,Q9EQ21,Hamp,1,13,3,2,Q9EQ21,MOUSE,9865.4,45.7,302,302.1,54.27,42.54,,83,Hepcidin,extracellular region|extracellular space|nucleus|,negative regulation of transcription from RNA polymerase II promoter|myeloid cell homeostasis|cellular iron ion homeostasis|JAK-STAT cascade|cellular response to extracellular stimulus|membrane protein proteolysis|negative regulation of iron ion transmembrane transport|defense response to bacterium|positive regulation of macrophage activation|negative regulation of bone resorption|positive regulation of transcription from RNA polymerase II promoter|negative regulation of inflammatory response|defense response to fungus|iron ion homeostasis|cellular response to iron ion|positive regulation of cellular protein catabolic process|,hormone activity|copper ion binding|,3,13,505000000,45.7%
Q80T19,0.000279426,-0.2906,38.78218063,4.123166667,0.000132368,8.621722415,-2.932,-2.597,,1.941,1.26,0.875,Q80T19,Hamp2,Q80T19_Hamp2,Q80T19,Hamp2,1,4,3,2,Q5M9M1|Q80T19,MOUSE,9923.4,46.9,302,302.2,41.37,29.64,,83,Hepcidin-2,extracellular region|cell|,cellular iron ion homeostasis|killing of cells of other organism|defense response to bacterium|defense response to fungus|,hormone activity|,2,4,57500000,30.1%
P97464,0.000165321,-0.5998,43.6873222,4.040333333,4.27827E-05,10.51698114,-3.022,-3.026,,1.205,0.93,0.914,P97464,Ext1,P97464_Ext1,P97464,Ext1,1,7,6,6,P97464,MOUSE,87047.9,6.7,303,303.1,53.83,53.83,,746,Exostosin-1,Golgi membrane|endoplasmic reticulum|Golgi apparatus|integral component of endoplasmic reticulum membrane|,"ossification|glycosaminoglycan biosynthetic process|protein glycosylation|gastrulation|axon guidance|brain development|endoderm development|mesoderm development|heparan sulfate proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|olfactory bulb development|cellular polysaccharide biosynthetic process|embryonic skeletal joint development|","acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity, transferring glycosyl groups|protein homodimerization activity|metal ion binding|protein heterodimerization activity|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|",6,7,91000000,6.7%
Q6P069,0.000180141,-0.6522,42.58831524,4.378833333,5.51021E-05,10.06264003,-3.637,-2.922,,1.043,0.91,1.345,Q6P069,Sri,Q6P069_Sri,Q6P069,Sri,1,6,5,5,Q6P069|Q6P069-2,MOUSE,21912.2,28.7,304,304.1,52.92,52.92,,198,Sorcin,intracellular|nucleoplasm|cytoplasm|mitochondrion|endoplasmic reticulum membrane|smooth endoplasmic reticulum|cytosol|plasma membrane|membrane|Z disc|T-tubule|vesicle|sarcoplasmic reticulum membrane|axon terminus|dendritic spine neck|extracellular exosome|chromaffin granule membrane|,proteolysis|calcium ion transport|heart development|negative regulation of heart rate|positive regulation of insulin secretion involved in cellular response to glucose stimulus|cytoplasmic sequestering of transcription factor|positive regulation of release of sequestered calcium ion into cytosol|regulation of calcium ion transport|negative regulation of ryanodine-sensitive calcium-release channel activity|regulation of cardiac muscle cell contraction|regulation of relaxation of muscle|regulation of high voltage-gated calcium channel activity|regulation of cell communication by electrical coupling involved in cardiac conduction|negative regulation of transcription regulatory region DNA binding|,protease binding|calcium-dependent cysteine-type endopeptidase activity|calcium ion binding|protein binding|protein heterodimerization activity|repressing transcription factor binding|,5,6,409000000,28.7%
E9Q0F0,0.08303632,-0.669166667,11.15043548,2.019666667,0.076728455,2.083934381,0.217,-1.388,-3.866,0.165,0.7,0.157,E9Q0F0,Krt78,E9Q0F0_Krt78,E9Q0F0,Krt78,1,18,3,3,E9Q0F0,MOUSE,114088.5,1.9,305,305.1,52.67,52.67,,1068,Keratin 78,extracellular space|keratin filament|extracellular exosome|,,structural molecule activity|,3,18,24200000000,1.9%
A0A140T8P6,0.003423685,-1.476666667,25.66764671,4.842666667,0.002711661,4.584402616,-3.075,-2.139,-6.48,1.059,0.847,0.928,A0A140T8P6,NotFound,A0A140T8P6_NotFound,A0A140T8P6,Igkv12-46,1,14,3,3,A0A140T8P6,MOUSE,12733.1,40.8,306,306.1,52.03,52.03,,115,Immunoglobulin kappa variable 12-46 (Fragment),,,,3,14,1070000000,40.8%
A0A0A6YYE7,0.002394317,-0.633,27.33142147,4.484666667,0.001848663,4.921171034,-1.857,-1.812,-4.957,1,2.407,1.421,A0A0A6YYE7,NotFound,A0A0A6YYE7_NotFound,A0A0A6YYE7,Igkv4-57,1,5,3,2,A0A0A6YYE7|A0A0B4J1I4|A0A0B4J1I3|A0A0A6YYE5|A0A075B5L8|A0A075B5M4,MOUSE,12803.3,39.3,307,307.1,52.02,31.14,,117,Immunoglobulin kappa variable 4-57 (Fragment),,,,3,5,430000000,39.3%
A0A0B4J1I9,0.000347515,-0.398,37.24818329,4.269166667,0.000188444,8.094255667,-2.723,-3.196,,0.999,2.073,0.857,A0A0B4J1I9,NotFound,A0A0B4J1I9_NotFound,A0A0B4J1I9,Igkv4-55,1,3,2,1,A0A0B4J1I9|P04945,MOUSE,12850.3,27.3,307,307.2,37.9,17.02,,117,Immunoglobulin kappa variable 4-55 (Fragment),,,,1,3,105000000,13.6%
P01639,0.000364071,-0.2952,36.92251388,4.432166667,0.000203118,7.985911479,-3.349,-2.56,,1.324,2.212,0.897,P01639,NotFound,P01639_NotFound,P01639,Gm5571,1,5,3,3,P01639|A0A140T8N0,MOUSE,14482,28.4,308,308.1,51.78,51.78,,130,Ig kappa chain V-V region MOPC 41,,,antigen binding|,3,5,223000000,28.4%
P26618,0.000214915,-0.3776,40.86727158,3.698166667,8.18979E-05,9.386578021,-2.525,-2.668,,1.33,1.088,0.887,P26618,Pdgfra,P26618_Pdgfra,P26618,Pdgfra,1,7,6,6,P26618|P26618-2|A0A0J9YV87,MOUSE,123651.1,6.4,309,309.1,51.27,51.27,,1089,Platelet-derived growth factor receptor alpha,nucleus|cytoplasm|cytosol|integral component of plasma membrane|microvillus|external side of plasma membrane|cell surface|membrane|intrinsic component of plasma membrane|protein complex|,luteinization|in utero embryonic development|hematopoietic progenitor cell differentiation|positive regulation of cytosolic calcium ion concentration|estrogen metabolic process|positive regulation of cell proliferation|female gonad development|anatomical structure morphogenesis|organ morphogenesis|response to inorganic substance|negative regulation of platelet activation|positive regulation of phospholipase C activity|cell migration|peptidyl-tyrosine phosphorylation|signal transduction involved in regulation of gene expression|extracellular matrix organization|lung development|adrenal gland development|positive regulation of cell migration|male genitalia development|response to estradiol|Leydig cell differentiation|response to cytokine|cellular response to reactive oxygen species|platelet-derived growth factor receptor-alpha signaling pathway|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway|wound healing|gliogenesis|odontogenesis of dentin-containing tooth|positive regulation of phosphatidylinositol 3-kinase activity|positive regulation of DNA replication|protein autophosphorylation|platelet-derived growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of fibroblast proliferation|embryonic digestive tract morphogenesis|embryonic cranial skeleton morphogenesis|skeletal system morphogenesis|inner ear development|regulation of chemotaxis|cardiac myofibril assembly|response to hyperoxia|palate development|face morphogenesis|cell chemotaxis|retina vasculature development in camera-type eye|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to amino acid stimulus|metanephric glomerular capillary formation|regulation of mesenchymal stem cell differentiation|,protein kinase activity|transmembrane receptor protein tyrosine kinase activity|platelet-derived growth factor alpha-receptor activity|vascular endothelial growth factor-activated receptor activity|platelet-derived growth factor receptor binding|ATP binding|protein complex binding|vascular endothelial growth factor binding|protein homodimerization activity|phosphatidylinositol 3-kinase binding|platelet-derived growth factor binding|,6,7,85700000,6.4%
Q61646,0.043072458,-1.575,14.1197869,3.944666667,0.038727665,2.554388863,-0.011,-3.834,-6.797,0.807,0.318,0.067,Q61646,Hp,Q61646_Hp,Q61646,Hp,1,6,4,4,Q61646,MOUSE,39265.1,10,310,310.1,51.27,51.27,,347,Haptoglobin,extracellular space|endoplasmic reticulum|Golgi apparatus|haptoglobin-hemoglobin complex|extracellular exosome|blood microparticle|,response to hypoxia|liver development|immune system process|acute-phase response|Notch signaling pathway|spermatogenesis|response to heat|response to X-ray|response to lead ion|positive regulation of cell death|organ regeneration|response to magnesium ion|response to lipopolysaccharide|response to cobalamin|response to L-ascorbic acid|response to drug|response to hydrogen peroxide|defense response to bacterium|negative regulation of oxidoreductase activity|response to glucocorticoid|response to electrical stimulus|response to growth hormone|negative regulation of hydrogen peroxide catabolic process|,antioxidant activity|hemoglobin binding|protein homodimerization activity|,4,6,144000000,10.0%
A0A140T8N3,0.00014804,-1.077,46.98288148,4.333333333,2.00314E-05,10.08009252,-2.48,-3.69,-3.561,0.94,1.254,1.075,A0A140T8N3,NotFound,A0A140T8N3_NotFound,A0A140T8N3,Igkv13-84,1,7,4,4,A0A140T8N3|A0A075B666,MOUSE,12788.3,37.3,311,311.1,51.01,51.01,,115,Immunoglobulin kappa chain variable 13-84 (Fragment),,,,4,7,852000000,37.3%
Q8BM72,0.000612967,-0.607333333,34.122702,3.682,0.000387017,6.336819306,-3.563,-2.36,-1.422,1.581,1.227,0.893,Q8BM72,Hspa13,Q8BM72_Hspa13,Q8BM72,Hspa13,1,6,5,5,Q8BM72|D3Z0Y0|Q8BM72-2,MOUSE,51765.4,10.8,312,312.1,50.57,50.57,,471,Heat shock 70 kDa protein 13,endoplasmic reticulum|extracellular exosome|,,ATP binding|,5,6,68400000,10.8%
O54819,0.000288867,-0.9008,38.51897658,5.020333333,0.000140638,8.529165236,-4.743,-3.083,,1.009,1.376,0.937,O54819,Tfpi,O54819_Tfpi,O54819,Tfpi,1,6,4,4,O54819|A2ARA0|O54819-2|A2ARA3|Q8BSB7,MOUSE,36070.2,16.3,313,313.1,50.35,50.35,,306,Tissue factor pathway inhibitor,extracellular space|cell surface|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,4,6,203000000,16.3%
Q8CAR0,0.000215131,-0.6784,40.82053242,4.191833333,8.27841E-05,9.368798052,-3.656,-2.731,,1.05,0.998,0.947,Q8CAR0,Igf1,Q8CAR0_Igf1,Q8CAR0,Igf1,1,8,4,4,Q8CAR0|Q4VJB9|P05017-2|P05017|E9PU89|E9Q138,MOUSE,18872.4,25.4,314,314.1,50.21,50.21,,165,Insulin-like growth factor I,extracellular space|intracellular|insulin-like growth factor ternary complex|,"cell activation|regulation of protein phosphorylation|blood vessel remodeling|nervous system development|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|response to heat|glial cell differentiation|regulation of gene expression|positive regulation of glycoprotein biosynthetic process|positive regulation of cardiac muscle hypertrophy|phosphatidylinositol 3-kinase signaling|positive regulation of phosphatidylinositol 3-kinase signaling|skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration|muscle hypertrophy|myotube cell development|positive regulation of smooth muscle cell migration|positive regulation of cerebellar granule cell precursor proliferation|water homeostasis|proteoglycan biosynthetic process|lung development|positive regulation of cell migration|mammary gland development|exocrine pancreas development|regulation of establishment or maintenance of cell polarity|positive regulation of protein import into nucleus, translocation|negative regulation of smooth muscle cell apoptotic process|multicellular organism growth|bone mineralization involved in bone maturation|regulation of multicellular organism growth|positive regulation of activated T cell proliferation|positive regulation of tyrosine phosphorylation of Stat5 protein|negative regulation of apoptotic process|positive regulation of DNA binding|positive regulation of MAPK cascade|protein kinase B signaling|positive regulation of insulin-like growth factor receptor signaling pathway|myoblast differentiation|positive regulation of osteoblast differentiation|positive regulation of glycogen biosynthetic process|positive regulation of DNA replication|positive regulation of glycolytic process|positive regulation of mitotic nuclear division|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of glucose import|positive regulation of Ras protein signal transduction|insulin-like growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of fibroblast proliferation|lung alveolus development|cell development|positive regulation of smooth muscle cell proliferation|branching morphogenesis of an epithelial tube|inner ear development|chondroitin sulfate proteoglycan biosynthetic process|positive regulation of epithelial cell proliferation|positive regulation of protein secretion|positive regulation of peptidyl-tyrosine phosphorylation|protein stabilization|regulation of protein metabolic process|myoblast proliferation|positive regulation of protein kinase B signaling|negative regulation of oocyte development|lung vasculature development|lung lobe morphogenesis|Type I pneumocyte differentiation|Type II pneumocyte differentiation|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis|prostate gland growth|prostate gland epithelium morphogenesis|prostate gland stromal morphogenesis|negative regulation of androgen receptor signaling pathway|ERK1 and ERK2 cascade|negative regulation of ERK1 and ERK2 cascade|positive regulation of calcineurin-NFAT signaling cascade|extrinsic apoptotic signaling pathway in absence of ligand|positive regulation of trophectodermal cell proliferation|positive regulation of myoblast proliferation|negative regulation of extrinsic apoptotic signaling pathway|",insulin receptor binding|insulin-like growth factor receptor binding|integrin binding|hormone activity|protein binding|growth factor activity|,4,8,509000000,25.4%
Q62178,0.000164821,-0.842666667,44.17863072,4.476,3.82065E-05,9.136705788,-3.826,-2.314,-3.102,1.649,1.638,0.899,Q62178,Sema4a,Q62178_Sema4a,Q62178,Sema4a,1,4,4,4,Q62178|D3YWV5,MOUSE,84389.1,5.9,315,315.1,49.74,49.74,,760,Semaphorin-4A,plasma membrane|integral component of membrane|,angiogenesis|T cell differentiation involved in immune response|axonogenesis|regulation of cell shape|regulation of endothelial cell migration|negative regulation of angiogenesis|T-helper 1 cell differentiation|semaphorin-plexin signaling pathway|,,4,4,43300000,5.9%
Q04592,0.00046467,-0.286,35.51829364,2.46,0.000280654,6.678206053,-1.981,-1.307,-1.26,1.185,0.782,0.865,Q04592,Pcsk5,Q04592_Pcsk5,Q04592,Pcsk5,1,7,7,7,Q04592|Q04592-2,MOUSE,220321.6,3.9,316,316.1,49.41,49.41,,1877,Proprotein convertase subtilisin/kexin type 5,extracellular space|endoplasmic reticulum lumen|Golgi apparatus|integral component of membrane|secretory granule|,kidney development|renin secretion into blood stream|signal peptide processing|heart development|embryo implantation|anterior/posterior pattern specification|protein processing|peptide hormone processing|viral life cycle|respiratory tube development|limb morphogenesis|cytokine biosynthetic process|peptide biosynthetic process|embryonic digestive tract development|embryonic skeletal system development|,endopeptidase activity|serine-type endopeptidase activity|peptidase activity|peptide binding|,7,7,593000000,3.9%
A0A087WPN7,0.000206123,-0.704333333,41.31197246,3.808666667,7.39269E-05,8.252017855,-3.153,-2.893,-1.78,0.921,1.496,1.183,A0A087WPN7,NotFound,A0A087WPN7_NotFound,A0A087WPN7,Ighv13-2,1,7,4,4,A0A087WPN7,MOUSE,11456.7,44,317,317.1,49.3,49.3,,100,Immunoglobulin heavy variable 13-2,,,,4,7,316000000,44.0%
A0A1Y7VJX7,0.000265003,-0.728,39.14438279,4.194666667,0.000121776,7.631725216,-2.04,-2.618,-3.818,1.44,0.827,1.841,A0A1Y7VJX7,NotFound,A0A1Y7VJX7_NotFound,A0A1Y7VJX7,Ighe,1,6,4,4,A0A1Y7VJX7|P06336,MOUSE,55752.3,13.7,318,318.1,49.02,49.02,,486,Immunoglobulin heavy constant epsilon (Fragment),,,,4,6,85300000,13.7%
Q9Z1R3,0.000261034,-0.4458,39.37336515,3.947,0.000115522,8.832810539,-3.213,-2.415,,1.275,1.263,0.861,Q9Z1R3,Apom,Q9Z1R3_Apom,Q9Z1R3,Apom,1,9,4,4,Q9Z1R3,MOUSE,21615.3,16.3,319,319.1,48.7,48.7,,190,Apolipoprotein M,extracellular region|very-low-density lipoprotein particle|low-density lipoprotein particle|high-density lipoprotein particle|discoidal high-density lipoprotein particle|spherical high-density lipoprotein particle|extracellular exosome|,response to glucose|cholesterol efflux|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|high-density lipoprotein particle clearance|negative regulation of plasma lipoprotein particle oxidation|lipoprotein metabolic process|reverse cholesterol transport|,lipid transporter activity|phospholipid binding|antioxidant activity|,4,9,348000000,16.3%
Q09200,0.000647424,-0.345,33.82563491,2.582,0.000414416,6.265862618,-1.993,-1.985,-0.93,1.071,0.927,0.84,Q09200,B4galnt1,Q09200_B4galnt1,Q09200,B4galnt1,1,8,5,5,Q09200|A0A1W2P6F0,MOUSE,59610.2,8.6,320,320.1,48.7,48.7,,533,"Beta-1,4 N-acetylgalactosaminyltransferase 1",plasma membrane|integral component of Golgi membrane|,ganglioside biosynthetic process|protein glycosylation|glycosphingolipid metabolic process|spermatogenesis|lipid storage|lipid glycosylation|,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity|,5,8,76600000,8.6%
O35622,0.000145021,-1.115,49.92753856,4.244,1.01682E-05,11.16262074,-3.42,-2.695,-3.596,1.192,0.944,0.885,O35622,Fgf15,O35622_Fgf15,O35622,Fgf15,1,5,4,4,O35622,MOUSE,25520.6,19.7,321,321.1,48.18,48.18,,218,Fibroblast growth factor 15,extracellular region|,neural crest cell migration|positive regulation of protein phosphorylation|heart development|positive regulation of cell proliferation|fibroblast growth factor receptor signaling pathway|negative regulation of gene expression|positive regulation of glucose import|positive regulation of JNK cascade|positive regulation of ERK1 and ERK2 cascade|negative regulation of bile acid biosynthetic process|,fibroblast growth factor receptor binding|growth factor activity|,4,5,52300000,19.7%
P10126,0.025734704,-0.4018,16.41106844,2.205333333,0.022850366,3.038668699,-2.897,-0.553,,0.403,0.399,0.639,P10126,Eef1a1,P10126_Eef1a1,P10126,Eef1a1,1,7,4,4,P10126|P62631,MOUSE,50455.3,8.4,322,322.1,47.83,47.83,,462,Elongation factor 1-alpha 1,extracellular space|nucleus|nucleolus|cytoplasm|cytosol|plasma membrane|membrane|cortical actin cytoskeleton|ruffle membrane|myelin sheath|extracellular exosome|,translational elongation|cellular response to epidermal growth factor stimulus|,tRNA binding|translation elongation factor activity|GTPase activity|protein binding|GTP binding|protein kinase binding|poly(A) RNA binding|,4,7,375000000,8.4%
P01675,0.000157801,-1.1775,44.74275373,5.085666667,3.35525E-05,9.32003401,-3.693,-2.778,-4.69,0.947,1.696,1.453,P01675,NotFound,P01675_NotFound,P01675,,1,7,4,4,P01675|P01676|P01677|P01678|P01679|A0A075B5L5,MOUSE,11741,36.4,323,323.1,47.55,47.55,,107,Ig kappa chain V-VI region XRPC 44,,,antigen binding|,4,7,1940000000,36.4%
P16056,0.000574718,-1.024166667,34.45422941,4.179,0.000358573,6.416706185,-3.05,-1.859,-4.432,1.352,0.997,0.847,P16056,NotFound,P16056_NotFound,P16056,Met,1,6,5,5,P16056|F8VQL0,MOUSE,155885.1,5.6,324,324.1,46.7,46.7,,1379,Hepatocyte growth factor receptor,basal plasma membrane|cell surface|membrane|integral component of membrane|,activation of MAPK activity|endothelial cell morphogenesis|liver development|placenta development|synaptic transmission|brain development|muscle organ development|skeletal muscle tissue development|positive regulation of glucose transport|muscle cell migration|myotube differentiation|peptidyl-tyrosine phosphorylation|adult behavior|glucose homeostasis|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|hepatocyte growth factor receptor signaling pathway|branching morphogenesis of an epithelial tube|regulation of synaptic transmission|positive chemotaxis|myoblast proliferation|regulation of excitatory postsynaptic membrane potential|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling|semaphorin-plexin signaling pathway|negative regulation of hydrogen peroxide-mediated programmed cell death|positive regulation of endothelial cell chemotaxis|,protein kinase activity|hepatocyte growth factor-activated receptor activity|protein binding|ATP binding|protein phosphatase binding|,5,6,89300000,5.6%
P01728,0.000229743,-0.9188,40.41046426,5.523666667,9.09816E-05,9.214081276,-5.055,-3.411,,0.951,1.63,1.291,P01728,NotFound,P01728_NotFound,P01728,,1,10,3,2,P01728|A0A075B664|P01729|P01726,MOUSE,12392.7,41.8,325,325.1,46.68,34.36,,117,Ig lambda-2 chain V region,,,antigen binding|,4,10,13000000000,41.8%
P01723,0.001870086,0.19625,28.5038138,3.681666667,0.001411298,6.354669724,,-2.565,,0.896,1.525,0.929,P01723,NotFound,P01723_NotFound,P01723,,1,3,3,1,P01727|A0A075B663|P01723,MOUSE,12335.6,41.8,325,325.2,44.07,25.25,,117,Ig lambda-1 chain V region,plasma membrane|,,antigen binding|,1,3,256000000,28.2%
A0A075B6D5,0.000564021,0.0306,34.54655734,4.456833333,0.00035103,7.231801041,-2.676,-2.611,,0.857,2.713,1.87,A0A075B6D5,NotFound,A0A075B6D5_NotFound,A0A075B6D5,Igkv19-93,1,7,5,5,A0A075B6D5,MOUSE,12905.5,42.1,326,326.1,46.34,46.34,,114,Immunoglobulin kappa chain variable 19-93,,,,5,7,369000000,42.1%
Q8CF98,0.000165321,-0.836,44.08949118,3.850666667,3.89988E-05,9.108024402,-3.246,-3.002,-2.036,1.133,1.221,0.914,Q8CF98,Colec10,Q8CF98_Colec10,Q8CF98,Colec10,1,10,4,4,Q8CF98,MOUSE,30922.6,15.1,327,327.1,46.2,46.2,,277,Collectin-10,extracellular region|collagen trimer|nucleus|cytoplasm|cytosol|,defense response|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|embryo development|,mannose binding|,4,10,285000000,15.1%
P09803,0.000165321,-0.6318,43.61013244,4.340333333,4.35499E-05,10.48447258,-2.931,-3.541,,1.25,0.971,1.092,P09803,Cdh1,P09803_Cdh1,P09803,Cdh1,1,4,4,4,A0A0R4IZW5|P09803,MOUSE,98767.5,5.3,328,328.1,45.05,45.05,,884,Cadherin-1,cytoplasm|endosome|trans-Golgi network|plasma membrane|cell-cell junction|adherens junction|cell-cell adherens junction|focal adhesion|cytoplasmic side of plasma membrane|cell surface|actin cytoskeleton|integral component of membrane|aggresome|basolateral plasma membrane|lateral plasma membrane|catenin complex|flotillin complex|lamellipodium|cell junction|axon|node of Ranvier|lateral loop|Schmidt-Lanterman incisure|apical junction complex|axon terminus|apical part of cell|perinuclear region of cytoplasm|extracellular exosome|cell periphery|catenin complex|cortical actin cytoskeleton|,"in utero embryonic development|trophectodermal cell differentiation|epithelial cell morphogenesis|homophilic cell adhesion via plasma membrane adhesion molecules|embryo implantation|sensory perception of sound|single organismal cell-cell adhesion|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|protein metabolic process|negative regulation of cell-cell adhesion|regulation of protein localization|regulation of water loss via skin|adherens junction organization|uterine epithelium development|positive regulation of transcription factor import into nucleus|regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of transcription, DNA-templated|decidualization|negative regulation of epithelial cell proliferation|protein homooligomerization|intestinal epithelial cell development|salivary gland cavitation|regulation of branching involved in salivary gland morphogenesis|bicellular tight junction assembly|cellular response to amino acid stimulus|cellular response to lithium ion|cellular response to indole-3-methanol|protein localization to plasma membrane|establishment of protein localization to plasma membrane|negative regulation of canonical Wnt signaling pathway|cochlea development|regulation of protein localization to cell surface|regulation of neuron migration|",glycoprotein binding|calcium ion binding|protein binding|beta-catenin binding|protein phosphatase binding|protein domain specific binding|ankyrin binding|GTPase activating protein binding|gamma-catenin binding|cell adhesion molecule binding|,4,4,30500000,5.3%
P01655,0.000156464,-0.520666667,45.09239868,3.538666667,3.09571E-05,9.435255561,-1.983,-2.105,-2.782,1.323,1.423,1,P01655,NotFound,P01655_NotFound,P01655,,1,6,3,1,P01655|P01654|P01656|A0A075B5P0|P01659|P01667|P01672|P01669|P01671|P01673,MOUSE,12168.4,51.7,329,329.1,44.96,12.77,,112,Ig kappa chain V-III region PC 7132,,,antigen binding|,4,6,234000000,51.7%
P01660,0.000218124,-0.2746,40.71857535,4.368166667,8.47505E-05,9.330116477,-2.94,-2.851,,0.881,1.912,1.625,P01660,NotFound,P01660_NotFound,P01660,,1,2,3,1,P01660|A0A140T8M6,MOUSE,12213.3,31.5,329,329.2,39.91,14.79,,111,Ig kappa chain V-III region PC 3741/TEPC 111,,,antigen binding|,1,2,53600000,9.9%
P03977,0.005442843,0.6185,23.52648402,4.786,0.004439679,5.031331142,-2.971,,,0.905,3.005,1.535,P03977,NotFound,P03977_NotFound,P03977,,1,1,3,1,P03977,MOUSE,12156.3,39.6,329,329.3,38.55,6.36,,111,Ig kappa chain V-III region 50S10.1,,,antigen binding|,1,1,1760000000,9.9%
A0A075B5N9,0.000153199,-0.6584,45.34767543,4.766833333,2.91899E-05,11.23892367,-3.651,-3.386,,1.63,0.929,1.186,A0A075B5N9,NotFound,A0A075B5N9_NotFound,A0A075B5N9,Igkv3-7,1,1,2,1,A0A075B5N9|P01674,MOUSE,10969.9,29.2,329,329.4,34.71,16.12,,99,Immunoglobulin kappa variable 3-7,,,,1,1,44800000,12.1%
P01657,0.000426279,-0.8862,35.99593148,5.258,0.000251424,7.684355821,-5.067,-3.015,,0.908,1.615,1.128,P01657,NotFound,P01657_NotFound,P01657,,1,1,2,1,P01657,MOUSE,12063.3,23.4,329,329.5,31.66,13.07,,111,Ig kappa chain V-III region PC 2413,,,antigen binding|,1,1,39800000,8.1%
P01665,0.000579764,-0.741166667,34.39034098,3.286333333,0.000363886,6.401253438,-2.825,-1.36,-2.968,0.711,0.75,1.245,P01665,NotFound,P01665_NotFound,P01665,,1,2,2,1,P01665|P01664|P01666|P01668|A0A140T8Q0|A0A140T8Q4,MOUSE,12116.1,29.7,329,329.6,28.88,10.29,,111,Ig kappa chain V-III region PC 7043,,,antigen binding|,1,2,113000000,14.4%
A0A0A6YWI9,0.000230407,-0.667,40.37070316,4.143333333,9.18184E-05,9.199200671,-3.628,-2.678,,0.996,1.011,0.964,A0A0A6YWI9,NotFound,A0A0A6YWI9_NotFound,A0A0A6YWI9,Ighv1-11,1,8,4,4,A0A0A6YWI9,MOUSE,13035.6,40.1,330,330.1,44.37,44.37,,117,Immunoglobulin heavy variable V1-11 (Fragment),,,,4,8,13600000000,40.1%
P07356,0.136871188,-0.961,8.870188505,2.104,0.129712297,1.723041605,0.099,-1.12,-5.018,0.065,0.165,0.043,P07356,Anxa2,P07356_Anxa2,P07356,Anxa2,1,4,3,3,P07356,MOUSE,38960.8,10.6,331,331.1,44.01,44.01,,339,Annexin A2,ruffle|basement membrane|extracellular space|nucleus|cytoplasm|lysosomal membrane|endosome|early endosome|lipid particle|cytosol|plasma membrane|cell cortex|cell surface|membrane|basolateral plasma membrane|extrinsic component of plasma membrane|midbody|late endosome membrane|vesicle|myelin sheath adaxonal region|sarcolemma|melanosome|Schmidt-Lanterman incisure|macropinosome|perinuclear region of cytoplasm|extracellular exosome|PCSK9-AnxA2 complex|membrane raft|,angiogenesis|membrane raft assembly|positive regulation of protein phosphorylation|negative regulation of receptor internalization|membrane budding|body fluid secretion|collagen fibril organization|positive regulation of vesicle fusion|negative regulation of low-density lipoprotein particle receptor catabolic process|osteoclast development|fibrinolysis|negative regulation of catalytic activity|positive regulation of fibroblast proliferation|positive regulation of binding|protein heterotetramerization|protein targeting to plasma membrane|negative regulation of receptor binding|positive regulation of receptor activity|,"calcium ion binding|protein binding|calcium-dependent phospholipid binding|phosphatidylinositol-4,5-bisphosphate binding|cytoskeletal protein binding|Rab GTPase binding|phospholipase A2 inhibitor activity|S100 protein binding|poly(A) RNA binding|calcium-dependent protein binding|receptor activator activity|",3,4,111000000,10.6%
Q6T5E4,0.001318297,-1.3455,30.20526225,4.933666667,0.000953836,5.538569642,-2.912,-2.57,-5.955,1.486,1.043,0.835,Q6T5E4,Gcnt2,Q6T5E4_Gcnt2,Q6T5E4,Gcnt2,1,4,4,4,Q6T5E4,MOUSE,46854.9,10.9,332,332.1,43.51,43.51,,401,"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme",membrane|,protein glycosylation|transforming growth factor beta receptor signaling pathway|posttranscriptional regulation of gene expression|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-substrate adhesion|positive regulation of cell migration|positive regulation of heterotypic cell-cell adhesion|maintenance of lens transparency|positive regulation of protein kinase B signaling|positive regulation of ERK1 and ERK2 cascade|,"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity|acetylglucosaminyltransferase activity|",4,4,70000000,10.9%
Q9Z0L8,0.000338812,-0.4962,37.43525288,3.7155,0.000180499,8.157055529,-3.166,-2.285,,1.245,0.856,0.869,Q9Z0L8,Ggh,Q9Z0L8_Ggh,Q9Z0L8,Ggh,1,6,3,3,Q9Z0L8|Q9Z0L8-2,MOUSE,35697.1,12.3,333,333.1,43.4,43.4,,317,Gamma-glutamyl hydrolase,extracellular space|nucleus|lysosome|cytosol|melanosome|extracellular exosome|,proteolysis|glutamine metabolic process|response to zinc ion|response to insulin|response to drug|response to ethanol|,gamma-glutamyl-peptidase activity|,3,6,536000000,12.3%
Q9EQI5,0.000259624,-0.3006,39.5381263,4.417333333,0.000111221,8.892439063,-3.153,-2.749,,2.07,0.899,1.43,Q9EQI5,Ppbp,Q9EQI5_Ppbp,Q9EQI5,Ppbp,1,9,3,3,Q9EQI5,MOUSE,12593.7,20.3,334,334.1,42.98,42.98,,113,"Chemokine (C-X-C motif) ligand 7, isoform CRA_b",extracellular space|cell|,leukocyte migration involved in inflammatory response|positive regulation of leukocyte chemotaxis|inflammatory response|immune response|G-protein coupled receptor signaling pathway|neutrophil chemotaxis|response to lipopolysaccharide|regulation of cell proliferation|neutrophil degranulation|chemokine-mediated signaling pathway|,chemokine activity|CXCR chemokine receptor binding|,3,9,7890000000,20.3%
Q3UFC6,0.000657922,-0.964,33.73860201,4.4,0.000422805,6.300050878,-2.783,-2.047,-4.662,1.147,0.814,1.747,Q3UFC6,Dsg3,Q3UFC6_Dsg3,Q3UFC6,Dsg3,1,6,4,4,Q3UFC6|O35902|O35902-2,MOUSE,109212.9,4.8,335,335.1,42.79,42.79,,993,Desmoglein-3,plasma membrane|integral component of membrane|extracellular exosome|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|,4,6,201000000,4.8%
A0A0B4J1N0,0.001363461,0.2698,30.02916821,3.566333333,0.000993306,5.957054381,-2.131,-1.609,,1.747,2.518,0.824,A0A0B4J1N0,NotFound,A0A0B4J1N0_NotFound,A0A0B4J1N0,Ighv1-76,1,9,4,4,A0A0B4J1N0|A0A075B5Y2|A0A075B5Y5,MOUSE,10993.2,48.9,336,336.1,42.41,42.41,,98,Immunoglobulin heavy variable 1-76,,,,5,9,2190000000,48.9%
A0A0A6YXQ0,0.000145021,-1.1055,49.80822023,4.191,1.04515E-05,11.11680265,-3.614,-2.659,-3.33,0.98,1.031,0.959,A0A0A6YXQ0,NotFound,A0A0A6YXQ0_NotFound,A0A0A6YXQ0,Ighv8-8,1,10,4,4,A0A0A6YXQ0,MOUSE,13299,26,337,337.1,41.57,41.57,,119,Immunoglobulin heavy variable 8-8 (Fragment),,,,4,10,1510000000,26.0%
G5E8D6,0.000180141,-0.4715,42.54685647,2.899,5.56307E-05,8.623758728,-2.156,-1.594,-2.013,1.045,0.946,0.943,G5E8D6,Efemp2,G5E8D6_Efemp2,G5E8D6,Efemp2,1,8,4,4,G5E8D6|Q9WVJ9|E9Q3N9,MOUSE,53745,8.6,338,338.1,41.31,41.31,,462,EGF-containing fibulin-like extracellular matrix protein 2,proteinaceous extracellular matrix|extracellular exosome|extracellular vesicle|,,calcium ion binding|,4,8,1490000000,8.6%
Q9EPS3,0.000145021,-0.707333333,48.45186612,3.555333333,1.42828E-05,10.60776173,-2.626,-2.283,-2.546,1.304,0.844,1.063,Q9EPS3,Glce,Q9EPS3_Glce,Q9EPS3,Glce,1,5,4,4,Q9EPS3,MOUSE,70429.9,7.7,339,339.1,40.96,40.96,,618,D-glucuronyl C5-epimerase,Golgi membrane|Golgi apparatus|integral component of membrane|,heparan sulfate proteoglycan biosynthetic process|heparin biosynthetic process|,"racemase and epimerase activity, acting on carbohydrates and derivatives|heparosan-N-sulfate-glucuronate 5-epimerase activity|UDP-glucuronate 5'-epimerase activity|",4,5,27300000,7.7%
P02666,0.02350011,-0.825666667,16.81776055,2.521333333,0.020807694,2.992409821,-2.909,-3.284,-0.066,0.622,0.524,0.159,P02666,NotFound,P02666_NotFound,P02666,CSN2,1,7,3,3,P02666,BOVIN,25163.9,14.7,340,340.1,40.96,40.96,,224,Beta-casein,,,,3,7,684000000,14.7%
F8VQD7,0.000209249,-0.4958,41.17184827,4.052,7.63511E-05,9.50317843,-3.276,-2.578,,1.272,1.162,0.941,F8VQD7,Ptprg,F8VQD7_Ptprg,F8VQD7,Ptprg,1,6,5,5,F8VQD7|Q05909|D6RD11,MOUSE,162430.7,4.7,341,341.1,40.01,40.01,,1442,Receptor-type tyrosine-protein phosphatase gamma,extracellular exosome|,negative regulation of epithelial cell migration|peptidyl-tyrosine dephosphorylation|toxin transport|,protein tyrosine phosphatase activity|identical protein binding|,5,6,274000000,4.7%
Q05144,0.000185939,-0.4858,42.2037259,3.7345,6.02043E-05,9.907887876,-2.754,-2.699,,1.095,0.985,0.944,Q05144,Rac2,Q05144_Rac2,Q05144,Rac2,1,4,4,4,Q05144|Q3TLP8|P63001|P60764,MOUSE,21839.8,23.9,342,342.1,39.72,39.72,,192,Ras-related C3 botulinum toxin substrate 2,nuclear envelope|cytoplasm|cytosol|focal adhesion|membrane|lamellipodium|extracellular exosome|actin filament|,chemotaxis|actin filament organization|G-protein coupled receptor signaling pathway|small GTPase mediated signal transduction|positive regulation of cell proliferation|positive regulation of lamellipodium assembly|regulation of cell-substrate adhesion|cell projection assembly|actin cytoskeleton organization|regulation of T cell proliferation|regulation of mast cell degranulation|bone resorption|regulation of protein kinase activity|regulation of respiratory burst|regulation of mast cell chemotaxis|lymphocyte aggregation|positive regulation of neutrophil chemotaxis|regulation of neutrophil migration|positive regulation of protein targeting to mitochondrion|,GTPase activity|GTP binding|protein kinase regulator activity|,4,4,21500000,23.9%
P35454,0.000165321,-0.794833333,43.90047819,3.615,4.07335E-05,9.047464529,-1.994,-2.733,-3.08,1.2,0.926,0.912,P35454,Oxt,P35454_Oxt,P35454,Oxt,1,4,3,3,P35454|P35455,MOUSE,13934.7,36.8,343,343.1,39.71,39.71,,125,Oxytocin-neurophysin 1,extracellular region|extracellular space|cytoplasm|cytosol|secretory granule|terminal bouton|,response to amphetamine|regulation of heart rate|maternal aggressive behavior|positive regulation of cytosolic calcium ion concentration|heart development|female pregnancy|memory|grooming behavior|response to mechanical stimulus|response to sucrose|positive regulation of norepinephrine secretion|response to activity|sleep|response to food|positive regulation of prostaglandin secretion|response to estradiol|response to retinoic acid|response to progesterone|response to prostaglandin E|social behavior|negative regulation of urine volume|positive regulation of renal sodium excretion|response to cocaine|hyperosmotic salinity response|maternal behavior|sperm ejaculation|eating behavior|drinking behavior|response to external biotic stimulus|response to peptide hormone|response to ether|negative regulation of blood pressure|positive regulation of blood pressure|positive regulation of ossification|positive regulation of female receptivity|positive regulation of synaptic transmission|response to glucocorticoid|response to cAMP|response to electrical stimulus|regulation of sensory perception of pain|positive regulation of synapse assembly|male mating behavior|positive regulation of penile erection|positive regulation of hindgut contraction|negative regulation of gastric acid secretion|positive regulation of uterine smooth muscle contraction|,neurohypophyseal hormone activity|oxytocin receptor binding|,3,4,13800000,36.8%
O08807,0.105607249,-0.1284,10.04226841,1.467666667,0.099031455,1.954802096,-2.194,0.176,,0.808,0.154,0.414,O08807,Prdx4,O08807_Prdx4,O08807,Prdx4,1,4,3,1,O08807,MOUSE,31280.1,13.8,344,344.1,39.54,16.93,,274,Peroxiredoxin-4,extracellular space|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|smooth endoplasmic reticulum|cytosol|extracellular exosome|,spermatogenesis|male gonad development|4-hydroxyproline metabolic process|protein maturation by protein folding|extracellular matrix organization|cell redox homeostasis|oxidation-reduction process|reactive oxygen species metabolic process|negative regulation of male germ cell proliferation|,peroxidase activity|protein homodimerization activity|peroxiredoxin activity|,3,4,1490000000,13.8%
P35700,0.156479503,-0.1442,8.271647288,1.058,0.148879627,1.655066795,-1.691,0.133,,0.521,-0.147,0.463,P35700,Prdx1,P35700_Prdx1,P35700,Prdx1,1,1,3,1,P35700,MOUSE,22404.3,14.5,344,344.2,38.77,16.16,,199,Peroxiredoxin-1,extracellular space|nucleus|cytoplasm|mitochondrion|melanosome|myelin sheath|extracellular exosome|,response to reactive oxygen species|retina homeostasis|response to oxidative stress|cell proliferation|removal of superoxide radicals|regulation of stress-activated MAPK cascade|erythrocyte homeostasis|natural killer cell mediated cytotoxicity|regulation of NF-kappaB import into nucleus|hydrogen peroxide catabolic process|oxidation-reduction process|,peroxidase activity|protein binding|thioredoxin peroxidase activity|identical protein binding|poly(A) RNA binding|,1,1,3400000,5.0%
Q6S5C2-2,0.000165321,-0.661666667,43.63647524,3.334666667,4.32865E-05,8.963457808,-2.591,-2.557,-1.839,1.242,0.893,0.882,Q6S5C2,Gnptg,Q6S5C2-2_Gnptg,Q6S5C2-2,Gnptg,1,6,3,3,Q6S5C2-2|A0A140T8R4|Q6S5C2|A0A0R4J0H5,MOUSE,35349.5,13,345,345.1,39.5,39.5,,307,Isoform 2 of N-acetylglucosamine-1-phosphotransferase subunit gamma,Golgi apparatus|extracellular exosome|,carbohydrate phosphorylation|,protein homodimerization activity|,3,6,478000000,13.0%
Q9Z2L6,0.000194435,-1.303833333,41.89429312,4.918333333,6.46503E-05,8.425598919,-3.403,-2.89,-4.996,1.473,1.067,0.926,Q9Z2L6,Minpp1,Q9Z2L6_Minpp1,Q9Z2L6,Minpp1,1,5,3,3,Q9Z2L6,MOUSE,55164,7.9,346,346.1,39.24,39.24,,481,Multiple inositol polyphosphate phosphatase 1,endoplasmic reticulum lumen|plasma membrane|extracellular exosome|,dephosphorylation|,acid phosphatase activity|bisphosphoglycerate 3-phosphatase activity|inositol hexakisphosphate 2-phosphatase activity|,3,5,22000000,7.9%
A0A0B4J1J6,0.000148189,-0.7978,46.29958837,4.812833333,2.34445E-05,11.67309796,-3.953,-3.418,,0.978,1.341,1.063,A0A0B4J1J6,NotFound,A0A0B4J1J6_NotFound,A0A0B4J1J6,Ighv10-1,1,8,4,4,A0A0B4J1J6,MOUSE,13720.5,35.2,347,347.1,38.95,38.95,,119,Immunoglobulin heavy variable 10-1 (Fragment),,,,4,8,499000000,35.2%
A0A075B5M3,0.002126439,-1.46,27.91021339,5.764,0.001618001,5.041746085,-3.283,-2.662,-7.081,1.08,2.223,0.963,A0A075B5M3,NotFound,A0A075B5M3_NotFound,A0A075B5M3,Igkv4-58,1,8,3,2,A0A075B5M3|P01680|A0A075B5L2,MOUSE,10407.3,40.2,348,348.1,38.91,23.55,,97,Immunoglobulin kappa variable 4-58,,,,3,8,1550000000,40.2%
A0A075B5M2,0.000734441,-0.0952,33.1530306,3.198833333,0.000483835,6.817549353,-2.501,-1.528,,1.207,1.4,0.946,A0A075B5M2,NotFound,A0A075B5M2_NotFound,A0A075B5M2,Igkv4-61,1,3,2,1,A0A075B5M2|J3QNZ9|L7N239,MOUSE,10267.2,29.7,348,348.2,35.96,20.6,,94,Immunoglobulin kappa chain variable 4-61,,,,1,3,45700000,18.0%
A0A075B677,0.000629468,-0.6138,33.97321052,4.621166667,0.00040057,7.058958394,-4.356,-2.417,,1.497,1.325,0.882,A0A075B677,NotFound,A0A075B677_NotFound,A0A075B677,Igkv4-53,1,6,2,2,A0A075B677,MOUSE,10480.4,40.2,349,349.1,38.37,38.37,,97,Immunoglobulin kappa variable 4-53,,,,2,6,188000000,40.2%
P01751,0.00014804,-0.6692,46.93695713,4.844666667,2.02444E-05,11.97242862,-3.518,-3.634,,0.951,1.505,1.35,P01751,NotFound,P01751_NotFound,P01751,Ighv1-72,1,6,3,3,P01751|P01754|P01753,MOUSE,15590.3,14.3,350,350.1,38.31,38.31,,139,Ig heavy chain V region B1-8/186-2,,,,3,6,2130000000,14.3%
P10854,0.853623005,0.1185,0.714465431,-0.170333333,0.848307794,-0.198683395,-1.281,2.221,-0.329,0.051,-0.046,0.095,P10854,Hist1h2bm,P10854_Hist1h2bm,P10854,Hist1h2bm,1,8,5,5,P10854|Q64478|Q64525|Q6ZWY9|Q8CGP2-2|Q8CBB6|P70696|Q8CGP2|Q64475|P10853|Q8CGP1|Q9D2U9|Q64524|Q8CGP0,MOUSE,13935.9,31.7,351,351.1,37.77,37.77,,126,Histone H2B type 1-M,nuclear nucleosome|nucleus|nucleoplasm|extracellular exosome|,nucleosome assembly|,DNA binding|protein heterodimerization activity|,5,8,406000000,31.7%
P01634,0.000163538,-0.5606,44.38618303,4.4915,3.64235E-05,10.81551635,-3.39,-3.121,,1.116,1,1.592,P01634,NotFound,P01634_NotFound,P01634,,1,7,4,4,P01634|A0A140T8P2|A0A075B5N2|A0A075B5N1|P01632,MOUSE,15072.8,22.7,352,352.1,37.3,37.3,,136,Ig kappa chain V-V region MOPC 21,,,antigen binding|,4,7,1060000000,22.7%
Q8VI78,0.015429413,-0.308666667,18.74381334,2.678,0.013354224,3.315528927,-2.886,-2.326,0.269,1.18,0.848,1.063,Q8VI78,Pla1a,Q8VI78_Pla1a,Q8VI78,Pla1a,1,5,4,4,Q8VI78,MOUSE,50838.6,11.4,353,353.1,37.23,37.23,,456,Phospholipase A1 member A,acrosomal membrane|extracellular exosome|,lipid catabolic process|,phosphatidylcholine 1-acylhydrolase activity|,4,5,76700000,11.4%
Q9D1Q6,0.008416065,-1.647833333,21.52237213,5.295666667,0.007043083,3.802028126,-2.873,-2.196,-7.818,1.13,1.037,0.833,Q9D1Q6,Erp44,Q9D1Q6_Erp44,Q9D1Q6,Erp44,1,5,3,3,Q9D1Q6,MOUSE,47251.5,7.1,354,354.1,37.16,37.16,,406,Endoplasmic reticulum resident protein 44,endoplasmic reticulum lumen|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|cell surface|extracellular exosome|,protein folding|response to unfolded protein|glycoprotein metabolic process|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|protein binding|,3,5,107000000,7.1%
P16014,0.00844018,-0.845166667,21.5034877,3.719,0.007073775,3.798628746,-1.784,-1.241,-5.089,1.319,0.723,1.001,P16014,Chgb,P16014_Chgb,P16014,Chgb,1,7,5,5,P16014,MOUSE,78081.7,6.9,355,355.1,37.05,37.05,,677,Secretogranin-1,extracellular region|secretory granule|,,protein binding|,5,7,53400000,6.9%
Q60805,0.000614446,-1.377333333,34.10368116,4.993333333,0.000388716,6.458484292,-3.494,-2.505,-5.623,1.193,1.282,0.883,Q60805,Mertk,Q60805_Mertk,Q60805,Mertk,1,4,4,4,Q60805,MOUSE,111239.5,3.3,356,356.1,36.83,36.83,,994,Tyrosine-protein kinase Mer,photoreceptor outer segment|extracellular space|cytoplasm|integral component of membrane|rhabdomere|,natural killer cell differentiation|phagocytosis|spermatogenesis|peptidyl-tyrosine phosphorylation|platelet activation|secretion by cell|substrate adhesion-dependent cell spreading|apoptotic cell clearance|protein kinase B signaling|positive regulation of phagocytosis|negative regulation of lymphocyte activation|retina development in camera-type eye|vagina development|negative regulation of leukocyte apoptotic process|,transmembrane receptor protein tyrosine kinase activity|ATP binding|,4,4,82800000,3.3%
Q91W90,0.000284375,-0.5074,38.64236838,4.065166667,0.000136698,8.572448639,-2.403,-3.49,,1.202,1.148,1.006,Q91W90,Txndc5,Q91W90_Txndc5,Q91W90,Txndc5,1,2,2,2,Q91W90|E9PXX7|A0A0R4J1Y7,MOUSE,47099.3,6.2,357,357.1,35.79,35.79,,417,Thioredoxin domain-containing protein 5,endoplasmic reticulum lumen|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|apoptotic cell clearance|cell redox homeostasis|,protein disulfide isomerase activity|,2,2,552000000,6.2%
A0A075B697,0.000263875,-0.5262,39.21024132,4.4855,0.000119943,8.774119707,-3.658,-2.777,,1.039,1.834,0.931,A0A075B697,NotFound,A0A075B697_NotFound,A0A075B697,Ighv2-9-1,1,12,3,1,A0A075B697|P01820|P01819|A0A075B5Q1|P01821|A0A075B6A7|A0A075B696|A0A075B5Q7,MOUSE,12709.4,22.4,358,358.1,35.78,17.8,,116,Immunoglobulin heavy variable 2-9-1 (Fragment),,,,4,12,5440000000,22.4%
A0A075B5Q5,0.001682366,-0.532,29.02820756,3.555833333,0.001250775,5.699671729,-3.607,-1.724,,0.763,0.955,0.953,A0A075B5Q5,NotFound,A0A075B5Q5_NotFound,A0A075B5Q5,Ighv2-9,1,1,3,1,A0A075B5Q5,MOUSE,12705.5,26.7,358,358.2,28.74,10.76,,116,Immunoglobulin heavy variable 2-9 (Fragment),,,,1,1,12200000,13.7%
A0A075B5P8,0.001320533,0.133,30.18297773,3.761333333,0.000958743,6.915500356,,-2.688,,1.321,0.883,1.016,A0A075B5P8,NotFound,A0A075B5P8_NotFound,A0A075B5P8,Ighv2-2,1,1,3,1,A0A075B5P8,MOUSE,12806.4,26.7,358,358.3,28.38,10.2,,116,Immunoglobulin heavy variable 2-2 (Fragment),,,,1,1,23000000,13.7%
A0A075B680,0.00100208,-0.614333333,31.50996667,3.592,0.000706323,5.732246701,-3.607,-2.401,-1.223,0.892,1.602,1.051,A0A075B680,NotFound,A0A075B680_NotFound,A0A075B680,Ighv1-62-2,1,5,3,3,A0A075B680|A0A0G2JFL3|A0A075B5V8,MOUSE,11338.5,40,359,359.1,35.28,35.28,,100,Immunoglobulin heavy variable 1-62-2,,,,3,5,839000000,40.0%
A0A075B5W3,0.00014804,-0.6614,46.84117407,4.889333333,2.06958E-05,11.92699516,-3.701,-3.489,,0.98,1.575,1.328,A0A075B5W3,NotFound,A0A075B5W3_NotFound,A0A075B5W3,Ighv1-53,1,6,2,2,A0A075B5W3,MOUSE,12962.4,27.3,360,360.1,35.22,35.22,,117,Immunoglobulin heavy variable 1-53 (Fragment),,,,2,6,2150000000,27.3%
P12382,0.000372266,-0.5208,36.75850687,3.656166667,0.000210935,7.931818191,-3.221,-2.208,,1.014,0.885,0.926,P12382,Pfkl,P12382_Pfkl,P12382,Pfkl,1,6,3,2,P12382|Q9WUA3-2,MOUSE,86157.1,5.3,361,361.1,35.21,23.89,,780,"ATP-dependent 6-phosphofructokinase, liver type",cytosol|6-phosphofructokinase complex|membrane|extracellular exosome|,"fructose 6-phosphate metabolic process|glycolytic process|response to glucose|fructose 1,6-bisphosphate metabolic process|negative regulation of insulin secretion|carbohydrate phosphorylation|protein oligomerization|protein homotetramerization|",6-phosphofructokinase activity|ATP binding|kinase binding|identical protein binding|metal ion binding|fructose binding|fructose-6-phosphate binding|6-phosphofructokinase activity|,3,6,140000000,5.3%
P47857-3,0.019652321,-0.4626,17.61268428,2.5665,0.017327327,3.29310784,-3.258,-0.747,,0.813,0.285,0.594,P47857,Pfkm,P47857-3_Pfkm,P47857-3,Pfkm,1,2,3,2,P47857-3|P47857-2|P47857,MOUSE,103523.5,3.6,361,361.2,26.23,14.91,,780,"Isoform 3 of ATP-dependent 6-phosphofructokinase, muscle type",cytosol|6-phosphofructokinase complex|apical plasma membrane|extracellular exosome|sperm principal piece|,fructose 6-phosphate metabolic process|glycolytic process|positive regulation of insulin secretion|glucose homeostasis|muscle cell cellular homeostasis|carbohydrate phosphorylation|protein oligomerization|glycolytic process through fructose-6-phosphate|,6-phosphofructokinase activity|protein binding|ATP binding|protein C-terminus binding|phosphofructokinase activity|kinase binding|identical protein binding|protein homodimerization activity|metal ion binding|fructose binding|,2,2,3900000,2.6%
Q8C605,0.000873557,0.004,32.222725,4.069333333,0.000599415,7.652139164,,-3.048,,1.206,0.948,0.91,Q8C605,Pfkp,Q8C605_Pfkp,Q8C605,Pfkp,1,1,2,1,Q8C605|Q9WUA3,MOUSE,86686.7,2.6,361,361.3,17.93,6.61,,784,ATP-dependent 6-phosphofructokinase,nucleus|cytosol|6-phosphofructokinase complex|membrane|extracellular exosome|,fructose 6-phosphate metabolic process|glycolytic process|carbohydrate phosphorylation|activation of mitophagy in response to mitochondrial depolarization|,6-phosphofructokinase activity|ATP binding|protein complex binding|metal ion binding|,1,1,2660000,1.5%
Q8K2I4,0.000165321,-1.117333333,43.61003812,4.244,4.35508E-05,8.955082442,-2.729,-2.824,-4.165,1.207,0.894,0.913,Q8K2I4,Manba,Q8K2I4_Manba,Q8K2I4,Manba,1,3,3,3,A0A0R4J092|Q8K2I4|D6RGR1,MOUSE,101513.6,4.3,362,362.1,34.92,34.92,,879,Beta-mannosidase,lysosome|intracellular membrane-bounded organelle|,carbohydrate metabolic process|glycoprotein catabolic process|mannan catabolic process|,beta-mannosidase activity|,3,3,18400000,4.3%
P10107,0.004575493,-0.223833333,24.32702682,3.198333333,0.003692303,4.3230226,-1.818,-0.727,-2.924,1.245,0.389,2.492,P10107,Anxa1,P10107_Anxa1,P10107,Anxa1,1,4,4,4,P10107,MOUSE,39018.9,12.7,363,363.1,34.86,34.86,,346,Annexin A1,cornified envelope|extracellular space|nucleus|cytoplasm|endosome|cytosol|plasma membrane|focal adhesion|cilium|cell surface|basolateral plasma membrane|mitochondrial membrane|vesicle|sarcolemma|mast cell granule|protein complex|extracellular exosome|,DNA strand renaturation|neutrophil homeostasis|signal transduction|cell surface receptor signaling pathway|response to X-ray|myoblast migration involved in skeletal muscle regeneration|peptide cross-linking|insulin secretion|keratinocyte differentiation|prostate gland development|endocrine pancreas development|positive regulation of vesicle fusion|positive regulation of prostaglandin biosynthetic process|response to estradiol|DNA duplex unwinding|positive regulation of neutrophil apoptotic process|DNA rewinding|gliogenesis|regulation of cell proliferation|response to drug|response to peptide hormone|estrous cycle|alpha-beta T cell differentiation|arachidonic acid secretion|cellular response to hydrogen peroxide|hepatocyte differentiation|prolactin secretion|response to interleukin-1|cellular response to glucocorticoid stimulus|neutrophil clearance|positive regulation of G1/S transition of mitotic cell cycle|negative regulation of phospholipase A2 activity|negative regulation of interleukin-8 secretion|,"single-stranded DNA binding|single-stranded RNA binding|helicase activity|structural molecule activity|calcium ion binding|protein binding|calcium-dependent phospholipid binding|phospholipase A2 inhibitor activity|protein binding, bridging|double-stranded DNA-dependent ATPase activity|annealing helicase activity|protein homodimerization activity|calcium-dependent protein binding|",4,4,40600000,12.7%
P09542,0.897423074,0.0268,0.486283265,0.2255,0.894070311,0.139090993,-3.051,2.834,,0.34,0.046,-0.035,P09542,Myl3,P09542_Myl3,P09542,Myl3,1,4,4,4,P09542|A0A0G2JDM3,MOUSE,22535.3,20,364,364.1,33.67,33.67,,204,Myosin light chain 3,myosin complex|A band|I band|,regulation of the force of heart contraction|regulation of striated muscle contraction|skeletal muscle tissue development|metabolic process|ventricular cardiac muscle tissue morphogenesis|cardiac muscle contraction|,motor activity|actin monomer binding|calcium ion binding|,4,4,418000000,20.0%
Q80W65,0.01551188,-1.054333333,18.71441873,3.422666667,0.013444917,3.310518484,-3.197,-0.405,-4.695,1.23,0.309,0.432,Q80W65,Pcsk9,Q80W65_Pcsk9,Q80W65,Pcsk9,1,4,3,3,Q80W65,MOUSE,76419.3,5.4,365,365.1,32.73,32.73,,694,Proprotein convertase subtilisin/kexin type 9,extracellular region|extracellular space|cytoplasm|lysosome|early endosome|late endosome|endoplasmic reticulum|endoplasmic reticulum lumen|rough endoplasmic reticulum|Golgi apparatus|plasma membrane|cell surface|ER to Golgi transport vesicle|perinuclear region of cytoplasm|PCSK9-LDLR complex|PCSK9-AnxA2 complex|,kidney development|liver development|negative regulation of receptor recycling|positive regulation of receptor internalization|triglyceride metabolic process|phospholipid metabolic process|apoptotic process|lysosomal transport|cholesterol metabolic process|cellular response to starvation|regulation of receptor activity|negative regulation of low-density lipoprotein particle clearance|protein autoprocessing|neurogenesis|neuron differentiation|low-density lipoprotein receptor particle metabolic process|low-density lipoprotein particle receptor catabolic process|regulation of low-density lipoprotein particle receptor catabolic process|positive regulation of low-density lipoprotein particle receptor catabolic process|cellular response to insulin stimulus|lipoprotein metabolic process|cholesterol homeostasis|regulation of neuron apoptotic process|positive regulation of neuron apoptotic process|negative regulation of receptor activity|negative regulation of sodium ion transmembrane transporter activity|,serine-type endopeptidase activity|sodium channel inhibitor activity|low-density lipoprotein particle binding|receptor inhibitor activity|apolipoprotein binding|very-low-density lipoprotein particle binding|apolipoprotein receptor binding|protein self-association|poly(A) RNA binding|low-density lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,3,4,101000000,5.4%
Q9CYA0,0.000164241,-0.9292,44.29846133,4.724666667,3.71667E-05,10.77762399,-4.197,-3.331,,0.971,0.947,0.964,Q9CYA0,Creld2,Q9CYA0_Creld2,Q9CYA0,Creld2,1,3,2,2,Q9CYA0,MOUSE,40386.9,9.7,366,366.1,32.65,32.65,,350,Cysteine-rich with EGF-like domain protein 2,extracellular space|endoplasmic reticulum|Golgi apparatus|,,calcium ion binding|,2,3,20600000,9.7%
O08742,0.001806964,-0.792166667,28.67448658,3.243666667,0.001356911,5.122449019,-2.707,-1.044,-3.491,0.937,0.593,0.959,O08742,NotFound,O08742_NotFound,O08742,Gp5,1,4,3,3,O08742,MOUSE,63980.2,5.2,367,367.1,32.51,32.51,,567,Platelet glycoprotein V,integral component of membrane|,cell adhesion|blood coagulation|,,3,4,321000000,5.2%
Q62351,0.00048211,-0.7915,35.32260301,3.366333333,0.000293589,6.629521374,-2.983,-1.412,-3.029,0.943,0.833,0.899,Q62351,Tfrc,Q62351_Tfrc,Q62351,Tfrc,1,4,4,4,Q62351|Q8C872,MOUSE,86129.2,5.3,368,368.1,32.18,32.18,,763,Transferrin receptor protein 1,extracellular region|extracellular space|mitochondrion|endosome|plasma membrane|coated pit|external side of plasma membrane|cell surface|membrane|integral component of membrane|cytoplasmic membrane-bounded vesicle|melanosome|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|recycling endosome|recycling endosome membrane|extracellular exosome|blood microparticle|extracellular vesicle|HFE-transferrin receptor complex|,response to hypoxia|cellular iron ion homeostasis|receptor-mediated endocytosis|acute-phase response|aging|response to nutrient|response to manganese ion|osteoclast differentiation|cellular response to extracellular stimulus|response to retinoic acid|transferrin transport|iron ion transmembrane transport|cellular response to drug|positive regulation of bone resorption|response to copper ion|cellular response to iron ion|iron ion import|,glycoprotein binding|double-stranded RNA binding|transferrin receptor activity|iron ion transmembrane transporter activity|protein binding|Hsp70 protein binding|transferrin transmembrane transporter activity|identical protein binding|poly(A) RNA binding|chaperone binding|,4,4,121000000,5.3%
A0A0B4J1I1,0.000145021,-1.281666667,47.60029631,5.030666667,1.73768E-05,10.29895373,-4.303,-2.805,-4.283,1.261,1.117,1.323,A0A0B4J1I1,NotFound,A0A0B4J1I1_NotFound,A0A0B4J1I1,Igkv16-104,1,4,2,2,A0A0B4J1I1,MOUSE,13045.5,23.2,369,369.1,32.13,32.13,,116,Immunoglobulin kappa variable 16-104 (Fragment),,,,2,4,284000000,23.2%
A0A075B5R4,0.006326758,-0.28,22.80234167,2.454666667,0.005245246,3.988546665,-2.765,-1.373,-0.384,0.998,0.69,1.154,A0A075B5R4,NotFound,A0A075B5R4_NotFound,A0A075B5R4,Ighv14-1,1,4,2,2,A0A075B5R4|A0A075B5R9|A0A075B5R7|A0A075B5S3,MOUSE,13162.6,19.6,370,370.1,31.83,31.83,,117,Immunoglobulin heavy variable 14-1 (Fragment),,,,2,4,149000000,19.6%
Q6GSS7,0.418365942,-0.313666667,3.871844905,0.898666667,0.410029883,0.877605758,-1.12,1.554,-2.723,0.483,-0.395,0.319,Q6GSS7,Hist2h2aa1,Q6GSS7_Hist2h2aa1,Q6GSS7,Hist2h2aa1,1,6,5,3,Q6GSS7|Q64523|Q8R1M2|A0A0N4SV66|P27661|Q8CGP5|Q8CGP7|C0HKE6|Q8BFU2|Q8CGP4|Q8CGP6|Q64522,MOUSE,14095.2,25.3,371,371.1,31.76,17.12,,130,Histone H2A type 2-A,nucleosome|nucleus|extracellular exosome|,nucleosome assembly|,DNA binding|protein heterodimerization activity|,5,6,123000000,25.3%
P0C0S6,0.009050105,-1.482833333,21.16832254,4.685,0.007641309,3.738520616,-2.642,-1.868,-6.966,0.788,0.944,0.847,P0C0S6,H2afz,P0C0S6_H2afz,P0C0S6,H2afz,1,1,3,1,P0C0S6|Q3THW5|Q3UA95|G3UWL7,MOUSE,13552.5,17.1,371,371.2,19.58,4.94,,128,Histone H2A.Z,nucleosome|nucleus|nuclear euchromatin|nuclear heterochromatin|extracellular exosome|Barr body|,multicellular organismal development|positive regulation of transcription from RNA polymerase II promoter|cellular response to estradiol stimulus|,RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|chromatin DNA binding|nucleosomal DNA binding|protein heterodimerization activity|,1,1,73100000,11.7%
P27046,0.078469425,-0.433666667,11.41370635,2.51,0.072215324,2.125445077,-4.447,-1.181,0.562,1.321,0.617,0.526,P27046,Man2a1,P27046_Man2a1,P27046,Man2a1,1,2,2,2,P27046,MOUSE,132370.8,2.2,372,372.1,31.51,31.51,,1150,Alpha-mannosidase 2,Golgi membrane|Golgi apparatus|cis-Golgi network|membrane|integral component of membrane|extracellular exosome|,in utero embryonic development|liver development|mannose metabolic process|N-glycan processing|mitochondrion organization|vacuole organization|respiratory gaseous exchange|lung alveolus development|positive regulation of neurogenesis|retina morphogenesis in camera-type eye|,"mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity|zinc ion binding|mannosidase activity|hydrolase activity, hydrolyzing N-glycosyl compounds|carbohydrate binding|",2,2,9350000,2.2%
A0A075B5T7,0.00080842,-0.501333333,32.66296361,3.912666667,0.000541631,5.993706474,-3.607,-2.543,-1.223,0.934,2.041,1.39,A0A075B5T7,NotFound,A0A075B5T7_NotFound,A0A075B5T7,Ighv1-7,1,4,2,2,A0A075B5T7|A0A075B5T4,MOUSE,13273.8,23.9,373,373.1,31.48,31.48,,117,Immunoglobulin heavy variable V1-7 (Fragment),,,,2,4,799000000,23.9%
Q8VCN3,0.002398765,-0.2738,27.3163616,3.470333333,0.001855085,5.278318058,-3.32,-1.392,,1.522,0.912,0.909,Q8VCN3,Ugt2b37,Q8VCN3_Ugt2b37,Q8VCN3,Ugt2b37,1,3,3,3,Q8VCN3|Q91WH2|Q8K169|P17717|Q8BJL9|Q8R084|Q3UEP4|K9J7B2|Q64435|E9PXN7|P70691|D3Z748|Q63886|B2RT14|Q62452|Q6ZQM8|D3YZE6,MOUSE,61328.4,6.6,374,374.1,30.92,30.92,,530,UDP-glucuronosyltransferase,mitochondrial inner membrane|endoplasmic reticulum|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|,glucuronosyltransferase activity|,3,3,61900000,6.6%
P17742,0.282195815,-1.158833333,5.620703738,2.482333333,0.274112996,1.189281191,-2.085,2.095,-7.21,0.262,-0.229,0.214,P17742,Ppia,P17742_Ppia,P17742,Ppia,1,4,4,4,P17742|A0A1L1SST0|F8VPN3,MOUSE,18142.2,17.6,375,375.1,30.78,30.78,,164,Peptidyl-prolyl cis-trans isomerase A,extracellular space|nucleus|cytosol|focal adhesion|membrane|myelin sheath|extracellular exosome|,protein peptidyl-prolyl isomerization|protein folding|neuron differentiation|lipid particle organization|regulation of viral genome replication|positive regulation of viral genome replication|positive regulation of protein secretion|,peptidyl-prolyl cis-trans isomerase activity|peptide binding|poly(A) RNA binding|,4,4,41400000,17.6%
P15116,0.000145021,-1.344333333,49.37691243,4.858,1.15427E-05,10.95259582,-3.691,-3.097,-4.532,1.189,1.065,1,P15116,Cdh2,P15116_Cdh2,P15116,Cdh2,1,5,3,3,P15116|D3YYT0,MOUSE,100251,4.6,376,376.1,30.14,30.14,,906,Cadherin-2,cell-cell junction|adherens junction|cell-cell adherens junction|fascia adherens|focal adhesion|intercalated disc|membrane|integral component of membrane|basolateral plasma membrane|apical plasma membrane|catenin complex|lamellipodium|plasma membrane raft|synapse|extracellular exosome|cortical actin cytoskeleton|,cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|glial cell differentiation|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|cell migration|regulation of myelination|regulation of Rho protein signal transduction|positive regulation of MAPK cascade|cell-cell adhesion mediated by cadherin|blood vessel morphogenesis|regulation of axonogenesis|striated muscle cell differentiation|protein heterooligomerization|establishment of protein localization to plasma membrane|negative regulation of canonical Wnt signaling pathway|neuroligin clustering involved in postsynaptic membrane assembly|neuronal stem cell maintenance|regulation of postsynaptic density protein 95 clustering|positive regulation of synaptic vesicle clustering|,calcium ion binding|protein binding|beta-catenin binding|enzyme binding|protein kinase binding|protein phosphatase binding|protein complex binding|alpha-catenin binding|gamma-catenin binding|nitric-oxide synthase binding|,3,5,17400000,4.6%
A0A0B4J1H6,0.000209249,-0.7264,41.18129866,5.327666667,7.61851E-05,9.506816838,-4.543,-3.303,,0.939,1.921,1.354,A0A0B4J1H6,NotFound,A0A0B4J1H6_NotFound,A0A0B4J1H6,Igkv2-137,1,5,2,2,A0A0B4J1H6|P01630,MOUSE,13302,20,377,377.1,29.72,29.72,,120,Immunoglobulin kappa chain variable 2-137 (Fragment),,,,2,5,2600000000,20.0%
P10404,0.000165321,-0.6408,43.84458988,4.062833333,4.12611E-05,10.5834987,-3.233,-2.924,,0.99,1.027,0.936,P10404,NotFound,P10404_NotFound,P10404,,1,3,2,2,P10404,MOUSE,70752.6,4,378,378.1,29.47,29.47,,641,MLV-related proviral Env polyprotein,plasma membrane|integral component of membrane|viral capsid|viral envelope|virion membrane|,viral life cycle|,metal ion binding|,2,3,65300000,4.0%
A0A075B5R0,0.000165321,-0.8785,43.64827995,3.763,4.3169E-05,8.967199752,-2.504,-2.311,-3.465,0.903,0.877,1.229,A0A075B5R0,NotFound,A0A075B5R0_NotFound,A0A075B5R0,Ighv5-16,1,4,2,2,A0A075B5R0,MOUSE,13388.1,23.2,379,379.1,29.37,29.37,,116,Immunoglobulin heavy variable 5-16,,,,2,4,88700000,23.2%
E9QNX4,0.000195332,-0.8712,41.84189245,4.817166667,6.54351E-05,9.764250212,-4.358,-3.165,,1.172,1.078,0.917,E9QNX4,Alpk1,E9QNX4_Alpk1,E9QNX4,Alpk1,1,6,3,3,E9QNX4|Q9CXB8,MOUSE,137413.2,2.1,380,380.1,29.21,29.21,,1231,Alpha-protein kinase 1,,positive regulation of defense response to virus by host|protein phosphorylation|activation of mitophagy in response to mitochondrial depolarization|,protein serine/threonine kinase activity|ATP binding|,3,6,559000000,2.1%
P02668,0.000418835,-0.881333333,36.10575092,3.856,0.000245146,6.825995688,-3.414,-3.396,-1.618,1.397,0.999,0.744,P02668,NotFound,P02668_NotFound,P02668,CSN3,1,3,2,2,P02668,BOVIN,21383.1,14.7,381,381.1,28.9,28.9,,190,Kappa-casein,,,,2,3,74100000,14.7%
Q9EPL0,0.000312497,-1.047666667,37.9391897,4.153333333,0.000160724,7.303614414,-3.154,-2.037,-4.182,1.234,0.813,1.04,Q9EPL0,Xylt2,Q9EPL0_Xylt2,Q9EPL0,Xylt2,1,3,3,3,Q9EPL0|F2Z436,MOUSE,97608.3,4.1,382,382.1,28.85,28.85,,865,Xylosyltransferase 2,Golgi membrane|endoplasmic reticulum membrane|integral component of membrane|,glycosaminoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process|proteoglycan biosynthetic process|chondroitin sulfate biosynthetic process|heparin biosynthetic process|,acetylglucosaminyltransferase activity|protein xylosyltransferase activity|,3,3,13600000,4.1%
Q59IW6,0.00016068,-0.794333333,44.50780523,3.39,3.54176E-05,9.243297419,-2.473,-2.061,-2.934,1.022,0.842,0.838,Q59IW6,Abi3bp,Q59IW6_Abi3bp,Q59IW6,Abi3bp,1,4,3,3,Q59IW6|Q59IW5|Q59IW9|E9Q8E3,MOUSE,130163.5,2,383,383.1,28.44,28.44,,1179,"ABI gene family, member 3 (NESH)-binding protein",proteinaceous extracellular matrix|interstitial matrix|extracellular space|,positive regulation of cell-substrate adhesion|extracellular matrix organization|,collagen binding|glycosaminoglycan binding|heparin binding|,3,4,67200000,2.0%
P17182,0.093895525,-0.9335,10.57009387,2.283666667,0.087698187,1.992409066,-1.481,0.06,-4.805,0.41,-0.064,0.279,P17182,Eno1,P17182_Eno1,P17182,Eno1,1,6,4,4,P17182,MOUSE,47482.3,6.9,384,384.1,28.29,28.29,,434,Alpha-enolase,phosphopyruvate hydratase complex|plasma membrane|myelin sheath|,glycolytic process|,magnesium ion binding|phosphopyruvate hydratase activity|,4,6,17800000000,6.9%
P47880,0.00014804,-0.6876,46.8116035,4.658166667,2.08372E-05,11.91300114,-3.439,-3.526,,1.282,0.934,1.311,P47880,Igfbp6,P47880_Igfbp6,P47880,Igfbp6,1,4,3,3,P47880,MOUSE,26259,11.7,385,385.1,28.29,28.29,,238,Insulin-like growth factor-binding protein 6,extracellular space|Golgi apparatus|extracellular exosome|,regulation of cell growth|regulation of insulin-like growth factor receptor signaling pathway|,insulin-like growth factor I binding|insulin-like growth factor II binding|,3,4,113000000,11.7%
Q9CQ45,0.000228633,-0.4268,40.46856415,4.052,8.97726E-05,9.235863484,-3.206,-2.51,,1.428,1.24,0.914,Q9CQ45,Nenf,Q9CQ45_Nenf,Q9CQ45,Nenf,1,3,3,3,Q9CQ45,MOUSE,18904.1,17.5,386,386.1,27.96,27.96,,171,Neudesin,extracellular space|nucleus|nucleoplasm|endomembrane system|membrane|,negative regulation of appetite|positive regulation of MAPK cascade|,growth factor activity|heme binding|metal ion binding|,3,3,32100000,17.5%
P18528,0.000304552,-0.2318,38.1252862,3.828666667,0.000153983,8.392329448,-2.578,-2.48,,1.213,1.83,0.856,P18528,NotFound,P18528_NotFound,P18528,,1,4,2,2,P18528,MOUSE,11121.3,24.4,387,387.1,27.92,27.92,,98,Ig heavy chain V region 6.96,,,antigen binding|,2,4,134000000,24.4%
A2ASS6,0.003717029,-2.020833333,25.2563376,6.083666667,0.002981029,4.503297843,-3.75,-2.971,-8.467,0.942,0.98,1.141,A2ASS6,NotFound,A2ASS6_NotFound,A2ASS6,Ttn,1,12,5,5,A2ASS6|E9Q8K5|E9Q8N1|A2ASS6-2,MOUSE,3935740.7,0.1,388,388.1,27.84,27.84,,35213,Titin,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,5,12,81000000000,0.1%
P97333,0.062852687,-0.2415,12.4010436,2.003666667,0.057530168,2.281287851,-2.979,-1.466,0.715,0.891,0.601,0.789,P97333,Nrp1,P97333_Nrp1,P97333,Nrp1,1,5,4,4,P97333,MOUSE,104253.4,5.6,389,389.1,27.62,27.62,,923,Neuropilin-1,extracellular space|early endosome|cytosol|neurofilament|plasma membrane|focal adhesion|integral component of membrane|axon|sorting endosome|,angiogenesis|patterning of blood vessels|neuron migration|sprouting angiogenesis|cell migration involved in sprouting angiogenesis|axon guidance|axonal fasciculation|heart development|motor neuron axon guidance|dendrite development|cell migration|facial nerve structural organization|trigeminal nerve morphogenesis|trigeminal nerve structural organization|vestibulocochlear nerve structural organization|nerve development|branchiomotor neuron axon guidance|gonadotrophin-releasing hormone neuronal migration to the hypothalamus|negative regulation of axon extension|retinal ganglion cell axon guidance|cellular response to hepatocyte growth factor stimulus|endothelial cell chemotaxis|cellular response to vascular endothelial growth factor stimulus|ventral trunk neural crest cell migration|VEGF-activated neuropilin signaling pathway|otic placode formation|negative regulation of neuron apoptotic process|platelet-derived growth factor receptor signaling pathway|vascular endothelial growth factor receptor signaling pathway|hepatocyte growth factor receptor signaling pathway|sympathetic nervous system development|neuron development|regulation of axon extension involved in axon guidance|positive regulation of axon extension involved in axon guidance|negative regulation of axon extension involved in axon guidance|artery morphogenesis|axon extension involved in axon guidance|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|axonogenesis involved in innervation|dichotomous subdivision of terminal units involved in salivary gland branching|angiogenesis involved in coronary vascular morphogenesis|cell migration involved in coronary vasculogenesis|coronary artery morphogenesis|retina vasculature morphogenesis in camera-type eye|renal artery morphogenesis|sympathetic ganglion development|trigeminal ganglion development|ganglion morphogenesis|positive regulation of ERK1 and ERK2 cascade|semaphorin-plexin signaling pathway|commissural neuron axon guidance|regulation of retinal ganglion cell axon guidance|sensory neuron axon guidance|sympathetic neuron projection extension|sympathetic neuron projection guidance|neural crest cell migration involved in autonomic nervous system development|toxin transport|semaphorin-plexin signaling pathway involved in neuron projection guidance|semaphorin-plexin signaling pathway involved in axon guidance|positive regulation of retinal ganglion cell axon guidance|VEGF-activated neuropilin signaling pathway involved in axon guidance|protein localization to early endosome|facioacoustic ganglion development|negative regulation of extrinsic apoptotic signaling pathway|,vascular endothelial growth factor-activated receptor activity|protein binding|heparin binding|semaphorin receptor activity|growth factor binding|vascular endothelial growth factor binding|metal ion binding|,4,5,17000000,5.6%
Q922Q9,0.005418577,-0.591833333,23.55252574,3.021666667,0.004413137,4.175804589,-1.385,-1.136,-3.787,1.177,0.687,0.893,Q922Q9,Chid1,Q922Q9_Chid1,Q922Q9,Chid1,1,4,4,4,A0A0R4J242|Q922Q9|A0A0R4J058|Q922Q9-2|A0A1B0GSH5,MOUSE,45075.9,8.3,390,390.1,27.55,27.55,,393,Chitinase domain-containing protein 1,extracellular region|extracellular space|nucleus|lysosome|late endosome|trans-Golgi network|membrane|extracellular exosome|,carbohydrate metabolic process|chitin catabolic process|innate immune response|negative regulation of cytokine production involved in inflammatory response|,chitinase activity|chitin binding|oligosaccharide binding|,4,4,206000000,8.3%
Q923X1,0.000261273,-0.460166667,39.28714099,3.346333333,0.000117838,7.671364905,-2.797,-2.145,-1.458,1.458,1.048,1.133,Q923X1,Adgrl4,Q923X1_Adgrl4,Q923X1,Adgrl4,1,2,2,2,Q923X1,MOUSE,84526.8,4.6,391,391.1,27.52,27.52,,739,Adhesion G protein-coupled receptor L4,plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|,G-protein coupled receptor activity|calcium ion binding|,2,2,21000000,4.6%
Q9Z126,0.000148189,-0.6375,46.39848878,3.461,2.29166E-05,9.876742576,-2.478,-2.39,-2.236,1.494,0.825,0.96,Q9Z126,Pf4,Q9Z126_Pf4,Q9Z126,Pf4,1,6,3,3,Q9Z126|A0A0J9YTR7,MOUSE,11471.5,25.7,392,392.1,27.38,27.38,,105,Platelet factor 4,extracellular space|platelet alpha granule|protein complex|,positive regulation of leukocyte chemotaxis|protein complex assembly|inflammatory response|immune response|G-protein coupled receptor signaling pathway|positive regulation of gene expression|positive regulation of macrophage derived foam cell differentiation|negative regulation of angiogenesis|cytokine-mediated signaling pathway|platelet activation|leukocyte chemotaxis|positive regulation of cAMP metabolic process|response to lipopolysaccharide|positive regulation of tumor necrosis factor production|regulation of cell proliferation|positive regulation of cAMP-mediated signaling|negative regulation of MHC class II biosynthetic process|positive regulation of macrophage differentiation|negative regulation of megakaryocyte differentiation|negative regulation of cytolysis|positive regulation of transcription from RNA polymerase II promoter|chemokine-mediated signaling pathway|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|,chemokine activity|heparin binding|CXCR chemokine receptor binding|CXCR3 chemokine receptor binding|,3,6,86900000,25.7%
P24270,0.007389722,-0.917,22.10661325,3.229333333,0.006156568,3.907879845,-2.932,-0.647,-4.016,0.934,0.445,0.714,P24270,Cat,P24270_Cat,P24270,Cat,1,4,3,3,P24270|A2AL20,MOUSE,60079.5,5.1,393,393.1,27.11,27.11,,527,Catalase,extracellular space|mitochondrion|mitochondrial intermembrane space|lysosome|peroxisome|peroxisomal membrane|endoplasmic reticulum|Golgi apparatus|cytosol|plasma membrane|focal adhesion|membrane|intracellular membrane-bounded organelle|extracellular exosome|,response to reactive oxygen species|osteoblast differentiation|ureteric bud development|response to hypoxia|triglyceride metabolic process|response to oxidative stress|aging|cholesterol metabolic process|aerobic respiration|response to toxic substance|response to light intensity|UV protection|response to ozone|response to lead ion|positive regulation of phosphatidylinositol 3-kinase signaling|response to activity|response to inactivity|hemoglobin metabolic process|negative regulation of NF-kappaB transcription factor activity|response to estradiol|response to insulin|response to vitamin A|response to vitamin E|response to L-ascorbic acid|response to drug|hydrogen peroxide catabolic process|negative regulation of apoptotic process|response to ethanol|response to cadmium ion|positive regulation of NF-kappaB transcription factor activity|protein tetramerization|protein homotetramerization|positive regulation of cell division|response to hyperoxia|response to fatty acid|cellular response to growth factor stimulus|response to phenylpropanoid|,"aminoacylase activity|catalase activity|receptor binding|antioxidant activity|oxidoreductase activity, acting on peroxide as acceptor|enzyme binding|heme binding|protein homodimerization activity|metal ion binding|NADP binding|",3,4,61800000,5.1%
A0A0B4J1I8,0.00021605,-1.090833333,40.78800511,5.212333333,8.34064E-05,8.098394062,-3.328,-2.75,-5.013,0.899,1.901,1.746,A0A0B4J1I8,NotFound,A0A0B4J1I8_NotFound,A0A0B4J1I8,Igkv4-59,1,10,3,3,A0A0B4J1I8|P04944|P04940|P04941|P04942|P04943|A0A0B4J1I5|P70670|Q9JKC6|A0N8I8,MOUSE,12784.1,17.9,394,394.1,27.03,27.03,,117,Immunoglobulin kappa variable 4-59 (Fragment),,,,3,10,2950000000,17.9%
Q0VBK2,0.017086926,-0.607333333,18.26807916,2.066666667,0.0149002,3.206054651,-0.603,-1.235,-3.084,0.577,0.376,0.325,Q0VBK2,Krt80,Q0VBK2_Krt80,Q0VBK2,Krt80,1,2,2,2,Q0VBK2,MOUSE,51173.1,5,395,395.1,26.99,26.99,,452,"Keratin, type II cytoskeletal 80",cytoplasm|intermediate filament|keratin filament|,,structural molecule activity|,2,2,49000000,5.0%
Q61268,0.000167312,-0.4954,43.23254834,4.587666667,4.75056E-05,10.32676467,-3.492,-3.004,,1.583,1.538,0.898,Q61268,Apoc4,Q61268_Apoc4,Q61268,Apoc4,1,6,2,2,Q61268,MOUSE,14459.4,16.1,396,396.1,26.89,26.89,,124,Apolipoprotein C-IV,very-low-density lipoprotein particle|high-density lipoprotein particle|,lipid transport|positive regulation of sequestering of triglyceride|triglyceride homeostasis|,,2,6,1320000000,16.1%
D3Z450,0.000854278,-1.5685,32.3512913,5.407666667,0.00058193,6.032352489,-3.777,-2.676,-6.364,1.071,1.385,0.95,D3Z450,Serpina3i,D3Z450_Serpina3i,D3Z450,Serpina3i,1,24,3,3,D3Z450,MOUSE,45964.2,6.3,397,397.1,26.64,26.64,,408,"Serine (or cysteine) peptidase inhibitor, clade A, member 3I",extracellular space|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,3,24,3.63E+11,6.3%
Q9D0F3,0.002476634,-1.6865,27.15669044,5.527666667,0.001924558,4.885126365,-3.426,-2.67,-7.255,1.189,1.161,0.882,Q9D0F3,Lman1,Q9D0F3_Lman1,Q9D0F3,Lman1,1,3,3,3,Q9D0F3,MOUSE,58073,5.2,398,398.1,26.64,26.64,,517,Protein ERGIC-53,Golgi membrane|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|sarcomere|ER to Golgi transport vesicle|endoplasmic reticulum-Golgi intermediate compartment membrane|host cell perinuclear region of cytoplasm|extracellular exosome|,ER to Golgi vesicle-mediated transport|endoplasmic reticulum organization|Golgi organization|positive regulation of organelle organization|protein transport|,carbohydrate binding|metal ion binding|,3,3,63800000,5.2%
A0A075B5Q6,0.00026945,-0.381,39.04863225,4.615,0.000124491,8.716310235,-3.641,-2.659,,0.916,1.936,1.543,A0A075B5Q6,NotFound,A0A075B5Q6_NotFound,A0A075B5Q6,Ighv5-9-1,1,6,3,3,A0A075B5Q6|P18526|A0A075B5Q0,MOUSE,13238,28.4,399,399.1,26.42,26.42,,116,Immunoglobulin heavy variable 5-9-1,,,,4,6,288000000,28.4%
Q64339,0.000210213,-0.478,41.10764549,3.7625,7.74882E-05,9.478493133,-2.944,-2.527,,1.04,0.882,1.159,Q64339,Isg15,Q64339_Isg15,Q64339,Isg15,1,2,2,2,Q64339,MOUSE,18068.5,16.7,400,400.1,26.38,26.38,,161,Ubiquitin-like protein ISG15,extracellular region|cytoplasm|,modification-dependent protein catabolic process|negative regulation of protein ubiquitination|ISG15-protein conjugation|regulation of interferon-gamma production|response to type I interferon|defense response to bacterium|negative regulation of viral genome replication|positive regulation of erythrocyte differentiation|defense response to virus|,protein binding|protein tag|,2,2,2280000,16.7%
A0A075B5K2,0.00028606,-0.3556,38.58309016,4.0165,0.000138577,8.55163128,-2.505,-3.026,,1.076,1.785,0.892,A0A075B5K2,NotFound,A0A075B5K2_NotFound,A0A075B5K2,Igkv9-124,1,4,2,2,A0A075B5K2,MOUSE,10533.4,32.6,401,401.1,26.33,26.33,,95,Immunoglobulin kappa chain variable 9-124,,,,2,4,154000000,32.6%
F8WID5,0.519405905,-0.120833333,2.904834812,0.551666667,0.512290755,0.691200105,-1.505,1.387,-1.072,0.324,-0.503,0.644,F8WID5,NotFound,F8WID5_NotFound,F8WID5,Tpm1,1,4,2,2,F8WID5|E9Q454|E9Q450|Q8BP43|E9Q448|P58771-2|Q8BSH3|P58771|B7ZNL3|E9Q452|E9Q455|G5E8R2|E9Q456|G5E8R1|E9Q453|G5E8R0|E9Q5J9|P21107|A0A0R4J1P2|P21107-2|D3Z2H9|D3Z6I8|E9Q7Q3|A2AIM4|P58774-2|P58774|S4R2U0,MOUSE,37469.2,5.5,402,402.1,26.26,26.26,,326,Tropomyosin alpha-1 chain,cytoplasm|muscle thin filament tropomyosin|myofibril|filamentous actin|,in utero embryonic development|,structural constituent of cytoskeleton|,3,4,70700000,5.5%
P70194,0.000261034,-0.5458,39.38079158,3.807833333,0.000115324,8.835490672,-3.189,-2.472,,0.895,1.194,0.843,P70194,Clec4f,P70194_Clec4f,P70194,Clec4f,1,2,2,2,P70194|A0A0R4IZZ5,MOUSE,61667,3.6,403,403.1,26.05,26.05,,548,C-type lectin domain family 4 member F,plasma membrane|integral component of membrane|,endocytosis|NK T cell activation|,galactose binding|glycolipid binding|,2,2,172000000,3.6%
P00974,0.000991453,-0.089333333,31.5716425,-2.087333333,0.000696363,-5.746026736,1.374,0.915,0.574,-1.135,-1.297,-0.967,P00974,NotFound,P00974_NotFound,P00974,,1,5,2,2,P00974,BOVIN,11359,19,404,404.1,25.88,25.88,,100,Pancreatic trypsin inhibitor,,,,2,5,413000000,19.0%
Q61592,0.000210994,-0.5106,41.0768872,3.772333333,7.80389E-05,9.46668714,-2.975,-2.573,,1.182,0.945,0.868,Q61592,Gas6,Q61592_Gas6,Q61592,Gas6,1,3,3,3,Q61592,MOUSE,76548.1,5,405,405.1,25.84,25.84,,674,Growth arrest-specific protein 6,extracellular space|cytoplasm|extracellular exosome|,"neuron migration|positive regulation of protein phosphorylation|positive regulation of cytokine-mediated signaling pathway|positive regulation of glomerular filtration|protein phosphorylation|phagocytosis|signal transduction|enzyme linked receptor protein signaling pathway|blood coagulation|cellular response to starvation|positive regulation of gene expression|negative regulation of tumor necrosis factor-mediated signaling pathway|macrophage cytokine production|peptidyl-serine phosphorylation|fusion of virus membrane with host plasma membrane|viral genome replication|organ regeneration|cell-substrate adhesion|positive regulation of TOR signaling|activation of protein kinase B activity|negative regulation of interferon-gamma production|negative regulation of interleukin-6 production|negative regulation of tumor necrosis factor production|positive regulation of natural killer cell differentiation|positive regulation of peptidyl-serine phosphorylation|negative regulation of protein import into nucleus, translocation|cellular response to interferon-alpha|cellular response to drug|B cell chemotaxis|regulation of growth|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|apoptotic cell clearance|negative regulation of sequence-specific DNA binding transcription factor activity|protein kinase B signaling|positive regulation of protein kinase activity|negative regulation of transcription, DNA-templated|viral entry into host cell|receptor-mediated virion attachment to host cell|positive regulation of protein export from nucleus|positive regulation of fibroblast proliferation|negative regulation of interleukin-1 secretion|positive regulation of phagocytosis|positive regulation of protein kinase B signaling|positive regulation of protein tyrosine kinase activity|negative regulation of biomineral tissue development|positive regulation of ERK1 and ERK2 cascade|calcium ion transmembrane transport|cellular response to vitamin K|cellular response to glucose stimulus|cellular response to growth factor stimulus|protein targeting to plasma membrane|extracellular matrix assembly|dendritic cell differentiation|hematopoietic stem cell migration to bone marrow|negative regulation of oligodendrocyte apoptotic process|negative regulation of interleukin-6 secretion|negative regulation of fibroblast apoptotic process|negative regulation of endothelial cell apoptotic process|positive regulation of dendritic cell chemotaxis|negative regulation of renal albumin absorption|negative regulation of dendritic cell apoptotic process|","phosphatidylserine binding|receptor binding|voltage-gated calcium channel activity|calcium ion binding|protein tyrosine kinase activator activity|receptor tyrosine kinase binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|receptor agonist activity|binding, bridging|",3,3,72100000,5.0%
P08003,0.001058061,-0.5292,31.2205034,3.529666667,0.000755005,6.274646135,-1.858,-3.436,,0.932,0.966,0.75,P08003,Pdia4,P08003_Pdia4,P08003,Pdia4,1,3,3,3,A0A0R4J0Z1|P08003,MOUSE,72323.4,4.8,406,406.1,25.77,25.77,,638,Protein disulfide-isomerase A4,endoplasmic reticulum|endoplasmic reticulum lumen|cell surface|endoplasmic reticulum chaperone complex|melanosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|chaperone-mediated protein folding|,protein disulfide isomerase activity|poly(A) RNA binding|,3,3,233000000,4.8%
P01662,0.000347515,-1.1435,37.2435472,4.307666667,0.000188645,7.119411577,-2.689,-2.534,-4.669,0.96,1.004,1.067,P01662,NotFound,P01662_NotFound,P01662,,1,2,2,2,P01662|P01663,MOUSE,12155.2,21.6,407,407.1,24.96,24.96,,111,Ig kappa chain V-III region ABPC 22/PC 9245,,,antigen binding|,2,2,40900000,21.6%
H7BWY6,0.005974803,-1.005166667,23.10166081,4.063666667,0.004895916,4.09131814,-2.032,-1.617,-5.462,1.42,0.823,0.837,H7BWY6,Rbp4,H7BWY6_Rbp4,H7BWY6,Rbp4,1,4,3,3,H7BWY6|Q00724,MOUSE,28746.7,12.2,408,408.1,24.92,24.92,,245,Retinol-binding protein 4,extracellular space|protein complex|extracellular exosome|,maintenance of gastrointestinal epithelium|positive regulation of insulin secretion|response to retinoic acid|retinol transport|retinol metabolic process|glucose homeostasis|response to ethanol|,retinol binding|retinol transporter activity|protein heterodimerization activity|,3,4,539000000,12.2%
P01724,0.000165321,-0.9184,43.84830626,4.984333333,4.12258E-05,10.5850752,-4.439,-3.379,,0.946,1.111,1.169,P01724,NotFound,P01724_NotFound,P01724,,1,2,2,2,P01724,MOUSE,13593.1,31,409,409.1,24.8,24.8,,129,Ig lambda-1 chain V regions MOPC 104E/RPC20/J558/S104,,,antigen binding|,2,2,2390000000,31.0%
O35490,0.672532924,0.131,1.766348663,-0.3125,0.665832721,-0.453883386,-0.324,0.961,,1.021,-0.64,-0.363,O35490,Bhmt,O35490_Bhmt,O35490,Bhmt,1,2,2,2,O35490,MOUSE,45476.1,5.8,410,410.1,24.78,24.78,,407,Betaine--homocysteine S-methyltransferase 1,cytoplasm|,amino-acid betaine catabolic process|methionine biosynthetic process|methylation|,zinc ion binding|S-adenosylmethionine-homocysteine S-methyltransferase activity|betaine-homocysteine S-methyltransferase activity|,2,2,815000000,5.8%
P35822,0.000165321,-0.733,44.02697103,4.396666667,3.95642E-05,10.66111813,-3.675,-3.067,,1.158,1.008,0.911,P35822,Ptprk,P35822_Ptprk,P35822,Ptprk,1,3,3,3,A0A1W2P7Y1|P35822|B2RRF0,MOUSE,166179.6,1.8,411,411.1,24.67,24.67,,1457,Receptor-type tyrosine-protein phosphatase kappa,photoreceptor outer segment|cell-cell junction|cell surface|integral component of membrane|axon|dendrite|leading edge membrane|neuronal cell body|,"protein dephosphorylation|cell adhesion|signal transduction|transforming growth factor beta receptor signaling pathway|negative regulation of cell proliferation|negative regulation of keratinocyte proliferation|cell migration|negative regulation of cell migration|protein localization to cell surface|cellular response to reactive oxygen species|cellular response to UV|peptidyl-tyrosine dephosphorylation|negative regulation of cell cycle|negative regulation of transcription, DNA-templated|focal adhesion assembly|",protein tyrosine phosphatase activity|beta-catenin binding|protein kinase binding|gamma-catenin binding|,3,3,129000000,1.8%
A0A075B5N6,0.000158712,-0.6494,44.62118825,4.977666667,3.45049E-05,10.91763099,-3.933,-3.339,,0.931,1.719,1.375,A0A075B5N6,NotFound,A0A075B5N6_NotFound,A0A075B5N6,Igkv8-16,1,5,2,2,A0A075B5N6|A0A0G2JGT0,MOUSE,13623.3,15.8,412,412.1,24.62,24.62,,120,Immunoglobulin kappa variable 8-16,,,,2,5,1150000000,15.8%
P08032,0.064628293,-0.609833333,12.27415044,1.898333333,0.059235895,2.261232947,-2.132,-2.918,0.373,0.772,-0.065,0.311,P08032,Spta1,P08032_Spta1,P08032,Spta1,1,3,3,3,P08032,MOUSE,281001,1.5,413,413.1,24.51,24.51,,2415,"Spectrin alpha chain, erythrocytic 1",spectrin|spectrin-associated cytoskeleton|membrane|cortical cytoskeleton|cuticular plate|,porphyrin-containing compound biosynthetic process|plasma membrane organization|regulation of cell shape|actin cytoskeleton organization|hemopoiesis|positive regulation of protein binding|positive regulation of T cell proliferation|actin filament capping|,actin binding|calcium ion binding|protein heterodimerization activity|,3,3,98300000,1.5%
P02468,0.001424262,-1.026333333,29.81748369,4.062666667,0.001042922,5.452443378,-2.443,-1.943,-4.787,1.203,0.732,1.08,P02468,NotFound,P02468_NotFound,P02468,Lamc1,1,2,2,2,P02468|F8VQJ3,MOUSE,182943.8,1.9,414,414.1,24.37,24.37,,1607,Laminin subunit gamma-1,extracellular region|basement membrane|basal lamina|extracellular matrix|laminin-10 complex|extracellular exosome|basement membrane|extracellular matrix|,protein complex assembly|cell adhesion|cell migration|extracellular matrix disassembly|neuron projection development|hemidesmosome assembly|substrate adhesion-dependent cell spreading|,extracellular matrix structural constituent|protein binding|glycosphingolipid binding|,2,2,42100000,1.9%
Q91V80,0.000175749,-0.6008,42.77805674,4.178666667,5.27466E-05,10.13978883,-3.401,-2.815,,1.231,1.034,0.947,Q91V80,Apof,Q91V80_Apof,Q91V80,Apof,1,2,1,1,A0A0R4J0M4|Q91V80,MOUSE,34701.1,6,415,415.1,24.35,24.35,,315,Apolipoprotein F,low-density lipoprotein particle|high-density lipoprotein particle|,triglyceride metabolic process|cholesterol metabolic process|cholesterol efflux|,,1,2,100000000,6.0%
A0A075B5X7,0.002836074,-0.5198,26.5473038,4.5445,0.002214469,5.200698158,-4.638,-1.855,,1.314,0.785,1.795,A0A075B5X7,NotFound,A0A075B5X7_NotFound,A0A075B5X7,Ighv1-69,1,1,1,1,A0A075B5X7|A0A075B5W1,MOUSE,13062.5,21.5,416,416.1,23.77,23.77,,116,Immunoglobulin heavy variable 1-69,,,,1,1,18700000,21.5%
P60335,0.000415901,-0.598,36.18147313,3.138,0.000240909,6.845226519,-2.561,-1.315,-2.625,0.799,0.878,1.236,P60335,Pcbp1,P60335_Pcbp1,P60335,Pcbp1,1,2,2,2,P60335,MOUSE,38010.7,6.1,417,417.1,23.68,23.68,,356,Poly(rC)-binding protein 1,nucleoplasm|cytoplasm|membrane|ribonucleoprotein complex|intracellular membrane-bounded organelle|extracellular exosome|,mRNA processing|positive regulation of translation|,single-stranded DNA binding|RNA binding|protein binding|translation activator activity|poly(A) RNA binding|,2,2,144000000,6.1%
P13609,0.000225016,-0.3592,40.55571848,3.9055,8.7989E-05,9.268623975,-2.495,-2.91,,1.548,0.98,1.081,P13609,Srgn,P13609_Srgn,P13609,Srgn,1,2,2,2,P13609,MOUSE,16825.2,19.7,418,418.1,22.81,22.81,,152,Serglycin,Golgi membrane|extracellular space|Golgi apparatus|secretory granule|zymogen granule|mast cell granule|,granzyme-mediated apoptotic signaling pathway|protein processing|negative regulation of bone mineralization|biomineral tissue development|mast cell secretory granule organization|T cell secretory granule organization|maintenance of protease location in mast cell secretory granule|maintenance of granzyme B location in T cell secretory granule|negative regulation of cytokine secretion|,protein binding|collagen binding|,2,2,29700000,19.7%
A0A087WRT4,0.001043839,-0.386833333,31.30969764,2.749666667,0.000739657,5.687658639,-2.622,-1.318,-1.345,1.389,0.569,1.006,A0A087WRT4,Fat1,A0A087WRT4_Fat1,A0A087WRT4,Fat1,1,3,3,3,A0A1L1SQU7|A0A087WRT4|F2Z4A3,MOUSE,511001.9,0.5,419,419.1,22.45,22.45,,4602,FAT atypical cadherin 1,nucleus|plasma membrane|cell-cell junction|focal adhesion|lamellipodium|cell junction|filopodium|perinuclear region of cytoplasm|extracellular exosome|,actin filament organization|homophilic cell adhesion via plasma membrane adhesion molecules|establishment or maintenance of cell polarity|single organismal cell-cell adhesion|,calcium ion binding|protein binding|,3,3,265000000,0.5%
Q9ES89,0.000596728,-0.6165,34.24788749,3.095666667,0.00037602,6.366897622,-2.925,-1.289,-2.279,1.206,0.747,0.841,Q9ES89,Extl2,Q9ES89_Extl2,Q9ES89,Extl2,1,5,2,2,Q9ES89|Q3TSR0,MOUSE,37618.1,4.2,420,420.1,22.33,22.33,,330,Exostosin-like 2,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|extracellular exosome|,glycosaminoglycan biosynthetic process|N-acetylglucosamine metabolic process|heparan sulfate proteoglycan biosynthetic process|UDP-N-acetylgalactosamine metabolic process|,"glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|alpha-1,4-N-acetylgalactosaminyltransferase activity|metal ion binding|",2,5,232000000,4.2%
E9Q401,0.000215131,-1.087,40.83191343,5.34,8.25674E-05,9.373124725,-5.106,-3.476,,1.01,1.068,1.069,E9Q401,Ryr2,E9Q401_Ryr2,E9Q401,Ryr2,1,7,3,3,E9Q401|F6U7V1,MOUSE,570001.1,0.6,421,421.1,22.25,22.25,,4966,Ryanodine receptor 2,smooth endoplasmic reticulum|membrane|integral component of membrane|sarcoplasmic reticulum|sarcomere|Z disc|sarcoplasmic reticulum membrane|calcium channel complex|protein complex|extracellular exosome|,response to hypoxia|regulation of heart rate|embryonic heart tube morphogenesis|left ventricular cardiac muscle tissue morphogenesis|cardiac muscle hypertrophy|detection of calcium ion|calcium ion transport|cellular calcium ion homeostasis|positive regulation of heart rate|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion|regulation of cardiac muscle contraction by calcium ion signaling|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|response to muscle activity|calcium-mediated signaling|BMP signaling pathway|response to caffeine|calcium-mediated signaling using intracellular calcium source|response to muscle stretch|release of sequestered calcium ion into cytosol|positive regulation of sequestering of calcium ion|response to redox state|regulation of cardiac muscle contraction|cardiac muscle contraction|canonical Wnt signaling pathway|cytosolic calcium ion transport|calcium ion transport into cytosol|calcium ion transmembrane transport|cellular response to caffeine|cellular response to epinephrine stimulus|establishment of protein localization to endoplasmic reticulum|ventricular cardiac muscle cell action potential|Purkinje myocyte to ventricular cardiac muscle cell signaling|type B pancreatic cell apoptotic process|positive regulation of the force of heart contraction|regulation of AV node cell action potential|regulation of SA node cell action potential|regulation of atrial cardiac muscle cell action potential|regulation of ventricular cardiac muscle cell action potential|positive regulation of calcium-transporting ATPase activity|,intracellular ligand-gated calcium channel activity|ryanodine-sensitive calcium-release channel activity|calcium channel activity|calcium ion binding|protein binding|calmodulin binding|calcium-release channel activity|enzyme binding|protein kinase binding|protein kinase A catalytic subunit binding|protein kinase A regulatory subunit binding|identical protein binding|protein self-association|suramin binding|calcium-induced calcium release activity|organic cyclic compound binding|,3,7,20000000000,0.6%
F6R7E8,0.00318327,-0.215833333,26.01124995,1.528333333,0.002505388,4.588568288,-0.671,-1.158,-1.111,0.634,0.517,0.494,F6R7E8,Gm2663,F6R7E8_Gm2663,F6R7E8,Gm2663,1,4,3,3,F6R7E8|Q9CPN7,MOUSE,27260.6,16.1,422,422.1,22.16,22.16,,247,Predicted gene 2663,extracellular space|,proteolysis|,serine-type endopeptidase activity|,3,4,1230000000,16.1%
E9Q5D9,0.000158712,-0.6426,44.60508588,4.3215,3.46331E-05,10.91060611,-3.019,-3.452,,1.165,0.953,1.14,E9Q5D9,Igfbp7,E9Q5D9_Igfbp7,E9Q5D9,Igfbp7,1,3,3,3,E9Q5D9|F8WH23|Q61581,MOUSE,33887.1,9.2,423,423.1,22.12,22.12,,313,Insulin-like growth factor-binding protein 7,extracellular space|extracellular matrix|extracellular exosome|,regulation of cell growth|cell adhesion|,insulin-like growth factor binding|,3,3,124000000,9.2%
Q9DAU1,0.00018504,-0.4204,42.3094465,4.096833333,5.87564E-05,9.95021295,-2.727,-3.03,,1.359,1.409,0.887,Q9DAU1,Cnpy3,Q9DAU1_Cnpy3,Q9DAU1,Cnpy3,1,3,2,2,Q9DAU1,MOUSE,30936.7,6.5,424,424.1,22.03,22.03,,276,Protein canopy homolog 3,endoplasmic reticulum|,innate immune response|,receptor binding|,2,3,38200000,6.5%
P55104,0.01955694,-0.2725,17.63995222,2.587666667,0.017218875,3.129104512,-3.567,-0.662,-0.47,1.142,0.935,0.987,P55104,Inhbc,P55104_Inhbc,P55104,Inhbc,1,4,3,3,P55104,MOUSE,40085.3,7.6,425,425.1,21.91,21.91,,352,Inhibin beta C chain,extracellular space|extracellular exosome|,positive regulation of pathway-restricted SMAD protein phosphorylation|regulation of apoptotic process|regulation of MAPK cascade|cell development|SMAD protein signal transduction|,cytokine activity|transforming growth factor beta receptor binding|hormone activity|growth factor activity|,3,4,34300000,7.6%
Q9Z0J1,0.000215131,-0.4168,40.82916508,3.6245,8.26197E-05,9.372079733,-2.703,-2.48,,1.1,1.134,0.865,Q9Z0J1,Reck,Q9Z0J1_Reck,Q9Z0J1,Reck,1,3,2,2,Q9Z0J1,MOUSE,111101,2.1,426,426.1,21.86,21.86,,971,Reversion-inducing cysteine-rich protein with Kazal motifs,plasma membrane|anchored component of membrane|,blood vessel maturation|embryo implantation|negative regulation of endopeptidase activity|extracellular matrix organization|embryonic forelimb morphogenesis|positive regulation of Notch signaling pathway|,endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity|,2,3,198000000,2.1%
Q91Y97,0.491640425,-0.3102,3.154408689,1.088,0.483681115,0.747862337,-3.583,1.657,,0.375,-0.002,0.002,Q91Y97,Aldob,Q91Y97_Aldob,Q91Y97,Aldob,1,3,3,3,Q91Y97,MOUSE,39962.7,7.9,427,427.1,21.7,21.7,,364,Fructose-bisphosphate aldolase B,nucleus|lysosome|microtubule organizing center|cytosol|plasma membrane|rough endoplasmic reticulum membrane|smooth endoplasmic reticulum membrane|centriolar satellite|perinuclear region of cytoplasm|extracellular exosome|,"liver development|fructose metabolic process|glycolytic process|NADH oxidation|response to fructose|response to zinc ion|fructose 1,6-bisphosphate metabolic process|cellular response to extracellular stimulus|positive regulation of ATPase activity|cellular response to insulin stimulus|response to drug|response to starvation|response to amino acid|response to copper ion|response to glucocorticoid|response to cAMP|vacuolar proton-transporting V-type ATPase complex assembly|response to interleukin-6|",fructose-bisphosphate aldolase activity|cytoskeletal protein binding|phosphatidylcholine binding|identical protein binding|ATPase binding|fructose-1-phosphate aldolase activity|fructose binding|,3,3,74200000,7.9%
A0A075B5Y1,0.000207028,-0.5806,41.26288858,4.570666667,7.47672E-05,9.538280715,-3.831,-2.815,,0.959,1.439,1.345,A0A075B5Y1,NotFound,A0A075B5Y1_NotFound,A0A075B5Y1,Ighv1-74,1,5,2,2,A0A075B5Y1|P01750,MOUSE,13070.6,16.3,428,428.1,21.6,21.6,,116,Immunoglobulin heavy variable V1-74,,,,2,5,2140000000,16.3%
Q9DC11,0.001318032,-0.671333333,30.21361588,3.508,0.000952003,5.4478067,-3.338,-2.972,-0.966,1.325,0.986,0.937,Q9DC11,Plxdc2,Q9DC11_Plxdc2,Q9DC11,Plxdc2,1,5,2,2,Q9DC11|B1AY85|B1AY86,MOUSE,60185.7,2.8,429,429.1,21.45,21.45,,530,Plexin domain-containing protein 2,plasma membrane|integral component of membrane|extracellular exosome|,,,2,5,80600000,2.8%
Q9CQV8,0.035923342,-0.4315,14.92609919,1.520333333,0.032165483,2.665195874,-1.865,0.011,-1.721,0.327,-0.011,0.67,Q9CQV8,Ywhab,Q9CQV8_Ywhab,Q9CQV8,Ywhab,1,3,2,2,Q9CQV8|P68254|P68254-2|Q9CQV8-2|P63101,MOUSE,28200,6.9,430,430.1,21.45,21.45,,246,14-3-3 protein beta/alpha,nucleus|cytoplasm|cytosol|focal adhesion|membrane|transcriptional repressor complex|cytoplasmic vesicle membrane|melanosome|perinuclear region of cytoplasm|extracellular exosome|,"protein targeting|negative regulation of protein dephosphorylation|positive regulation of catalytic activity|negative regulation of transcription, DNA-templated|cytoplasmic sequestering of protein|protein heterooligomerization|",transcription corepressor activity|protein binding|protein C-terminus binding|enzyme binding|protein domain specific binding|protein complex binding|histone deacetylase binding|phosphoserine binding|phosphoprotein binding|,2,3,12400000,6.9%
Q9WTL4,0.88910114,-0.23,0.53217599,-0.158666667,0.884672242,-0.15057325,1.38,0.83,-2.662,-0.575,-0.763,0.41,Q9WTL4,Insrr,Q9WTL4_Insrr,Q9WTL4,Insrr,1,5,2,2,Q9WTL4,MOUSE,147382.5,1.3,431,431.1,21.23,21.23,,1300,Insulin receptor-related protein,integral component of plasma membrane|receptor complex|,transmembrane receptor protein tyrosine kinase signaling pathway|peptidyl-tyrosine phosphorylation|male sex determination|actin cytoskeleton reorganization|protein autophosphorylation|cellular response to alkaline pH|,transmembrane receptor protein tyrosine kinase activity|ATP binding|phosphatidylinositol 3-kinase binding|insulin receptor substrate binding|,2,5,1450000000,1.3%
P13707,0.006047971,-0.473666667,23.04220413,3.082,0.004963404,4.080241678,-2.153,-0.641,-3.25,2.039,0.442,0.721,P13707,Gpd1,P13707_Gpd1,P13707,Gpd1,1,3,2,2,P13707|E0CXN5,MOUSE,38199.6,6,432,432.1,21.13,21.13,,349,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",mitochondrion|cytosol|glycerol-3-phosphate dehydrogenase complex|extracellular exosome|,glycerol-3-phosphate metabolic process|gluconeogenesis|NADH oxidation|glycerophosphate shuttle|positive regulation of glycolytic process|glycerol-3-phosphate catabolic process|glycerolipid metabolic process|cellular response to cAMP|cellular response to tumor necrosis factor|,glycerol-3-phosphate dehydrogenase [NAD+] activity|glycerol-3-phosphate dehydrogenase activity|protein homodimerization activity|NAD binding|,2,3,17400000,6.0%
P01642,0.000529792,-0.4094,34.86005248,3.752666667,0.000326584,7.327765423,-2.069,-3.253,,0.817,1.046,1.412,P01642,NotFound,P01642_NotFound,P01642,Gm10881,1,3,2,2,P01642,MOUSE,12729,15.6,433,433.1,20.89,20.89,,115,Ig kappa chain V-V region L7 (Fragment),,,,2,3,154000000,15.6%
P19639,0.441498212,-0.245666667,3.632603784,0.732666667,0.433251048,0.832649558,-1.966,1.496,-1.366,0.372,-0.126,0.116,P19639,Gstm3,P19639_Gstm3,P19639,Gstm3,1,2,2,2,G5E8M7|P19639|P15626|Q80W21|O35660|D3YVP5|D3YX76|D3YVP6,MOUSE,25929.4,8.7,434,434.1,20.81,20.81,,218,Glutathione S-transferase Mu 3,cytoplasm|,metabolic process|cellular response to drug|cellular response to organic cyclic compound|,glutathione transferase activity|protein homodimerization activity|,2,2,72800000,8.7%
Q9CZB2,0.000234537,-0.2846,40.25301054,3.690666667,9.43407E-05,9.155278623,-2.548,-2.45,,1.157,0.931,1.487,Q9CZB2,Pmel,Q9CZB2_Pmel,Q9CZB2,Pmel,1,2,2,2,Q9CZB2|Q60696,MOUSE,66927.6,4.1,435,435.1,20.78,20.78,,626,Melanocyte protein PMEL,endoplasmic reticulum membrane|Golgi apparatus|multivesicular body membrane|melanosome|,melanosome organization|melanin biosynthetic process|,,2,2,74500000,4.1%
Q80T14,0.000250561,-0.4944,39.78201051,3.649333333,0.000105147,8.981351109,-2.968,-2.4,,1.038,1.002,0.856,Q80T14,Fras1,Q80T14_Fras1,Q80T14,Fras1,1,2,2,2,Q80T14,MOUSE,453771.9,0.7,436,436.1,20.68,20.68,,4010,Extracellular matrix protein FRAS1,basement membrane|plasma membrane|integral component of membrane|sublamina densa|,morphogenesis of an epithelium|metanephros morphogenesis|cell communication|protein transport|embryonic limb morphogenesis|skin development|palate development|,metal ion binding|,2,2,15500000,0.7%
P97927,0.003165836,-0.0254,26.04197747,2.636,0.002487724,4.979097238,-2.272,-0.942,,1.02,1.285,0.782,P97927,Lama4,P97927_Lama4,P97927,Lama4,1,2,2,2,P97927,MOUSE,204497.2,0.8,437,437.1,20.59,20.59,,1816,Laminin subunit alpha-4,extracellular region|basement membrane|basal lamina|extracellular exosome|,blood vessel development|cell adhesion|regulation of cell adhesion|regulation of cell migration|regulation of embryonic development|brown fat cell differentiation|,receptor binding|,2,2,7840000,0.8%
A0A075B5Q3,0.000238627,-0.864166667,40.0848272,4.353,9.80657E-05,7.895958534,-4.069,-2.939,-2.114,0.912,1.61,1.415,A0A075B5Q3,NotFound,A0A075B5Q3_NotFound,A0A075B5Q3,Ighv2-5,1,5,2,2,A0A075B5Q3,MOUSE,12727.5,16.5,438,438.1,20.52,20.52,,115,Immunoglobulin heavy variable 2-5,,,,2,5,1570000000,16.5%
Q8K1I3,0.025738362,0.040833333,16.40436437,1.381,0.022885666,2.901553059,-1.083,-0.039,-0.827,1.249,0.038,0.907,Q8K1I3,Spp2,Q8K1I3_Spp2,Q8K1I3,Spp2,1,3,2,2,Q8K1I3,MOUSE,23421,8.3,439,439.1,20.39,20.39,,203,Secreted phosphoprotein 24,extracellular exosome|,bone remodeling|,,2,3,40900000,8.3%
D3YYQ8,0.000148189,-0.9072,46.39035881,5.114666667,2.29596E-05,11.71529873,-4.361,-3.591,,0.96,1.327,1.129,D3YYQ8,Dnah10,D3YYQ8_Dnah10,D3YYQ8,Dnah10,1,10,3,3,D3YYQ8|F7ABZ6,MOUSE,532755.8,0.7,440,440.1,20.37,20.37,,4591,"Dynein, axonemal, heavy chain 10",inner dynein arm|,cilium movement|metabolic process|,microtubule motor activity|ATP binding|ATPase activity|,3,10,2310000000,0.7%
D3YZ61,0.000866335,0.022,32.27457194,2.844166667,0.000592301,6.566367644,-1.827,-1.542,,1.58,1.085,0.814,D3YZ61,C1qtnf3,D3YZ61_C1qtnf3,D3YZ61,C1qtnf3,1,3,2,2,D3YZ61|Q9ES30,MOUSE,35268.9,5.9,441,441.1,20.25,20.25,,319,Complement C1q tumor necrosis factor-related protein 3,extracellular region|collagen trimer|extracellular space|cell|membrane|extracellular exosome|,negative regulation of gene expression|cellular triglyceride homeostasis|negative regulation of NF-kappaB import into nucleus|glucose homeostasis|negative regulation of gluconeogenesis|positive regulation of cytokine secretion|negative regulation of inflammatory response|protein oligomerization|positive regulation of protein kinase B signaling|positive regulation of adiponectin secretion|protein trimerization|positive regulation of ERK1 and ERK2 cascade|negative regulation of monocyte chemotactic protein-1 production|negative regulation of interleukin-6 secretion|,identical protein binding|,2,3,44100000,5.9%
Q63836,0.000767465,-0.411666667,32.92115526,2.196666667,0.000510369,6.05339151,-1.443,-1.148,-1.939,0.769,0.497,0.794,Q63836,Selenbp2,Q63836_Selenbp2,Q63836,Selenbp2,1,2,2,2,Q63836|P17563|D6RHN2|A0A0R4J135|G3UYY2,MOUSE,53179.6,5.9,442,442.1,20.25,20.25,,472,Selenium-binding protein 2,extracellular space|nucleolus|cytosol|membrane|extracellular exosome|,protein transport|,selenium binding|,2,2,10100000,5.9%
E9Q8Y0,0.943898934,0.1272,0.261575334,-0.112166667,0.941548003,-0.076549139,-2.45,2.839,,0.25,-0.061,0.058,E9Q8Y0,NotFound,E9Q8Y0_NotFound,E9Q8Y0,Myl2,1,3,2,2,E9Q8Y0|P51667,MOUSE,19865,12.5,443,443.1,20.25,20.25,,176,"Myosin regulatory light chain 2, ventricular/cardiac muscle isoform",cytoskeleton|myofibril|actin cytoskeleton|,heart morphogenesis|heart development|post-embryonic development|negative regulation of cell growth|muscle cell fate specification|muscle fiber development|cardiac myofibril assembly|ventricular cardiac muscle tissue morphogenesis|heart contraction|cardiac muscle contraction|,actin monomer binding|calcium ion binding|,2,3,7910000,12.5%
Q9EPK6,0.000165808,-1.168333333,43.37182588,4.256666667,4.60063E-05,8.879918064,-2.647,-3.015,-4.228,1.101,0.829,0.95,Q9EPK6,Sil1,Q9EPK6_Sil1,Q9EPK6,Sil1,1,2,2,2,Q9EPK6,MOUSE,52771.3,5.5,444,444.1,20.24,20.24,,465,Nucleotide exchange factor SIL1,extracellular space|endoplasmic reticulum|endoplasmic reticulum lumen|,protein transport|,,2,2,5310000,5.5%
Q8CG85,0.000237548,-0.213,40.17390567,3.474166667,9.60748E-05,9.125861471,-2.223,-2.372,,1.144,1.089,1.297,Q8CG85,Mamdc2,Q8CG85_Mamdc2,Q8CG85,Mamdc2,1,2,2,2,A0A0R4J0J7|Q8CG85,MOUSE,78406.9,3.2,445,445.1,20.16,20.16,,686,MAM domain-containing protein 2,proteinaceous extracellular matrix|interstitial matrix|endoplasmic reticulum|membrane|,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|,glycosaminoglycan binding|,2,2,17000000,3.2%
O88569,0.005133854,-0.876666667,23.79696987,2.904666667,0.004171603,4.19324144,-2.322,-0.951,-3.714,0.842,0.245,0.64,O88569,Hnrnpa2b1,O88569_Hnrnpa2b1,O88569,Hnrnpa2b1,1,2,2,2,O88569|Q5EBP8|O88569-2|P49312|O88569-3|P49312-2,MOUSE,37459.1,5,446,446.1,20.04,20.04,,353,Heterogeneous nuclear ribonucleoproteins A2/B1,nucleus|nucleoplasm|spliceosomal complex|cytoplasm|membrane|ribonucleoprotein complex|catalytic step 2 spliceosome|,"negative regulation of transcription from RNA polymerase II promoter|mRNA processing|RNA splicing|negative regulation of mRNA splicing, via spliceosome|RNA transport|",nucleotide binding|RNA binding|single-stranded telomeric DNA binding|poly(A) RNA binding|pre-mRNA intronic binding|,2,2,9900000,5.0%
A0A075B5V5,0.000376636,-0.2476,36.68877037,4.032333333,0.00021435,7.908911893,-3.101,-2.233,,1.519,1.764,0.813,A0A075B5V5,NotFound,A0A075B5V5_NotFound,A0A075B5V5,Ighv1-39,1,2,2,2,A0A075B5V5,MOUSE,13044.4,29.9,447,447.1,20.01,20.01,,117,Immunoglobulin heavy variable 1-39 (Fragment),,,,2,2,267000000,29.9%
P52431,,1.304333333,,,,,,,,1,1.538,1.375,P52431,Pold1,P52431_Pold1,P52431,Pold1,1,3,2,2,P52431|D6RFB8,MOUSE,125271.5,2.1,448,448.1,19.84,19.84,,1105,DNA polymerase delta catalytic subunit,nucleotide-excision repair complex|nucleus|nucleoplasm|cytoplasm|membrane|aggresome|delta DNA polymerase complex|,"DNA synthesis involved in DNA repair|DNA replication|DNA-dependent DNA replication|base-excision repair, gap-filling|nucleotide-excision repair, DNA gap filling|cellular response to UV|DNA replication proofreading|fatty acid homeostasis|nucleic acid phosphodiester bond hydrolysis|","nucleotide binding|DNA binding|chromatin binding|damaged DNA binding|DNA-directed DNA polymerase activity|3'-5'-exodeoxyribonuclease activity|3'-5' exonuclease activity|metal ion binding|4 iron, 4 sulfur cluster binding|",2,3,276000000,2.1%
A0A075B5W6,,1.470333333,,,,,,,,1,2.135,1.276,A0A075B5W6,NotFound,A0A075B5W6_NotFound,A0A075B5W6,Ighv1-55,1,1,1,1,A0A075B5W6,MOUSE,12858.3,21.3,449,449.1,19.35,19.35,,117,Immunoglobulin heavy variable 1-55 (Fragment),,,,1,1,1740000,21.3%
Q8BYC6,0.000145021,-1.365,51.07161549,4.854,7.81337E-06,11.61072669,-4.223,-3.067,-4.086,1.047,1.19,0.949,Q8BYC6,Taok3,Q8BYC6_Taok3,Q8BYC6,Taok3,1,15,3,3,Q8BYC6|Q3V3K3,MOUSE,105790.3,4,450,450.1,19.29,19.29,,898,Serine/threonine-protein kinase TAO3,nucleus|cytoplasm|,MAPK cascade|activation of MAPKK activity|DNA repair|protein phosphorylation|cellular response to DNA damage stimulus|mitotic G2 DNA damage checkpoint|regulation of mitotic cell cycle|signal transduction by protein phosphorylation|stress-activated protein kinase signaling cascade|positive regulation of stress-activated MAPK cascade|regulation of apoptotic process|positive regulation of JUN kinase activity|negative regulation of JNK cascade|positive regulation of JNK cascade|protein autophosphorylation|,protein serine/threonine kinase activity|MAP kinase kinase kinase activity|ATP binding|transferase activity|,3,15,28600000000,4.0%
A0A075B5L7,0.000197264,-0.5278,41.70335754,5.183666667,6.7556E-05,9.709752277,-4.092,-3.184,,0.933,1.665,2.039,A0A075B5L7,NotFound,A0A075B5L7_NotFound,A0A075B5L7,Igkv4-80,1,4,2,2,A0A075B5L7,MOUSE,12676,18.9,451,451.1,19.03,19.03,,116,Immunoglobulin kappa variable 4-80 (Fragment),,,,2,4,511000000,18.9%
P15535,0.000185112,-0.5136,42.2904031,3.9465,5.90146E-05,9.942576963,-3.111,-2.652,,1.057,0.969,1.169,P15535,B4galt1,P15535_B4galt1,P15535,B4galt1,1,2,2,2,P15535|P15535-2|B1AXY5,MOUSE,44809.7,7,452,452.1,19.03,19.03,,399,"Beta-1,4-galactosyltransferase 1",Golgi trans cisterna|extracellular space|Golgi apparatus|plasma membrane|external side of plasma membrane|cell surface|membrane|integral component of membrane|basolateral plasma membrane|desmosome|glycocalyx|filopodium|brush border membrane|Golgi cisterna membrane|extracellular exosome|,epithelial cell development|acute inflammatory response|lactose biosynthetic process|galactose metabolic process|protein glycosylation|protein N-linked glycosylation|cell adhesion|binding of sperm to zona pellucida|penetration of zona pellucida|negative regulation of cell proliferation|glycoprotein biosynthetic process|oligosaccharide biosynthetic process|extracellular matrix organization|mammary gland development|wound healing|regulation of cell proliferation|positive regulation of apoptotic process|development of secondary sexual characteristics|branching morphogenesis of an epithelial tube|leukocyte migration|regulation of cellular component movement|regulation of acrosome reaction|positive regulation of epithelial cell proliferation involved in wound healing|angiogenesis involved in wound healing|positive regulation of apoptotic process involved in mammary gland involution|,"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity|N-acetyllactosamine synthase activity|lactose synthase activity|protein binding|cytoskeletal protein binding|galactosyltransferase activity|protein kinase binding|manganese ion binding|UDP-galactosyltransferase activity|protein homodimerization activity|alpha-tubulin binding|beta-tubulin binding|",2,2,19200000,7.0%
P56480,0.135521041,-0.0496,8.918952245,1.825666667,0.128263999,1.772482592,-2.919,0.629,,1.009,0.546,0.487,P56480,Atp5b,P56480_Atp5b,P56480,Atp5b,1,2,2,2,P56480,MOUSE,56299.5,5.6,453,453.1,18.87,18.87,,529,"ATP synthase subunit beta, mitochondrial","nucleus|mitochondrion|mitochondrial inner membrane|mitochondrial proton-transporting ATP synthase complex|plasma membrane|cell surface|membrane|mitochondrial membrane|mitochondrial nucleoid|myelin sheath|proton-transporting ATP synthase complex, catalytic core F(1)|extracellular exosome|",angiogenesis|osteoblast differentiation|lipid metabolic process|ATP biosynthetic process|negative regulation of cell adhesion involved in substrate-bound cell migration|ATP synthesis coupled proton transport|ATP hydrolysis coupled proton transport|proton transport|regulation of intracellular pH|,"ATP binding|MHC class I protein binding|proton-transporting ATP synthase activity, rotational mechanism|proton-transporting ATPase activity, rotational mechanism|ATPase activity|",2,2,3710000,5.6%
Q3U515,0.011596303,0.2305,20.01546901,1.655,0.009964445,3.499798021,-1.472,-0.389,0.07,0.828,1.11,1.236,Q3U515,Vwce,Q3U515_Vwce,Q3U515,Vwce,1,2,2,2,Q3U515,MOUSE,103029.8,2.9,454,454.1,18.81,18.81,,929,von Willebrand factor C and EGF domain-containing protein,extracellular region|,positive regulation of cell proliferation|regulation of signal transduction|,calcium ion binding|,2,2,6430000,2.9%
F6VAN0,0.000156464,-0.6862,45.11897385,4.439666667,3.07682E-05,11.13685444,-3.561,-3.139,,1.199,1.154,0.916,F6VAN0,Atf6,F6VAN0_Atf6,F6VAN0,Atf6,1,5,2,2,F6VAN0,MOUSE,73149.6,3,455,455.1,18.58,18.58,,656,Cyclic AMP-dependent transcription factor ATF-6 alpha,nucleus|endoplasmic reticulum|Golgi apparatus|membrane|integral component of endoplasmic reticulum membrane|,"transcription, DNA-templated|endoplasmic reticulum unfolded protein response|positive regulation of transcription from RNA polymerase II promoter|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|",RNA polymerase II regulatory region sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|cAMP response element binding|protein heterodimerization activity|,2,5,300000000,3.0%
P97821,0.000164821,-0.8944,44.15860974,4.720166667,3.8383E-05,10.71746443,-3.291,-4.162,,0.924,1.057,1,P97821,Ctsc,P97821_Ctsc,P97821,Ctsc,1,1,1,1,P97821,MOUSE,53174.2,2.5,456,456.1,18.55,18.55,,462,Dipeptidyl peptidase 1,extracellular space|lysosome|endoplasmic reticulum|Golgi apparatus|membrane|extracellular exosome|,T cell mediated cytotoxicity|proteolysis|apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|aging|response to organic substance|proteolysis involved in cellular protein catabolic process|positive regulation of proteolysis involved in cellular protein catabolic process|positive regulation of apoptotic signaling pathway|,cysteine-type endopeptidase activity|serine-type endopeptidase activity|cysteine-type peptidase activity|cysteine-type endopeptidase activator activity involved in apoptotic process|peptidase activator activity involved in apoptotic process|phosphatase binding|chloride ion binding|identical protein binding|protein self-association|chaperone binding|,1,1,3870000,2.5%
A0A075B5K6,0.000426238,-0.0996,36.02042363,4.470666667,0.00025001,7.692201375,-3.232,-2.332,,2.059,2.142,0.865,A0A075B5K6,NotFound,A0A075B5K6_NotFound,A0A075B5K6,Igkv2-109,1,5,1,1,A0A075B5K6|P03976,MOUSE,13170.8,10.8,457,457.1,18.38,18.38,,120,Immunoglobulin kappa variable 2-109 (Fragment),,,,1,5,488000000,10.8%
A0A075B5L4,0.000285163,-0.919166667,38.60790619,4.346333333,0.000137787,7.484239906,-2.699,-2.257,-4.321,1.184,1,1.578,A0A075B5L4,NotFound,A0A075B5L4_NotFound,A0A075B5L4,Igkv12-89,1,6,2,2,A0A075B5L4,MOUSE,12138.5,24.3,458,458.1,18.19,18.19,,111,Immunoglobulin kappa chain variable 12-89,,,,2,6,2330000000,24.3%
A0A1W2P6U8,0.001742333,0.19425,28.86157439,3.444333333,0.001299698,6.470903235,,-2.389,,1.242,0.99,0.934,A0A1W2P6U8,LOC102635990,A0A1W2P6U8_LOC102635990,A0A1W2P6U8,4932415D10Rik,1,4,3,3,A0A1W2P6U8,MOUSE,557033.8,0.4,459,459.1,18.14,18.14,,4986,RIKEN cDNA 4932415D10 gene,,,,3,4,1290000000,0.4%
Q9R1P4,0.000165321,-0.6116,43.63419445,4.275666667,4.33092E-05,10.49459651,-3.424,-2.93,,1.253,1.141,0.902,Q9R1P4,Psma1,Q9R1P4_Psma1,Q9R1P4,Psma1,1,6,2,2,Q9R1P4|A0A1B0GS70,MOUSE,29831.3,5.7,460,460.1,17.88,17.88,,263,Proteasome subunit alpha type-1,"proteasome complex|nucleus|nucleoplasm|cytoplasm|centrosome|cytosol|proteasome core complex|proteasome core complex, alpha-subunit complex|extracellular exosome|",immune system process|negative regulation of inflammatory response to antigenic stimulus|proteasomal ubiquitin-independent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,lipopolysaccharide binding|endopeptidase activity|threonine-type endopeptidase activity|protein binding|,2,6,1790000000,5.7%
Q9WU60,0.001454196,-1.0535,29.71240681,4.061,0.001068463,5.429262614,-2.579,-1.856,-4.817,1.032,0.99,0.909,Q9WU60,Atrn,Q9WU60_Atrn,Q9WU60,Atrn,1,4,2,2,Q9WU60,MOUSE,163133.2,1.4,461,461.1,17.68,17.68,,1428,Attractin,extracellular space|cytoplasm|plasma membrane|integral component of membrane|extracellular exosome|,inflammatory response|response to oxidative stress|cerebellum development|regulation of multicellular organism growth|myelination|pigmentation|,receptor activity|protein binding|carbohydrate binding|,2,4,24700000,1.4%
Q2XU92,0.000165321,-1.0152,43.54590063,5.7255,4.41987E-05,10.45749098,-5.155,-3.746,,1.401,0.952,1.472,Q2XU92,Acsbg2,Q2XU92_Acsbg2,Q2XU92,Acsbg2,1,7,2,2,Q2XU92,MOUSE,75116.7,2.5,462,462.1,17.65,17.65,,667,Long-chain-fatty-acid--CoA ligase ACSBG2,cytoplasm|mitochondrion|cytosol|membrane|,long-chain fatty acid metabolic process|fatty acid metabolic process|fatty acid beta-oxidation|multicellular organismal development|spermatogenesis|cell differentiation|,long-chain fatty acid-CoA ligase activity|ATP binding|acyl-CoA hydrolase activity|,2,7,10500000000,2.5%
O89023,0.000279725,-0.2584,38.74785343,4.076833333,0.000133418,8.609601799,-2.796,-2.613,,1.953,0.877,1.287,O89023,Tpp1,O89023_Tpp1,O89023,Tpp1,1,3,2,2,O89023,MOUSE,61797.5,3.5,463,463.1,17.64,17.64,,562,Tripeptidyl-peptidase 1,mitochondrion|lysosome|melanosome|extracellular exosome|,proteolysis|lysosome organization|nervous system development|central nervous system development|epithelial cell differentiation|peptide catabolic process|bone resorption|neuromuscular process controlling balance|,endopeptidase activity|serine-type endopeptidase activity|protein binding|peptidase activity|serine-type peptidase activity|tripeptidyl-peptidase activity|metal ion binding|,2,3,39200000,3.5%
Q8BKH7,0.034478516,-0.6515,15.1164782,2.726333333,0.030785923,2.714573772,0.019,-1.776,-4.287,0.708,0.782,0.645,Q8BKH7,Mapkap1,Q8BKH7_Mapkap1,Q8BKH7,Mapkap1,1,4,2,2,Q8BKH7|Q8BKH7-2|Q8BKH7-3,MOUSE,59521.1,3.4,464,464.1,17.62,17.62,,522,Target of rapamycin complex 2 subunit MAPKAP1,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|cytoplasmic membrane-bounded vesicle|,substantia nigra development|negative regulation of Ras protein signal transduction|,"protein binding|phosphatidylinositol-4,5-bisphosphate binding|phosphatidylinositol-3,4,5-trisphosphate binding|Ras GTPase binding|protein kinase binding|phosphatidylinositol-3,4-bisphosphate binding|phosphatidic acid binding|phosphatidylinositol-3,5-bisphosphate binding|",2,4,6260000000,3.4%
P07743,0.000165808,-0.6322,43.43580444,4.662166667,4.53335E-05,10.41139008,-3.861,-2.998,,1.268,1.39,1.04,P07743,Bpifa2,P07743_Bpifa2,P07743,Bpifa2,1,2,1,1,P07743,MOUSE,24923.6,6.8,465,465.1,17.57,17.57,,235,BPI fold-containing family A member 2,extracellular region|secretory granule|extracellular exosome|,defense response to bacterium|,lipopolysaccharide binding|,1,2,12000000,6.8%
A0A075B5P9,0.000851727,-0.4666,32.38816357,4.039833333,0.00057701,6.598427638,-3.745,-2.036,,1.055,1.528,0.865,A0A075B5P9,NotFound,A0A075B5P9_NotFound,A0A075B5P9,Ighv5-4,1,3,2,2,A0A075B5P9,MOUSE,13135.8,14.5,466,466.1,17.47,17.47,,117,Immunoglobulin heavy variable 5-4 (Fragment),,,,2,3,65700000,14.5%
E9Q3P4,0.172533983,0.0684,7.830455342,1.919833333,0.16479896,1.588698655,0.586,-2.753,,0.417,2.351,-0.259,E9Q3P4,Cenpf,E9Q3P4_Cenpf,E9Q3P4,Cenpf,1,7,2,2,E9Q3P4,MOUSE,345546.7,0.9,467,467.1,17.42,17.42,,2997,Centromere protein F,"chromosome, centromeric region|spindle pole|condensed chromosome outer kinetochore|nucleus|nuclear envelope|nucleoplasm|cytoplasm|spindle|nuclear matrix|midbody|pronucleus|kinetochore|","mitotic cell cycle|chromosome segregation|regulation of G2/M transition of mitotic cell cycle|protein transport|regulation of striated muscle tissue development|negative regulation of transcription, DNA-templated|metaphase plate congression|",protein C-terminus binding|transcription factor binding|protein homodimerization activity|dynein binding|,2,7,3440000000,0.9%
Q3UHI0-2,0.000145021,-1.605166667,53.33527929,5.393666667,4.63951E-06,12.54617053,-4.567,-3.56,-4.779,0.954,1.328,0.993,Q3UHI0,Ccser2,Q3UHI0-2_Ccser2,Q3UHI0-2,Ccser2,1,6,2,2,Q3UHI0-2|Q3UHI0,MOUSE,115944.3,1.9,468,468.1,17.36,17.36,,833,Isoform 2 of Serine-rich coiled-coil domain-containing protein 2,microtubule cytoskeleton|,,microtubule binding|,2,6,1E+12,1.9%
Q9JHJ8-2,0.000290673,-0.3366,38.480254,3.6265,0.000141897,8.51562126,-2.779,-2.246,,1.396,1.107,0.839,Q9JHJ8,Icosl,Q9JHJ8-2_Icosl,Q9JHJ8-2,Icoslg,1,3,3,3,Q9JHJ8-2|A0A1W2P6Q2|Q9JHJ8,MOUSE,39426.3,11.8,469,469.1,17.23,17.23,,322,Isoform 2 of ICOS ligand,integral component of plasma membrane|external side of plasma membrane|integral component of membrane|extracellular exosome|,signal transduction|positive regulation of activated T cell proliferation|T cell activation|isotype switching|positive regulation of interleukin-4 biosynthetic process|,receptor binding|protein binding|,3,3,126000000,11.8%
A0A075B5R1,0.000463978,-0.4812,35.55171182,4.098,0.000278502,7.543218216,-3.646,-2.234,,1.236,1.356,0.882,A0A075B5R1,NotFound,A0A075B5R1_NotFound,A0A075B5R1,Ighv5-17,1,2,1,1,A0A075B5R1,MOUSE,13075.8,16.2,470,470.1,17.1,17.1,,117,Immunoglobulin heavy variable 5-17 (Fragment),,,,1,2,10200000,16.2%
O35452,0.000829174,-0.502166667,32.5448119,2.780333333,0.000556569,5.966534528,-2.292,-1.02,-2.365,1.181,0.747,0.736,O35452,NotFound,O35452_NotFound,O35452,Tnxb,1,5,2,2,O35452|E9Q2T3,MOUSE,442488.3,0.4,471,471.1,17.03,17.03,,4006,Tenascin X,extracellular region|proteinaceous extracellular matrix|extracellular space|intracellular|extracellular exosome|fibrillar collagen trimer|extracellular matrix|,lipid metabolic process|fatty acid metabolic process|triglyceride metabolic process|cell-matrix adhesion|single organismal cell-cell adhesion|extracellular matrix organization|collagen fibril organization|collagen metabolic process|extracellular fibril organization|regulation of JUN kinase activity|elastic fiber assembly|phospholipid metabolic process|positive regulation of cell adhesion|,collagen binding|heparin binding|,2,5,39100000,0.4%
Q7TNB8,0.011238884,-0.262833333,20.16682608,1.897,0.009623153,3.525668852,-0.403,-2.329,-0.902,0.659,0.831,0.567,Q7TNB8,Sbno2,Q7TNB8_Sbno2,Q7TNB8,Sbno2,1,3,3,3,Q7TNB8|Q7TNB8-2,MOUSE,150546.2,3.1,472,472.1,16.97,16.97,,1349,Protein strawberry notch homolog 2,,"macrophage activation involved in immune response|transcription, DNA-templated|bone mineralization|osteoclast differentiation|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|regulation of inflammatory response|bone trabecula morphogenesis|multinuclear osteoclast differentiation|osteoclast fusion|",protein binding|,3,3,15300000000,3.1%
Q9Z222,0.000185939,-0.637,42.23192147,4.3925,5.98147E-05,9.919160059,-3.666,-2.879,,1.326,1.14,0.894,Q9Z222,B3gnt2,Q9Z222_B3gnt2,Q9Z222,B3GNT2,1,2,2,2,Q9Z222|P59997|F6YRW4|P59997-2|A0A087WP68|P59997-3|Q3U4H6-2|Q3U4H6|G3UWI7,MOUSE,46281.5,3.2,473,473.1,16.72,16.72,,397,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2",Golgi membrane|integral component of membrane|extracellular exosome|,protein glycosylation|axon guidance|sensory perception of smell|poly-N-acetyllactosamine biosynthetic process|,"galactosyltransferase activity|N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity|",2,2,63300000,3.2%
Q00612,0.001779012,0.035166667,28.75662285,2.467,0.001331489,5.13948704,-1.664,-1.191,-0.74,1.721,0.46,1.625,Q00612,G6pdx,Q00612_G6pdx,Q00612,G6pdx,1,3,3,3,Q00612|P97324|G3UWD6,MOUSE,59717.9,4.8,474,474.1,16.49,16.49,,515,Glucose-6-phosphate 1-dehydrogenase X,cytoplasm|centrosome|microtubule organizing center|cytosol|cytoplasmic side of plasma membrane|membrane|intracellular membrane-bounded organelle|extracellular exosome|,"cytokine production|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|vasodilation by angiotensin involved in regulation of systemic arterial blood pressure|glucose metabolic process|pentose-phosphate shunt|cholesterol biosynthetic process|NADP metabolic process|NADPH regeneration|NADP biosynthetic process|glutathione metabolic process|response to oxidative stress|pentose-phosphate shunt, oxidative branch|negative regulation of protein glutathionylation|pentose biosynthetic process|interleukin-10 production|interleukin-12 production|cellular response to oxidative stress|regulation of multicellular organism growth|erythrocyte maturation|ribose phosphate biosynthetic process|erythrocyte development|glucose 6-phosphate metabolic process|oxidation-reduction process|",glucose-6-phosphate dehydrogenase activity|glucose binding|identical protein binding|protein homodimerization activity|NADP binding|,3,3,44800000,4.8%
A6H584,0.00216217,-0.9126,27.8165725,5.019833333,0.001653266,5.516644825,,-2.377,-5.472,1.26,0.979,1.047,A6H584,Col6a5,A6H584_Col6a5,A6H584,Col6a5,1,2,2,2,A0A140T8W1|A6H584|A0A140T8T7|E9Q6A6|Q8C6K9|Q8C6K9-2,MOUSE,291566.4,1.1,475,475.1,16.44,16.44,,2640,Collagen alpha-5(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|,cell adhesion|,,2,2,6250000,1.1%
A0A075B5X8,0.000157801,-0.6728,44.8472115,4.152,3.27551E-05,11.01667539,-3.191,-3.137,,0.903,1.006,1.055,A0A075B5X8,NotFound,A0A075B5X8_NotFound,A0A075B5X8,Ighv8-12,1,5,2,2,A0A075B5X8|A0A075B693,MOUSE,11636.9,11.4,476,476.1,16.38,16.38,,105,Immunoglobulin heavy variable V8-12,,,,2,5,1470000000,11.4%
Q9CPN9,0.000231076,-0.499,40.34455326,3.09,9.23729E-05,7.970238033,-2.047,-1.579,-2.506,1.35,0.921,0.867,Q9CPN9,2210010C04Rik,Q9CPN9_2210010C04Rik,Q9CPN9,2210010C04Rik,1,5,1,1,Q9CPN9,MOUSE,27106.2,4.8,477,477.1,16.12,16.12,,247,RIKEN cDNA 2210010C04 gene,extracellular space|,proteolysis|,serine-type endopeptidase activity|,1,5,867000000,4.8%
Q91WR8,0.000180141,-0.568,42.53964376,4.265,5.57231E-05,10.04293581,-3.48,-2.774,,1.285,1,1.129,Q91WR8,Gpx6,Q91WR8_Gpx6,Q91WR8,Gpx6,1,3,1,1,Q91WR8,MOUSE,25188.2,7.6,478,478.1,16.05,16.05,,221,Glutathione peroxidase 6,extracellular region|,response to oxidative stress|oxidation-reduction process|,glutathione peroxidase activity|,1,3,12600000,7.6%
A0A075B5S9,0.00078174,-0.0806,32.83299404,3.934833333,0.000520836,6.725170645,-2.228,-2.655,,1.245,2.416,0.819,A0A075B5S9,NotFound,A0A075B5S9_NotFound,A0A075B5S9,Ighv9-4,1,2,2,2,A0A075B5S9,MOUSE,11048.3,19.3,479,479.1,15.83,15.83,,98,Immunoglobulin heavy variable 9-4,,,,2,2,48200000,19.3%
A2AQH1,0.000415901,-0.258,36.1727531,2.939333333,0.000241393,6.843009808,-2.058,-2.04,-1.085,1.6,0.813,1.222,A2AQH1,Cerkl,A2AQH1_Cerkl,A2AQH1,Cerkl,1,3,3,3,A2AQH1,MOUSE,59694.4,5.5,480,480.1,15.76,15.76,,525,Ceramide kinase-like,nucleolus|cytoplasm|endoplasmic reticulum|Golgi apparatus|,phosphorylation|negative regulation of apoptotic process|,kinase activity|,3,3,219000000,5.5%
Q9DBH5,0.000213663,-0.3818,40.98041556,3.946166667,7.97918E-05,9.429743197,-2.887,-2.612,,1.553,1.128,0.909,Q9DBH5,Lman2,Q9DBH5_Lman2,Q9DBH5,Lman2,1,2,1,1,Q9DBH5,MOUSE,40771.4,3.6,481,481.1,15.65,15.65,,358,Vesicular integral-membrane protein VIP36,Golgi membrane|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|integral component of plasma membrane|cell surface|extracellular exosome|,"retrograde vesicle-mediated transport, Golgi to ER|protein transport|positive regulation of phagocytosis|",glycoprotein binding|mannose binding|carbohydrate binding|heat shock protein binding|metal ion binding|,1,2,6690000,3.6%
Q9QUK9,0.025382038,-0.126666667,16.47709063,0.990666667,0.022505618,2.91328817,-0.276,-0.711,-0.879,0.283,0.399,0.424,Q9QUK9,Try5,Q9QUK9_Try5,Q9QUK9,Try5,1,3,2,2,Q9QUK9|Q9R0T7|Q792Z0|Q9Z1R9|Q792Y8|Q792Y9,MOUSE,26961,12.1,482,482.1,15.64,15.64,,246,MCG15083,extracellular space|extracellular exosome|,proteolysis|digestion|,serine-type endopeptidase activity|calcium ion binding|serine-type peptidase activity|,2,3,176000000,12.1%
P12804,0.000165193,-0.8954,44.12565589,4.815166667,3.86754E-05,10.70333349,-4.248,-3.321,,1.045,0.926,1.121,P12804,Fgl2,P12804_Fgl2,P12804,Fgl2,1,1,1,1,P12804,MOUSE,49634.7,2.3,483,483.1,15.42,15.42,,432,Fibroleukin,extracellular exosome|,cytolysis|,,1,1,12000000,2.3%
Q61627,0.000265003,-0.833,39.15285512,4.923333333,0.000121539,8.75355377,-4.557,-3.017,,1.293,0.902,1.214,Q61627,Grid1,Q61627_Grid1,Q61627,Grid1,1,3,2,2,Q61627,MOUSE,113178,2.7,484,484.1,15.39,15.39,,1009,"Glutamate receptor ionotropic, delta-1",plasma membrane|ionotropic glutamate receptor complex|cell junction|dendrite|postsynaptic membrane|extracellular exosome|,"ion transmembrane transport|social behavior|ionotropic glutamate receptor signaling pathway|synaptic transmission, glutamatergic|",ionotropic glutamate receptor activity|extracellular-glutamate-gated ion channel activity|,2,3,1430000000,2.7%
Q792Z1,0.07542987,-0.070666667,11.59704695,0.843333333,0.069230155,2.143199256,-0.246,-0.119,-1.112,0.283,0.27,0.5,Q792Z1,Try10,Q792Z1_Try10,Q792Z1,Try10,1,4,1,1,Q792Z1,MOUSE,26905,4,485,485.1,15.38,15.38,,246,MCG140784,extracellular space|extracellular exosome|blood microparticle|,proteolysis|digestion|,serine-type endopeptidase activity|,1,4,289000000,4.0%
P49452,0.000158712,-0.5538,44.58594193,4.416166667,3.47861E-05,10.90225967,-3.389,-3.018,,1.383,1.301,0.954,P49452,Cenpc1,P49452_Cenpc1,P49452,Cenpc,1,2,2,2,P49452,MOUSE,102722.5,2.4,486,486.1,15.3,15.3,,906,Centromere protein C,"kinetochore|condensed chromosome kinetochore|condensed nuclear chromosome, centromeric region|nucleus|nucleoplasm|pericentric heterochromatin|cytoplasm|",mitotic cell cycle|chromosome segregation|mitotic nuclear division|cell division|kinetochore assembly|,protein binding|centromeric DNA binding|,2,2,2730000000,2.4%
F8VQ75,0.000172925,-0.524,42.88577853,3.820833333,5.14544E-05,10.18382588,-2.814,-2.819,,1.053,0.999,0.961,F8VQ75,Kif13a,F8VQ75_Kif13a,F8VQ75,Kif13a,1,3,3,3,F8VQ75|Q9EQW7,MOUSE,197294.8,2.1,487,487.1,15.15,15.15,,1749,Kinesin-like protein KIF13A,centrosome|kinesin complex|microtubule|endosome membrane|midbody|,cytokinesis|intracellular protein transport|microtubule-based movement|metabolic process|endosome to lysosome transport|melanosome organization|cargo loading into vesicle|,microtubule motor activity|ATP binding|microtubule binding|ATPase activity|,3,3,99800000,2.1%
A0A075B5K3,0.000596728,-0.6674,34.2491853,4.269333333,0.000375908,7.1417281,-4.102,-2.356,,0.872,1.107,1.142,A0A075B5K3,NotFound,A0A075B5K3_NotFound,A0A075B5K3,Igkv17-121,1,2,1,1,A0A075B5K3|A0A075B5J9,MOUSE,12863.4,13.7,488,488.1,15.02,15.02,,116,Immunoglobulin kappa variable 17-121,,,,1,2,118000000,13.7%
P54818,0.000164241,-0.781666667,44.26125558,3.676666667,3.74865E-05,9.16336059,-2.918,-2.079,-2.863,1.44,0.762,0.968,P54818,Galc,P54818_Galc,P54818,Galc,1,3,2,2,P54818,MOUSE,77483.2,5.1,489,489.1,15,15,,684,Galactocerebrosidase,mitochondrion|lysosome|extracellular exosome|,carbohydrate metabolic process|galactosylceramide catabolic process|,galactosylceramidase activity|,2,3,53900000,5.1%
Q3UGX2,0.416311863,-0.136333333,3.898742128,0.570666667,0.407498287,0.880988209,-1.475,-0.78,0.99,0.262,-0.184,0.369,Q3UGX2,Sptb,Q3UGX2_Sptb,Q3UGX2,Sptb,1,2,2,2,Q3UGX2|E9Q397|P15508,MOUSE,268999.3,0.9,490,490.1,14.95,14.95,,2329,Spectrin beta chain,cytoplasm|plasma membrane|spectrin|cell surface|spectrin-associated cytoskeleton|membrane|cortical cytoskeleton|protein complex|,porphyrin-containing compound biosynthetic process|plasma membrane organization|hemopoiesis|,actin binding|structural constituent of cytoskeleton|phospholipid binding|ankyrin binding|protein heterodimerization activity|actin filament binding|,2,2,23100000,0.9%
G3X9D6,0.008053575,-0.901666667,21.72652036,4.357333333,0.00671967,3.838864212,-1.822,-1.56,-5.859,1.264,0.732,1.835,G3X9D6,Apon,G3X9D6_Apon,G3X9D6,Apon,1,1,1,1,G3X9D6,MOUSE,28249.3,7.1,491,491.1,14.92,14.92,,251,Apolipoprotein N,extracellular space|cytoplasm|,,,1,1,123000000,7.1%
P01725,0.000148189,-0.9942,46.05619826,5.278,2.47959E-05,11.56063533,-4.577,-3.745,,0.945,0.977,1.429,P01725,NotFound,P01725_NotFound,P01725,,1,2,2,2,P01725,MOUSE,11767.9,26.3,492,492.1,14.83,14.83,,110,Ig lambda-1 chain V region S178,,,antigen binding|,2,2,2370000000,26.3%
P16460,0.249652894,-0.377166667,6.180772373,1.223666667,0.240947688,1.284375266,-2.71,1.197,-1.454,0.716,-0.127,0.115,P16460,Ass1,P16460_Ass1,P16460,Ass1,1,2,2,2,P16460,MOUSE,46868.9,4.8,493,493.1,14.82,14.82,,412,Argininosuccinate synthase,cytoplasm|mitochondrion|myelin sheath|extracellular exosome|,urea cycle|citrulline metabolic process|argininosuccinate metabolic process|arginine biosynthetic process|aspartate metabolic process|positive regulation of nitric oxide biosynthetic process|cellular response to laminar fluid shear stress|negative regulation of leukocyte cell-cell adhesion|,argininosuccinate synthase activity|ATP binding|amino acid binding|identical protein binding|poly(A) RNA binding|,2,2,6590000,4.8%
Q8BGS1-3,0.000351032,-0.4268,37.17895198,4.321166667,0.000191472,8.071119441,-3.646,-2.393,,1.524,1.505,0.876,Q8BGS1,Epb41l5,Q8BGS1-3_Epb41l5,Q8BGS1-3,Epb41l5,1,5,2,2,Q8BGS1-3|Q8BGS1|Q8BGS1-2,MOUSE,83272.7,2.8,494,494.1,14.8,14.8,,731,Isoform 3 of Band 4.1-like protein 5,nucleus|cytoplasm|cytoskeleton|plasma membrane|focal adhesion|extrinsic component of membrane|cell leading edge|ruffle membrane|,"cell morphogenesis involved in differentiation|in utero embryonic development|somitogenesis|epithelial to mesenchymal transition|neural plate morphogenesis|positive regulation of cell-matrix adhesion|epithelial cell morphogenesis|apical constriction|substrate-dependent cell migration, cell attachment to substrate|ectoderm development|endoderm development|mesoderm development|mesoderm migration involved in gastrulation|unidimensional cell growth|posttranscriptional regulation of gene expression|positive regulation of epithelial cell migration|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-cell adhesion|actin cytoskeleton organization|actomyosin structure organization|negative regulation of protein binding|positive regulation of protein binding|somite rostral/caudal axis specification|axial mesoderm development|axial mesoderm morphogenesis|paraxial mesoderm development|embryonic foregut morphogenesis|positive regulation of focal adhesion assembly|regulation of establishment of protein localization|left/right axis specification|cellular response to transforming growth factor beta stimulus|",protein binding|cytoskeletal protein binding|protein domain specific binding|,2,5,6100000000,2.8%
Q8C2E4,0.000397374,-0.960666667,36.41814644,3.965333333,0.000228132,6.90560303,-2.52,-2.135,-4.175,1.284,0.842,0.94,Q8C2E4,Ptcd1,Q8C2E4_Ptcd1,Q8C2E4,Ptcd1,1,3,3,3,Q8C2E4,MOUSE,78334.7,6,495,495.1,14.75,14.75,,695,"Pentatricopeptide repeat-containing protein 1, mitochondrial",mitochondrial matrix|,tRNA 3'-end processing|,,3,3,105000000,6.0%
Q9CSN1,0.000145021,-1.245666667,54.59386986,4.993333333,3.47227E-06,13.09587657,-3.777,-3.307,-4.143,1.484,1.341,0.928,Q9CSN1,Snw1,Q9CSN1_Snw1,Q9CSN1,Snw1,1,8,2,2,Q9CSN1|A0A0B4J1E2,MOUSE,61531.4,2.6,496,496.1,14.69,14.69,,536,SNW domain-containing protein 1,nucleus|nucleoplasm|spliceosomal complex|nuclear matrix|catalytic step 2 spliceosome|positive transcription elongation factor complex b|SMAD3-SMAD4 protein complex|,"negative regulation of transcription from RNA polymerase II promoter|mRNA splicing, via spliceosome|transcription, DNA-templated|positive regulation of transforming growth factor beta receptor signaling pathway|skeletal muscle cell differentiation|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|positive regulation by host of viral transcription|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of mRNA splicing, via spliceosome|retinoic acid receptor signaling pathway|regulation of retinoic acid receptor signaling pathway|positive regulation of neurogenesis|positive regulation of histone H3-K4 methylation|regulation of vitamin D receptor signaling pathway|positive regulation of vitamin D receptor signaling pathway|cellular response to retinoic acid|",transcription coactivator activity|transcription corepressor activity|Notch binding|protein binding|nuclear hormone receptor binding|vitamin D receptor binding|retinoic acid receptor binding|poly(A) RNA binding|SMAD binding|,2,8,1.71E+11,2.6%
E9Q1W3,0.000261034,-0.4246,39.30511652,4.414833333,0.000117351,8.808213505,-3.323,-2.824,,1.999,1.131,0.894,E9Q1W3,Neb,E9Q1W3_Neb,E9Q1W3,Neb,1,6,2,2,E9Q1W3|A2AQA9|B2RUJ5|B2RUJ5-3,MOUSE,831956.2,0.2,497,497.1,14.58,14.58,,7152,Nebulin,striated muscle thin filament|Z disc|protein complex|contractile fiber|extracellular exosome|,regulation of actin filament length|sarcomere organization|,actin binding|protein binding|,2,6,10100000000,0.2%
Q6P5E4,0.000208059,-0.4704,41.22636753,3.606,7.53986E-05,9.524185482,-2.643,-2.625,,1.088,0.95,0.878,Q6P5E4,Uggt1,Q6P5E4_Uggt1,Q6P5E4,Uggt1,1,1,1,1,Q6P5E4,MOUSE,177115,0.8,498,498.1,14.53,14.53,,1551,UDP-glucose:glycoprotein glucosyltransferase 1,endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|extracellular exosome|,protein glycosylation|UDP-glucosylation|,UDP-glucose:glycoprotein glucosyltransferase activity|protein binding|unfolded protein binding|,1,1,1840000,0.8%
Q9WV54,0.010708504,-0.747333333,20.39296165,2.548,0.009134901,3.592267982,-1.822,-0.681,-3.561,0.461,0.514,0.605,Q9WV54,Asah1,Q9WV54_Asah1,Q9WV54,Asah1,1,1,1,1,Q9WV54,MOUSE,45068.1,2,499,499.1,14.51,14.51,,394,Acid ceramidase,lysosome|extracellular exosome|,lipid metabolic process|,ceramidase activity|,1,1,22200000,2.0%
H3BKH6,0.000302646,-0.2255,38.17398833,3.274333333,0.000152265,7.366633931,-1.393,-1.832,-2.363,1.713,0.782,1.74,H3BKH6,Esd,H3BKH6_Esd,H3BKH6,Esd,1,3,2,2,H3BKH6|Q9R0P3|H3BJL6|H3BLJ9,MOUSE,33399.4,8.4,500,500.1,14.48,14.48,,295,S-formylglutathione hydrolase,nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|extracellular exosome|,formaldehyde catabolic process|,"hydrolase activity, acting on ester bonds|S-formylglutathione hydrolase activity|",2,3,19500000,8.4%
A0A075B5M1,0.008445497,-1.654666667,21.49430419,6.145333333,0.007088749,3.796976117,-3.379,-2.093,-8.71,2.295,1.149,0.81,A0A075B5M1,NotFound,A0A075B5M1_NotFound,A0A075B5M1,Igkv4-63,1,4,2,2,A0A075B5M1|Q569Z6,MOUSE,10271.2,14.7,502,502.1,14.38,14.38,,95,Immunoglobulin kappa variable 4-63,,,,2,4,180000000,14.7%
F6ZDS4,0.000145021,-0.8732,48.8680771,5.123833333,1.29775E-05,12.92359837,-4.057,-3.838,,1.237,1.362,0.93,F6ZDS4,Tpr,F6ZDS4_Tpr,F6ZDS4,Tpr,1,2,2,2,F6ZDS4|Q7M739|Q8BQ30-2|Q8BQ30,MOUSE,274384.7,0.6,503,503.1,14.35,14.35,,2431,Nucleoprotein TPR,kinetochore|nucleus|nuclear envelope|nuclear pore|cytoplasm|cytoplasmic dynein complex|extrinsic component of membrane|nuclear membrane|nuclear periphery|nuclear inclusion body|nuclear pore nuclear basket|mitotic spindle|kinetochore|,negative regulation of transcription from RNA polymerase II promoter|MAPK import into nucleus|RNA import into nucleus|RNA export from nucleus|nuclear pore organization|mitotic nuclear division|mitotic spindle assembly checkpoint|regulation of mitotic sister chromatid separation|positive regulation of heterochromatin assembly|mRNA export from nucleus in response to heat stress|cellular response to heat|cellular response to interferon-alpha|positive regulation of protein import into nucleus|negative regulation of translational initiation|positive regulation of protein export from nucleus|negative regulation of RNA export from nucleus|cell division|response to epidermal growth factor|positive regulation of mitotic cell cycle spindle assembly checkpoint|positive regulation of intracellular protein transport|regulation of mitotic spindle assembly|protein import into nucleus|protein export from nucleus|nuclear pore organization|regulation of protein stability|regulation of protein import into nucleus|nuclear matrix organization|nuclear pore complex assembly|,chromatin binding|mRNA binding|nucleocytoplasmic transporter activity|protein binding|tubulin binding|heat shock protein binding|protein homodimerization activity|poly(A) RNA binding|mitogen-activated protein kinase binding|dynein complex binding|transporter activity|protein anchor|,2,2,379000000,0.6%
A0A075B5J6,0.000355201,-0.7662,37.10788111,4.563,0.000194631,8.047427161,-4.295,-2.713,,1.067,1.224,0.886,A0A075B5J6,NotFound,A0A075B5J6_NotFound,A0A075B5J6,Gm20730,1,1,1,1,A0A075B5J6|P01629,MOUSE,13242.9,10.9,504,504.1,14.25,14.25,,119,"Predicted gene, 20730",,,,1,1,7980000,10.9%
E9Q3M9,0.203671987,-0.437,7.087298659,1.21,0.195555545,1.462135235,-2.546,0.22,,0.119,-0.006,0.028,E9Q3M9,2010300C02Rik,E9Q3M9_2010300C02Rik,E9Q3M9,2010300C02Rik,1,3,2,2,E9Q3M9|Q3TYL0,MOUSE,126478.6,1.1,505,505.1,14.1,14.1,,1175,RIKEN cDNA 2010300C02 gene,,,,2,3,591000000,1.1%
P10166,0.000185032,-0.692,42.34347272,4.5625,5.82979E-05,9.963869867,-3.911,-2.948,,1.19,1.233,0.976,P10166,Mycl,P10166_Mycl,P10166,Mycl,1,6,2,2,P10166,MOUSE,41361,2.9,506,506.1,14.1,14.1,,368,Protein L-Myc,nucleus|,"regulation of transcription, DNA-templated|",DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|protein dimerization activity|,2,6,5510000000,2.9%
P61027,0.008812891,-0.007666667,21.29650461,1.19,0.007419071,3.72110846,-0.54,-0.609,-0.659,0.689,0.392,0.681,P61027,Rab10,P61027_Rab10,P61027,Rab10,1,1,1,1,P61027,MOUSE,22768.7,6,507,507.1,14.06,14.06,,200,Ras-related protein Rab-10,endosome|endoplasmic reticulum membrane|Golgi apparatus|trans-Golgi network|focal adhesion|endosome membrane|phagocytic vesicle membrane|insulin-responsive compartment|perinuclear region of cytoplasm|recycling endosome|recycling endosome membrane|extracellular exosome|endoplasmic reticulum tubular network|primary cilium|exocyst|plasma membrane|,intracellular protein transport|Golgi to plasma membrane transport|vesicle docking involved in exocytosis|axonogenesis|protein secretion|vesicle-mediated transport|endosomal transport|regulation of exocytosis|antigen processing and presentation|polarized epithelial cell differentiation|Rab protein signal transduction|cellular response to insulin stimulus|Golgi to plasma membrane protein transport|establishment of neuroblast polarity|basolateral protein localization|cellular response to antibiotic|endoplasmic reticulum tubular network organization|protein localization to plasma membrane|establishment of protein localization to membrane|establishment of protein localization to endoplasmic reticulum membrane|,GTPase activity|protein binding|GTP binding|GDP binding|myosin V binding|,1,1,33500000,6.0%
Q0KL02-4,0.002392145,0.0684,27.34237483,3.763166667,0.001844007,5.284550779,-2.513,-1.866,,2.836,0.787,1.098,Q0KL02,Trio,Q0KL02-4_Trio,Q0KL02-4,Trio,1,4,2,2,Q0KL02-4|Q0KL02|Q0KL02-3|Q0KL02-2|G5E825|Q9CWR0|A0A0R4J211|Q9CWR0-2|A0A1Y7VNM7|A0A1W2P6R9,MOUSE,351137,0.7,508,508.1,14.05,14.05,,3102,Isoform 4 of Triple functional domain protein,cytoplasm|,protein phosphorylation|regulation of Rho protein signal transduction|positive regulation of GTPase activity|,protein serine/threonine kinase activity|Rho guanyl-nucleotide exchange factor activity|ATP binding|enzyme binding|,2,4,57600000000,0.7%
F8VQL9,0.000357489,-0.8326,37.04017592,5.478166667,0.000197689,8.024912027,-5.177,-3.062,,1.415,1.565,1.096,F8VQL9,Ncor2,F8VQL9_Ncor2,F8VQL9,Ncor2,1,2,2,2,F8VQL9|E9Q701|Q9WU42|E9PY55|E9Q9V3|Q9WU42-2,MOUSE,274089,1.1,509,509.1,14,14,,2507,Nuclear receptor corepressor 2,histone deacetylase complex|nucleus|nucleoplasm|membrane|nuclear matrix|nuclear body|transcriptional repressor complex|,"negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|heart morphogenesis|telencephalon development|cell proliferation in forebrain|forebrain development|glucose homeostasis|negative regulation of fat cell differentiation|negative regulation of transcription, DNA-templated|white fat cell differentiation|Type I pneumocyte differentiation|regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter|positive regulation of protein deacetylation|",DNA binding|chromatin binding|transcription corepressor activity|Notch binding|protein binding|histone deacetylase binding|sequence-specific DNA binding|protein N-terminus binding|,2,2,11700000000,1.1%
A0A1Y7VLS3,0.0001947,-0.975,41.87214874,5.3475,6.49808E-05,9.776189081,-4.913,-3.454,,1.365,1.17,0.957,A0A1Y7VLS3,Togaram1,A0A1Y7VLS3_Togaram1,A0A1Y7VLS3,Togaram1,1,2,2,2,A0A1Y7VLS3|Q6A070|Q6A070-2,MOUSE,201882.1,0.9,510,510.1,13.98,13.98,,1826,TOG array regulator of axonemal microtubules protein 1,,,,2,2,957000000,0.9%
A4Q9F4,0.000213663,-0.3992,40.95769923,3.989666667,8.02103E-05,9.421062634,-3.031,-2.555,,1.434,1.284,0.872,A4Q9F4,Ttll11,A4Q9F4_Ttll11,A4Q9F4,Ttll11,1,3,2,2,A4Q9F4|A4Q9F4-2|A4Q9F4-3,MOUSE,83044.2,3.9,511,511.1,13.97,13.97,,727,Tubulin polyglutamylase TTLL11,cytoplasm|cytoskeleton|cilium|,protein polyglutamylation|microtubule severing|,ligase activity|,2,3,135000000,3.9%
Q7TQ48,0.000415901,-1.121166667,36.16408192,4.350333333,0.000241875,6.840806063,-3.046,-2.19,-4.653,0.868,0.968,1.326,Q7TQ48,Srl,Q7TQ48_Srl,Q7TQ48,Srl,1,3,2,2,Q7TQ48,MOUSE,99581.6,1.9,512,512.1,13.92,13.92,,910,Sarcalumenin,sarcoplasmic reticulum lumen|,,GTP binding|,2,3,15700000,1.9%
A2AQB2,0.000148189,-0.6965,46.34741978,4.041666667,2.31877E-05,9.85914547,-2.829,-2.545,-2.778,1.999,1.105,0.869,A2AQB2,NotFound,A2AQB2_NotFound,A2AQB2,Neb,1,6,2,2,A2AQB2,MOUSE,354700.3,0.4,513,513.1,13.88,13.88,,3044,Nebulin,striated muscle thin filament|Z disc|protein complex|contractile fiber|extracellular exosome|,regulation of actin filament length|sarcomere organization|,actin binding|protein binding|,2,6,10000000000,0.4%
P10639,0.019920499,-0.5165,17.54769092,2.273,0.017588585,3.113677807,-1.984,-0.09,-2.885,0.925,0.085,0.85,P10639,Txn1,P10639_Txn1,P10639,Txn,1,2,2,2,P10639,MOUSE,12017.6,19,514,514.1,13.85,13.85,,105,Thioredoxin,nucleus|cytoplasm|mitochondrion|cytosol|extracellular exosome|,"sulfate assimilation|negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|protein folding|glycerol ether metabolic process|response to radiation|positive regulation of peptidyl-serine phosphorylation|regulation of protein import into nucleus, translocation|cellular response to oxidative stress|positive regulation of DNA binding|cell redox homeostasis|negative regulation of protein export from nucleus|oxidation-reduction process|negative regulation of hydrogen peroxide-induced cell death|","protein binding|protein disulfide oxidoreductase activity|peptide disulfide oxidoreductase activity|oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor|poly(A) RNA binding|",2,2,12300000,19.0%
P29416,0.000634503,-0.05925,33.9301163,4.425,0.000404565,8.319926912,,-3.378,,1.231,0.981,0.929,P29416,Hexa,P29416_Hexa,P29416,Hexa,1,1,1,1,P29416,MOUSE,61182.5,2,515,515.1,13.83,13.83,,528,Beta-hexosaminidase subunit alpha,lysosome|membrane|extracellular exosome|,skeletal system development|carbohydrate metabolic process|ganglioside catabolic process|lysosome organization|sensory perception of sound|locomotory behavior|adult walking behavior|lipid storage|sexual reproduction|glycosaminoglycan metabolic process|myelination|cell morphogenesis involved in neuron differentiation|neuromuscular process controlling posture|neuromuscular process controlling balance|SMAD protein signal transduction|,beta-N-acetylhexosaminidase activity|protein heterodimerization activity|,1,1,5130000,2.0%
Q8R116,0.000905276,-0.522,32.03641442,3.023333333,0.000625689,5.850611089,-2.665,-1.114,-2.322,1.539,0.621,0.809,Q8R116,Notum,Q8R116_Notum,Q8R116,Notum,1,3,1,1,Q8R116|Q8R116-2,MOUSE,57496.3,1.3,516,516.1,13.83,13.83,,503,Palmitoleoyl-protein carboxylesterase NOTUM,extracellular region|,Wnt signaling pathway|negative regulation of Wnt signaling pathway|protein depalmitoleylation|GPI anchor release|,palmitoleyl hydrolase activity|,1,3,11300000,1.3%
Q6JHY2,0.004545668,0.3068,24.36213508,2.266333333,0.003662575,4.602089626,-1.044,-1.062,,0.599,1.814,1.227,Q6JHY2,Smgc,Q6JHY2_Smgc,Q6JHY2,Muc19,1,1,1,1,Q6JHY2|Q6JHY2-2|Q6JHY2-5|Q6JHY2-3,MOUSE,74495.3,2.5,517,517.1,13.8,13.8,,733,Submandibular gland protein C,extracellular region|,,,1,1,2090000,2.5%
A0A0B4J1J5,0.000145021,-1.304833333,47.77890472,4.758333333,1.66767E-05,10.36304979,-4.458,-3.655,-2.939,1.028,1.253,0.942,A0A0B4J1J5,NotFound,A0A0B4J1J5_NotFound,A0A0B4J1J5,Ighv9-3,1,4,2,2,A0A0B4J1J5,MOUSE,13109.7,17,518,518.1,13.74,13.74,,117,Immunoglobulin heavy variable V9-3 (Fragment),,,,2,4,275000000,17.0%
Q8BMJ2,0.967200185,-0.120166667,0.144836293,0.016333333,0.967200185,0.042609895,-0.023,-0.416,0.054,0.154,-0.633,0.143,Q8BMJ2,Lars,Q8BMJ2_Lars,Q8BMJ2,Lars,1,3,2,2,Q8BMJ2,MOUSE,135445.1,1.3,519,519.1,13.69,13.69,,1178,"Leucine--tRNA ligase, cytoplasmic",nucleus|cytoplasm|cytosol|,leucyl-tRNA aminoacylation|regulation of translational fidelity|methionyl-tRNA aminoacylation|,aminoacyl-tRNA editing activity|leucine-tRNA ligase activity|ATP binding|methionine-tRNA ligase activity|,2,3,3090000000,1.3%
Q9ESG6,0.00075017,-0.467166667,33.0364425,3.337666667,0.000496999,6.080179105,-3.177,-1.954,-1.277,1.614,0.839,1.152,Q9ESG6,P2ry14,Q9ESG6_P2ry14,Q9ESG6,P2ry14,1,4,2,2,A0A0G2JEW9|Q9ESG6,MOUSE,39259.9,6.5,520,520.1,13.42,13.42,,338,P2Y purinoceptor 14,integral component of plasma membrane|,G-protein coupled receptor signaling pathway|G-protein coupled purinergic nucleotide receptor signaling pathway|,G-protein coupled purinergic nucleotide receptor activity|,2,4,17300000000,6.5%
A0A075B5T9,0.000347515,-0.5856,37.24255373,4.299,0.000188688,8.092372225,-3.821,-2.509,,0.867,1.437,1.098,A0A075B5T9,NotFound,A0A075B5T9_NotFound,A0A075B5T9,Ighv1-9,1,1,1,1,A0A075B5T9,MOUSE,13045.5,21.5,521,521.1,13.4,13.4,,116,Immunoglobulin heavy variable V1-9,,,,1,1,37800000,21.5%
Q3U2I3,0.000873678,-1.04,32.21424886,3.9,0.000600586,5.890977897,-2.881,-1.708,-4.381,0.845,0.905,0.98,Q3U2I3,Fam160a2,Q3U2I3_Fam160a2,Q3U2I3,Fam160a2,1,2,2,2,A0A1C7CYU5|Q3U2I3|Q3U2I3-2|F8WHJ1|Q3U2I3-3,MOUSE,107509.4,1.7,522,522.1,13.24,13.24,,975,FTS and Hook-interacting protein,FHF complex|,endosome organization|lysosome organization|endosome to lysosome transport|protein transport|early endosome to late endosome transport|,,2,2,242000000,1.7%
P86793,0.000341559,-0.5088,37.36981871,3.562833333,0.000183239,8.135041867,-3.066,-2.227,,0.881,0.837,1.031,P86793,Ccl21c,P86793_Ccl21c,P86793,Ccl21c,1,1,1,1,P86793|P84444,MOUSE,14983.2,7.5,523,523.1,13.24,13.24,,133,C-C motif chemokine 21c,extracellular space|,inflammatory response|immune response|cell chemotaxis|,chemokine activity|CCR7 chemokine receptor binding|,1,1,1630000,7.5%
E9PZ36,0.006053235,-0.483333333,23.03184098,3.07,0.004975261,4.078312611,-2.377,-3.353,-0.325,0.96,0.928,1.267,E9PZ36,Pkhd1,E9PZ36_Pkhd1,E9PZ36,Pkhd1,1,3,2,2,E9PZ36,MOUSE,450351.1,0.7,524,524.1,13.16,13.16,,4059,Polycystic kidney and hepatic disease 1,cytoplasm|centrosome|apical plasma membrane|ciliary basal body|perinuclear region of cytoplasm|extracellular exosome|primary cilium|mitotic spindle|,kidney development|cellular calcium ion homeostasis|positive regulation of cell proliferation|regulation of centrosome duplication|regulation of TOR signaling|negative regulation of NF-kappaB transcription factor activity|cilium assembly|negative regulation of apoptotic process|negative regulation of protein kinase B signaling|regulation of ERK1 and ERK2 cascade|,protein binding|,2,3,278000000,0.7%
Q9ESK3,0.000912037,-0.2058,31.98847788,3.9845,0.000632634,6.486163697,-3.174,-2.019,,2.205,1.127,0.832,Q9ESK3,Capn10,Q9ESK3_Capn10,Q9ESK3,Capn10,1,3,2,2,Q9ESK3|D6RGR0|Q9CPY2,MOUSE,76078.2,4.9,525,525.1,13.08,13.08,,666,Calpain-10,cell|cytoplasm|mitochondrion|cytosol|,proteolysis|actin cytoskeleton reorganization|positive regulation of insulin secretion|positive regulation of intracellular transport|cellular response to insulin stimulus|positive regulation of glucose import|type B pancreatic cell apoptotic process|positive regulation of type B pancreatic cell apoptotic process|,calcium-dependent cysteine-type endopeptidase activity|,2,3,182000000,4.9%
Q80UM7,0.00493569,-0.714166667,23.9845427,2.764333333,0.003995266,4.204564807,-1.916,-0.899,-3.474,0.656,0.381,0.967,Q80UM7,Mogs,Q80UM7_Mogs,Q80UM7,Mogs,1,2,2,2,Q80UM7,MOUSE,92000.8,1.7,526,526.1,13.05,13.05,,834,Mannosyl-oligosaccharide glucosidase,endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,protein N-linked glycosylation|oligosaccharide metabolic process|,mannosyl-oligosaccharide glucosidase activity|,2,2,778000000,1.7%
P10648,0.947338511,0.5728,0.240359844,-0.0695,0.946158762,-0.070498622,,2.021,-0.792,1.651,-0.158,0.142,P10648,Gsta2,P10648_Gsta2,P10648,Gsta2,1,2,1,1,P13745|Q6P8Q0|P10648|P30115,MOUSE,25655.6,4.9,527,527.1,13.04,13.04,,222,Glutathione S-transferase A2,extracellular exosome|,glutathione metabolic process|response to stilbenoid|,glutathione transferase activity|,1,2,68000000,4.9%
A11112,0.000309044,-0.2072,38.01911506,3.587166667,0.000157793,8.355753751,-2.308,-2.411,,1.579,0.799,1.305,A11112,NotFound,A11112_NotFound,A11112,,1,2,2,2,A11112,MOUSE,26302.5,9.4,528,528.1,13.02,13.02,,,mKate2,,,,2,2,9990000,9.4%
Q9R0P5,0.082110043,0.1642,11.21087548,1.697,0.075668034,2.15863659,-1.834,0.126,,1.373,-0.138,1.294,Q9R0P5,Dstn,Q9R0P5_Dstn,Q9R0P5,Dstn,1,1,1,1,Q9R0P5,MOUSE,18863.6,7.8,529,529.1,13.01,13.01,,165,Destrin,cytoplasm|cortical actin cytoskeleton|extracellular exosome|,actin filament depolymerization|positive regulation of actin filament depolymerization|actin filament severing|,actin binding|,1,1,9280000,7.8%
P97873,0.000271142,-0.271,39.00976391,3.8025,0.00012561,8.702456261,-2.731,-2.374,,1.467,1.482,0.801,P97873,Loxl1,P97873_Loxl1,P97873,Loxl1,1,2,2,2,P97873|A0A0R4J0Q4,MOUSE,67189.7,3.4,530,530.1,12.98,12.98,,607,Lysyl oxidase homolog 1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|,oxidation-reduction process|,"copper ion binding|protein binding|oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor|",2,2,156000000,3.4%
E9PUR0,0.37606141,0.000333333,4.351407123,-0.361333333,0.36716332,-0.963860878,0.019,0.543,-0.019,0.082,-0.6,-0.023,E9PUR0,Ankhd1,E9PUR0_Ankhd1,E9PUR0,Ankhd1,1,2,2,2,E9PUR0|E9Q1M6|A0A0A6YX17|Q9CWU0|E1BKR4|Q5RJG1|Q9ET22,MOUSE,271726.3,0.5,531,531.1,12.98,12.98,,2548,Ankyrin repeat and KH domain-containing 1,,,poly(A) RNA binding|,2,2,97000000,0.5%
Q8VHI3,0.0018143,-0.160333333,28.64969493,2.363333333,0.001364679,5.117313361,-2.041,-1.28,-0.705,1.4,0.588,1.076,Q8VHI3,Pofut2,Q8VHI3_Pofut2,Q8VHI3,Pofut2,1,2,2,2,Q8VHI3,MOUSE,49770.7,3.9,532,532.1,12.97,12.97,,429,GDP-fucose protein O-fucosyltransferase 2,endoplasmic reticulum|Golgi apparatus|,mesoderm formation|fucose metabolic process|regulation of gene expression|regulation of epithelial to mesenchymal transition|fucosylation|protein O-linked fucosylation|regulation of secretion|,fucosyltransferase activity|peptide-O-fucosyltransferase activity|,2,2,38100000,3.9%
P00342,0.01334775,-0.5104,19.39201378,3.2235,0.011502669,3.635809024,-3.925,-0.964,,1.097,0.573,0.667,P00342,Ldhc,P00342_Ldhc,P00342,Ldhc,1,3,2,2,P00342|A0A1B0GRE9|A0A1B0GSR2|A0A1B0GSX0|P06151|A0A1B0GSR9|A0A1B0GQX5,MOUSE,36253.5,6.3,533,533.1,12.95,12.95,,332,L-lactate dehydrogenase C chain,nucleus|cytoplasm|cilium|motile cilium|extracellular exosome|,carbohydrate metabolic process|pyruvate metabolic process|ATP biosynthetic process|lactate biosynthetic process from pyruvate|lactate oxidation|sperm motility|,L-lactate dehydrogenase activity|protein binding|,2,3,132000000,6.3%
F1MB32,0.000988663,-0.555833333,31.59158998,3.337666667,0.000693172,5.750488442,-3.282,-2.271,-1.121,1.251,0.756,1.332,F1MB32,NotFound,F1MB32_NotFound,F1MB32,A2ML1,1,2,2,2,F1MB32,BOVIN,157039.4,1.8,534,534.1,12.95,12.95,,1396,Uncharacterized protein,,,,2,2,749000000,1.8%
E9QAX2,0.000575192,-1.1084,34.44199068,5.8135,0.000359584,7.408226681,-5.866,-3.327,,1.392,1.333,0.926,E9QAX2,Myo18a,E9QAX2_Myo18a,E9QAX2,Myo18a,1,4,2,2,E9QAX2|Q9JMH9-6|Q9JMH9|B2RRE2|K3W4L0|Q9JMH9-1|Q9JMH9-4|A0A1C7ZN10|Q9JMH9-2|Q9JMH9-7|Q9JMH9-5|E9Q405|E9QA74,MOUSE,237125.2,1.5,535,535.1,12.74,12.74,,2083,Unconventional myosin-XVIIIa,Golgi membrane|trans-Golgi network|cytoskeleton|membrane|myosin complex|actomyosin|,Golgi organization|metabolic process|cell migration|actomyosin structure organization|negative regulation of apoptotic process|Golgi vesicle budding|positive regulation of protein secretion|Golgi ribbon formation|asymmetric Golgi ribbon formation|,motor activity|ATP binding|ADP binding|poly(A) RNA binding|actin filament binding|,2,4,7130000000,1.5%
Q9DBN5,0.00046422,-0.4882,35.53146231,3.8505,0.000279804,7.536836522,-3.43,-2.167,,1.179,1.147,0.83,Q9DBN5,Lonp2,Q9DBN5_Lonp2,Q9DBN5,Lonp2,1,3,2,2,Q9DBN5|Q9DBN5-3|Q8BK80,MOUSE,95038.2,3.5,536,536.1,12.71,12.71,,852,"Lon protease homolog 2, peroxisomal",nucleus|cytoplasm|peroxisome|peroxisomal matrix|membrane|,misfolded or incompletely synthesized protein catabolic process|protein targeting to peroxisome|response to organic cyclic compound|protein processing|protein import into peroxisome matrix|regulation of fatty acid beta-oxidation|,protease binding|ATP-dependent peptidase activity|serine-type endopeptidase activity|receptor binding|protein binding|ATP binding|peptidase activity|enzyme binding|,2,3,1830000000,3.5%
Q9CR42,0.001806964,-0.9136,28.67657033,4.755666667,0.00135626,5.738428122,-5.149,-2.385,,1.075,1.036,0.855,Q9CR42,Ankrd1,Q9CR42_Ankrd1,Q9CR42,Ankrd1,1,3,2,2,Q9CR42,MOUSE,36345.4,5.6,537,537.1,12.7,12.7,,319,Ankyrin repeat domain-containing protein 1,nucleus|transcription factor complex|nucleolus|cytoplasm|cytosol|myofibril|sarcomere|I band|,"negative regulation of transcription from RNA polymerase II promoter|regulation of transcription from RNA polymerase II promoter|positive regulation of neuron projection development|cellular response to drug|skeletal muscle cell differentiation|response to muscle stretch|positive regulation of apoptotic process|positive regulation of DNA damage response, signal transduction by p53 class mediator|positive regulation of transcription from RNA polymerase II promoter|positive regulation of protein secretion|cardiac muscle tissue morphogenesis|cellular response to lipopolysaccharide|cellular response to mechanical stimulus|cellular response to interleukin-1|cellular response to tumor necrosis factor|cellular response to organic cyclic compound|cellular response to hypoxia|cellular response to transforming growth factor beta stimulus|negative regulation of DNA biosynthetic process|",RNA polymerase II transcription factor binding|RNA polymerase II transcription coactivator activity|p53 binding|DNA binding|transcription corepressor activity|protein binding|titin binding|histone deacetylase binding|R-SMAD binding|,2,3,1270000000,5.6%
Q8BYY9,0.03072918,-1.803666667,15.62251545,5.416,0.027399867,2.79657785,-2.359,-1.689,-9.487,1.026,0.93,0.757,Q8BYY9,Serpina3b,Q8BYY9_Serpina3b,Q8BYY9,Serpina3b,1,1,1,1,Q8BYY9,MOUSE,47642.2,2.6,538,538.1,12.69,12.69,,420,Serine protease inhibitor A3B,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,1,1,6810000,2.6%
Q61884,0.000544817,-0.636333333,34.72108723,2.913333333,0.000337203,6.481552065,-2.36,-1.279,-2.64,1.051,0.682,0.728,Q61884,Mns1,Q61884_Mns1,Q61884,Mns1,1,5,2,2,Q61884,MOUSE,60291.8,2.8,539,539.1,12.66,12.66,,491,Meiosis-specific nuclear structural protein 1,nuclear envelope|intermediate filament|axoneme|sperm flagellum|,spermatogenesis|cilium organization|positive regulation of cilium assembly|meiotic cell cycle|left/right axis specification|,identical protein binding|,2,5,223000000,2.8%
Q5S006,0.000336397,-0.5992,37.48453872,4.6005,0.000178462,8.173670136,-4.103,-2.616,,1.444,1.371,0.908,Q5S006,Lrrk2,Q5S006_Lrrk2,Q5S006,Lrrk2,1,4,2,2,Q5S006|V9GX76|V9GXM4|E9Q174|Q64331|E9PVU0|E9Q3L1|E9Q175,MOUSE,288720.5,0.4,540,540.1,12.63,12.63,,2527,Leucine-rich repeat serine/threonine-protein kinase 2,extracellular space|cytoplasm|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|mitochondrial matrix|lysosome|endosome|endoplasmic reticulum|Golgi apparatus|trans-Golgi network|cytosol|plasma membrane|synaptic vesicle|inclusion body|cell junction|axon|dendrite|ribonucleoprotein complex|synaptic vesicle membrane|cytoplasmic vesicle|mitochondrial membrane|cytoplasmic side of mitochondrial outer membrane|dendrite cytoplasm|neuron projection|neuronal cell body|terminal bouton|perikaryon|membrane raft|synapse|extracellular exosome|,"MAPK cascade|activation of MAPKK activity|activation of MAPK activity|negative regulation of protein phosphorylation|positive regulation of protein phosphorylation|protein phosphorylation|endocytosis|autophagy|response to oxidative stress|mitochondrion organization|Golgi organization|lysosome organization|small GTPase mediated signal transduction|neuromuscular junction development|determination of adult lifespan|positive regulation of autophagy|regulation of protein kinase A signaling|negative regulation of protein processing|regulation of neuron maturation|peptidyl-serine phosphorylation|peptidyl-threonine phosphorylation|calcium-mediated signaling|olfactory bulb development|tangential migration from the subventricular zone to the olfactory bulb|positive regulation of protein ubiquitination|negative regulation of protein binding|positive regulation of protein binding|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|negative regulation of GTPase activity|cellular response to oxidative stress|cellular protein localization|intracellular signal transduction|regulation of kidney size|exploration behavior|locomotory exploration behavior|synaptic vesicle recycling|regulation of locomotion|regulation of membrane potential|positive regulation of programmed cell death|positive regulation of GTPase activity|GTP metabolic process|protein autophosphorylation|intracellular distribution of mitochondria|neuron projection morphogenesis|mitochondrion localization|regulation of mitochondrial depolarization|regulation of synaptic transmission, glutamatergic|regulation of excitatory postsynaptic membrane potential|regulation of dopamine receptor signaling pathway|positive regulation of dopamine receptor signaling pathway|regulation of dendritic spine morphogenesis|neuron death|cellular response to manganese ion|reactive oxygen species metabolic process|regulation of neuron death|negative regulation of neuron death|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|positive regulation of protein autoubiquitination|regulation of neuroblast proliferation|regulation of synaptic vesicle transport|negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation|negative regulation of hydrogen peroxide-induced cell death|negative regulation of protein targeting to mitochondrion|cellular response to dopamine|regulation of branching morphogenesis of a nerve|regulation of synaptic vesicle exocytosis|negative regulation of peroxidase activity|",SNARE binding|glycoprotein binding|actin binding|GTPase activity|protein kinase activity|protein serine/threonine kinase activity|MAP kinase kinase activity|GTPase activator activity|protein binding|ATP binding|GTP binding|tubulin binding|kinase activity|Rho GTPase binding|syntaxin-1 binding|clathrin binding|GTP-dependent protein kinase activity|peroxidase inhibitor activity|identical protein binding|protein homodimerization activity|ion channel binding|protein kinase A binding|,2,4,999000000,0.4%
Q8VCC9,0.000714299,0.11125,33.29849506,4.517666667,0.000467897,8.067168645,-3.277,,,0.924,1.492,1.306,Q8VCC9,Spon1,Q8VCC9_Spon1,Q8VCC9,Spon1,1,1,1,1,Q8VCC9,MOUSE,93444.1,1.3,541,541.1,12.6,12.6,,807,Spondin-1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|,cell adhesion|,,1,1,9600000,1.3%
Q3U492,0.000676049,-0.7445,33.57702362,3.386333333,0.000438831,6.206929669,-1.91,-1.784,-3.619,1.06,0.898,0.888,Q3U492,Kcp,Q3U492_Kcp,Q3U492,Kcp,1,2,1,1,Q3U492|Q3U492-2|E9QNB3,MOUSE,178777.4,0.7,542,542.1,12.57,12.57,,1550,Kielin/chordin-like protein,extracellular space|,hematopoietic progenitor cell differentiation|positive regulation of BMP signaling pathway|,protein binding|,1,2,4270000,0.7%
P01627,0.000847266,-0.5176,32.42696386,4.438166667,0.000571878,6.609406857,-4.171,-2.19,,1.492,1.455,0.826,P01627,NotFound,P01627_NotFound,P01627,Gm5153,1,2,1,1,P01627|A0A075B5K5|P01628,MOUSE,13451,13.3,543,543.1,12.56,12.56,,120,Ig kappa chain V-II region VKappa167,,,,1,2,31900000,13.3%
K7N784,0.000176613,-0.627166667,42.72086134,3.155,5.34458E-05,8.677258651,-2.672,-1.969,-1.973,1.116,0.94,0.795,K7N784,NotFound,K7N784_NotFound,K7N784,Vmn2r4,1,2,2,2,K7N784|E9Q277|E9PYL5|H3BK29|E9PZ74|L7N478,MOUSE,104813.9,4.3,544,544.1,12.51,12.51,,913,"Vomeronasal 2, receptor 4",plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|,G-protein coupled receptor activity|,2,2,111000000,4.3%
Q62266,0.72845055,0.25,1.414024017,-0.1825,0.722100421,-0.372776495,0.08,0.639,,-0.085,-0.171,0.787,Q62266,Sprr1a,Q62266_Sprr1a,Q62266,Sprr1a,1,1,1,1,Q62266,MOUSE,16620.8,5.5,545,545.1,12.5,12.5,,144,Cornifin-A,cornified envelope|cytoplasm|cell periphery|,peptide cross-linking|keratinocyte differentiation|keratinization|,"structural molecule activity|protein binding, bridging|",1,1,23300000,5.5%
A0A0A6YW72,0.000153199,-0.6654,45.55631824,4.337666667,2.78207E-05,11.33279127,-3.296,-3.24,,0.922,1.219,1.068,A0A0A6YW72,NotFound,A0A0A6YW72_NotFound,A0A0A6YW72,Dchs2,1,3,2,2,A0A0A6YW72,MOUSE,367194.3,0.7,546,546.1,12.43,12.43,,3346,Dachsous cadherin-related 2,plasma membrane|integral component of membrane|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|,2,3,1980000000,0.7%
E9Q328,0.021806564,-0.254333333,17.14869948,2.01,0.019281022,3.022194818,-0.4,-0.638,-2.74,0.832,0.313,1.107,E9Q328,5430401F13Rik,E9Q328_5430401F13Rik,E9Q328,5430401F13Rik,1,1,1,1,E9Q328|F6URP1,MOUSE,18977.3,6.8,547,547.1,12.39,12.39,,175,RIKEN cDNA 5430401F13 gene,,,,1,1,48900000,6.8%
Q9QYX7,0.004766138,-0.5958,24.14304272,4.890333333,0.003852084,4.636678225,-5.177,-1.883,,2.32,0.809,0.952,Q9QYX7,Pclo,Q9QYX7_Pclo,Q9QYX7,Pclo,1,2,2,2,Q9QYX7|Q9QYX7-2,MOUSE,552707.3,0.6,548,548.1,12.36,12.36,,5068,Protein piccolo,intracellular|postsynaptic density|cell junction|synapse|presynaptic active zone|extracellular exosome|,cytoskeleton organization|synapse assembly|synaptic vesicle targeting|regulation of exocytosis|cAMP-mediated signaling|insulin secretion|,calcium ion binding|protein binding|profilin binding|calcium-dependent phospholipid binding|,2,2,11700000000,0.6%
Q8K426,0.000357489,-0.563166667,37.0421133,3.423,0.000197601,7.066762513,-1.539,-2.729,-2.556,0.935,0.725,1.785,Q8K426,Retnlg,Q8K426_Retnlg,Q8K426,Retnlg,1,2,1,1,Q8K426,MOUSE,13276.1,10.2,550,550.1,12.31,12.31,,117,Resistin-like gamma,extracellular space|,myeloid dendritic cell chemotaxis|,hormone activity|,1,2,23500000,10.2%
Q9WUF3,0.000944378,0.206,31.81381733,4.596,0.000658595,7.499318884,,-3.241,,1.816,1.327,0.922,Q9WUF3,Casp8ap2,Q9WUF3_Casp8ap2,Q9WUF3,Casp8ap2,1,2,2,2,Q9WUF3|E9Q368|Q3V2J0|Q9R0K4|B1AX75,MOUSE,221996.7,0.7,551,551.1,12.3,12.3,,1962,CASP8-associated protein 2,nucleus|cytoplasm|mitochondrion|PML body|,"transcription, DNA-templated|regulation of transcription, DNA-templated|activation of cysteine-type endopeptidase activity involved in apoptotic process|cell cycle|extrinsic apoptotic signaling pathway via death domain receptors|Fas signaling pathway|negative regulation of nucleic acid-templated transcription|",protease binding|DNA binding|transcription corepressor activity|protein binding|cysteine-type endopeptidase activator activity involved in apoptotic process|SUMO polymer binding|identical protein binding|,2,2,764000000,0.7%
Q60963,0.000255214,-0.820166667,39.63784241,3.463,0.000108697,7.769455355,-2.406,-1.915,-3.334,1.074,0.841,0.819,Q60963,Pla2g7,Q60963_Pla2g7,Q60963,Pla2g7,1,2,1,1,Q60963,MOUSE,49599.7,2.7,552,552.1,12.27,12.27,,440,Platelet-activating factor acetylhydrolase,cytoplasm|low-density lipoprotein particle|,inflammatory response|lipid catabolic process|low-density lipoprotein particle remodeling|lipid oxidation|plasma lipoprotein particle oxidation|positive regulation of monocyte chemotaxis|,1-alkyl-2-acetylglycerophosphocholine esterase activity|phospholipid binding|calcium-independent phospholipase A2 activity|,1,2,15800000,2.7%
A0A140LIJ4,0.000368398,-0.724833333,36.82299545,3.921666667,0.000207826,7.009838067,-3.628,-1.764,-2.665,1.731,0.692,1.285,A0A140LIJ4,NotFound,A0A140LIJ4_NotFound,A0A140LIJ4,Dnah14,1,3,2,2,A0A140LIJ4,MOUSE,521611.8,0.6,553,553.1,12.21,12.21,,4489,"Dynein, axonemal, heavy chain 14",,,,2,3,170000000,0.6%
Q8R5K4,0.005133854,0.547,23.79358859,3.84,0.004174853,4.971489863,,-2.333,,2.411,1.11,1,Q8R5K4,Nol6,Q8R5K4_Nol6,Q8R5K4,Nol6,1,6,2,2,Q8R5K4|Q8R5K4-2|Q810B6,MOUSE,130081.4,1.1,554,554.1,11.99,11.99,,1152,Nucleolar protein 6,condensed nuclear chromosome|nucleus|nucleolus|mitochondrion|small-subunit processome|CURI complex|UTP-C complex|,rRNA processing|tRNA export from nucleus|,poly(A) RNA binding|,2,6,1090000000,1.1%
B2RQC6,0.466579682,0.4938,3.38712719,1.148,0.458445043,0.793852049,-2.748,2.358,,1.513,0.408,0.938,B2RQC6,Cad,B2RQC6_Cad,B2RQC6,Cad,1,2,2,2,B2RQC6|G3UWN2|E9QAI5|B2RQC6-2,MOUSE,245801.4,0.7,555,555.1,11.93,11.93,,2225,CAD protein,nucleus|nucleoplasm|cytoplasm|cytosol|plasma membrane|membrane|nuclear matrix|neuronal cell body|terminal bouton|protein complex|extracellular exosome|,urea cycle|liver development|'de novo' pyrimidine nucleobase biosynthetic process|UTP biosynthetic process|arginine biosynthetic process|glutamine metabolic process|heart development|female pregnancy|lactation|response to amine|drug metabolic process|peptidyl-threonine phosphorylation|response to caffeine|organ regeneration|response to testosterone|cellular response to drug|'de novo' UMP biosynthetic process|protein autophosphorylation|response to cortisol|cellular response to epidermal growth factor stimulus|,UTP binding|aspartate carbamoyltransferase activity|carbamoyl-phosphate synthase (ammonia) activity|carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity|dihydroorotase activity|protein kinase activity|ATP binding|zinc ion binding|amino acid binding|enzyme binding|identical protein binding|,2,2,348000000,0.7%
E9Q043,0.000153199,-0.9504,45.40974152,5.867666667,2.87757E-05,11.26677185,-4.999,-3.943,,1.833,1.405,0.952,E9Q043,Fndc1,E9Q043_Fndc1,E9Q043,Fndc1,1,2,1,1,E9Q043,MOUSE,189544.2,0.4,556,556.1,11.86,11.86,,1732,Fibronectin type III domain-containing 1,nucleoplasm|cytoplasm|plasma membrane|cell-cell junction|mitochondrial membrane|,positive regulation of protein phosphorylation|positive regulation of cardiac muscle cell apoptotic process|regulation of protein transport|cellular response to hypoxia|,,1,2,24400000,0.4%
O09010,,1.226,,,,,,,,1,1.399,1.279,O09010,Lfng,O09010_Lfng,O09010,Lfng,1,2,2,2,O09010,MOUSE,42464.9,5.8,557,557.1,11.86,11.86,,378,"Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe",Golgi membrane|integral component of Golgi membrane|extracellular vesicle|,ovarian follicle development|somitogenesis|female meiotic division|compartment pattern specification|metabolic process|regulation of Notch signaling pathway|regulation of somitogenesis|positive regulation of protein binding|positive regulation of Notch signaling pathway|,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity|metal ion binding|,2,2,1.05E+11,5.8%
P24369,0.045611391,-1.3935,13.84705605,3.924333333,0.041237696,2.510823991,-2.471,-0.427,-7.169,0.826,0.551,0.329,P24369,Ppib,P24369_Ppib,P24369,Ppib,1,1,1,1,P24369,MOUSE,23713,6,558,558.1,11.84,11.84,,216,Peptidyl-prolyl cis-trans isomerase B,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|focal adhesion|membrane|macromolecular complex|endoplasmic reticulum chaperone complex|melanosome|perinuclear region of cytoplasm|extracellular exosome|,protein peptidyl-prolyl isomerization|positive regulation of multicellular organism growth|positive regulation by host of viral process|positive regulation by host of viral genome replication|protein stabilization|bone development|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|protein complex binding|peptide binding|poly(A) RNA binding|RNA polymerase binding|collagen binding|,1,1,913000,6.0%
P16015,0.280403902,-0.3774,5.653940354,1.269333333,0.272023212,1.21321019,-2.93,0.652,,0.438,0.237,-0.284,P16015,Car3,P16015_Car3,P16015,Ca3,1,1,1,1,P16015,MOUSE,29651,4.6,559,559.1,11.81,11.81,,260,Carbonic anhydrase 3,cytosol|,one-carbon metabolic process|response to oxidative stress|dephosphorylation|response to ethanol|,carbonate dehydratase activity|zinc ion binding|nickel cation binding|phosphatase activity|,1,1,24900000,4.6%
P21550,0.092313464,-0.924833333,10.66129895,2.301,0.085875663,2.006798377,-1.481,0.06,-4.805,0.414,-0.064,0.327,P21550,Eno3,P21550_Eno3,P21550,Eno3,1,4,2,2,P21550,MOUSE,47366.4,2.9,560,560.1,11.79,11.79,,434,Beta-enolase,phosphopyruvate hydratase complex|extracellular space|cytoplasm|plasma membrane|extracellular exosome|,glycolytic process|aging|response to drug|skeletal muscle tissue regeneration|,magnesium ion binding|phosphopyruvate hydratase activity|protein homodimerization activity|protein heterodimerization activity|,2,4,17700000000,2.9%
K3W4R5,0.000431712,-0.7568,35.92827433,4.330333333,0.000255372,7.662718145,-4.152,-2.558,,1.098,0.921,0.907,K3W4R5,Ckap5,K3W4R5_Ckap5,K3W4R5,Ckap5,1,2,2,2,K3W4R5|A2AGT5|A0A0R4J0K2|A2AGT5-3|Z4YL78|A2AGT5-2,MOUSE,227286.2,0.7,561,561.1,11.78,11.78,,2032,Cytoskeleton-associated protein 5,spindle pole|cytoplasm|centrosome|membrane|protein complex|gamma-tubulin complex|microtubule plus-end|,spindle organization|establishment or maintenance of microtubule cytoskeleton polarity|centrosome organization|,microtubule binding|ribonucleoprotein complex binding|,2,2,274000000,0.7%
Q8VCY6,0.013155023,0.4128,19.4614589,2.904666667,0.0113202,3.649500409,-0.258,-2.402,,1.897,2.128,0.699,Q8VCY6,Utp6,Q8VCY6_Utp6,Q8VCY6,Utp6,1,2,2,2,Q8VCY6|Q6I6G8|Q9JLV2|Q9JLV2-2|A0A0R4J0M8|Q8CDV6|Q8CDV6-2|Q9DAQ9|Q9DAQ9-2|A0A1L1SQQ1,MOUSE,70941.6,2.1,562,562.1,11.78,11.78,,597,U3 small nucleolar RNA-associated protein 6 homolog,nucleolus|small-subunit processome|Pwp2p-containing subcomplex of 90S preribosome|,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|",snoRNA binding|,2,2,76400000,2.1%
Q64323,0.000145021,-1.1156,49.43269949,5.745666667,1.13954E-05,13.21480545,-4.198,-4.928,,1.217,1.371,0.96,Q64323,Piga,Q64323_Piga,Q64323,Piga,1,1,1,1,Q64323|A0A140LI97,MOUSE,55095.4,1.4,563,563.1,11.77,11.77,,485,N-acetylglucosaminyl-phosphatidylinositol biosynthetic protein,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex|endoplasmic reticulum membrane|membrane|integral component of membrane|,GPI anchor biosynthetic process|,"transferase activity, transferring glycosyl groups|",1,1,154000000,1.4%
O89001,0.000854278,-0.532,32.35967961,5.0925,0.000580807,6.702305022,-4.57,-2.605,,2.36,0.876,1.279,O89001,Cpd,O89001_Cpd,O89001,Cpd,1,6,2,2,O89001,MOUSE,153429.8,1,564,564.1,11.77,11.77,,1377,Carboxypeptidase D,membrane|integral component of membrane|extracellular exosome|,proteolysis|,metallocarboxypeptidase activity|serine-type carboxypeptidase activity|zinc ion binding|,2,6,6510000000,1.0%
O54988,0.000145021,-0.9714,49.06273112,5.450166667,1.24087E-05,13.02330366,-4.511,-3.972,,1.317,1.366,0.943,O54988,Slk,O54988_Slk,O54988,Slk,1,7,2,2,O54988|O54988-2,MOUSE,142138.8,1.3,565,565.1,11.67,11.67,,1233,STE20-like serine/threonine-protein kinase,cytoplasm|extracellular exosome|,apoptotic process|regulation of mitotic cell cycle|signal transduction by protein phosphorylation|stress-activated protein kinase signaling cascade|activation of protein kinase activity|regulation of apoptotic process|protein autophosphorylation|,protein serine/threonine kinase activity|ATP binding|identical protein binding|protein homodimerization activity|,2,7,388000000,1.3%
A2AFQ0,0.010708504,-0.538,20.39544658,3.155,0.009129676,3.836118031,-3.799,-1.063,,0.857,0.71,0.605,A2AFQ0,Huwe1,A2AFQ0_Huwe1,A2AFQ0,Huwe1,1,2,2,2,A2AFQ0|Q7TMY8|Q7TMY8-3|Q7TMY8-4|Q7TMY8-2|Q8K482|Q8BLW8,MOUSE,486619.9,0.2,566,566.1,11.67,11.67,,4378,E3 ubiquitin-protein ligase HUWE1,nucleoplasm|cytoplasm|membrane|extracellular exosome|,protein polyubiquitination|base-excision repair|protein monoubiquitination|histone ubiquitination|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of protein targeting to mitochondrion|,ubiquitin-protein transferase activity|ligase activity|poly(A) RNA binding|,2,2,49700000,0.2%
Q80TF3,0.366239447,1.2516,4.47188664,2.415166667,0.357117667,0.999943532,-2.142,1.747,,6.816,0.408,-0.571,Q80TF3,Pcdh19,Q80TF3_Pcdh19,Q80TF3,Pcdh19,1,2,2,2,Q80TF3|E9Q5E1,MOUSE,127231.1,1.5,567,567.1,11.66,11.66,,1145,Protocadherin-19,plasma membrane|integral component of membrane|,homophilic cell adhesion via plasma membrane adhesion molecules|brain development|,calcium ion binding|,2,2,20600000000,1.5%
A0A075B5L3,0.002477539,-0.208833333,27.14814967,2.076333333,0.001928346,4.812182473,-1.787,-0.611,-1.343,1.021,0.428,1.039,A0A075B5L3,NotFound,A0A075B5L3_NotFound,A0A075B5L3,Igkv4-90,1,1,1,1,A0A075B5L3,MOUSE,12723.1,13.6,568,568.1,11.65,11.65,,117,Immunoglobulin kappa chain variable 4-90 (Fragment),,,,1,1,3050000,13.6%
P09411,0.000304926,-1.147666667,38.10250388,4.381333333,0.000154792,7.347401936,-3.323,-2.191,-4.501,1.244,0.957,0.928,P09411,Pgk1,P09411_Pgk1,P09411,Pgk1,1,3,2,2,P09411,MOUSE,44949.1,4.3,569,569.1,11.62,11.62,,417,Phosphoglycerate kinase 1,cytoplasm|,glycolytic process|phosphorylation|,phosphoglycerate kinase activity|ATP binding|,2,3,205000000,4.3%
E9PUU4,0.000167312,-0.5254,43.23827971,4.719333333,4.7443E-05,10.32914234,-3.362,-3.352,,1.905,1.254,0.928,E9PUU4,Gemin5,E9PUU4_Gemin5,E9PUU4,Gemin5,1,5,2,2,E9PUU4|Q8BX17|A2AFQ9,MOUSE,169370,1.3,570,570.1,11.56,11.56,,1503,Gem-associated protein 5,nucleus|nucleoplasm|cytoplasm|cytosol|membrane|nuclear body|SMN complex|SMN-Sm protein complex|,spliceosomal snRNP assembly|,snRNA binding|poly(A) RNA binding|,2,5,3090000000,1.3%
Q8BLR5,0.026296486,0.3638,16.30511786,3.777166667,0.023414679,3.050358612,-3.02,-0.785,,4.05,0.506,1.068,Q8BLR5,Psd4,Q8BLR5_Psd4,Q8BLR5,Psd4,1,2,1,1,Q8BLR5,MOUSE,113986.3,0.7,571,571.1,11.54,11.54,,1005,PH and SEC7 domain-containing protein 4,plasma membrane|membrane|cell junction|trans-Golgi network|,neuron differentiation|regulation of ARF protein signal transduction|positive regulation of GTPase activity|vesicle-mediated transport|,ARF guanyl-nucleotide exchange factor activity|lipid binding|,1,2,109000000,0.7%
P27106,0.000167312,-0.655,43.23332205,4.536666667,4.74972E-05,10.32708561,-3.747,-3.007,,1.362,0.907,1.21,P27106,NotFound,P27106_NotFound,P27106,Amh,1,4,1,1,P27106|Q5EC55,MOUSE,60405,1,572,572.1,11.49,11.49,,555,Muellerian-inhibiting factor,extracellular region|,gonadal mesoderm development|cell differentiation|,growth factor activity|,1,4,406000000,1.0%
Q8BYH8,0.000158712,-0.8262,44.61725911,4.6305,3.45362E-05,10.91591647,-3.237,-3.972,,0.921,1.092,1.065,Q8BYH8,Chd9,Q8BYH8_Chd9,Q8BYH8,Chd9,1,2,2,2,Q8BYH8|Q8BYH8-2|A0A1B0GR76,MOUSE,326022.2,0.8,573,573.1,11.48,11.48,,2885,Chromodomain-helicase-DNA-binding protein 9,nucleus|cytoplasm|plasma membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|",DNA binding|helicase activity|ATP binding|,2,2,58600000,0.8%
Q03717,0.009178009,-0.269,21.10097313,3.167333333,0.007760732,3.726493097,-3.759,-1.341,-0.458,1.625,0.683,1.636,Q03717,Kcnb1,Q03717_Kcnb1,Q03717,Kcnb1,1,3,2,2,Q03717,MOUSE,96445.6,2.2,574,574.1,11.39,11.39,,857,Potassium voltage-gated channel subfamily B member 1,intracellular|plasma membrane|voltage-gated potassium channel complex|integral component of membrane|lateral plasma membrane|cell junction|axon|dendrite|dendrite membrane|neuronal cell body membrane|sarcolemma|perikaryon|postsynaptic membrane|,action potential|potassium ion transport|vesicle docking involved in exocytosis|glutamate receptor signaling pathway|positive regulation of norepinephrine secretion|cellular response to nutrient levels|positive regulation of catecholamine secretion|regulation of ion transmembrane transport|glucose homeostasis|positive regulation of calcium ion-dependent exocytosis|negative regulation of insulin secretion|protein homooligomerization|cellular response to glucose stimulus|potassium ion transmembrane transport|protein targeting to plasma membrane|positive regulation of protein targeting to membrane|regulation of action potential|positive regulation of long term synaptic depression|regulation of motor neuron apoptotic process|,voltage-gated potassium channel activity|delayed rectifier potassium channel activity|protein binding|outward rectifier potassium channel activity|ubiquitin-like protein binding|ion channel binding|protein heterodimerization activity|protein N-terminus binding|,2,3,56500000,2.2%
Q3TQQ9-2,0.000514795,-0.775333333,34.99354078,3.291333333,0.000316698,6.548262453,-1.786,-2.025,-3.452,0.786,0.992,0.833,Q3TQQ9,BC055324,Q3TQQ9-2_BC055324,Q3TQQ9-2,,1,5,1,1,Q3TQQ9-2|Q3TQQ9|Q3TQQ9-3,MOUSE,105599.9,1.5,575,575.1,11.33,11.33,,903,Isoform 2 of Uncharacterized protein C1orf112 homolog,,,,1,5,188000000,1.5%
Q8CB77,0.00029264,-0.5946,38.42885513,4.494,0.000143587,8.4976723,-3.992,-2.59,,1.22,1.303,1.086,Q8CB77,Eloa,Q8CB77_Eloa,Q8CB77,Eloa,1,2,2,2,Q8CB77,MOUSE,87502.1,3.6,576,576.1,11.33,11.33,,773,Elongin-A,extracellular space|nucleus|cytoplasm|integral component of membrane|elongin complex|,regulation of transcription from RNA polymerase II promoter|transcription elongation from RNA polymerase II promoter|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,DNA binding|ubiquitin-protein transferase activity|,2,2,217000000,3.6%
A7DTG3,0.000237548,-0.3968,40.14415791,3.573666667,9.67351E-05,9.114820625,-2.372,-2.71,,0.996,1.19,0.912,A7DTG3,Sertad4,A7DTG3_Sertad4,A7DTG3,Sertad4,1,4,1,1,A7DTG3,MOUSE,41836.9,1.8,577,577.1,11.31,11.31,,377,SERTA domain-containing protein 4,nucleus|,,,1,4,177000000,1.8%
E9PZ26,0.000145021,-0.572,47.58889814,4.693333333,1.74225E-05,12.28597396,-3.415,-3.361,,1.463,1.264,1.189,E9PZ26,Brd1,E9PZ26_Brd1,E9PZ26,Brd1,1,2,2,2,E9PZ26|G5E8P1|E9Q412,MOUSE,135652.4,1.2,578,578.1,11.3,11.3,,1189,Bromodomain-containing 1,nucleus|nucleoplasm|dendrite|perikaryon|MOZ/MORF histone acetyltransferase complex|,response to immobilization stress|histone H3 acetylation|response to electrical stimulus|,zinc ion binding|histone binding|,2,2,788000000,1.2%
P97366,0.000265003,-0.2302,39.17593588,3.698833333,0.000120894,8.761820333,-2.367,-2.532,,1.635,1.194,0.919,P97366,NotFound,P97366_NotFound,P97366,Evi5,1,2,2,2,P97366|F8VPT6,MOUSE,93682.9,3.4,579,579.1,11.24,11.24,,809,Ecotropic viral integration site 5 protein,nucleus|Golgi apparatus|microtubule organizing center|spindle|cytosol|intracellular membrane-bounded organelle|,"cell cycle|retrograde transport, endosome to Golgi|positive regulation of GTPase activity|cell division|",GTPase activator activity|Rab GTPase binding|,2,2,354000000,3.4%
P62242,0.062729412,-0.104666667,12.4154827,1.148,0.057339213,2.27078261,-1.687,-0.178,-0.171,0.153,0.595,0.66,P62242,Rps8,P62242_Rps8,P62242,Rps8,1,1,1,1,P62242,MOUSE,24490,4.3,580,580.1,11.22,11.22,,208,40S ribosomal protein S8,nucleus|cytoplasm|focal adhesion|membrane|cytosolic small ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|translation|",structural constituent of ribosome|poly(A) RNA binding|,1,1,2470000000,4.3%
Q6A037,0.000305711,-0.4904,38.07681458,3.991,0.000155711,8.375613999,-3.383,-2.387,,1.397,1.005,0.916,Q6A037,N4bp1,Q6A037_N4bp1,Q6A037,N4bp1,1,6,2,2,Q6A037,MOUSE,99886.7,3.1,581,581.1,11.18,11.18,,893,NEDD4-binding protein 1,nucleus|nucleolus|PML body|,negative regulation of protein ubiquitination|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|cellular response to UV|,protein binding|,2,6,1240000000,3.1%
E9PX59,0.000152509,-0.6492,45.82486292,5.103,2.61525E-05,11.45467252,-3.518,-3.904,,1.45,1.776,0.95,E9PX59,Samd9l,E9PX59_Samd9l,E9PX59,Samd9l,1,3,2,2,E9PX59|Q69Z37,MOUSE,184076.8,1,582,582.1,11.15,11.15,,1579,Sterile alpha motif domain-containing protein 9-like,early endosome|,hematopoietic progenitor cell differentiation|stem cell division|endosomal vesicle fusion|common myeloid progenitor cell proliferation|regulation of protein catabolic process|spleen development|,,2,3,395000000,1.0%
Q69ZS0,0.000153199,-0.66,45.39925284,4.874166667,2.88453E-05,11.26206127,-3.986,-3.183,,1.226,1.398,1.245,Q69ZS0,Pdzrn3,Q69ZS0_Pdzrn3,Q69ZS0,Pdzrn3,1,2,2,2,Q69ZS0|Q69ZS0-3|Q69ZS0-2,MOUSE,120996.6,1.6,583,583.1,11.12,11.12,,1063,E3 ubiquitin-protein ligase PDZRN3,neuromuscular junction|,neuromuscular junction development|protein ubiquitination|,ubiquitin-protein transferase activity|protein binding|zinc ion binding|ligase activity|ubiquitin protein ligase activity|,2,2,889000000,1.6%
Q3TPE1,0.002407041,0.093,27.28743962,2.1275,0.00186748,5.271394395,-1.433,-0.934,,1.051,0.996,0.785,Q3TPE1,NotFound,Q3TPE1_NotFound,Q3TPE1,Vwf,1,2,2,2,Q3TPE1|Q3TD35|Q8CIZ8-2,MOUSE,46792.8,3.7,584,584.1,11.11,11.11,,405,von Willebrand factor,extracellular region|proteinaceous extracellular matrix|endoplasmic reticulum|external side of plasma membrane|extracellular matrix|Weibel-Palade body|extracellular exosome|,liver development|placenta development|cell adhesion|blood coagulation|hemostasis|platelet activation|cell-substrate adhesion|protein homooligomerization|platelet activation|,glycoprotein binding|protease binding|integrin binding|protein binding|collagen binding|immunoglobulin binding|identical protein binding|protein homodimerization activity|protein N-terminus binding|chaperone binding|,2,2,116000000,3.7%
Q9JK39-2,0.000261034,-0.4778,39.36671039,3.6995,0.000115699,8.8304095,-3.029,-2.366,,1.06,1.096,0.85,Q9JK39,Btnl10,Q9JK39-2_Btnl10,Q9JK39-2,Btnl10,1,2,1,1,Q9JK39-2|Q9JK39|A0A0R4J1C6,MOUSE,54778.1,1.4,585,585.1,11.03,11.03,,275,Isoform 2 of Butyrophilin-like protein 10,integral component of membrane|,,,1,2,9720000,1.4%
P54822,0.000336397,-0.215,37.48657977,3.73,0.000178378,8.174358813,-2.759,-2.147,,1.504,0.827,1.5,P54822,Adsl,P54822_Adsl,P54822,Adsl,1,1,1,1,P54822|E9Q242,MOUSE,55607,2.2,586,586.1,11.02,11.02,,484,Adenylosuccinate lyase,mitochondrion|cytosol|,response to hypoxia|AMP biosynthetic process|'de novo' IMP biosynthetic process|response to nutrient|aerobic respiration|response to muscle activity|response to starvation|'de novo' AMP biosynthetic process|protein tetramerization|,"N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity|(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity|",1,1,28900000,2.2%
A2AFG3,0.000164821,-0.7448,44.16046289,5.022,3.83666E-05,10.71825958,-4.187,-3.329,,1.562,1.304,0.926,A2AFG3,Pdzd4,A2AFG3_Pdzd4,A2AFG3,Pdzd4,1,3,2,2,A2AFG3,MOUSE,74414.1,2.4,587,587.1,10.97,10.97,,657,PDZ domain-containing protein 4,,protein ubiquitination|,ubiquitin protein ligase activity|,2,3,889000000,2.4%
Q62056,0.000347959,-0.8888,37.22706013,4.5395,0.000189363,8.087190581,-4.406,-2.819,,0.894,0.969,0.918,Q62056,Psg17,Q62056_Psg17,Q62056,Psg17,1,1,1,1,Q62056,MOUSE,53425.2,4,588,588.1,10.95,10.95,,475,MCG130054,,immune response|female pregnancy|,protein binding|heparan sulfate proteoglycan binding|,1,1,227000000,4.0%
Q8BXX9,0.000145021,-1.0175,51.82200774,3.856333333,6.57354E-06,11.91347691,-2.962,-2.726,-3.149,0.935,0.903,0.894,Q8BXX9,Ccdc169,Q8BXX9_Ccdc169,Q8BXX9,Ccdc169,1,4,1,1,Q8BXX9|D3YWT6|Q8BXX9-2|E9Q3J3,MOUSE,24753.8,4.6,589,589.1,10.92,10.92,,214,Coiled-coil domain-containing protein 169,,,,1,4,99200000,4.6%
Q8VCQ6,0.000332899,-0.138,37.55110952,5.568,0.000175747,9.910575658,,-4.314,,1.555,1.244,0.963,Q8VCQ6,Sgms1,Q8VCQ6_Sgms1,Q8VCQ6,Sgms1,1,1,1,1,Q8VCQ6|E3W996|Q8VCQ6-3|Q8VCQ6-2,MOUSE,49829.3,2.1,590,590.1,10.92,10.92,,419,Phosphatidylcholine:ceramide cholinephosphotransferase 1,Golgi trans cisterna|nucleus|endoplasmic reticulum|plasma membrane|membrane|integral component of Golgi membrane|,sphingomyelin biosynthetic process|apoptotic process|cell growth|phosphorylation|negative regulation of extrinsic apoptotic signaling pathway|,kinase activity|sphingomyelin synthase activity|ceramide cholinephosphotransferase activity|,1,1,31400000,2.1%
P07214,0.000261034,-0.5232,39.36613955,3.793,0.000115714,8.830203569,-3.181,-2.417,,1.048,0.858,1.076,P07214,Sparc,P07214_Sparc,P07214,Sparc,1,1,1,1,A0A1L1SSH9|P07214|Q5NCU4,MOUSE,35305.2,3.3,591,591.1,10.9,10.9,,302,SPARC,proteinaceous extracellular matrix|basement membrane|extracellular space|cell surface|nuclear matrix|platelet alpha granule|platelet alpha granule membrane|,negative regulation of endothelial cell proliferation|signal transduction|heart development|response to gravity|response to lead ion|positive regulation of endothelial cell migration|negative regulation of angiogenesis|regulation of cell morphogenesis|lung development|response to lipopolysaccharide|response to L-ascorbic acid|response to cytokine|wound healing|regulation of cell proliferation|response to peptide hormone|response to ethanol|response to cadmium ion|inner ear development|response to glucocorticoid|response to cAMP|response to calcium ion|bone development|cellular response to growth factor stimulus|,calcium ion binding|collagen binding|extracellular matrix binding|,1,1,6280000,3.3%
P50544,0.004454698,-1.202166667,24.45664733,4.755,0.00358373,4.347925622,-2.839,-1.761,-6.139,1.938,0.765,0.823,P50544,Acadvl,P50544_Acadvl,P50544,Acadvl,1,3,2,2,P50544|B1AR28,MOUSE,71273.6,4.2,592,592.1,10.89,10.89,,656,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial",nucleus|nucleolus|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial nucleoid|,temperature homeostasis|epithelial cell differentiation|fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of fatty acid biosynthetic process|negative regulation of fatty acid oxidation|regulation of cholesterol metabolic process|,acyl-CoA dehydrogenase activity|flavin adenine dinucleotide binding|,2,3,102000000,4.2%
P08228,0.051413778,-0.552,13.30313167,1.686666667,0.046739798,2.416124245,-2.18,0.235,-2.241,0.462,0.053,0.359,P08228,Sod1,P08228_Sod1,P08228,Sod1,1,2,2,2,P08228,MOUSE,16113.6,13.6,593,593.1,10.87,10.87,,154,Superoxide dismutase [Cu-Zn],extracellular space|nucleus|nucleoplasm|cytoplasm|mitochondrion|mitochondrial intermembrane space|lysosome|peroxisome|cytosol|extracellular matrix|dense core granule|cytoplasmic vesicle|dendrite cytoplasm|neuronal cell body|myelin sheath|protein complex|extracellular exosome|plasma membrane|,activation of MAPK activity|response to reactive oxygen species|response to superoxide|ovarian follicle development|positive regulation of cytokine production|retina homeostasis|response to amphetamine|myeloid cell homeostasis|glutathione metabolic process|superoxide metabolic process|cellular iron ion homeostasis|response to oxidative stress|spermatogenesis|embryo implantation|aging|cell aging|sensory perception of sound|locomotory behavior|anterograde axon cargo transport|retrograde axon cargo transport|regulation of blood pressure|response to heat|response to organic substance|transmission of nerve impulse|removal of superoxide radicals|response to nutrient levels|peripheral nervous system myelin maintenance|positive regulation of superoxide anion generation|response to carbon monoxide|cellular response to potassium ion|regulation of multicellular organism growth|response to drug|response to hydrogen peroxide|superoxide anion generation|negative regulation of apoptotic process|positive regulation of catalytic activity|regulation of GTPase activity|negative regulation of neuron apoptotic process|response to ethanol|negative regulation of cholesterol biosynthetic process|regulation of protein kinase activity|response to antibiotic|response to copper ion|muscle cell cellular homeostasis|response to axon injury|hydrogen peroxide biosynthetic process|regulation of mitochondrial membrane potential|oxidation-reduction process|heart contraction|neurofilament cytoskeleton organization|relaxation of vascular smooth muscle|auditory receptor cell stereocilium organization|cellular response to cadmium ion|cellular response to ATP|reactive oxygen species metabolic process|response to antipsychotic drug|positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,superoxide dismutase activity|copper ion binding|protein binding|zinc ion binding|protein phosphatase 2B binding|identical protein binding|Rac GTPase binding|chaperone binding|,2,2,13900000,13.6%
Q8VGD7,0.361624526,-0.694666667,4.532509147,1.356666667,0.352167347,0.998493364,0.731,-0.065,-4.785,0.062,-0.317,0.206,Q8VGD7,Olfr1395,Q8VGD7_Olfr1395,Q8VGD7,Olfr1395,1,3,1,1,Q8VGD7|Q8VFM4|Q9EPF5|Q8VFM5|Q9EPF6|Q7TRN3|K7N641,MOUSE,36080.7,2.2,594,594.1,10.85,10.85,,317,Olfactory receptor 1395,plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|sensory perception of smell|detection of chemical stimulus involved in sensory perception of smell|,G-protein coupled receptor activity|olfactory receptor activity|,1,3,993000000,2.2%
S4R1G0,0.000157801,-0.6074,44.73608864,4.449333333,3.3604E-05,10.96787836,-3.547,-3.007,,1.119,1.313,1.085,S4R1G0,NotFound,S4R1G0_NotFound,S4R1G0,Dnase2a,1,2,2,2,S4R1G0,MOUSE,16303.3,13.4,595,595.1,10.83,10.83,,149,Deoxyribonuclease II alpha,lysosome|extracellular exosome|,"DNA catabolic process, endonucleolytic|DNA catabolic process|apoptotic DNA fragmentation|erythrocyte differentiation|",deoxyribonuclease II activity|,2,2,81600000,13.4%
Q80W93,0.000192766,-0.4862,41.98192201,4.1905,6.33589E-05,9.819614684,-3.271,-2.73,,1.438,1.245,0.887,Q80W93,Hydin,Q80W93_Hydin,Q80W93,Hydin,1,2,2,2,Q80W93|Q80W93-2,MOUSE,587046.8,0.3,596,596.1,10.78,10.78,,5154,Hydrocephalus-inducing protein,axonemal central pair projection|,epithelial cell development|cilium movement|multicellular organismal development|ventricular system development|axoneme assembly|trachea development|,,2,2,4010000000,0.3%
Q3U129,0.001545835,-0.524,29.41035522,3.769166667,0.001145419,5.796944784,-3.78,-1.791,,0.906,0.861,1.184,Q3U129,B3gntl1,Q3U129_B3gntl1,Q3U129,B3gntl1,1,2,2,2,Q3U129|Q3U129-2,MOUSE,41042.7,7.8,597,597.1,10.78,10.78,,357,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1",,metabolic process|,"transferase activity, transferring glycosyl groups|",2,2,27000000,7.8%
A0A0B4J1K5,0.000867406,0.04075,32.26130287,4.039666667,0.000594114,7.666694715,,-2.989,,1.1,0.906,1.146,A0A0B4J1K5,NotFound,A0A0B4J1K5_NotFound,A0A0B4J1K5,Iglv3,1,1,1,1,A0A0B4J1K5,MOUSE,13587,8.1,598,598.1,10.77,10.77,,122,Immunoglobulin lambda variable 3 (Fragment),,,,1,1,9210000,8.1%
Q9JL04,0.000145021,-0.8508,48.62105426,5.438666667,1.37371E-05,12.79810092,-4.023,-4.205,,0.964,1.705,1.305,Q9JL04,Fmn2,Q9JL04_Fmn2,Q9JL04,Fmn2,1,3,1,1,Q9JL04,MOUSE,168696,0.5,599,599.1,10.73,10.73,,1578,Formin-2,nucleolus|endoplasmic reticulum|endoplasmic reticulum membrane|spindle|cytosol|actin filament|plasma membrane|microvillus|cell cortex|cytoplasmic vesicle membrane|actin cytoskeleton|,cellular response to DNA damage stimulus|multicellular organismal development|protein transport|vesicle-mediated transport|meiotic chromosome movement towards spindle pole|polar body extrusion after meiotic divisions|negative regulation of protein catabolic process|negative regulation of apoptotic process|actin nucleation|intracellular transport|oogenesis|actin filament bundle assembly|establishment of meiotic spindle localization|homologous chromosome movement towards spindle pole involved in homologous chromosome segregation|formin-nucleated actin cable assembly|cellular response to hypoxia|,actin binding|microtubule binding|,1,3,84100000,0.5%
Q9R0N0,0.045818319,-0.1652,13.82141986,2.454666667,0.04148184,2.606791794,-3.141,-0.135,,1.197,0.123,1.13,Q9R0N0,Galk1,Q9R0N0_Galk1,Q9R0N0,Galk1,1,1,1,1,Q9R0N0,MOUSE,42693.8,2.2,600,600.1,10.7,10.7,,392,Galactokinase,cytoplasm|membrane|extracellular exosome|,galactose metabolic process|galactitol metabolic process|carbohydrate phosphorylation|,galactokinase activity|protein binding|ATP binding|galactose binding|,1,1,9090000,2.2%
Q8R422,0.002005185,-1.0875,28.17943744,4.771666667,0.001520745,5.098458425,-4.966,-4.228,-1.226,0.977,1.512,1.406,Q8R422,Cd109,Q8R422_Cd109,Q8R422,Cd109,1,5,1,1,Q8R422,MOUSE,162454.4,0.4,601,601.1,10.68,10.68,,1442,CD109 antigen,extracellular space|plasma membrane|cell surface|anchored component of membrane|,negative regulation of protein phosphorylation|hair follicle development|negative regulation of keratinocyte proliferation|negative regulation of endopeptidase activity|negative regulation of transforming growth factor beta receptor signaling pathway|regulation of keratinocyte differentiation|negative regulation of wound healing|osteoclast fusion|,serine-type endopeptidase inhibitor activity|transforming growth factor beta binding|,1,5,23300000000,0.4%
Q8R1L8,0.000504365,-0.3192,35.10889458,3.3705,0.000308397,7.404684386,-2.788,-1.895,,1.166,0.792,1.129,Q8R1L8,Angptl8,Q8R1L8_Angptl8,Q8R1L8,Angptl8,1,1,1,1,Q8R1L8,MOUSE,22119.7,8,602,602.1,10.67,10.67,,198,Angiopoietin-like protein 8,extracellular region|,glucose metabolic process|positive regulation of protein processing|regulation of lipid metabolic process|cellular lipid metabolic process|type B pancreatic cell proliferation|fat cell differentiation|cell maturation|regulation of lipoprotein metabolic process|negative regulation of lipoprotein lipase activity|triglyceride homeostasis|glucose metabolic process|type B pancreatic cell proliferation|,hormone activity|,1,1,22500000,8.0%
Q922W6,0.000353996,-0.226,37.1325299,4.075,0.000193529,8.055637388,-3.197,-2.145,,1.818,1.086,1.308,Q922W6,Mmp3,Q922W6_Mmp3,Q922W6,Mmp3,1,2,2,2,Q922W6|P28862,MOUSE,54388.8,3.3,603,603.1,10.65,10.65,,479,Matrix metalloproteinase,extracellular matrix|,proteolysis|negative regulation of hydrogen peroxide metabolic process|regulation of cell migration|positive regulation of protein oligomerization|cellular response to amino acid stimulus|,endopeptidase activity|metalloendopeptidase activity|calcium ion binding|zinc ion binding|,2,2,2640000000,3.3%
P15105,0.244422611,0.0805,6.278332052,0.633666667,0.235595394,1.2972144,-0.683,0.181,-0.207,0.885,-0.466,0.773,P15105,Glul,P15105_Glul,P15105,Glul,1,1,1,1,P15105,MOUSE,42860.6,2.1,604,604.1,10.63,10.63,,373,Glutamine synthetase,nucleus|cytoplasm|mitochondrion|rough endoplasmic reticulum|perikaryon|myelin sheath|protein complex|axon terminus|cell body|extracellular exosome|glial cell projection|,"glutamate metabolic process|glutamine biosynthetic process|cell proliferation|cellular response to starvation|response to glucose|positive regulation of insulin secretion|positive regulation of epithelial cell proliferation|protein homooligomerization|positive regulation of synaptic transmission, glutamatergic|",magnesium ion binding|glutamate decarboxylase activity|glutamate-ammonia ligase activity|protein binding|ATP binding|glutamate binding|manganese ion binding|identical protein binding|dynein light chain binding|,1,1,14000000,2.1%
E9Q9C6,0.193514027,-0.599666667,7.320767547,1.493333333,0.185320407,1.473220168,0.544,-0.855,-3.728,0.048,0.364,0.029,E9Q9C6,Fcgbp,E9Q9C6_Fcgbp,E9Q9C6,Fcgbp,1,7,1,1,E9PVG8|E9Q9C6|E9Q0B5,MOUSE,287674,0.3,605,605.1,10.61,10.61,,2583,Fc fragment of IgG-binding protein,proteinaceous extracellular matrix|extracellular exosome|,,,1,7,24200000000,0.3%
P68500,0.000426279,-0.0385,36.00875653,5.083333333,0.000250683,9.202239003,,,-3.851,1.462,1.286,0.949,P68500,Cntn5,P68500_Cntn5,P68500,Cntn5,1,2,2,2,P68500|E9PYK7,MOUSE,121542.8,4.8,606,606.1,10.61,10.61,,1098,Contactin-5,cytoplasm|plasma membrane|anchored component of membrane|,cell adhesion|sensory perception of sound|,,2,2,277000000,4.8%
Q8R000,0.000926766,0.2705,31.90333779,4.595333333,0.000645158,7.532548125,,-3.176,,0.918,1.744,1.596,Q8R000,Slc51a,Q8R000_Slc51a,Q8R000,Slc51a,1,1,1,1,Q8R000,MOUSE,38614.3,2.3,607,607.1,10.57,10.57,,340,Organic solute transporter subunit alpha,endoplasmic reticulum membrane|plasma membrane|integral component of membrane|protein complex|,transport|bile acid and bile salt transport|,transporter activity|protein binding|protein homodimerization activity|protein heterodimerization activity|,1,1,53700000,2.3%
E9Q3E2,0.00172683,-0.4535,28.90764855,3.106333333,0.001285983,5.170908868,-1.229,-3.337,-1.454,0.955,0.98,1.364,E9Q3E2,Synpo,E9Q3E2_Synpo,E9Q3E2,Synpo,1,2,2,2,E9Q3E2|Q8CC35|Q8CC35-2|Q8CC35-3,MOUSE,118083.3,2.9,608,608.1,10.52,10.52,,1100,Synaptopodin,actin cytoskeleton|dendrite|axon|,positive regulation of actin filament bundle assembly|,actin binding|,2,2,574000000,2.9%
Q9D6P8,0.130951589,-0.966166667,9.085088929,2.222333333,0.123450004,1.757282135,-2.424,0.802,-4.61,0.549,-0.465,0.351,Q9D6P8,Calml3,Q9D6P8_Calml3,Q9D6P8,Calml3,1,1,1,1,P0DP28|Q9D6P8,MOUSE,16701.1,8.7,609,609.1,10.52,10.52,,149,Calmodulin-like protein 3,extracellular exosome|,,calcium ion binding|,1,1,3520000,8.7%
Q6DFZ1,0.000145021,-0.852,48.3907227,5.365,1.44853E-05,12.68211421,-4.009,-4.133,,1.174,1.708,1,Q6DFZ1,Gbf1,Q6DFZ1_Gbf1,Q6DFZ1,Gbf1,1,3,2,2,Q6DFZ1,MOUSE,208832.4,1,610,610.1,10.49,10.49,,1861,Golgi-specific brefeldin A-resistance factor 1,Golgi membrane|mitochondrion|peroxisome|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi stack|cis-Golgi network|trans-Golgi network|plasma membrane|membrane|cell leading edge|trans-Golgi network|,"cell activation involved in immune response|retrograde vesicle-mediated transport, Golgi to ER|Golgi to endosome transport|Golgi organization|regulation of mitotic cell cycle|regulation of cell adhesion|neutrophil chemotaxis|regulation of ARF protein signal transduction|protein localization to Golgi apparatus|retrograde transport, endosome to Golgi|positive regulation of GTPase activity|COPI coating of Golgi vesicle|establishment of monopolar cell polarity|protein localization to endoplasmic reticulum exit site|Golgi disassembly|endoplasmic reticulum-Golgi intermediate compartment organization|reactive oxygen species biosynthetic process|protein localization to endoplasmic reticulum tubular network|regulation of protein localization to cell surface|vesicle-mediated transport|","ARF guanyl-nucleotide exchange factor activity|protein binding|phosphatidylinositol-3,4,5-trisphosphate binding|phosphatidylinositol-3,5-bisphosphate binding|",2,3,641000000,1.0%
Q9R0M0,0.001055746,0.08675,31.24520181,4.205,0.000750723,7.291177374,,-3.067,,1.536,0.967,0.911,Q9R0M0,NotFound,Q9R0M0_NotFound,Q9R0M0,Celsr2,1,2,2,2,Q9R0M0|A2AEE7|Q9R0M0-2,MOUSE,322437.2,0.9,611,611.1,10.48,10.48,,2920,Cadherin EGF LAG seven-pass G-type receptor 2,cytoplasm|plasma membrane|integral component of membrane|,"neuron migration|cilium movement|regulation of transcription, DNA-templated|homophilic cell adhesion via plasma membrane adhesion molecules|G-protein coupled receptor signaling pathway|Wnt signaling pathway|ventricular system development|neural plate anterior/posterior regionalization|regulation of protein localization|cerebrospinal fluid secretion|cilium assembly|",G-protein coupled receptor activity|calcium ion binding|protein binding|,2,2,5280000000,0.9%
Q80VP2,0.000272387,-0.839333333,38.97820639,3.747333333,0.000126526,7.585792217,-2.234,-2.212,-3.693,1.28,1.022,0.801,Q80VP2,Spata7,Q80VP2_Spata7,Q80VP2,Spata7,1,3,2,2,Q80VP2|Q3TTL3|Q3U5D0,MOUSE,66223.9,1.5,612,612.1,10.41,10.41,,582,Spermatogenesis-associated protein 7 homolog,axoneme|microtubule cytoskeleton|photoreceptor connecting cilium|ciliary basal body|,spermatogenesis|visual perception|photoreceptor cell maintenance|response to stimulus|protein localization to photoreceptor outer segment|protein localization to photoreceptor connecting cilium|,,2,3,1750000000,1.5%
Q3V384,0.001098081,-0.1514,31.04413372,3.991,0.000786297,6.22683282,-3.276,-1.816,,2.108,1.451,0.776,Q3V384,Afg1l,Q3V384_Afg1l,Q3V384,Afg1l,1,2,2,2,Q3V384|E9Q4K2,MOUSE,54825.7,7.7,613,613.1,10.34,10.34,,480,AFG1-like ATPase,mitochondrion|,,ATP binding|,2,2,15100000,7.7%
E9Q7N9,0.000165808,-0.6066,43.39580912,4.524,4.57529E-05,10.3946885,-3.654,-2.988,,1.377,1.326,0.906,E9Q7N9,Dnah11,E9Q7N9_Dnah11,E9Q7N9,Dnah11,1,2,2,2,E9Q7N9,MOUSE,520359.5,0.5,614,614.1,10.33,10.33,,4488,"Dynein, axonemal, heavy chain 11",dynein complex|motile primary cilium|,cilium movement|regulation of cilium beat frequency|determination of left/right symmetry|metabolic process|sperm motility|,microtubule motor activity|ATP binding|ATPase activity|,2,2,23600000,0.5%
Q9QXK7,0.000303206,-1.0025,38.15522822,4.568333333,0.000152925,7.361582876,-4.217,-2.117,-3.526,1.974,0.813,1.058,Q9QXK7,Cpsf3,Q9QXK7_Cpsf3,Q9QXK7,Cpsf3,1,2,2,2,P79101|Q9QXK7|A0A1Y7VLY3,MOUSE,78131.2,3.6,615,615.1,10.3,10.3,,684,Cleavage and polyadenylation specificity factor subunit 3,mRNA cleavage and polyadenylation specificity factor complex|ribonucleoprotein complex|,"histone mRNA 3'-end processing|nucleic acid phosphodiester bond hydrolysis|RNA phosphodiester bond hydrolysis, endonucleolytic|",RNA binding|endoribonuclease activity|5'-3' exonuclease activity|metal ion binding|,2,2,49500000,3.6%
B1AZP2,0.000145021,-1.129833333,51.34895344,4.477666667,7.33001E-06,11.72179105,-3.094,-3.109,-3.903,1.358,0.951,1.018,B1AZP2,Dlgap4,B1AZP2_Dlgap4,B1AZP2,Dlgap4,1,3,2,2,B1AZP2|B1AZP2-2|B7ZNS2|B1AZP2-3|E9PUF2|I1E4X0,MOUSE,109004.9,1.9,616,616.1,10.3,10.3,,992,Disks large-associated protein 4,membrane|synapse|,signaling|,protein binding|,2,3,104000000,1.9%
A2BI80,0.000449978,0.021,35.70283294,3.691666667,0.000268978,7.59098703,-2.417,-1.971,,2.095,1.025,1.373,A2BI80,Ebf4,A2BI80_Ebf4,A2BI80,Ebf4,1,2,2,2,A2BI80,MOUSE,74942,2.8,617,617.1,10.28,10.28,,696,Transcription factor COE4,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|multicellular organismal development|",DNA binding|transcription factor binding|metal ion binding|protein dimerization activity|,2,2,720000000,2.8%
Q920R0-2,0.000205499,-0.6365,41.35540261,3.315,7.31913E-05,8.264859528,-1.965,-1.968,-2.949,1.1,0.863,1.1,Q920R0,Als2,Q920R0-2_Als2,Q920R0-2,Als2,1,2,1,1,Q920R0-2|Q8C025-2,MOUSE,101241.8,0.8,618,618.1,10.26,10.26,,1651,Isoform 2 of Alsin,ruffle|nucleus|cytoplasm|early endosome|centrosome|cytosol|postsynaptic density|membrane|lamellipodium|axon|dendrite|growth cone|vesicle|neuronal cell body|dendritic spine|protein complex|centrosome|,"behavioral fear response|in utero embryonic development|receptor recycling|response to oxidative stress|endosome organization|lysosomal transport|axonogenesis|neuromuscular junction development|locomotory behavior|protein localization|cell death|vesicle organization|endosomal transport|Rac protein signal transduction|regulation of Rho protein signal transduction|synaptic transmission, glutamatergic|regulation of GTPase activity|positive regulation of GTPase activity|positive regulation of protein kinase activity|neuron projection morphogenesis|regulation of endosome size|protein homooligomerization|positive regulation of protein serine/threonine kinase activity|",GTPase activator activity|protein binding|Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding|Rac guanyl-nucleotide exchange factor activity|identical protein binding|protein homodimerization activity|protein serine/threonine kinase activator activity|Rac GTPase binding|guanyl-nucleotide exchange factor activity|,1,2,17600000,0.8%
P21658,0.000163538,-0.9604,44.35825305,6.096,3.66585E-05,10.80343848,-5.277,-3.959,,0.953,1.786,1.695,P21658,Fgf6,P21658_Fgf6,P21658,Fgf6,1,4,1,1,P21658,MOUSE,22912,3.3,619,619.1,10.24,10.24,,208,Fibroblast growth factor 6,extracellular space|sarcolemma|,cartilage condensation|angiogenesis|positive regulation of cell proliferation|fibroblast growth factor receptor signaling pathway|myoblast differentiation|positive regulation of cell division|,fibroblast growth factor receptor binding|growth factor activity|,1,4,1640000000,3.3%
D3YYT1,0.000332899,-0.5706,37.55037585,4.284,0.000175777,8.195909515,-3.786,-2.496,,1.362,1.201,0.866,D3YYT1,Glyr1,D3YYT1_Glyr1,D3YYT1,Glyr1,1,1,1,1,D3YYT1|Q922P9,MOUSE,61061.9,1.2,620,620.1,10.18,10.18,,552,Putative oxidoreductase GLYR1,nucleoplasm|cytoplasm|Golgi apparatus|,oxidation-reduction process|,DNA binding|phosphogluconate dehydrogenase (decarboxylating) activity|methylated histone binding|NAD binding|,1,1,51500000,1.2%
Q8BKN5,0.000296298,-1.0054,38.33103325,5.022666667,0.000146858,8.463602506,-4.886,-3.152,,0.949,1.136,0.926,Q8BKN5,Tubgcp5,Q8BKN5_Tubgcp5,Q8BKN5,Tubgcp5,1,2,1,1,Q8BKN5|Q8BKN5-3|Q8BKN5-2,MOUSE,118888,0.5,621,621.1,10.18,10.18,,1024,Gamma-tubulin complex component 5,spindle pole|nucleoplasm|cytoplasm|centrosome|microtubule|gamma-tubulin ring complex|,microtubule nucleation|,microtubule binding|,1,2,482000000,0.5%
P56386,0.000906492,-0.377833333,32.02276787,3.006333333,0.000627658,5.847521497,-1.511,-1.314,-2.818,1.605,0.676,1.095,P56386,Defb1,P56386_Defb1,P56386,Defb1,1,1,1,1,P56386,MOUSE,8148.4,14.4,622,622.1,10.17,10.17,,69,Beta-defensin 1,extracellular space|extracellular exosome|,innate immune response in mucosa|acute inflammatory response|response to bacterium|antibacterial humoral response|response to testosterone|innate immune response|defense response to Gram-positive bacterium|,,1,1,84500000,14.4%
Q49B93-2,0.000152509,-0.663,45.67628871,4.699166667,2.70627E-05,11.38709222,-3.653,-3.312,,1.204,0.941,1.505,Q49B93,Slc5a12,Q49B93-2_Slc5a12,Q49B93-2,Slc5a12,1,3,2,2,Q49B93-2|Q49B93,MOUSE,69495.6,2.7,623,623.1,10.16,10.16,,619,Isoform 2 of Sodium-coupled monocarboxylate transporter 2,integral component of membrane|apical plasma membrane|extracellular exosome|,sodium ion transport|lactate transmembrane transport|,lactate transmembrane transporter activity|symporter activity|,2,3,256000000,2.7%
Q6IE21,0.056538708,-1.151,12.87858587,2.758666667,0.051539644,2.356866063,-0.044,-2.41,-5.137,0.411,0.042,0.232,Q6IE21,Otud6a,Q6IE21_Otud6a,Q6IE21,Otud6a,1,1,1,1,Q6IE21,MOUSE,33908.8,2.7,624,624.1,10.15,10.15,,290,OTU domain-containing protein 6A,,protein K29-linked deubiquitination|protein K11-linked deubiquitination|protein K27-linked deubiquitination|protein K33-linked deubiquitination|,ubiquitin-specific protease activity|,1,1,2420000,2.7%
D3YTY6,0.00018504,-0.8505,42.30909728,4.389,5.87611E-05,8.551108926,-3.807,-3.221,-2.107,1.619,0.928,1.485,D3YTY6,NotFound,D3YTY6_NotFound,D3YTY6,Gm6096,1,12,1,1,D3YTY6,MOUSE,17281.2,7.9,625,625.1,10.04,10.04,,151,Predicted gene 6096,ribosome|,translation|,structural constituent of ribosome|,1,12,3350000000,7.9%
Q80T79,0.000261034,-0.813,39.36012882,5.009166667,0.000115874,8.828035428,-4.582,-3.055,,1.449,1.213,0.91,Q80T79,Csmd3,Q80T79_Csmd3,Q80T79,Csmd3,1,2,2,2,Q80T79|Q80T79-1|Q9D6E4|E9PWJ0,MOUSE,414027.5,0.3,626,626.1,10.03,10.03,,3707,CUB and sushi domain-containing protein 3,plasma membrane|integral component of membrane|,,,2,2,174000000,0.3%
Q80T21,0.000413644,-0.524333333,36.21570577,3.326,0.000239017,6.85393412,-1.634,-1.796,-3.132,1.336,1.207,0.873,Q80T21,Adamtsl4,Q80T21_Adamtsl4,Q80T21,Adamtsl4,1,2,1,1,Q80T21,MOUSE,116646.6,1.5,627,627.1,10.01,10.01,,1036,ADAMTS-like protein 4,proteinaceous extracellular matrix|interstitial matrix|,proteolysis|apoptotic process|extracellular matrix organization|positive regulation of apoptotic process|,protease binding|metalloendopeptidase activity|,1,2,1400000,1.5%
P40645,0.000165321,-0.7925,43.72637203,3.539,4.23997E-05,8.991987729,-3.159,-2.082,-2.445,1.016,1.045,0.87,P40645,Sox6,P40645_Sox6,P40645,Sox6,1,2,2,2,A0A0U1RNW8|P40645|E9PUW0|A0A0U1RPC1|P40645-2|Q8BSS6|P35710|B2KFM9|Q2TBA9|E9PVR0|P35710-2|B2KFM4|P35710-3,MOUSE,92201,2.9,628,628.1,9.97,9.97,,827,Transcription factor SOX-6,nucleus|nucleoplasm|transcription factor complex|,"negative regulation of transcription from RNA polymerase II promoter|cell morphogenesis|in utero embryonic development|transcription, DNA-templated|regulation of transcription, DNA-templated|post-embryonic development|regulation of gene expression|gene silencing|oligodendrocyte cell fate specification|hemopoiesis|erythrocyte differentiation|positive regulation of chondrocyte differentiation|muscle cell differentiation|cell fate commitment|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|oligodendrocyte differentiation|erythrocyte development|cartilage development|cardiac muscle cell differentiation|positive regulation of cartilage development|cellular response to transforming growth factor beta stimulus|positive regulation of mesenchymal stem cell differentiation|",DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|sequence-specific DNA binding|transcription regulatory region DNA binding|protein heterodimerization activity|,2,2,11400000000,2.9%
O54962,0.000145021,-0.972,50.68633567,5.501666667,8.5382E-06,13.88364393,-4.252,-4.294,,1.446,0.962,1.278,O54962,Banf1,O54962_Banf1,O54962,Banf1,1,1,1,1,O54962,MOUSE,10330.6,8.9,629,629.1,9.86,9.86,,89,Barrier-to-autointegration factor,nucleus|nucleoplasm|chromosome|cytoplasm|extracellular exosome|,DNA integration|establishment of integrated proviral latency|,DNA binding|,1,1,118000000,8.9%
Q059U7,0.000659498,-0.5144,33.71172095,4.221833333,0.00042543,6.98125444,-3.886,-2.209,,1.532,0.874,1.117,Q059U7,Intu,Q059U7_Intu,Q059U7,Intu,1,2,2,2,Q059U7|Q059U7-2,MOUSE,105789,2.6,630,630.1,9.83,9.83,,942,Protein inturned,cytoplasm|cell surface|,nervous system development|regulation of smoothened signaling pathway|negative regulation of keratinocyte proliferation|spinal cord dorsal/ventral patterning|keratinocyte differentiation|hair follicle morphogenesis|cilium assembly|positive regulation of smoothened signaling pathway|negative regulation of cell division|limb development|cilium morphogenesis|,,2,2,209000000,2.6%
Q3UY96,0.360647342,0.6488,4.549817759,-1.152833333,0.350766593,-1.014312558,-0.639,3.32,,-0.088,0.083,0.568,Q3UY96,Cfap74,Q3UY96_Cfap74,Q3UY96,Cfap74,1,2,1,1,Q3UY96|Q3UY96-2,MOUSE,180122.9,0.6,631,631.1,9.8,9.8,,1578,Cilia- and flagella-associated protein 74,cytoskeleton|axoneme|,axoneme assembly|,,1,2,123000000,0.6%
P68433,0.622057402,-0.1455,2.11611896,0.483666667,0.614310734,0.527906595,-0.604,1.658,-2.216,-0.05,0.049,0.29,P68433,Hist1h3g,P68433_Hist1h3g,P68433,Hist1h3a,1,1,1,1,A0A1W2P768|P68433|P84228|P84244|P02301|F8WI35,MOUSE,15517.9,5.1,632,632.1,9.76,9.76,,136,Histone H3.1,nuclear nucleosome|nucleoplasm|membrane|extracellular exosome|,chromatin silencing at rDNA|DNA replication-dependent nucleosome assembly|protein heterotetramerization|regulation of gene silencing|,DNA binding|protein binding|histone binding|protein heterodimerization activity|,1,1,64700000,5.1%
P17897,0.161771039,-0.780333333,8.12153336,1.665333333,0.154115622,1.603077961,0.139,-0.846,-4.132,0.172,-0.183,0.168,P17897,Lyz1,P17897_Lyz1,P17897,Lyz1,1,4,1,1,P17897|P08905,MOUSE,17250.3,6,633,633.1,9.72,9.72,,148,Lysozyme C-1,extracellular space|extracellular exosome|,metabolic process|cytolysis|defense response to Gram-negative bacterium|defense response to Gram-positive bacterium|,lysozyme activity|identical protein binding|,1,4,90100000,6.0%
E9PYT3,0.003490184,-0.1816,25.57727728,2.484833333,0.002768677,4.87288308,-1.11,-2.235,,1.175,0.763,0.499,E9PYT3,Atl3,E9PYT3_Atl3,E9PYT3,Atl3,1,2,2,2,E9PYT3,MOUSE,60687,4.6,634,634.1,9.69,9.69,,536,Atlastin-3,endoplasmic reticulum|membrane|integral component of membrane|,endoplasmic reticulum organization|Golgi organization|metabolic process|protein homooligomerization|,GTPase activity|GTP binding|identical protein binding|,2,2,11600000,4.6%
P08249,0.254391861,-0.432,6.093506117,1.380833333,0.245838212,1.290428768,-3.124,0.603,,0.375,-0.038,0.024,P08249,Mdh2,P08249_Mdh2,P08249,Mdh2,1,2,1,1,P08249,MOUSE,36067.2,2.3,635,635.1,9.66,9.66,,338,"Malate dehydrogenase, mitochondrial",nucleus|nucleoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|plasma membrane|membrane|myelin sheath|extracellular exosome|,carbohydrate metabolic process|tricarboxylic acid cycle|oxaloacetate metabolic process|malate metabolic process|internal protein amino acid acetylation|NADH metabolic process|,malate dehydrogenase activity|L-malate dehydrogenase activity|protein self-association|poly(A) RNA binding|malate dehydrogenase (NADP+) activity|,1,2,5420000,2.3%
Q684R7,0.002225115,-1.301,27.68487947,5.778333333,0.001704167,5.483243199,-6.609,-2.927,,0.917,1.135,0.979,Q684R7,Frem1,Q684R7_Frem1,Q684R7,Frem1,1,4,1,1,Q684R7|E9Q5Z7|Q684R7-2|Q684R7-3,MOUSE,246422,0.5,636,636.1,9.65,9.65,,2191,FRAS1-related extracellular matrix protein 1,basement membrane|integral component of membrane|,cell communication|cell-matrix adhesion|craniofacial suture morphogenesis|,carbohydrate binding|metal ion binding|,1,4,9920000000,0.5%
Q61495,0.107085791,-0.104833333,9.970367453,0.983666667,0.100684648,1.889384343,-0.221,0.047,-1.616,0.609,-0.017,0.569,Q61495,Dsg1a,Q61495_Dsg1a,Q61495,Dsg1a,1,2,2,2,Q61495|Q7TSF1,MOUSE,115622,1.9,637,637.1,9.62,9.62,,1057,Desmoglein-1-alpha,plasma membrane|cytoplasmic side of plasma membrane|integral component of membrane|desmosome|extracellular exosome|cell-cell junction|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|protein binding|gamma-catenin binding|,2,2,14000000,1.9%
Q8C3Y4,0.000477465,-0.1334,35.37354376,3.189333333,0.000290165,7.487222185,-2.356,-1.738,,1.327,1.217,0.883,Q8C3Y4,Kntc1,Q8C3Y4_Kntc1,Q8C3Y4,Kntc1,1,2,2,2,Q8C3Y4,MOUSE,253263.4,2.1,638,638.1,9.62,9.62,,2207,Kinetochore-associated protein 1,condensed chromosome kinetochore|spindle pole|nucleus|cytoplasm|kinetochore microtubule|plasma membrane|actin cytoskeleton|RZZ complex|,mitotic nuclear division|mitotic cell cycle checkpoint|cell division|,,2,2,136000000,2.1%
P18531,0.000657922,-0.0902,33.73050554,3.937166667,0.000423594,6.986813224,-2.669,-2.236,,0.825,2.331,1.298,P18531,NotFound,P18531_NotFound,P18531,Ighv3-6,1,2,1,1,P18531|A0A075B5S8,MOUSE,13208.7,5.1,639,639.1,9.61,9.61,,116,Ig heavy chain V region 3-6,,,,1,2,86600000,5.1%
Q3UMU9-3,0.221374861,-0.577,6.714077504,1.322666667,0.213104318,1.373407807,0.345,-0.494,-3.566,0.257,-0.079,0.075,Q3UMU9,Hdgfl2,Q3UMU9-3_Hdgfl2,Q3UMU9-3,Hdgfl2,1,1,1,1,Q3UMU9-3|Q3UMU9|Q3UMU9-2|Q3UMU9-4,MOUSE,75472.6,1.4,640,640.1,9.6,9.6,,669,Isoform 3 of Hepatoma-derived growth factor-related protein 2,nucleus|nucleoplasm|mitochondrion|,"transcription, DNA-templated|positive regulation of cell growth|",chromatin binding|protein binding|chromatin binding|,1,1,15500000,1.4%
P56546-2,0.006065485,0.59475,23.00808559,3.242333333,0.00500255,4.764735341,,-1.837,,1.988,0.782,1.446,P56546,Ctbp2,P56546-2_Ctbp2,P56546-2,Ctbp2,1,1,1,1,P56546-2|P56546|Q91YZ2,MOUSE,107866.3,2,641,641.1,9.59,9.59,,445,Isoform 2 of C-terminal-binding protein 2,nucleus|transcriptional repressor complex|cell junction|synapse|ribbon synapse|,"transcription, DNA-templated|positive regulation of chromatin binding|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of retinoic acid receptor signaling pathway|white fat cell differentiation|oxidation-reduction process|","chromatin binding|transcription coactivator activity|transcription corepressor activity|protein binding|oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor|retinoic acid receptor binding|NAD binding|",1,1,11100000,2.0%
E9PYL1,0.000237548,-0.3006,40.16331491,3.454833333,9.63094E-05,9.12192937,-2.36,-2.387,,1.091,1.184,0.969,E9PYL1,Chd5,E9PYL1_Chd5,E9PYL1,Chd5,1,2,2,2,E9PYL1|A2A8L1|E9PYU4|E9QAS5|Q6PDQ2|E9QAS4,MOUSE,224164.2,1.2,642,642.1,9.55,9.55,,1952,Chromodomain-helicase-DNA-binding protein 5,chromatin|nucleus|membrane|,transcription from RNA polymerase II promoter|regulation of transcription involved in cell fate commitment|histone H3-K27 trimethylation|,DNA binding|chromatin binding|ATP binding|ATP-dependent helicase activity|zinc ion binding|H3K27me3 modified histone binding|,2,2,1390000000,1.2%
Q8CGF6,0.000290716,-0.3846,38.46854472,3.939833333,0.000142281,8.511529384,-3.151,-2.346,,1.075,0.941,1.558,Q8CGF6,Wdr47,Q8CGF6_Wdr47,Q8CGF6,Wdr47,1,3,2,2,Q8CGF6|A0A0G2JFW8,MOUSE,103908.1,2.1,643,643.1,9.54,9.54,,920,WD repeat-containing protein 47,cytoplasm|microtubule|,multicellular organismal development|,,2,3,219000000,2.1%
Q91UZ1,0.000238627,-1.105,40.09624374,5.389166667,9.78083E-05,9.097062113,-5.204,-3.473,,0.934,1.144,1.074,Q91UZ1,Plcb4,Q91UZ1_Plcb4,Q91UZ1,Plcb4,1,3,1,1,Q91UZ1,MOUSE,135666.4,0.9,644,644.1,9.44,9.44,,1175,Phosphoinositide phospholipase C,nucleus|smooth endoplasmic reticulum|postsynaptic density|dendrite|,lipid catabolic process|intracellular signal transduction|negative regulation of potassium ion transport|,phosphatidylinositol phospholipase C activity|signal transducer activity|calcium ion binding|protein binding|mitogen-activated protein kinase binding|,1,3,3270000000,0.9%
P70269,0.015047884,0.113,18.85880651,2.141666667,0.013005269,3.485588969,,-0.507,-1.837,1.653,0.375,0.881,P70269,Ctse,P70269_Ctse,P70269,Ctse,1,1,1,1,P70269|D3Z6T3,MOUSE,43336.2,2,645,645.1,9.43,9.43,,397,Cathepsin E,endosome|extracellular exosome|,proteolysis|protein autoprocessing|antigen processing and presentation of exogenous peptide antigen via MHC class II|protein catabolic process|,aspartic-type endopeptidase activity|protein homodimerization activity|,1,1,5960000,2.0%
Q7TRP4,0.000296673,-0.8918,38.28913407,4.9895,0.000148281,8.449045891,-4.696,-3.075,,1.461,0.933,0.918,Q7TRP4,Olfr667,Q7TRP4_Olfr667,Q7TRP4,Olfr667,1,2,1,1,Q7TRP4,MOUSE,37372.7,1.8,646,646.1,9.42,9.42,,326,Olfactory receptor,plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|sensory perception of smell|detection of chemical stimulus involved in sensory perception of smell|,G-protein coupled receptor activity|olfactory receptor activity|,1,2,438000000,1.8%
Q8BK64,0.000205913,-0.9982,41.33148898,4.898833333,7.35955E-05,9.56480723,-4.599,-3.276,,0.934,1.026,0.924,Q8BK64,Ahsa1,Q8BK64_Ahsa1,Q8BK64,Ahsa1,1,3,1,1,Q8BK64,MOUSE,38344.6,3.5,647,647.1,9.4,9.4,,338,Activator of 90 kDa heat shock protein ATPase homolog 1,cytoplasm|endoplasmic reticulum|cytosol|extracellular exosome|,protein folding|response to stress|positive regulation of ATPase activity|,ATPase activator activity|chaperone binding|,1,3,2220000000,3.5%
Q9CXJ1,0.000213663,-0.8946,40.93639962,4.865666667,8.06046E-05,9.412929895,-4.474,-3.154,,0.993,1.223,0.939,Q9CXJ1,Ears2,Q9CXJ1_Ears2,Q9CXJ1,Ears2,1,3,1,1,Q9CXJ1,MOUSE,58724.7,1.1,648,648.1,9.4,9.4,,523,"Probable glutamate--tRNA ligase, mitochondrial",mitochondrion|mitochondrial matrix|,glutamyl-tRNA aminoacylation|tRNA aminoacylation for mitochondrial protein translation|,tRNA binding|glutamate-tRNA ligase activity|ATP binding|glutamate-tRNA(Gln) ligase activity|,1,3,1320000000,1.1%
Q8BWP8,0.000207028,-0.3736,41.27396073,3.758166667,7.45768E-05,9.542557663,-2.492,-2.765,,1.307,1.149,0.933,Q8BWP8,B4gat1,Q8BWP8_B4gat1,Q8BWP8,B4gat1,1,2,2,2,Q8BWP8|Q8BWP8-2,MOUSE,47839.9,3.8,649,649.1,9.39,9.39,,415,"Beta-1,4-glucuronyltransferase 1",Golgi membrane|Golgi apparatus|integral component of membrane|extracellular exosome|,protein glycosylation|axon guidance|protein O-linked mannosylation|poly-N-acetyllactosamine biosynthetic process|,"glucuronosyltransferase activity|metal ion binding|N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity|",2,2,18200000,3.8%
D3YTR0,0.000382614,-0.4118,36.61088781,3.622833333,0.000218228,7.883396159,-3.044,-2.127,,1.254,1.033,0.825,D3YTR0,NotFound,D3YTR0_NotFound,D3YTR0,Apc2,1,2,2,2,D3YTR0|Q9Z1K7|G5E832,MOUSE,248334.3,0.8,650,650.1,9.38,9.38,,2303,Adenomatous polyposis coli protein 2,cytoplasm|Golgi apparatus|actin filament|microtubule cytoskeleton|catenin complex|lamellipodium membrane|perinuclear region of cytoplasm|cytoplasmic microtubule|,Wnt signaling pathway|negative regulation of catenin import into nucleus|negative regulation of canonical Wnt signaling pathway|,beta-catenin binding|microtubule binding|,2,2,213000000,0.8%
A0A087WQT6,0.017086926,-1.6825,18.26333596,5.277,0.014916482,3.233953037,-2.676,-1.82,-8.467,1.237,0.78,0.851,A0A087WQT6,Casp8,A0A087WQT6_Casp8,A0A087WQT6,Casp8,1,3,2,2,A0A087WQT6|O89110,MOUSE,58846.9,4.4,651,651.1,9.32,9.32,,500,Caspase-8,nucleus|nucleoplasm|cytoplasm|mitochondrion|microtubule organizing center|cytosol|Noc1p-Noc2p complex|death-inducing signaling complex|CD95 death-inducing signaling complex|ripoptosome|,angiogenesis|neural tube formation|proteolysis|apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|heart development|extrinsic apoptotic signaling pathway via death domain receptors|macrophage differentiation|response to tumor necrosis factor|TRAIL-activated apoptotic signaling pathway|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of macrophage differentiation|positive regulation of proteolysis|proteolysis involved in cellular protein catabolic process|negative regulation of necroptotic process|regulation of thymocyte apoptotic process|apoptotic signaling pathway|extrinsic apoptotic signaling pathway|execution phase of apoptosis|activation of cysteine-type endopeptidase activity|hepatocyte apoptotic process|regulation of apoptotic signaling pathway|positive regulation of extrinsic apoptotic signaling pathway|,endopeptidase activity|cysteine-type endopeptidase activity|protein binding|peptidase activity|ubiquitin protein ligase binding|death effector domain binding|protein heterodimerization activity|scaffold protein binding|cysteine-type endopeptidase activity involved in apoptotic process|cysteine-type endopeptidase activity involved in apoptotic signaling pathway|,2,3,53100000,4.4%
A0A140LJ72,0.000196267,-0.5744,41.80504268,4.0535,6.59927E-05,9.749727271,-3.321,-2.692,,1.205,0.951,0.985,A0A140LJ72,NotFound,A0A140LJ72_NotFound,A0A140LJ72,Muc16,1,2,2,2,A0A140LJ72,MOUSE,911055.7,0.2,652,652.1,9.31,9.31,,8478,Mucin 16,,,,2,2,93000000,0.2%
Q3UHK6-2,0.001640957,0.44,29.14372138,3.910666667,0.001217946,6.563791836,,-2.493,,0.959,1.709,1.585,Q3UHK6,Tenm4,Q3UHK6-2_Tenm4,Q3UHK6-2,Tenm4,1,2,2,2,Q3UHK6-2|Q3UHK6-4|Q3UHK6|Q3UHK6-3,MOUSE,318101.1,1.1,653,653.1,9.31,9.31,,2771,Isoform 2 of Teneurin-4,nucleus|cytoplasm|integral component of plasma membrane|neuron projection|,gastrulation with mouth forming second|signal transduction|positive regulation of myelination|central nervous system myelin formation|neuron development|positive regulation of oligodendrocyte differentiation|cardiac muscle cell proliferation|cardiac cell fate specification|self proteolysis|positive regulation of gastrulation|,protein homodimerization activity|,2,2,35600000,1.1%
Q8C115,0.000148189,-0.7518,46.22620557,4.6795,2.3844E-05,11.63908398,-3.389,-3.73,,1.374,0.988,0.998,Q8C115,Plekhh2,Q8C115_Plekhh2,Q8C115,Plekhh2,1,2,2,2,Q8C115|Q8C115-3,MOUSE,169955.2,1.2,654,654.1,9.29,9.29,,1491,Pleckstrin homology domain-containing family H member 2,cytoplasm|plasma membrane|lamellipodium|cortical actin cytoskeleton|,negative regulation of actin filament depolymerization|,actin binding|protein binding|identical protein binding|,2,2,3740000000,1.2%
Q6P1B9,0.00091708,0.1245,31.95674348,4.096666667,0.000637273,7.55243222,,-2.948,,1.318,1.225,0.903,Q6P1B9,Bin1,Q6P1B9_Bin1,Q6P1B9,Bin1,1,3,1,1,Q6P1B9|O08539-2,MOUSE,52934.3,3.1,655,655.1,9.28,9.28,,477,Bin1 protein,nucleus|cytoplasm|membrane|axon|lipid tube|,regulation of endocytosis|muscle cell differentiation|positive regulation of apoptotic process|regulation of neuron differentiation|positive regulation of astrocyte differentiation|lipid tube assembly|regulation of cell cycle arrest|,protein binding|identical protein binding|tau protein binding|RNA polymerase binding|,1,3,689000000,3.1%
Q80YY7,0.000145021,-0.749333333,49.66709801,3.774,1.07967E-05,11.06283159,-2.904,-2.476,-2.529,0.929,1.103,1.381,Q80YY7,NotFound,Q80YY7_NotFound,Q80YY7,Znf618,1,6,1,1,Q80YY7|F8WIU3,MOUSE,106576.1,1,656,656.1,9.26,9.26,,953,Zinc finger protein 618,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",DNA binding|metal ion binding|,1,6,3510000000,1.0%
Q8BI79,0.005616011,-0.245,23.3772225,4.414166667,0.004594918,4.465771179,-4.261,-1.526,,2.645,0.615,1.302,Q8BI79,Ccdc40,Q8BI79_Ccdc40,Q8BI79,Ccdc40,1,2,2,2,Q8BI79|Q8BI79-2|Q8BI79-3,MOUSE,137283.3,1.6,657,657.1,9.26,9.26,,1192,Coiled-coil domain-containing protein 40,cytoplasm|cilium|axoneme|,heart looping|cilium movement|epithelial cilium movement|regulation of cilium beat frequency|sperm motility|lung development|determination of pancreatic left/right asymmetry|inner dynein arm assembly|motile cilium assembly|epithelial cilium movement involved in determination of left/right asymmetry|axonemal dynein complex assembly|determination of digestive tract left/right asymmetry|determination of liver left/right asymmetry|,,2,2,37500000,1.6%
Q8BUH1,0.000316234,-0.8856,37.85613718,4.9615,0.000163827,8.299875586,-4.734,-2.991,,1.129,0.931,1.237,Q8BUH1,Txnl4b,Q8BUH1_Txnl4b,Q8BUH1,Txnl4b,1,5,1,1,Q8BUH1,MOUSE,17076.4,8,658,658.1,9.23,9.23,,149,Thioredoxin-like protein 4B,nucleus|spliceosomal complex|U5 snRNP|U4/U6 x U5 tri-snRNP complex|,"spliceosomal complex assembly|mRNA splicing, via spliceosome|mitotic nuclear division|positive regulation of cell proliferation|",,1,5,1510000000,8.0%
Q6ZPY7,0.000261034,-0.4104,39.34461706,4.737666667,0.000116289,8.822442316,-3.769,-2.737,,1.852,0.892,1.71,Q6ZPY7,NotFound,Q6ZPY7_NotFound,Q6ZPY7,Kdm3b,1,10,1,1,B9EKS2|Q6ZPY7,MOUSE,172583.6,0.8,659,659.1,9.19,9.19,,1562,Lysine-specific demethylase 3B,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|oxidation-reduction process|",metal ion binding|dioxygenase activity|,1,10,8610000000,0.8%
A2ARP1,0.057884571,0.9596,12.77048754,3.149333333,0.052838593,2.424648849,-1.452,-0.408,,1.647,0.293,4.718,A2ARP1,Ppip5k1,A2ARP1_Ppip5k1,A2ARP1,Ppip5k1,1,2,1,1,A2ARP1|A2ARP1-2|A2ARP1-3,MOUSE,161745.4,0.4,660,660.1,9.13,9.13,,1436,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1,nucleoplasm|cytoplasm|cytosol|plasma membrane|,inositol metabolic process|phosphorylation|dephosphorylation|,"inositol-1,3,4,5,6-pentakisphosphate kinase activity|inositol hexakisphosphate 5-kinase activity|acid phosphatase activity|ATP binding|diphosphoinositol-pentakisphosphate kinase activity|inositol hexakisphosphate 1-kinase activity|inositol hexakisphosphate 3-kinase activity|",1,2,283000000,0.4%
Q3TYU2,0.003303381,-0.401,25.84353148,2.818,0.002604035,4.556095903,-1.946,-0.711,-2.773,1.624,0.319,1.081,Q3TYU2,Atp13a5,Q3TYU2_Atp13a5,Q3TYU2,Atp13a5,1,2,2,2,Q3TYU2|D3YU82|Q3TYU2-2|D6RHM2,MOUSE,138469.1,3.3,661,661.1,9.12,9.12,,1216,Probable cation-transporting ATPase 13A5,integral component of membrane|,cation transport|metabolic process|,ATP binding|ATPase activity|metal ion binding|,2,2,32800000,3.3%
A2AKX3,,2.186,,,,,,,,1,2.66,2.898,A2AKX3,Setx,A2AKX3_Setx,A2AKX3,Setx,1,2,1,1,A2AKX3|A2AKX3-2,MOUSE,301805.8,0.2,662,662.1,9.12,9.12,,2646,Probable helicase senataxin,"nuclear chromosome|chromosome, telomeric region|nucleus|nucleoplasm|nucleolus|cytoplasm|axon|growth cone|","MAPK cascade|double-strand break repair|DNA recombination|termination of RNA polymerase II transcription|mRNA splice site selection|cellular response to DNA damage stimulus|spermatogenesis|circadian rhythm|fibroblast growth factor receptor signaling pathway|positive regulation of neuron projection development|positive regulation of RNA splicing|cellular response to oxidative stress|negative regulation of apoptotic process|protein kinase B signaling|cellular response to fibroblast growth factor stimulus|positive regulation of transcription from RNA polymerase II promoter|positive regulation of DNA-templated transcription, termination|cellular response to hydrogen peroxide|cellular response to retinoic acid|positive regulation of DNA-templated transcription, initiation|positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled|",transcription termination site sequence-specific DNA binding|helicase activity|protein binding|ATP binding|identical protein binding|,1,2,14800000,0.2%
P06869,0.000157801,-0.6482,44.88902572,4.334666667,3.24412E-05,11.03508866,-3.35,-3.148,,1.032,1.309,0.916,P06869,Plau,P06869_Plau,P06869,Plau,1,1,1,1,P06869,MOUSE,49693.4,2.3,663,663.1,9.09,9.09,,433,Urokinase-type plasminogen activator,extracellular space|focal adhesion|cell surface|membrane|extracellular exosome|,angiogenesis|response to hypoxia|spermatogenesis|embryo implantation|positive regulation of cell proliferation|regulation of receptor activity|response to activity|smooth muscle cell migration|regulation of smooth muscle cell migration|positive regulation of smooth muscle cell migration|plasminogen activation|regulation of cell adhesion mediated by integrin|cellular response to hepatocyte growth factor stimulus|regulation of cell proliferation|fibrinolysis|skeletal muscle tissue regeneration|response to hyperoxia|positive regulation of ovulation|neuron death|cellular response to lipopolysaccharide|cellular response to glucose stimulus|cellular response to hypoxia|cellular response to fluid shear stress|cellular response to staurosporine|regulation of smooth muscle cell-matrix adhesion|regulation of hepatocyte proliferation|positive regulation of reactive oxygen species metabolic process|,serine-type endopeptidase activity|,1,1,75500000,2.3%
Q6ZQ93,0.000165321,-0.7195,43.54285734,3.413666667,4.42297E-05,8.933829542,-2.952,-2.335,-1.992,1.172,0.89,0.9,Q6ZQ93,Usp34,Q6ZQ93_Usp34,Q6ZQ93,Usp34,1,3,1,1,Q6ZQ93|Q6ZQ93-2|Q6ZQ93-3|Q6ZQ93-4,MOUSE,413969.6,0.1,664,664.1,9.07,9.07,,3582,Ubiquitin carboxyl-terminal hydrolase 34,nucleus|cytoplasm|,Wnt signaling pathway|protein deubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of proteasomal protein catabolic process|protein K48-linked deubiquitination|positive regulation of canonical Wnt signaling pathway|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|,1,3,24700000,0.1%
B1B507,0.000311377,-0.4768,37.96531345,3.7445,0.00015976,8.337271754,-3.146,-2.301,,1.252,0.965,0.846,B1B507,Sell,B1B507_Sell,B1B507,Sell,1,1,1,1,B1B507|P18337|Q3TCF3,MOUSE,45124.3,2.8,665,665.1,9.06,9.06,,387,L-selectin,plasma membrane|external side of plasma membrane|cell surface|,cell adhesion|response to ATP|,protease binding|protein binding|carbohydrate binding|cell adhesion molecule binding|,1,1,2530000,2.8%
Q8BJI1,0.000366887,-0.4202,36.85788752,3.7755,0.000206163,7.96455893,-2.181,-3.19,,1.234,1.205,0.831,Q8BJI1,Slc6a17,Q8BJI1_Slc6a17,Q8BJI1,Slc6a17,1,1,1,1,Q8BJI1|A0A0R4J087,MOUSE,81868.7,1.7,666,666.1,9.04,9.04,,727,Sodium-dependent neutral amino acid transporter SLC6A17,integral component of plasma membrane|synaptic vesicle|cell junction|synaptic vesicle membrane|,neurotransmitter transport|brain development|neutral amino acid transport|glycine transport|leucine transport|proline transport|alanine transport|transmembrane transport|,neurotransmitter:sodium symporter activity|,1,1,1500000,1.7%
E9Q616,0.000156464,-0.8382,45.2071872,4.989666667,3.01496E-05,11.17612249,-4.275,-3.389,,1.299,1.134,1.04,E9Q616,Ahnak,E9Q616_Ahnak,E9Q616,Ahnak,1,2,2,2,E9Q616,MOUSE,605040.9,0.5,667,667.1,9.04,9.04,,5656,AHNAK nucleoprotein (desmoyokin),nucleus|cytoplasm|lysosomal membrane|cytosol|plasma membrane|cell-cell junction|focal adhesion|actin cytoskeleton|membrane|vesicle|sarcolemma|costamere|cell-cell contact zone|extracellular exosome|T-tubule|membrane raft|,regulation of RNA splicing|protein oligomerization|regulation of voltage-gated calcium channel activity|,S100 protein binding|poly(A) RNA binding|structural molecule activity conferring elasticity|,2,2,132000000,0.5%
Q5FW85,0.000260537,-1.1678,39.47266318,6.171166667,0.00011291,8.868705281,-5.953,-3.788,,1.41,1.492,1,Q5FW85,Ecm2,Q5FW85_Ecm2,Q5FW85,Ecm2,1,3,1,1,Q5FW85,MOUSE,77644.3,0.8,668,668.1,8.98,8.98,,670,Extracellular matrix protein 2,proteinaceous extracellular matrix|interstitial matrix|,positive regulation of cell-substrate adhesion|extracellular matrix organization|,collagen binding|heparin binding|collagen V binding|,1,3,3540000000,0.8%
E9QN12,0.000678549,-0.251,33.53802905,4.1875,0.000442789,6.930024321,-3.493,-2.034,,1.87,1.562,0.84,E9QN12,NotFound,E9QN12_NotFound,E9QN12,Pdgfrb,1,5,1,1,E9QN12|E9QPE2|P05622,MOUSE,124435,1.1,669,669.1,8.92,8.92,,1103,Platelet-derived growth factor receptor beta,cytoplasm|focal adhesion|cell surface|membrane|integral component of membrane|cytoplasmic membrane-bounded vesicle|intrinsic component of plasma membrane|lysosomal lumen|extracellular exosome|,in utero embryonic development|kidney development|tissue homeostasis|nitrogen compound metabolic process|signal transduction|positive regulation of cell proliferation|positive regulation of phospholipase C activity|positive regulation of smooth muscle cell migration|cell migration|peptidyl-tyrosine phosphorylation|adrenal gland development|positive regulation of cell migration|positive regulation of phosphoprotein phosphatase activity|platelet-derived growth factor receptor-beta signaling pathway|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway|positive regulation of phosphatidylinositol 3-kinase activity|phosphatidylinositol metabolic process|protein autophosphorylation|platelet-derived growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of smooth muscle cell proliferation|skeletal system morphogenesis|smooth muscle tissue development|regulation of peptidyl-tyrosine phosphorylation|cell chemotaxis|positive regulation of ERK1 and ERK2 cascade|,protein tyrosine kinase activity|signal transducer activity|platelet-derived growth factor beta-receptor activity|receptor binding|platelet-derived growth factor receptor binding|ATP binding|kinase activity|protein kinase binding|vascular endothelial growth factor binding|platelet-derived growth factor binding|,1,5,3110000000,1.1%
Q3UHU5,0.001381653,0.182,29.96419026,3.758666667,0.00100828,6.840183567,,-2.637,,1.409,0.974,0.982,Q3UHU5,Mtcl1,Q3UHU5_Mtcl1,Q3UHU5,Mtcl1,1,2,2,2,Q3UHU5|Q3UHU5-3|H3BL83|Q3UHU5-2,MOUSE,215456.2,1.3,670,670.1,8.92,8.92,,1945,Microtubule cross-linking factor 1,spindle pole|extracellular space|cytoplasm|cytoskeleton|apical plasma membrane|apicolateral plasma membrane|lateral plasma membrane|midbody|microtubule bundle|,microtubule bundle formation|regulation of autophagy|establishment or maintenance of epithelial cell apical/basal polarity|positive regulation of protein targeting to membrane|positive regulation of microtubule motor activity|,protein binding|microtubule binding|protein homodimerization activity|poly(A) RNA binding|,2,2,932000000,1.3%
P17751,0.044484317,-1.302666667,13.97370325,3.530666667,0.040052504,2.531041213,-2.657,-0.226,-6.321,0.669,0.196,0.523,P17751,Tpi1,P17751_Tpi1,P17751,Tpi1,1,1,1,1,P17751|H7BXC3,MOUSE,32704.7,5,671,671.1,8.86,8.86,,299,Triosephosphate isomerase,extracellular space|nucleus|extracellular exosome|,glucose metabolic process|gluconeogenesis|glycolytic process|pentose-phosphate shunt|multicellular organismal development|glyceraldehyde-3-phosphate metabolic process|,triose-phosphate isomerase activity|isomerase activity|ubiquitin protein ligase binding|,1,1,2820000,5.0%
Q3U5H1,0.000863249,0.062,32.29799041,4.285333333,0.000589116,7.680559285,,-3.152,,1.032,1.452,0.916,Q3U5H1,Tas1r1,Q3U5H1_Tas1r1,Q3U5H1,Tas1r1,1,1,1,1,Q3U5H1,MOUSE,95296.1,3.3,673,673.1,8.8,8.8,,842,Taste receptor type 1 member 1,plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|detection of chemical stimulus involved in sensory perception of taste|sensory perception of umami taste|,taste receptor activity|,1,1,5230000,3.3%
F8WGL3,0.010104171,-0.661166667,20.67067735,2.681,0.008569042,3.65004265,-2.733,-0.314,-2.958,0.945,0.258,0.835,F8WGL3,NotFound,F8WGL3_NotFound,F8WGL3,Cfl1,1,1,1,1,F8WGL3|P18760,MOUSE,25089.5,5.2,674,674.1,8.79,8.79,,227,Cofilin-1,extracellular space|cytoplasm|cell-cell junction|focal adhesion|membrane|cortical actin cytoskeleton|vesicle|extracellular exosome|,mitotic cytokinesis|neural crest cell migration|neural fold formation|protein phosphorylation|cytoskeleton organization|actin filament organization|response to virus|regulation of cell morphogenesis|establishment of cell polarity|cell projection organization|actin filament depolymerization|positive regulation of actin filament depolymerization|response to amino acid|negative regulation of cell size|regulation of dendritic spine morphogenesis|,actin binding|,1,1,38500000,5.2%
P19157,0.000220514,-0.3852,40.65735607,3.6455,8.59537E-05,9.306958616,-2.692,-2.453,,1.166,0.862,1.191,P19157,Gstp1,P19157_Gstp1,P19157,Gstp1,1,1,1,1,P19157|P46425,MOUSE,23779.9,3.3,675,675.1,8.79,8.79,,210,Glutathione S-transferase P 1,extracellular space|intracellular|nucleus|cytoplasm|mitochondrion|cytosol|plasma membrane|vesicle|protein complex|extracellular exosome|TRAF2-GSTP1 complex|,response to reactive oxygen species|negative regulation of acute inflammatory response|glutathione metabolic process|xenobiotic metabolic process|response to toxic substance|negative regulation of biosynthetic process|oligodendrocyte development|organ regeneration|response to nutrient levels|response to estradiol|negative regulation of interleukin-1 beta production|negative regulation of tumor necrosis factor production|cellular response to insulin stimulus|regulation of stress-activated MAPK cascade|negative regulation of stress-activated MAPK cascade|positive regulation of superoxide anion generation|response to L-ascorbic acid|common myeloid progenitor cell proliferation|negative regulation of apoptotic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|response to amino acid|negative regulation of MAP kinase activity|negative regulation of JUN kinase activity|response to ethanol|negative regulation of fibroblast proliferation|negative regulation of nitric-oxide synthase biosynthetic process|regulation of ERK1 and ERK2 cascade|negative regulation of ERK1 and ERK2 cascade|negative regulation of leukocyte proliferation|cellular response to lipopolysaccharide|cellular response to epidermal growth factor stimulus|cellular response to glucocorticoid stimulus|cellular response to cell-matrix adhesion|negative regulation of monocyte chemotactic protein-1 production|negative regulation of neutrophil aggregation|negative regulation of peroxidase activity|negative regulation of extrinsic apoptotic signaling pathway|,glutathione transferase activity|protein binding|drug binding|JUN kinase binding|kinase regulator activity|S-nitrosoglutathione binding|dinitrosyl-iron complex binding|,1,1,3540000,3.3%
A0A1D5RLM8,0.000293415,-0.6542,38.40635803,4.812166667,0.000144333,8.489826426,-4.286,-2.797,,1.595,0.966,1.251,A0A1D5RLM8,NotFound,A0A1D5RLM8_NotFound,A0A1D5RLM8,Gm11639,1,2,2,2,A0A1D5RLM8|P09041,MOUSE,655392.6,0.2,676,676.1,8.77,8.77,,5808,Predicted gene 11639,,,,2,2,90500000,0.2%
Q3UES3,0.000205499,-0.6128,41.35973384,3.872,7.31184E-05,9.575748117,-3.21,-2.662,,1.046,0.887,0.875,Q3UES3,Tnks2,Q3UES3_Tnks2,Q3UES3,Tnks2,1,3,1,1,Q3UES3,MOUSE,128395.8,0.7,678,678.1,8.77,8.77,,1166,Tankyrase-2,"Golgi membrane|pericentriolar material|chromosome, telomeric region|nucleus|nuclear envelope|cytoplasm|perinuclear region of cytoplasm|","protein polyubiquitination|telomere maintenance|protein ADP-ribosylation|Wnt signaling pathway|multicellular organism growth|regulation of multicellular organism growth|protein localization to chromosome, telomeric region|protein auto-ADP-ribosylation|positive regulation of canonical Wnt signaling pathway|telomere maintenance|",NAD+ ADP-ribosyltransferase activity|enzyme binding|metal ion binding|,1,3,406000000,0.7%
P34884,0.017700155,-1.171333333,18.10401357,4.119333333,0.015473859,3.207052211,-3.077,-0.526,-6.09,1.251,0.385,1.029,P34884,Mif,P34884_Mif,P34884,Mif,1,1,1,1,P34884,MOUSE,12675.2,7.8,679,679.1,8.74,8.74,,115,Macrophage migration inhibitory factor,extracellular region|extracellular space|nucleoplasm|cytoplasm|cell surface|vesicle|myelin sheath|extracellular exosome|,"prostaglandin biosynthetic process|positive regulation of protein phosphorylation|positive regulation of adaptive immune response|negative regulation of mature B cell apoptotic process|inflammatory response|cell surface receptor signaling pathway|cell aging|cell proliferation|negative regulation of gene expression|positive regulation of protein kinase A signaling|carboxylic acid metabolic process|DNA damage response, signal transduction by p53 class mediator|positive regulation of B cell proliferation|positive regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of cellular protein metabolic process|negative regulation of myeloid cell apoptotic process|positive regulation of peptidyl-serine phosphorylation|regulation of cell proliferation|positive regulation of phosphorylation|negative regulation of apoptotic process|positive regulation of MAP kinase activity|negative regulation of DNA damage response, signal transduction by p53 class mediator|innate immune response|positive regulation of fibroblast proliferation|positive regulation of cytokine secretion|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|positive regulation of prostaglandin secretion involved in immune response|positive regulation of myeloid leukocyte cytokine production involved in immune response|protein homotrimerization|positive regulation of ERK1 and ERK2 cascade|negative regulation of cell cycle arrest|positive regulation of arachidonic acid secretion|negative regulation of cell aging|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|positive regulation of chemokine (C-X-C motif) ligand 2 production|",dopachrome isomerase activity|receptor binding|cytokine activity|cytokine receptor binding|chemoattractant activity|phenylpyruvate tautomerase activity|,1,1,5910000,7.8%
Q9ERS4,0.000426279,-0.773333333,35.99243447,4.22,0.000251627,6.797294907,-4.118,-2.549,-1.983,1.874,0.782,1.354,Q9ERS4,Plekha3,Q9ERS4_Plekha3,Q9ERS4,Plekha3,1,2,1,1,Q9ERS4,MOUSE,33992.9,7,680,680.1,8.73,8.73,,297,Pleckstrin homology domain-containing family A member 3,Golgi apparatus|membrane|,,phospholipid binding|1-phosphatidylinositol binding|,1,2,427000000,7.0%
Q9QVP9,0.000321082,-0.2725,37.74850344,5.259333333,0.000167938,10.00473836,-4.217,,,0.989,0.961,1.177,Q9QVP9,Ptk2b,Q9QVP9_Ptk2b,Q9QVP9,Ptk2b,1,1,1,1,Q9QVP9|Q3UDE9|E9Q2A6,MOUSE,117104.6,1.9,681,681.1,8.71,8.71,,1009,Protein-tyrosine kinase 2-beta,nucleus|nucleoplasm|cytoplasm|cytosol|cytoskeleton|focal adhesion|cell cortex|postsynaptic density|N-methyl-D-aspartate selective glutamate receptor complex|lamellipodium|axon|dendrite|growth cone|extrinsic component of cytoplasmic side of plasma membrane|neuronal cell body|cell body|membrane raft|perinuclear region of cytoplasm|apical dendrite|,"MAPK cascade|oocyte maturation|response to hypoxia|positive regulation of cell-matrix adhesion|sprouting angiogenesis|marginal zone B cell differentiation|protein phosphorylation|cellular defense response|response to osmotic stress|cytoskeleton organization|cell adhesion|cell surface receptor signaling pathway|signal complex assembly|epidermal growth factor receptor signaling pathway|positive regulation of cytosolic calcium ion concentration|integrin-mediated signaling pathway|positive regulation of cell proliferation|negative regulation of cell proliferation|regulation of cell shape|response to mechanical stimulus|response to hormone|response to glucose|response to lithium ion|positive regulation of endothelial cell migration|negative regulation of muscle cell apoptotic process|regulation of cGMP-mediated signaling|regulation of macrophage chemotaxis|positive regulation of neuron projection development|glial cell proliferation|cell migration|peptidyl-tyrosine phosphorylation|regulation of cell adhesion|positive regulation of cell growth|positive regulation of cell migration|negative regulation of bone mineralization|regulation of cGMP biosynthetic process|positive regulation of actin filament polymerization|neuron projection development|regulation of inositol trisphosphate biosynthetic process|tumor necrosis factor-mediated signaling pathway|ionotropic glutamate receptor signaling pathway|response to immobilization stress|peptidyl-tyrosine autophosphorylation|response to cocaine|response to drug|response to hydrogen peroxide|activation of Janus kinase activity|negative regulation of apoptotic process|stress fiber assembly|negative regulation of potassium ion transport|positive regulation of JUN kinase activity|negative regulation of neuron apoptotic process|blood vessel endothelial cell migration|positive regulation of phosphatidylinositol 3-kinase activity|innate immune response|regulation of nitric oxide biosynthetic process|bone resorption|response to ethanol|negative regulation of myeloid cell differentiation|positive regulation of translation|positive regulation of angiogenesis|positive regulation of protein kinase activity|positive regulation of JNK cascade|vascular endothelial growth factor receptor signaling pathway|focal adhesion assembly|positive regulation of peptidyl-tyrosine phosphorylation|regulation of calcium-mediated signaling|positive regulation of nitric-oxide synthase activity|regulation of release of sequestered calcium ion into cytosol|response to cAMP|response to calcium ion|positive regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|chemokine-mediated signaling pathway|positive regulation of ERK1 and ERK2 cascade|cellular response to retinoic acid|cellular response to fluid shear stress|activation of GTPase activity|regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|regulation of establishment of cell polarity|regulation of actin cytoskeleton reorganization|regulation of N-methyl-D-aspartate selective glutamate receptor activity|positive regulation of reactive oxygen species metabolic process|positive regulation of excitatory postsynaptic membrane potential|positive regulation of B cell chemotaxis|",protein kinase activity|calmodulin-dependent protein kinase activity|non-membrane spanning protein tyrosine kinase activity|receptor binding|protein binding|ATP binding|protein complex binding|3-phosphoinositide-dependent protein kinase binding|N-methyl-D-aspartate selective glutamate receptor activity|,1,1,84600000,1.9%
E9PYJ0,0.000345866,-0.2654,37.29320018,3.360166667,0.0001865,8.109330096,-2.59,-1.973,,1,1,1.236,E9PYJ0,Tcp10b,E9PYJ0_Tcp10b,E9PYJ0,Tcp10b,1,3,1,1,E9PYJ0|Q80W76|E9Q2X0,MOUSE,49759.8,1.3,682,682.1,8.69,8.69,,438,T-complex protein 10b,,,,1,3,3020000000,1.3%
Q8BJH1,0.001318729,0.0848,30.19636949,3.611333333,0.000955791,6.000876238,-2.302,-1.862,,2.483,0.787,1.318,Q8BJH1,Zc2hc1a,Q8BJH1_Zc2hc1a,Q8BJH1,Zc2hc1a,1,1,1,1,Q8BJH1|Q8BJH1-2,MOUSE,35779.1,3.7,683,683.1,8.69,8.69,,324,Zinc finger C2HC domain-containing protein 1A,,,metal ion binding|,1,1,13300000,3.7%
A0A1B0GT72,0.000417869,-0.7024,36.1342999,4.676,0.00024354,7.728767711,-4.342,-2.674,,1.07,1.552,0.882,A0A1B0GT72,NotFound,A0A1B0GT72_NotFound,A0A1B0GT72,Gm29133,1,1,1,1,A0A1B0GT72,MOUSE,31614.6,4.1,684,684.1,8.68,8.68,,266,Predicted gene 29133,,,,1,1,14400000,4.1%
Q91Y21,0.000357489,-0.296,37.03092246,3.816666667,0.000198111,8.021838991,-2.93,-2.242,,1.694,0.821,1.177,Q91Y21,Pcdha1,Q91Y21_Pcdha1,Q91Y21,Pcdha1,1,2,2,2,Q91Y21|Q641K6,MOUSE,103087.5,3.2,685,685.1,8.68,8.68,,948,Protocadherin alpha 1,endoplasmic reticulum|plasma membrane|membrane|integral component of membrane|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|,2,2,1190000000,3.2%
Q8BK35,0.010184388,0.7695,20.62996252,3.432666667,0.008649754,4.174515673,,-1.805,,2.525,1.581,0.777,Q8BK35,Nop53,Q8BK35_Nop53,Q8BK35,Nop53,1,1,1,1,Q8BK35,MOUSE,55849,2,686,686.1,8.64,8.64,,484,Ribosome biogenesis protein NOP53,intracellular membrane-bounded organelle|,,poly(A) RNA binding|,1,1,83000000,2.0%
Q8BX70,0.003569923,0.0836,25.45876715,2.447666667,0.002845269,4.846035595,-1.444,-1.326,,0.679,1.803,0.706,Q8BX70,Vps13c,Q8BX70_Vps13c,Q8BX70,Vps13c,1,2,2,2,Q8BX70|Q8BX70-3|Q8BX70-2,MOUSE,422420.4,0.5,687,687.1,8.64,8.64,,3748,Vacuolar protein sorting-associated protein 13C,intracellular|cell|extrinsic component of membrane|extracellular exosome|,protein targeting to vacuole|protein retention in Golgi apparatus|,,2,2,122000000,0.5%
Q9QYK4,0.000796267,-0.4806,32.74491958,4.399833333,0.000531506,6.699923944,-3.976,-2.265,,1.916,1.081,0.841,Q9QYK4,Hs6st3,Q9QYK4_Hs6st3,Q9QYK4,Hs6st3,1,2,1,1,Q9QYK4,MOUSE,55777.7,4.2,688,688.1,8.64,8.64,,470,Heparan-sulfate 6-O-sulfotransferase 3,integral component of membrane|,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification|",heparan sulfate 6-O-sulfotransferase activity|,1,2,233000000,4.2%
Q8C351,0.006065485,-0.218333333,23.00336471,1.594666667,0.005007991,4.024888548,-0.612,-0.82,-1.615,0.805,0.504,0.428,Q8C351,Layn,Q8C351_Layn,Q8C351,Layn,1,1,1,1,Q8C351|A4QPF5|Q8C351-2,MOUSE,43952.5,2.6,690,690.1,8.62,8.62,,381,Layilin,ruffle|cell surface|integral component of membrane|focal adhesion|,,hyaluronic acid binding|carbohydrate binding|,1,1,5510000,2.6%
Q8BSV3,0.000299378,-0.5368,38.23190614,3.832,0.000150248,8.429198747,-3.305,-2.367,,1.156,0.944,0.888,Q8BSV3,Bend7,Q8BSV3_Bend7,Q8BSV3,Bend7,1,3,1,1,Q8BSV3|Q8BSV3-3,MOUSE,48849.2,3.6,691,691.1,8.61,8.61,,434,BEN domain-containing protein 7,extracellular exosome|,,,1,3,14300000,3.6%
P04919,0.630568885,-0.269166667,2.051625058,0.752333333,0.623501488,0.513989177,-2.522,-2.237,2.823,0.925,-1.268,0.664,P04919,Slc4a1,P04919_Slc4a1,P04919,Slc4a1,1,1,1,1,P04919|P04919-2,MOUSE,103475.9,1.3,692,692.1,8.59,8.59,,929,Band 3 anion transport protein,integral component of plasma membrane|membrane|basolateral plasma membrane|Z disc|cortical cytoskeleton|extracellular exosome|blood microparticle|,anion transport|chloride transport|bicarbonate transport|regulation of intracellular pH|anion transmembrane transport|chloride transmembrane transport|,actin binding|inorganic anion exchanger activity|protein binding|protein C-terminus binding|bicarbonate transmembrane transporter activity|chloride transmembrane transporter activity|anion:anion antiporter activity|ankyrin binding|protein homodimerization activity|,1,1,2680000,1.3%
O70372,0.000263575,-1.517166667,39.22709976,5.866333333,0.000119479,7.838308657,-3.726,-3.459,-6.166,1.596,1.701,0.951,O70372,Tert,O70372_Tert,O70372,Tert,1,7,1,1,O70372,MOUSE,129972.7,0.8,693,693.1,8.56,8.56,,1122,Telomerase reverse transcriptase,"telomerase catalytic core complex|chromosome, telomeric region|nucleoplasm|telomerase holoenzyme complex|nucleolus|mitochondrion|RNA-directed RNA polymerase complex|mitochondrial nucleoid|TERT-RMRP complex|PML body|","transcription, RNA-templated|RNA-dependent DNA replication|telomere maintenance via telomerase|mitochondrion organization|negative regulation of gene expression|DNA strand elongation|positive regulation of Wnt signaling pathway|production of siRNA involved in RNA interference|RNA biosynthetic process|positive regulation of hair cycle|positive regulation of nitric-oxide synthase activity|cellular response to hypoxia|DNA biosynthetic process|replicative senescence|positive regulation of pri-miRNA transcription from RNA polymerase II promoter|negative regulation of production of siRNA involved in RNA interference|positive regulation of stem cell proliferation|negative regulation of cellular senescence|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|",tRNA binding|transcription coactivator binding|DNA binding|telomerase activity|telomeric template RNA reverse transcriptase activity|RNA binding|RNA-directed DNA polymerase activity|protein binding|nucleotidyltransferase activity|telomeric DNA binding|protein homodimerization activity|metal ion binding|telomeric RNA binding|telomeric template RNA reverse transcriptase activity|RNA-directed RNA polymerase activity|,1,7,7090000000,0.8%
Q8C650,0.000153199,-0.727,45.49714706,4.409166667,2.82023E-05,11.30609726,-3.548,-3.197,,1.138,1.053,0.919,Q8C650,Sept10,Q8C650_Sept10,Q8C650,Sept10,1,1,1,1,A0A1W2P6J7|Q8C650|A0A0R4J233|Q8C650-2,MOUSE,53220,1.5,694,694.1,8.55,8.55,,452,Septin-10,cytoplasm|cytoskeleton|,cell cycle|cell division|,GTP binding|,1,1,4840000,1.5%
Q99K28-2,0.000153199,-0.9396,45.40685463,5.334,2.87948E-05,11.26547513,-4.645,-3.635,,1.31,1.331,0.941,Q99K28,Arfgap2,Q99K28-2_Arfgap2,Q99K28-2,Arfgap2,1,1,1,1,Q99K28-2|Q99K28,MOUSE,58508.5,1.4,695,695.1,8.55,8.55,,520,Isoform 2 of ADP-ribosylation factor GTPase-activating protein 2,Golgi membrane|nucleolus|cytoplasm|Golgi apparatus|plasma membrane|,protein transport|vesicle-mediated transport|positive regulation of GTPase activity|,GTPase activator activity|metal ion binding|,1,1,53000000,1.4%
A9Z1V5,0.001056329,-0.356166667,31.23520509,2.306333333,0.000752453,5.671134673,-1.059,-1.311,-2.158,0.604,0.824,0.963,A9Z1V5,Vwa5b1,A9Z1V5_Vwa5b1,A9Z1V5,Vwa5b1,1,5,1,1,A9Z1V5,MOUSE,135567.6,1,696,696.1,8.54,8.54,,1215,von Willebrand factor A domain-containing protein 5B1,extracellular region|,,,1,5,6420000000,1.0%
A2APZ7,0.000895565,0.204,32.09108505,4.353333333,0.000617862,7.602650836,,-3.061,,1.516,1.451,0.91,A2APZ7,Prrx2,A2APZ7_Prrx2,A2APZ7,Prrx2,1,2,1,1,A2APZ7|Q06348|Q9CY80,MOUSE,26556.2,6.4,697,697.1,8.5,8.5,,247,Paired mesoderm homeobox protein 2,nucleus|,"positive regulation of mesenchymal cell proliferation|regulation of transcription, DNA-templated|embryonic limb morphogenesis|inner ear morphogenesis|middle ear morphogenesis|positive regulation of smoothened signaling pathway|embryonic cranial skeleton morphogenesis|embryonic skeletal system morphogenesis|artery morphogenesis|cartilage development|",sequence-specific DNA binding|,1,2,52000000,6.4%